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“ Evidence that eukaryotic gene expression must be highly regulated is 
available to anyone visiting a butcher’s shop - various parts of the mammalian 
body on display differ dramatically in appearance, from the muscular legs … to 
the soft tissues of the kidneys. All these diverse tissues arose from a single cell, 
the fertilised egg, raising the question of how this diversity is achieved  ” 
David S Latchman  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Abstract 
Post-translational modifications (PTMs) to histones have long been associated 
with the regulation of gene transcription, a crucial mechanism for cell 
differentiation. Significant progress has been made towards our understanding 
of how these modifications affect transcription, through genome-wide 
mapping (ChIP-seq) and advances in proteomics methodologies but there 
remains limited evidence pertaining to certain modifications (e.g. H3K4me1) 
and the combinatorial effects of two or more modifications within the same 
histone. Here, ChIP was used to determine the spatio-temporal distributions of 
H3K4 methylations and H3K27ac across the developmentally regulated ß-
globin locus in primitive (5DCE) and definitive chicken erythrocytes (15DCE). 
Surprisingly high enrichments of H3K27ac were found together with H3K4me1 
at the inactive ßH and ßA genes in 5DCE. Since these genes will never be 
expressed in 5DCE, these PTMs may be related to their specific repression. 
However, in 15DCE the inactive genes carried lower H3K27ac than the active 
genes, so this modification is not simply linked to inactivity. In 5DCE, the 
enhancer was enriched in both H3K4me3 and K27ac but in 15DCE, increased 
enrichment of H3K4me3 and loss of K27ac was observed. These observations 
are consistent with the suggestion that H3K4me1 is a pioneering mark for 
establishment of the enhancer and an increase in modification status (to me3) 
is required for enhancer activity. H3K4me1 may also represent an additional 
mechanism to ensure gene repression. As observed in previous studies, 
H3K4me3 marked the active genes in both 5 and 15DCE. To identify effector 
proteins that bind H3K4me1 and/or K27ac to regulate transcription, histones 
carrying defined modifications were produced by reductive alkylation and 
genetic encoding and assembled into mono-nucleosomes for use in stable 
isotope labelling by amino acids in cell culture (SILAC) based nucleosome 
affinity pull downs (SNAP) coupled with tryptic MS analysis. These data show 
that the facilitates active chromatin transcription (FACT) complex binding was 
reduced by H3K4me1-containing nucleosomes, implicating H3K4 as a key 
residue for modulating FACT interaction with chromatin revealing at least one 
mechanism for transcriptional repression at inactive genes in this system.  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1 Introduction 
The regulation of gene expression is important for the correct spatial and 
temporal differentiation of cells, maintenance of differentiated states and 
response to environmental cues. In eukaryotic cells, small basic proteins called 
histones are associated with DNA, permitting the compaction of up to 2 m (in 
human diploid cells) of DNA into nuclei that have an approximate diameter of 
only 6 µm. However, the DNA sequence is identical in almost all the cells of a 
eukaryotic organism. Whilst exceptions to this general rule include the loss of 
nuclei from most mammalian erythrocytes and V(D)J recombination in 
lymphocytes for the production of antibodies, these do not amount to strict 
mechanisms of gene control. A number of more global mechanisms exist to 
regulate gene expression, including signalling systems, transcription factors, 
enhancers, promoters and interfering RNAs. In particular, a significant amount 
of research is focussed towards understanding epigenetic (from the Ancient 
Greek επί, meaning ‘upon’ or ‘around’ genetics) mechanisms, effected by 
modifications to the DNA and histones, and how they function in the 
regulation of transcription to produce the varied tissues with distinct 
phenotypes necessary for a fully functioning organism. 
1.1 Chromatin structure 
Histones are highly evolutionarily conserved, indicative of their importance in 
eukaryotic nuclei (figure 1.1, panel A). They are rich in the amino acids lysine 
and arginine, making them highly basic, therefore permitting their strong 
affinity for DNA. The association of histones with DNA was initially thought only 
to package DNA and observations by electron microscopy (EM) indicated its 
simplest structure - a fibre with diameter of ~10 nm and the appearance of 
“beads on a string” (Olins & Olins, 1974). Biochemical and structural studies 
involving treatment of chromatin with nucleases showed that the spheroid 
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particles (“beads”), termed nucleosomes, were repeated along the entire 
length of DNA, and had an average DNA to total histone ratio of 1.0 (Kornberg 
& Thomas, 1974; Kornberg, 1974; Finch et al., 1975; Oudet et al., 1975). The 
nucleosome was defined as the fundamental subunit of chromatin and further 
studies have since employed x-ray crystallography to determine its key 
features at high resolution (Richmond et al., 1984; Luger et al., 1997a; Suto et 
al., 2000; Davey et al., 2002). All of the histones contain a histone fold motif 
comprised of three α-helices, which allow the formation of H2A-H2B dimers 
and (H3)2(H4)2 tetramers (panel B), as well as contacting the DNA (Luger et al., 
1997a). 
!!
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1.1 • Evolutionary conservation and structure of histones 
(A) The core histones are highly evolutionarily conserved. Human, Xenopus laevis, and Gallus 
gallus sequences for H2A, H2B, H3 and H4 (GenBank IDs: AAN59974.1, AAA49762.1 and 
AAC60009.1; CAA41051, AAA49763 and AAC60000; AAN39284, AAA49765 and AAA48795; 
and NP_778224, NP_001087926 and NP_001032932, respectively) were aligned to generate 
sequence logos (Schneider & Stephens, 1990) using GENIO/logo software, available online at 
(http://www.biogenio.com/logo/logo.cgi). Three alpha helices (α1, α2 and α3) constitute the 
histone fold. The L1 loop (L1) and docking domain of H2A are highly varied between H2A 
variants. (B) The histone fold domain enables H2A-H2B dimer and H3-H4 tetramer formation.  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 2
1.1.1 Chromatin subunits - nucleosome core particles and chromatosomes 
Each nucleosome core particle consists of approximately ~147 base pairs of 
DNA wrapped in 1.65 left-handed superhelical turns around a histone octamer 
(Luger et al., 1997a). The octamer comprises two molecules of each of the core 
histones H2A, H2B, H3 (or variants thereof) and H4 (figure 1.2, panel A). 
As well as the requirement of the nucleosome for DNA compaction, it is now 
clear that the histone proteins also have roles in the regulation of gene 
expression, DNA damage response and other nuclear processes (reviews in 
Bannister & Kouzarides, 2011; Turner, 2012). The amino-terminal histone tails 
extend beyond the core of the nucleosome and represent approximately 28 % 
of each histone. Significant portions of these tails (29-100 %) are absent in the 
crystal structures (Luger & Richmond, 1998; Widom, 1997). Histone tails are 
the sites of numerous post-translational modifications (section 1.2.2) that 
mediate interactions with regulatory proteins (section 1.2.5) (review in 
Bannister & Kouzarides, 2011) and have also been shown by the crystal 
structure, computer modelling and small-angle x-ray scattering (SAXS) to 
interact with adjacent nucleosomes in the chromatin fibre (Luger et al., 1997a; 
Arya & Schlick, 2006; Kulaeva et al., 2012; Howell et al., 2013). 
A nucleosome core particle with approximately 20 bp of additional DNA and 
one molecule of bound linker histone H1 (or H5 in avian erythrocytes) 
constitutes the chromatosome (Simpson, 1978). Positioning of linker histones 
with respect to the nucleosome core particle has been the subject of intense 
study towards further understanding of their roles in chromatin structure and 
function (Harshman et al., 2013; Thomas & Stott, 2012). Existing evidence from 
foot-printing, crystallographic, EM and sedimentation data suggests that H1 is 
positioned close to the dyad axis of the nucleosome, at the entry/exit point of 
DNA (Meyer et al., 2011) and that it has a preference for methylated DNA 
(McArthur & Thomas, 1996), in keeping with its role in the higher-order folding 
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of chromatin (Bednar et al., 1995; Sato et al., 1999). However, its localisation 
and precise role in chromatin higher order structure remains to be fully 
characterised. 
!!!!!!
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1.2 • Structure of chromatin and its repeating unit, the nucleosome 
(A) The crystal structure of the nucleosome (Davey et al., 2002) illustrates how 146 bp of DNA 
(dark grey helices) is wrapped in 1.65 turns around an octamer that contains two of each histone 
- H2A, H2B, H3 and H4 (red, yellow, green and blue ribbons, respectively). The composition of 
the octamer (two H2A-H2B dimers and one H3-H4 tetramer) causes the nucleosome to exhibit an 
approximate two-fold symmetry about the dyad axis (❙ or ●). (B) DNA (∿) wraps around histone 
octamers (●) to form nucleosomes. The amino-terminal tails of the histones (∿) protrude beyond 
the core of the nucleosome and can carry specific post-translational modifications (●, ●, ●, ●, ●). 
The DNA can also be methylated (●). Further compaction might occur by folding of chromatin 
into a 30 nm fibre and looping to produce fully condensed mitotic chromosomes. 
(A) graphics constructed in UCSF Chimera (Pettersen et al., 2004) using co-ordinates deposited in the PDB with accession code 1kx5.  
A B
90˚
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1.1.2 Higher order structure of chromatin 
Further compaction of chromatin from the 10 nm fibre is generally considered 
to occur by folding into a 30 nm fibre, looping and finally full condensation to 
produce the mitotic chromosomes (Horn & Peterson, 2002; Felsenfeld & 
Groudine, 2003; Hübner et al., 2013) (figure 1.2, panel B). Since the inception 
of one-start solenoidal, two-start supercoiled and two-start twisted models for 
the 30 nm fibre (Finch & Klug, 1976; Woodcock et al., 1984; Williams et al., 
1986), this particular structure of chromatin has been the subject of 
considerable debate (van Holde & Zlatanova, 1995; Staynov, 2008; Grigoryev 
& Woodcock, 2012). Current evidence remains controversial, with data from 
EM and x-ray crystallography analyses of recombinant fibres conforming to 
both the one-start and two-start helical models (Dorigo et al., 2004; Robinson 
et al., 2006; Schalch et al., 2005; Song et al., 2014) (figure 1.3), whilst EM and 
SAXS measurements of DNA in situ, including human mitotic chromosomes 
and DNA in the nuclei of interphase HeLa or mouse embryonic fibroblast cells 
have been unable to detect a 30 nm fibre in vivo (Eltsov et al., 2008; Fussner et 
al., 2012; Joti et al., 2012; Nishino et al., 2012). Furthermore, the differing 
nucleosome compositions that are observed in vivo, including the presence of 
epigenetic modifications and variable repeat lengths, has been suggested to 
permit highly variable chromatin structures (Song et al., 2014). 
!
1.2 Epigenetics and gene regulation 
Cell fate depends on the expression of specific genes, driven by networks of 
transcription factors and regulatory proteins, so mechanisms which regulate 
how these genes are made accessible to the transcriptional machinery are key 
to our understanding of gene regulation. A number of gene regulatory 
mechanisms have been identified, including the blocking of transcription or 
translation by micro (mi) and short interfering (si) RNAs (Carthew & 
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Sontheimer, 2009). However, epigenetics lends an arguably more elaborate 
method for regulating gene expression. A complex system of modifications to 
the DNA and histones can define which genes are expressed and repressed by 
recruiting remodelling proteins to alter the structure of chromatin. Generally, 
higher order folding of chromatin is considered to be responsible for gene 
silencing (through formation of relatively inaccessible heterochromatin), whilst 
unfolding correlates with activation (euchromatin formation). These structural 
changes to chromatin are induced by DNA and histone modifications and 
include displacement (sliding or loss) of nucleosomes (section 1.2.5), loss of 
the linker histone H1 and exchange or replacement of histones or octamers by 
variant species (section 1.2.4). 
1.2.1 DNA methylation 
Briefly, the major modifications to DNA in eukaryotes are methylation of 
cytosine (5mC) (reviews in Deaton & Bird, 2011; Chatterjee & Vinson, 2012), 
which, in mammals, can be oxidised by Tet proteins to form a second 
modification, hydroxy-methyl cytosine (5hmC) (Kriaucionis & Heintz, 2009; 
Tahiliani et al., 2009). 5mC typically occurs on CG di-nucleotides in CpG 
islands, where it associates with repressive histone modifications (such as 
H3K9me3) to maintain heterochromatin for transcriptional silencing, 
imprinting and X-chromosome inactivation (reviews in Deaton & Bird, 2011; 
Chatterjee & Vinson, 2012). Furthermore, 5mC can persist throughout the cell 
cycle to maintain phenotypes, since DNA methyltransferases (DNMTs) 
recognise hemi-methylated DNA and re-instate methylation on the unmodified 
strands (reviews in Deaton & Bird, 2011; Chatterjee & Vinson, 2012). In 
contrast, 5hmC co-localises with histone modifications related to poised or 
active states of transcription (H3K4me3 and K27me3 at promoters and 
H3K4me1 and K27ac at enhancers) and is therefore linked to active genes 
(Pastor et al., 2011; Stroud et al., 2011).  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1.3 • Proposed models for the higher order chromatin structure 
(A) One model for the chromatin 30 nm fibre is the one-start solenoid, where nucleosomes 
condense into a one-start helix and has been demonstrated by EM measurements of 
recombinant poly-nucleosome fibres. (B) A separate model suggests a two-start helix based on a 
zig-zag conformation of nucleosomes, as observed in recombinant poly-nucleosomes by x-ray 
crystallography. ∿ or blue/purple helices, DNA; ● or yellow/green cores, histone octamers. 
(A) adapted from Robinson et al., 2006; (B) adapted from Woodcock et al., 1984; Schalch et al., 2004 and Robinson et al., 2006  
A
B
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1.2.2 Histone post-translational modifications (PTMs) 
Histone modifications occur mainly at specific residues on the amino-terminal 
tails (figure 1.4). Lysine acetylation and methylation were first suggested to 
play a role in the regulation of transcription by altered levels of RNA 
polymerase inhibition (Allfrey et al., 1964). Antibiotic inhibition of protein 
synthesis demonstrated that these modifications are added after the histones 
have been synthesised (Allfrey et al., 1964) and so they were determined to 
occur post-translationally. Most histone PTMs involve the covalent linkage of 
chemical groups to amino acid R-groups and include methylation, acetylation, 
phosphorylation and ADP-ribosylation. Others involve the addition of entire 
proteins or fatty acids to the histones (ubiquitination, sumoylation or O-
palmitoylation) and amino acid conversion (citrullination of arginine or 
isomerisation of proline). Following several decades of research, it is clear that 
both the type, position and level (for arginine and lysine methylation) of 
modification is important in terms of how transcription is affected. 
1.2.2.1 Histone acetylation 
One of the most studied and well-characterised PTMs is acetylation (Verdone 
et al., 2006). This modification was first identified in histones over fifty years 
ago (Phillips, 1963). It was subsequently demonstrated that acetylation occurs 
on the ε-amino groups of several lysine residues, particularly on histones H3 
and H4 (Allfrey et al., 1964). Unlike most other modifications, the addition of 
acetyl groups reduces the net positive charge of histones. Such charge 
differences can be seen by polyacrylamide gel electrophoreses of total histone 
extracts on acetic acid urea Triton™ X-100 (AUT) gels, which are capable of 
resolving the mono-, di-, tri- and even higher acetylated species of each 
histone (Bonner, et al., 1980). The reduced basicity of the histones in principle 
lowers their affinity for DNA and potential for contacts with adjacent 
nucleosomes and is widely thought to produce a more open chromatin 
structure. 
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1.4 • Post-translational modifications in the canonical histones 
Schematic representation of the different types and locations of post-translational modifications in 
histones H2A, H2B, H3 and H4. Sites of acetylation (●) and methylation (●) are indicated above 
each histone, with other modifications indicated below. Modifications are outlined in further detail 
in supplementary figure S1.1. This figure is not representative of all known histone modifications. 
Colours representing these modifications are retained throughout this thesis. 
Modification sites were obtained from the Abcam post-translational modifications poster (Kouzarides & Bannister, 2011); Chen et al. (2007); 
Daujat et al. (2009); Liu et al. (2009); Tan et al. (2011); Xie et al. (2012); Tessarz et al. (2014); and Di Cerbo et al. (2014).  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Histone acetyl-transferase (HAT) and de-acetylase (HDAC) enzymes mediate 
the turnover of acetylation to activate or repress gene transcription, 
respectively (Brownell et al., 1996; Taunton et al., 1996). The HATs are 
described as type A or type B, the former being divided into three families, 
GNAT, p300/CBP and MYST. The GNAT and p300/CBP families are responsible 
for the acetylation of histones within nucleosomes, whilst the MYST family HATs 
only acetylate free histones to signal for their deposition onto DNA (Ruiz-
Carrillo et al., 1975; Garcea & Alberts, 1980; Weigand & Brutlag, 1981; 
Richman et al., 1988; López-Rodas et al., 1991; Sobel et al., 1994). 
HDACs are classified into classes I, II, III and IV, based on their sequence 
homologies with the yeast deacetylases Rpd3, Hda1 and Sir2 (review in Yang & 
Seto, 2007). They have much broader specificity than HATs, which is suggested 
to be regulated by the complexes in which they are present. For example, 
HDAC1 and HDAC2 occur together in the co-repressor for element-1-silencing 
transcription (CoREST), nucleosome remodelling and deacetylation (NuRD) 
and Sin3A complexes, which all seem to have unique functions (review in Kelly 
& Cowley, 2013). For instance, although CoREST and NurD both have de-
acetylase activity, CoREST was shown by de-methylation assays using mono-
nucleosomes to also be capable of de-methylating histones (Lee et al., 2005), 
whilst NuRD deacetylation is stimulated by an ATP-dependent helicase in the 
complex, which is capable of repositioning nucleosomes, as shown by mono-
nucleosome disruption and deacetylation assays (Xue et al., 1998). 
Acetylation is a well established mark of transcriptional activation (Hebbes et 
al., 1988; Clayton et al., 1993; Myers et al., 2001) and this has been 
corroborated more recently by a large amount of data from genome-wide 
chromatin immunoprecipitation coupled with DNA sequencing (ChIP-seq) 
studies (Heintzman et al., 2007; Wang et al., 2008; Cui et al., 2009; Heintzman 
et al., 2009). Furthermore, high levels of acetylation, in particular at H3K27, 
 10
have been observed at the regulatory elements of active genes, such as 
enhancers (Creyghton et al., 2010; Rada-Iglesias et al., 2011; Zentner et al., 
2011). This is also true for acetylations of H3K4, K18, K23 and K36, as well as a 
number of acetylations on histones H2A, H2B and H4 (Wang et al., 2008). 
1.2.2.2 Histone methylation 
Methylation sites have been identified on a number of lysine and arginine 
residues in histones H2A, H3 and H4 (Bannister & Kouzarides, 2011) and a 
recent study has also shown glutamine to be a novel substrate for methylation 
in the human and yeast histone H2A (Tessarz et al., 2014). Uniquely, the 
regulation of gene expression by methylation depends not only on the site of 
modification but also the level of methylation, since lysine can carry one, two 
or three methyl groups (mono- (me1), di- (me2) or tri-methylation (me3)) on 
the ε-amino group (reviews in Lachner & Jenuwein, 2002; Bannister & 
Kouzarides, 2011). Similarly, one or two methyl groups can be added to the ω-
guanidino group of arginine (review in Wysocka et al., 2006a), with further 
complexity added by the di-methylation of arginine, which can be symmetric 
(me2s) or asymmetric (me2a). In contrast, all other modifications are achieved 
by the addition of single moieties to target residues. 
Addition of methyl groups to histones is achieved with histone methyl-
transferase (HMT) enzymes, most of which contain the conserved Su(var), 
enhancer of zeste, Trithorax (SET) domain (review in Bannister & Kouzarides, 
2011). All of these enzymes catalyse the transfer of methyl groups from S-
adenosylmethionine (SAM) molecules (figure 1.5, panel A) in a relatively 
specific manner, not only in terms of which residue they modify but also to 
what degree those residues are methylated. For example, SET7/9 only mono-
methylates H3K4, as shown by the incorporation of methyl-3H by this HMT into 
recombinant octamers carrying K→R mutations in histone H3 (Wang et al., 
2001a; Nishioka et al., 2002; Wilson et al., 2002; Xiao et al., 2003). Another 
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histone lysine methyl-transferase, G9a, is capable of modifying both H3K9 and 
K27, apparently since these residues both lie within the conserved consensus 
sequence N-ARKS-C (Tachibana et al., 2001). 
Histone methylation is involved in a number of processes, including gene 
activation, repression (linked with HDAC activity - see section 1.2.2.3) and DNA 
repair (review in Kouzarides, 2007). In particular, lysine methylation in H3 has 
been identified at residues 4, 9, 27, 36 and 79. H3K4 methylation has been 
associated with transcription and its effect (activation or repression) on gene 
expression depends on its state. For instance, tri-methylation enrichment at the 
transcription start sites of active genes and the more even distribution of di-
methylation across these genes is well established (Bernstein et al., 2002; 
Santos-Rosa et al., 2002; Schneider et al., 2004; Bernstein et al., 2005) and has 
been confirmed in a number of ChIP-seq studies (Heintzman et al., 2007; Cui 
et al., 2009; Heintzman et al., 2009). H3K4me1 is less well characterised, 
although evidence from some ChIP-seq studies has identified significant 
enrichments of this modification at the enhancers of genes poised for later 
activation and active enhancers (Heintzman et al., 2007; Wang et al., 2008; 
Heintzman et al., 2009; Creyghton et al., 2010; Rada-Iglesias et al., 2011; 
Zentner et al., 2011) (figure 1.6). 
The removal of methylation from histones remained elusive for some time, 
until the identification of the first histone lysine de-methylase (KDM), LSD1, a 
decade ago (Shi et al., 2004). Since then, a number of other de-methylases 
have been identified and it has been clearly demonstrated that only mono- or 
di-methyl marks on lysine residues can be removed by the LSD de-methylases, 
by FAD-dependent amine oxidation via their amine oxidase domains, whilst tri-
methylation is removed by KDMs containing the Jumonji C (JmjC) domain 
(JMJDs) by a Fe(II) and α-ketoglutarate-dependent dioxygenase reaction 
(Kooistra & Helin, 2012) (figure 1.5, panels B and C). LSD1 has been shown in 
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de-methylation assays using methylated H3 and H4 peptides followed by MS 
to reveal products of de-methylation and knockdown experiments, to 
specifically de-methylate H3K4me2 that marks actively transcribed genes (Shi 
et al., 2004). Furthermore, LSD1 co-immunoprecipitated with the androgen 
receptor and this complex was shown in human prostate cancer cells (by 
stimulation of androgen-induced transcription and monoamine oxidase 
inhibition) and by in vitro de-methylation assays that it removed repressive 
H3K9me1/2 modifications, thus implicating LSD1 in activation, as well as 
repression, of genes (Metzger et al., 2005). The JmjC domain-containing 
protein JMJD2A was shown by MS and over-expression in HeLa cells to have 
KDM activity specific to H3K9me3 and K36me3 (Whetstine et al., 2006). 
Further MS analysis showed that the closely-related JMJD2C and JMJD2D 
enzymes were also H3K9me3 and K36me3 or H3K9me3 and K9me2 specific 
de-methylases, respectively (Whetstine et al., 2006). 
1.2.3 Cross-talk between histone PTMs and the histone code (or language) 
To date, at least 14 types of modification have been identified at 62 residues 
in the canonical core histones alone, allowing for 142 possible single 
modifications (figure 1.4). However, it is becoming increasingly evident that 
histone PTMs can regulate each other (Izzo & Schneider, 2011) and the 
binding of regulatory proteins (review in Bartke & Kouzarides, 2011). 
Considered from a simplistic point of view, a canonical histone octamer could 
therefore carry one of 20,000 possible pair-wise combinations of 
modifications, assuming that each octamer: i) is only comprised of the 
canonical histones; ii) only carries two modifications; and iii) is symmetrically 
modified. Clearly nucleosomes can contain variant histones, which, like the 
canonical histones, can carry PTMs on a number of residues (McKittrick et al., 
2004; Bonenfant et al., 2005; Hake et al., 2005; Boyne et al., 2006; Chu et al.,  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1.5 • Mechanisms of histone lysine methylation and demethylation 
Reaction schemes are shown for the methyl-transferase reaction (A) and de-methylation by amine 
oxidation (B) or Fe(II) and α-ketoglutarate-dependent dioxygenation (C). Atoms are: black, 
carbon; red, oxygen; blue, nitrogen; and gold, sulphur. Most hydrogens are implicit.  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1.6 • Distributions of histone PTMs at enhancers and promoters, determined by ChIP-seq 
Histone modifications at H3K4 (top panel), H3K9 (middle panel) and H3K27 (bottom panel) 
have been determined at poised and active enhancers and at active promoters by ChIP-seq. 
Significant enrichments of H3K4me1 are observed at poised and active enhancers. Active 
enhancers are also marked by H3K27ac, whereas poised enhancers are not. Promoters are highly 
tri-methylated at H3K4 when active. Green tracks, me; red tracks, ac; ND, no data. ⦙ represents the 
location of enhancers or promoters and tracks extend for ±5 kb from these positions. 
Distributions are approximate. 
Adapted from Heintzman et al., 2007, Wang et al., 2008, Cui et al., 2009, Rada-Iglesias et al., 2011 and Zentner et al., 2011.  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2006), and each histone can carry more than two modifications, such as 
multiple acetyl groups (Bonner et al., 1980), simultaneously. Furthermore, 
there is some evidence from immunoaffinity purification of mono-nucleosomes 
prepared by MNase digestion coupled with mass spectrometry (MS) to 
quantify the abundance of H3K27 and H4K20 methylations to suggest that 
single nucleosomes may be asymmetrically modified (Voigt et al., 2012). 
Evidence from SILAC-based MS analysis comparing nucleosomes from HeLa 
cells expressing FLAG-tagged unmethylatable H3 or H4 (histones carrying 
K→R mutations at residues that can usually be methylated) and nucleosomes 
from heavy arginine labelled HeLa cells, has also suggested that symmetrical 
methylation is not required in vivo (Chen et al., 2011). The rapid turnover of 
some histone PTMs, such as acetylation, might also imply an increased level of 
complexity, making it difficult to determine which modifications actually co-
localise in vivo. For instance, a number of studies in the laboratory of 
Mahadevan have used the HDAC inhibitor, TSA (Yoshida et al., 1990), and the 
p300/CBP inhibitor, C646 (Bowers et al., 2010), to show that H3K4me3 is 
subject to high levels and rapid turnover of acetylation in several species 
(Hazzalin & Mahadevan, 2005; Crump et al., 2011; Hsu et al., 2012). 
Multiply modified nucleosomes have been proposed to constitute a ‘histone 
code’ (Strahl & Allis, 2000; Jenuwein & Allis, 2001), although the increasingly 
complex nature of epigenetic modifications has also given rise to the term, 
‘histone language’ (Oliver & Denu, 2011). These hypotheses suggest that 
histone PTMs can function individually, sequentially and combinatorially in 
cooperative or antagonistic mechanisms for the recruitment of regulatory 
proteins or complexes to modified nucleosomes (figure 1.7, panels A and B). 
These proteins or complexes then interpret the modification(s) so as to alter 
the structure of chromatin and initiate downstream responses, such as 
transcriptional activation or repression (Strahl & Allis, 2000) (section 1.2.5).  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1.7 • Histone PTM cross-talk 
(A) Histone PTMs can regulate each other, as shown here for modifications of H3. (B) They may 
also work individually to recruit (i) or exclude (ii) the binding of effector proteins (green or red) to 
nucleosomes. Alternatively, modifications may occur together and function in mechanisms co-
operatively or antagonistically to recruit (iii) or exclude (iv) effector proteins (blue or yellow), 
respectively. (C-D) SILAC-based peptide and nucleosome pull downs have begun to elucidate 
the regulation of chromatin interacting protein binding by different combinations of histone and 
DNA modifications. These include the interaction of: TAF3 (a component of the TFIID complex) 
with H3K4me3, which is potentiated by K9ac and K14ac and antagonised by R2me2a (C); the 
ORC with H3K9me3 and CpG methylation and PRC2 with K27me3, which is antagonised by CpG 
methylation (D). The N-terminal tails (∿) represent histone H3. 
(A) adapted from Bannister & Kouzarides, 2011; (B & D) adapted from Bartke et al., 2010; (C) adapted from Vermeulen et al., 2007  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Sequential in vitro methylation of histone H3 by the H3K4 and H3K9 HMTs, 
SET7/9 and SUV39H1, respectively (and vice versa), has shown that addition of 
the second methyl group was inhibited by the first methyl mark, 
demonstrating that methylated H3K4 and K9 are mutually exclusive (Wang et 
al., 2001a). This correlated well with earlier data from mapping of H3K4 and K9 
methylations across the chicken ß-globin locus by ChIP, which indicated that 
the two modifications had distinct distributions (Litt et al., 2001a). Indeed 
H3K4me1 localises to poised and active enhancers (Cui et al., 2009; Amar, 
2010), whilst H3K9me3 has been associated with transcriptional silencing and 
heterochromatin formation (Bannister et al., 2001; Lachner et al., 2001; 
Nakayama et al., 2001). Another example of this mutual exclusivity is the 
antagonism of histone arginine methylation and deimination (Cuthbert et al., 
2004). PADI4 was identified as a Ca2+ dependent histone H3 deiminase by a 
deiminase assay using purified histones and PADI4 with or without calcium 
(Cuthbert et al., 2004). N-terminal sequencing and MS analyses indicated that 
the target residues for deimination by PADI4 were H3R2, R8, R17 and R26 
(Cuthbert et al., 2004). N-terminal peptides of H3 carrying citrulline at R2, R17 
and R26 could not be methylated by the CARM1 methyltransferase (which 
methylates these residues) and PADI4 was not capable of converting 
symmetrically or asymmetrically methylated arginine residues to citrulline (but 
was able to deiminate mono-methylated arginine), demonstrating that di-
methylation and deimination of H3 are mutually exclusive (Cuthbert et al., 
2004). 
Phosphorylation of H3T6 has also been shown to promote the removal of 
methylation from H3K4 via recruitment of the de-methylase LSD1 (Metzger et 
al., 2010). Addition of repressive methylation to DNA has also been suggested 
to recruit MeCP2-associated HDACs in mouse (Nan et al., 1998) whilst 
repressive histone methylation recruits the yeast HDAC complex Rpd3S via the 
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chromo domain of Eaf3 (Carrozza et al., 2005). Both mechanisms function to 
remove active transcription-associated histone acetylation. Conversely, ChIP 
coupled with DNA microarray analyses (ChIP-chip) in Drosophila has indicated 
that acetylation of H3K27 by CBP antagonises gene silencing by Polycomb-
dependent H3K27 tri-methylation (Tie et al., 2009). 
Examples of cooperative modifications have been identified, including the 
interaction of TFIID with H3K4me3, promoted by acetylation of H3K9 and K14 
(Vermeulen et al., 2007) and recruitment of UHRF1, ORC and PRC2 to 
nucleosomes carrying H3K9me3 or H3K27me3 and methylated DNA (Bartke et 
al., 2010). Both studies determined these interactions using stable isotope 
labelling by amino acids in cell culture (SILAC) based pull downs. 
Vermeulen and colleagues identified all of the TAF and TBP subunits of the 
TFIID complex as novel H3K4me3 interacting proteins using SILAC-based 
peptide pull downs (Vermeulen et al., 2007). Furthermore, RNAi experiments 
against WDR5 in bone osteosarcoma (U2OS) cells to reduce the global levels 
of H3K4me3 (but not H3K4me1/2) (Dou et al., 2006; Steward et al., 2006) were 
used in tandem with mRNA expression level analysis and determination of TBP 
and TAF1 occupancy at the promoters of genes affected (i.e. genes marked 
with reduced levels of H3K4me3 and therefore exhibiting reduced 
transcription) or unaffected (i.e. genes marked with normal levels of H3K4me3) 
by the WDR5 knockdown by ChIP. The data showed that these subunits of the 
TFIID complex were less enriched at promoters of genes with reduced 
transcription (as a result of reduced H3K4me3 in WDR5 knockdown cells) but 
co-localised with peaks of H3K4me3 downstream of TSS, demonstrating that 
H3K4me3 is necessary for the association and retention of TFIID at promoters 
for transcriptional activity (Vermeulen et al., 2007). Peptide and nucleosome 
pull down experiments using full length TAF3, TAF3 lacking the C-terminal 
plant homeodomain (PHD) finger (section 1.2.5) or the isolated PHD finger 
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with or without mutations of key residues showed that mutants of TAF3 or 
TAF3 lacking the PHD finger were unable to bind H3K4me3. In addition, the 
dissociation constants for TAF3 PHD finger binding to various H3 peptides 
were measured and indicated that the strongest binding was to the H3K4me3 
peptide. Taken together, this suggested that the PHD finger of TAF3 is 
necessary for TAF3-H3K4me3 interaction (Vermeulen et al., 2007). A triple 
label SILAC-based pull down approach, which involves the use of protein 
extracts from three differently labelled cell cultures (chapter 6), was also used 
in this study. H3, H3K4me3 or H3K4me3 K9ac K14ac peptides were used as 
bait to pull down the TFIID TAF subunits. Of note, binding of TAF1 (which 
contains acetyl-binding bromodomains (Jacobson et al., 2000)) to H3K4me3 
was promoted by acetylation at K9 and K14 (Vermeulen et al., 2007). 
Moreover, pull down of TAF3 PHD to H3K4me3 peptides carrying each R2 
methylation (H3R2me1 K4me3, H3R2me2a K4me3 and H3R2me2s K4me3) 
showed that binding of the PHD finger protein TAF3 to H3K4me3 was 
inhibited by R2me2a. This was corroborated in a triple SILAC experiment, 
using H3, H3K4me3 or H3R2me2a K4me3 peptides as bait. The data obtained 
by tryptic-MS showed significantly reduced interaction of TAF3 when the bait 
peptide carried the repressive H3R2a modification, indicative of TAF3 as a 
regulator of active transcription (Vermeulen et al., 2007) (figure 1.7, panel C). 
A study by Bartke and colleagues examined the combinatorial effects of 
epigenetic modifications a little differently, with a focus on the association of 
histone with DNA methylation (Bartke et al., 2010). SILAC-based nucleosome 
affinity pull down (SNAP) experiments identified the enrichment of a number 
of factors, including UHRF1 and components of the origin recognition 
complex (ORC), by H3K9me3 or H3K27me3 and CpG methylation. Conversely, 
the EED and SUZ12 subunits of the polycomb recognition complex (PRC2) 
exhibited enrichments on H3K27me3 nucleosomes that was inhibited by DNA 
 20
methylation (Bartke et al., 2010) (figure 1.7, panel D). Further pull downs, using 
modified nucleosomes as bait, followed by Western blotting and cluster 
analysis of the proteins enriched by chromatin modifications in the SNAP 
experiments confirmed these interactions. Furthermore, the cluster analysis 
identified a novel protein, LRWD1, as a potential new component of the ORC 
(Bartke et al., 2010). Indeed, immunofluorescence staining in MCF7 cells 
indicated co-localisation of LRWD1 with the ORC and immunoprecipitation of 
FLAG-tagged LRWD1 constructs enriched ORC proteins, confirming this 
interaction (Bartke et al., 2010). 
The SILAC-based proteomics experiments described above demonstrate the 
usefulness of this approach, not only for the identification of protein 
interactions modulated by combinations of histone PTMs but also for their 
potential to uncover novel components in chromatin interacting complexes. 
1.2.4 Histone variants 
In addition to chromatin modifications, there exist a number of histone 
variants. These proteins differ from their canonical H2A, H2B and H3 
counterparts in their amino acid sequences (review in Talbert & Henikoff, 2010) 
- only one variant of histone H4 has been identified to date, in Tetrahymena 
pyriformis (Hayashi et al., 1984). Unlike most of the canonical histones, whose 
synthesis normally occurs in S phase and is tightly linked to DNA replication 
(Osley, 1991), histone variants are synthesised throughout the cell cycle. They 
have been shown to be involved in a number of aspects of chromatin 
organisation and function, such as X-chromosome inactivation, DNA damage 
repair and transcriptional activation or silencing (review in Talbert & Henikoff, 
2010). 
Variants of histone H2A differ from the canonical histone largely in the 
sequences and lengths of their carboxyl-terminal tails, which contain docking 
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domains responsible for interactions with H3-H4 tetramers. Their sequences 
also differ in the L1 loop of the histone fold (figure 1.1, panel A), which is 
involved in the interaction of H2A-H2B dimers (Bönisch & Hake, 2012). One 
such variant, H2A.X, has been implicated in DNA damage repair, regulated by 
serine phosphorylation (Rogakou et al., 1999; reviews in Bönisch & Hake, 
2012; Skene & Henikoff, 2013), with knock-out experiments in mice 
demonstrating increased sensitivity to irradiation-induced DNA damage 
(Celeste et al., 2002). The co-affinity purification of a number of DNA damage 
repair proteins, the ADP-ribosyltransferase, PARP1, and the facilitates active 
chromatin transcription (FACT) complex (which has histone chaperone activity 
and is capable of disassembly and re-assembly of nucleosomes (Orphanides 
et al., 1998; Belotserkovskaya et al., 2003; review in Formosa, 2012)) with 
H2A.X has further corroborated the involvement of this variant in DNA damage 
repair (Heo et al., 2008). Furthermore, mechanisms for the regulation of H2A.X 
variant exchange have been elucidated by exchange assays using H2A-
nucleosomes, H2A.X-H2B dimers and these H2A.X-associated factors. The 
results showed that these factors (specifically FACT) are responsible for H2A.X-
H2B dimer exchange and that exchange was inhibited by ADP-ribosylation of 
Spt16, a component of the FACT complex (Heo et al., 2008). Furthermore, 
increased accessibility to nucleosomal DNA by restriction enzymes following 
phosphorylation of H2A.X by the DNA-dependent protein kinase (DNA-PK) 
(Heo et al., 2008) confirmed earlier observations from an H2A.X S139ph 
(termed γH2A.X) mimic, H2A.X S139E, that suggested γH2A.X destabilises 
nucleosomes (Fink et al., 2007). Whilst γH2A.X has been suggested to be non-
essential for marking and repairing DNA damage (Skene & Henikoff, 2013), it is 
clear that this modified histone variant facilitates repair complex assembly, or 
at least their retention, at repair sites (van Attikum et al., 2004; Morrison et al., 
2004; reviews in van Attikum & Gasser, 2009; Bönisch & Hake, 2012; Seeber et 
al., 2013; Skene & Henikoff, 2013). 
 22
Nucleosomes containing the variant histone H2A.Z are unstable, as suggested 
by the crystal structure of an H2A.Z-containing nucleosome, which indicates 
that a Q→G substitution relative to the H2A-nucleosome might cause localised 
destabilisation between the H2A.Z-H2B dimers and the H3-H4 tetramer (Suto 
et al., 2000). This instability is also true for nucleosomes containing the 
replacement histone H3.3 and nucleosomes carrying both variants are even 
less stable, as determined by preparation of nucleosomes from 6C2 (colony 
forming unit erythroid precursor (CFU-e)) cells at varied salt concentrations (Jin 
& Felsenfeld, 2009). Furthermore, ChIP-seq and sequential FLAG 
immunoprecipitation and H2A.Z ChIP of mono-nucleosomes prepared at low 
ionic strength from a HeLa cell line containing FLAG-tagged H3.3 have been 
used to map nucleosomes containing both H2A.Z and H3.3 (Jin et al., 2009). 
The results of this study showed that these double variant-containing 
nucleosomes are localised at the promoters and CCCTC-binding factor (CTCF) 
sites of active genes, which had previously been considered to be nucleosome 
free regions (NFRs) (Jin et al., 2009; review in Henikoff, 2009). The instability of 
these double variant nucleosomes strongly supports their role in active gene 
expression by promoting dissociation of the histone octamer from DNA, 
allowing passage of transcriptional proteins. 
1.2.5 Read-out of histone PTMs 
Once incorporated into chromatin, DNA methylation, histone PTMs and 
variants must be recognised by the cell to achieve the desired regulatory 
effect. For instance, transcriptional activity of genes must involve chromatin 
remodelling at regulatory elements (such as enhancers and locus control 
regions) and the promoter and transcribed region. This causes the chromatin 
to take on a more open conformation (so-called euchromatin) to allow 
regulatory proteins to gain access and effect transcription. Whilst acetylation 
and phosphorylation might have more direct effects on chromatin structure, 
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owing to the reduced basicity that they impart on the histones, all 
modifications have the potential to modulate chromatin structure via effector 
proteins. Existing evidence shows many proteins that are capable of binding 
epigenetic modifications via a number of conserved recognition domains 
(reviews in Taverna et al., 2007; Patel & Wang, 2013). Examples include the 
bromodomains, which ‘read’ acetylated lysine residues and the chromo, Tudor 
and malignant brain tumour (MBT) domains (all members of the so-called royal 
family) and PHDs, which recognise lysine methylations (reviews in Taverna et 
al., 2007; Patel & Wang, 2013) (figure 1.8, panel A). 
Bromodomains comprise four core α-helices with the binding pocket being 
formed by loops between the first and last pairs of helices (Dhalluin et al., 
1999; Owen et al., 2000) (figure 1.8, panel B). Gcn5p contains a bromodomain 
and the crystal structure of this protein in complex with an acetylated H4 
peptide has indicated that binding is effected by a hydrogen bond between 
the acetyl carbonyl of acetylated H4K16 and the amide nitrogen of a 
conserved asparagine residue in the bromodomain (Owen et al. 2000). Gcn5p 
also has HAT activity, which might propagate histone acetylation to the 
chromatin surrounding acetylated H4 (Kuo et al., 1996). Another acetyl lysine 
reader is TAF1, a component of the TFIID complex, which contains two 
bromodomains, the binding pockets of which are separated by ~25 Å, 
allowing binding to di-acetylated H4, specifically H4 K5ac K12ac (Jacobson et 
al., 2000). 
Domains of the royal family recognition proteins are characterised by four ß-
strands that form an incomplete ß-barrel, in which the PTM recognition site 
resides (reviews in Taverna et al., 2007; Patel & Wang, 2013). Chromo domains 
only contain three of these ß-strands and a further separate ß-strand that form 
the completed ß-barrel upon formation of a complex with the modified 
histone, the tail of which contributes a fifth ß-strand (Jacobs & Khorasanizadeh, 
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2002; Nielsen et al., 2002) (figure 1.8, panel C). Heterochromatin protein 1 
(HP1) is a chromo domain protein that has been shown to interact with 
H3K9me3 to silence transcription (Bannister et al., 2001; Lachner et al., 2001). 
Furthermore, HP1 is associated with the SUV39H1 methyltransferase 
responsible for laying down H3K9me3 (Rea et al., 2000), which has been 
suggested to allow the spread of repressed regions of heterochromatin 
(Bannister et al. 2001; Lachner et al., 2001; Stewart et al., 2005). 
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1.8 • Readout of histone PTMs 
(A) Proteins recognising several PTMs in the N-terminal tail of histone H3 (∿). (B) The schematic 
structure of a bromodomain shows four α-helices, that contribute to two loops (LZA and LBC), 
which form the recognition domain for histone acetylation. (C) The royal family (chromo, Tudor 
and MBT) domains comprise four ß-strands, which form a ß-barrel upon interaction with the N-
terminal tail (curved transparent red arrow (1’)) of methylated histones. Chromo domains lack the 
first ß-strand (1) and instead have a separate short ß-strand close to the C-terminus (not shown). 
(D) PHD fingers comprise two anti-parallel ß-strands which bridge two zinc finger motifs (Zn co-
ordinated by cysteine, C, and histidine, H, residues) and conserved residues (●) that cage the N-
terminal tail (transparent red line) of modified or unmodified histones. 
(A) adapted from Bannister & Kouzarides, 2011; (B-D) adapted from Taverna et al., 2007  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PHDs comprise two zinc fingers separated by two ß-strands and an α-helix 
near the C-terminus. Recognition of unmodified or methylated lysine is 
achieved by several aromatic residues situated within this domain that form a 
cage around the target lysine residue (Li et al., 2006; Peña et al., 2006) (figure 
1.8, panel D). The interaction of the PHD of TAF3 (a subunit of the TFIID 
complex) with H3K4me3 was described earlier (section 1.2.3). This is an 
excellent example of the complexity of histone PTM readout, since TAF1, also 
in the TFIID complex, contains a double bromodomain (Jacobson et al., 2000; 
see above), which might be responsible for binding H3K9ac K14ac to 
potentiate the observed binding of TAF3 to H3K4me3 (Vermeulen et al., 2007). 
PHD fingers are also capable of recognising un-methylated lysine. One 
example is that of BHC80, which binds the ζ-ammonium group of H3K4me0 
with two hydrogen bonds from an aspartate side chain and amide carbonyl of 
the PHD finger (Lan et al., 2007). Methylated forms of H3K4 are assumed to be 
excluded from the recognition site due to steric hindrance. RNAi of LSD1 and 
BHC80 coupled with ChIP analysis showed that BHC80 was knocked down at 
LSD1-enriched loci. Thus, LSD1 and BHC80 co-localise with each other and, 
given that LSD1 is associated with transcriptional repression (Shi et al., 2004), 
BHC80 has also been linked to gene repression (Lan et al., 2007). 
Genome-wide mapping by ChIP-seq and, more recently, localised hydroxyl-
radical formation has indicated that nucleosomes around the TSS and 
regulatory elements of genes are highly phased (Albert et al., 2007; Barski et 
al., 2007; Schones et al., 2008; Brogaard et al., 2012; reviews in Jiang & Pugh, 
2009; Zhang & Pugh, 2011) (figure 1.9, panel A). Therefore, the interpretation 
of histone modifications is important to allow remodelling of the chromatin 
structure at these sites, to allow access for transcriptional machinery and other 
regulatory proteins. This is achieved by chromatin remodelling complexes in 
which the above described PTM recognition domains are present (reviews in 
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Clapier & Cairns, 2009; Narlikar et al., 2013) (figure 1.9, panel B). These 
complexes are capable of altering DNA-histone contacts via ATP hydrolysis to 
allow access for binding proteins by DNA unwrapping or nucleosome 
repositioning or ejection. Alternatively, they can alter nucleosome 
compositions through the exchange or ejection of histone dimers (reviews in 
Clapier & Cairns, 2009; Narlikar et al., 2013) (figure 1.9, panel C). 
Chromatin remodellers are divided into four families - SWI/SNF, ISWI, CHD and 
INO80 (review in Clapier & Cairns, 2009) (figure 1.9, panel B). SWI/SNF and 
CHD remodellers slide and eject nucleosomes to mediate a number of 
processes, including transcriptional activation (although the association of 
CHD1 with Mi2-NuRD implicates this remodeller in repression) (reviews in 
Mohrmann & Verrijzer, 2005; Marfella & Imbalzano, 2007) and INO80 
complexes also have diverse functions, including transcriptional activation and 
DNA repair (review in Bao & Shen, 2007), whilst ISWI remodellers typically 
promote nucleosome assembly with even spacing to repress transcription 
(review in Corona & Tamkun, 2004). The nucleosome remodelling factor 
(NURF) is an ISWI remodelling subunit that differs from this general role in that 
it binds H3K4me3 via its PHD finger to effect active transcription of Hox genes 
during development (Wysocka et al., 2006b). 
The FACT complex is a heterodimer of SSRP1 and Spt16 implicated in 
transcriptional elongation by RNA polymerase II (LeRoy et al., 1998; 
Orphanides et al., 1998; Orphanides et al., 1999; Saunders et al., 2003; Li et 
al., 2007b; Hsieh et al., 2013; review in Formosa, 2012). It has also been shown 
to facilitate RNA polymerase I and III-mediated transcription (Birch et al., 2009). 
Unlike chromatin remodellers, it does not contain an ATPase domain, yet it is 
still capable of nucleosome disruption via DNA uncoiling and its histone 
chaperone activity, which is capable of displacing H2A-H2B dimers 
(Orphanides et al., 1998; Belotserkovskaya et al., 2003; review in Formosa,  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1.9 • Nucleosome phasing and chromatin remodelling 
(A) MNase digestion of chromatin coupled with genome-wide mapping has shown that 
nucleosomes around active gene TSS and regulatory elements are highly phased (●) and usually 
contain variant histones associated with transcription (●). Nucleosome positions are less-well 
defined elsewhere (●). (B) Chromatin remodellers are necessary to recognise and bind to 
epigenetic modifications and effect downstream responses by remodelling chromatin. These 
complexes are grouped into four families - SWI/SNF, ISWI, CHD and INO80 - differing in their 
ATPase subunits, which comprise two regions separated by short or long insertions. They are 
defined further by other components involved in binding histone PTMs and nucleosomes, 
including helicase, bromo, SANT-SLIDE and chromo domains. (C) ATP hydrolysis provides the 
energy required by these remodellers to effect access to DNA binding elements (∿) by 
nucleosome repositioning or ejection, DNA unwrapping, or histone dimer exchange or ejection. 
Adapted from Rando & Chang (2009) and Narlikar et al., 2013 (A); Clapier & Cairns, 2009 (B & C); Jiang & Pugh, 2009 (C)  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2012). However, FACT has also been shown to interact with chromatin 
remodellers, such as CHD1 (Krogan et al., 2002), which has specificity for 
H3K4me (Flanagan et al., 2005) and is a component of the SAGA 
transcriptional co-activator complex (Pray-Grant et al., 2005), and is recruited 
to SETD2-mediated H3K36me3 (Carvalho et al., 2013). This supports the role 
of FACT at active chromatin. However, CHD1 has also been shown to be 
associated with the nuclear receptor co-repressor (NCoR) (Tai et al., 2003), 
which might also suggest a role for FACT in repression. Indeed, FACT has been 
shown to deposit histones onto DNA, as well as displacing them 
(Belotserkovskaya et al., 2003; review in Formosa, 2012), thus it is implicated in 
both active and repressed chromatin states. 
Chromatin recognition and remodelling are highly complex processes. Whilst 
a great deal of research has examined a number of chromatin interactors and 
the complexes they associate with to mediate downstream responses to 
epigenetic modifications, it is highly likely that there are additional PTM 
interactors to be identified and characterised. 
!
1.3 PTMs and their effects on developmental gene regulation 
Despite excellent progress made in the field of chromatin, there remains a 
significant gap in our knowledge of how histone modifications affect the 
transcriptional states of genes. Recent genome-wide studies have indicated 
that H3K4me1 marks both poised and active enhancers and that tri-
methylation or acetylation of H3K27 mark each of these states, respectively 
(Heintzman et al., 2009; Creyghton et al., 2010; Rada-Iglesias et al., 2011; 
Zentner et al., 2011). This has suggested roles for the regulation of gene 
expression by combinations of, rather than single, histone modifications and 
so the identification of further combinations of PTMs that exist in vivo and the 
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regulatory proteins and complexes they recruit is key to our understanding of 
which modifications signal for poised, active and repressed transcriptional 
states. 
Previous work in our laboratory (Amar, 2010) has already established that 
H3K4me1 is likely to be one of the first modifications that is deposited during 
embryonic development of the chicken to mark the ß-globin enhancer for later 
activation. Significantly reduced enrichment of this modification was observed 
at the enhancer in erythrocytes (15DCE) compared to erythroblasts (HD37) 
(Amar, 2010). In addition, H3K4me1 levels were higher at the promoters and 
transcribed regions of the folate receptor and embryonic globin genes when 
transcriptionally inactive, possibly as a repressive modification to prevent 
further expression (Amar, 2010) (supplementary figure S3.4). Therefore, 
H3K4me1 was of particular interest to study further, together with other states 
of methylation (H3K4me2, H3K4me3 and H3K27me3) and acetylation 
(H3K27ac), that have previously been associated with transcriptionally active 
and repressed states. Whilst genome-wide methodologies are capable of 
producing vast amounts of data, analysis of specific loci at mono-nucleosomal 
resolution offers a more cost-effective approach to further our understanding 
of gene activation and repression by histone modifications. 
The chick is an ideal model for the study of gene expression in blood cells 
throughout development. Since embryos develop in the egg very rapidly, it 
requires only up to 15 days to obtain sufficient quantities of blood for 
chromatin immunoprecipitation (ChIP) experiments. Unlike most eukaryotes, 
chickens retain the nuclei within their fully differentiated erythrocytes making it 
possible to compare PTM distributions throughout the entire process of 
erythropoiesis. The differentiation of the erythrocytic series of blood cells 
occurs within well documented time-frames (Lucas & Jamroz, 1961) with 
developmentally regulated changes in expression of the ß-globin genes 
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observed between younger and older embryos (Groudine et al., 1981; Landes 
& Martinson, 1982; Landes et al., 1982). The same is true in mammalian 
systems, inc luding mouse and human (Tr imborn et a l . , 1999; 
Stamatoyannopoulos, 2005; Kingsley et al., 2005; Kiefer et al., 2008). 
In this study, the distribution of several histone PTMs was mapped across the 
chicken ß-globin locus in 5 and 15DCE by nChIP so as to generate a more 
comprehensive picture of the epigenetic regulation of these genes at the end 
of the developmental pathway of erythropoeisis (chapter 3). Following this, a 
number of recently developed methods provided an elegant approach to the 
identification of nucleosome interacting proteins. Synthesis of histones 
carrying specific modifications was achieved by genetic encoding (review in 
Chin, 2012) and reductive alkylation (review in Shogren-Knaak, 2007) (chapter 
4). These ‘designer’ histones were assembled into nucleosomes and used in 
conjunction with stable isotope labelling by amino acids in cell culture (SILAC)-
based pull downs, coupled with tryptic MS to identify binding partners (review 
in Mann, 2006) (chapter 5). Of particular interest were any differences that 
could be identified in effector protein interactions with the nucleosome 
mediated by combinations of PTMs. Both proteins of the heterodimeric FACT 
complex, SSRP1 and Spt16, interacted with histone H3, as had been shown in 
previous studies (Stuwe et al., 2008; Myers et al., 2011; Winkler et al., 2011). 
Importantly, the findings have provided novel evidence that the binding of 
FACT to H3 is mediated by lysine 4, which, when mono-methylated, excludes 
the interaction.  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2 Methods 
A full alphabetical list of buffers and solutions is provided at the end of this 
chapter (section 2.7). 
2.1 General methods 
2.1.1 Preparation of ultra-competent Escherichia coli 
Ultra-competent E. coli were prepared from commercially obtainable strains 
according to Inoue et al. (1990). Un-transformed cells were grown on non-
selective LB agar overnight at 37 ˚C and 25 mL aliquots of LB media inoculated 
with single colonies. Cultures were incubated for 8 hr at 37 ˚C in an orbital 
shaker at 275 rpm and 2-10 mL used to seed 250 mL SOB. Cultures were 
incubated at 18 ˚C and 220 rpm, until the OD600 reached 0.55 AU (up to 34 hr), 
incubated on ice for 10 min and harvested by centrifugation (2,500 g, 10 min). 
Cells were washed in transformation buffer (55 mM MnCl2, 15 mM CaCl2, 250 
mM KCl, 10 mM PIPES pH 6.7), resuspended in 20 mL transformation buffer 
with 1.5 mL Hybri-Max™ DMSO (Sigma-Aldrich, D2650) and incubated on ice 
for 10 min. Cells were aliquoted, snap-frozen and stored at -80 ˚C. 
2.1.2 Transformation of E. coli with plasmid DNA 
50 µL aliquots of ultra-competent cells (DH5α, BL21(DE3) pLysS, or XL10-Gold) 
were incubated on ice with up to 200 ng of plasmid DNA for 15-30 min. Cells 
were heat-pulsed at 42 ˚C for 90 s and returned to ice for a further 5 min prior 
to incubation in 1.95 mL SOC or LB media for 20-60 min at 37 ˚C and 250 rpm. 
10-250 µL aliquots were spread onto selective LB agar and incubated 
overnight at 37 ˚C. 
2.1.3 Liquid cultures of transformed E. coli 
Single, transformed colonies were used to inoculate selective LB or 2-YT media 
and cultures incubated overnight at 25 or 37 ˚C and 60-250 rpm.  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2.1.4 Plasmid isolation by alkaline lysis 
Plasmids were isolated from transformed E. coli using NucleoBond® Xtra  Midi 
(Macherey-Nagel, 740410) or QIAfilter Mega (Qiagen, 12281) kits, which utilise 
modified versions of the alkaline lysis method described by Birnboim and Doly 
(1979) with the addition of proprietary binding agents (anion exchange 
columns) for removal of contaminants. Manufacturer protocols were followed. 
For large-scale preparations, anion exchange columns included in the kits 
were each used for up to six purifications of identical plasmids. Following 
precipitation with alcohol (section 2.1.7), DNA was redissolved in 10 mM Tris-
HCl [pH 8.5]. Samples were analysed by agarose gel electrophoresis and 
sequencing of the insert DNA (GATC Biotech AG) and stored at -20 ˚C. 
2.1.5 Restriction enzyme digests 
Restriction enzyme digestion reactions were typically constructed following 
NEB protocols, with 1 µg/µL plasmid DNA and 1 U/µL of the appropriate 
enzyme(s). Digests were usually left to proceed for 1 hr at 37 ˚C and 
terminated by heat inactivation at 80 ˚C for 20 min or by adjusting to 20 mM 
EDTA. 
2.1.6 Phenol-chloroform extraction 
DNA was purified from protein contaminants (and vice-versa) by adding one 
volume phenol-chloroform-isoamyl alcohol (25:24:1) and vortexing 1 min, 
followed by centrifugation at 16,000 g, 5 min. Organic phases were back-
extracted with one volume TE (10 mM Tris-HCl pH 7.5, 1 mM EDTA) and 
aqueous phases re-extracted with phenol-chloroform-isoamyl alcohol. 
Aqueous phases were finally extracted with chloroform and DNA recovered by 
precipitation with alcohol. Proteins were recovered from organic phases by 
acetone precipitation (section 2.1.8). 
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2.1.7 Alcohol precipitation of DNA 
Samples were adjusted to 300 mM NaAc [pH 5.2] and two volumes ethanol or 
one volume isopropanol added. DNA was left to precipitate overnight at -20 ˚C 
and collected with 18,000 g, 30-40 min. Pellets were washed with 80 % ethanol 
and reconstituted in 10 mM Tris-HCl [pH 8.5] or SSC. 
2.1.8 Acetone precipitation of proteins 
Following phenol-chloroform extraction, protein-containing organic phases 
were adjusted to 100 mM HCl and 10 volumes of acetone added. Samples 
were incubated at -20 ˚C overnight. Precipitated protein was collected with 
5,000 g, 20 min and the pellets washed twice with 100 mM HCl/acetone (1:10). 
Pellets were washed three times with acetone and dried under vacuum. 
2.1.9 Vanadate precipitation of histones 
Histones in samples at low concentrations were precipitated for analysis by gel 
electrophoresis using vanadate, as described by Michele et al. (1997). Samples 
were adjusted to 25 mM Tris-HCl [pH 7.5] and mixed 3:1 with vanadate 
solution (400 mM sodium orthovanadate, 131 mM NaCl, 4.8 mM KCl, 1.2 mM 
MgSO4, 1.3 mM CaCl2, 1.2 mM NaH2PO4, 25 mM HEPES, pH 7.4). Insoluble 
histone-vanadate complexes were collected with 16,000 g, 10 min and 
dissolved in 8 M urea/10 mM DTT for analysis by SDS PAGE (section 2.1.13.2). 
2.1.10 Nucleic acid and protein quantification 
Nucleic acid and protein samples were quantified using a NanoDrop 2000C 
(Thermo Scientific) micro-volume spectrophotometer, according to calculated 
molecular weights and extinction coefficients (figure 2.1). Comparison of this 
instrument against a Lambda 25 (Perkin Elmer) spectrophotometer indicated 
underestimates in quantification within 10 % of the values obtained with the 
Lambda 25 (figure 2.2) but the NanoDrop was preferred for routine use due to 
the necessity for quantifying low-volume and temperature sensitive samples.  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2.1 • Molecular masses and extinction coefficients for protein and DNA quantification 
Expected molecular weights for the core histones and histone octamers were provided previously 
(Luger et al., 1999) and an average molecular weight was determined for 601.2 DNA by running 
the 185 bp sequence through several online calculators (OligoCalc, available at: http://
www.basic.northwestern.edu/biotools/oligocalc.html; Sequence Manipulation Suite, available at: 
http://www.bioinformatics.org/sms2/dna_mw.html; Oligonucleotide Properties Calculator, 
available at: http://www.unc.edu/~cail/biotool/oligo/; and DNA/RNA/Protein/Chemical 
Molecular Weight Calculator, available at: http://www.changbioscience.com/genetics/mw.html). 
Extinction coefficients were calculated according to Gill & von Hippel (1989). The Beer-Lambert 
Law (i) is re-arranged to calculate the concentration of IgG, histones or octamers in mg/mL (ii). 
AU, absorbance units; ε, extinction coefficient; c, molar concentration; l, path length; MW, 
molecular weight.  
i) AU = ε c l 
 
 
ii) c =  AU 
    ε  l
MW(   )
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Sample MW               
(g/mol)
ε                        
(/M/cm)
1 AU @ 280 nm 
(mg/mL)
ε                   
((µg/mL)/cm)
1 AU @ 260 nm 
(µg/mL)
IgG 150,000 210,000 0.714 - - - - - -
xH2A 13,960 4,050 3.447 - - - - - -
xH2B 13,774 6,070 2.269 - - - - - -
xH3 15,273 4,040 3.781 - - - - - -
xH4 11,240 5,040 2.230 - - - - - -
G. gallus octamer 108,474 40,500 2.678 - - - - - -
X. laevis octamer 108,490 38,400 2.825 - - - - - -
601.2 DNA 114,521 - - - - - - 0.02 50.000
dsDNA - - - - - - - - - 0.02 50.000
!!!!!!!!!!!!!
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2.2 • Comparison of micro-volume and traditional spectrophotometers 
Two standard DNA samples were prepared and measured in triplicate both with a NanoDrop 
2000C (Thermo Scientific) instrument and a traditional Lambda 25 (Perkin Elmer) 
spectrophotometer. Although the NanoDrop indicated an underestimate of approximately -9.2 to 
-7.7 %, it was chosen for routine measurements due to the regular requirement for quantification 
of low-volume and temperature sensitive samples, such as histone octamers.  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Bicinchoninic Acid (BCA) protein assays (Smith et al., 1985) were used for 
quantification of total protein extracts. BSA standards were diluted in 0.25X 
K562 extraction buffer (5 mM HEPES pH 7.9, 105 mM NaCl, 1 mM MgCl2, 0.5 
mM EDTA, 6.25 % w/v glycerol, 0.025 % w/v NP-40) and unknown samples (in 
1X K562 extraction buffer) were diluted four-fold in water, to reduce glycerol 
below the maximum compatible concentration of 10 % (w/v). 3x 100 µL of each 
standard and unknown sample were mixed with 2 mL BCA working reagent 
(28.4 mM BCA, 158.1 mM Na2CO3∙H2O, 8.1 mM sodium tartrate, 110.8 mM 
NaHCO3, 98 mM NaOH, 3.1 mM CuSO4∙5H2O) and incubated at 37 ˚C for 30 
min. Tubes were allowed to cool to room temperature and the absorbance of 
each sample was measured at 562 nm. Average absorbance values were 
calculated from each triplicate and plotted on a standard curve to determine 
protein concentrations of the unknown samples. 
2.1.11 Purification of nucleosomes by sucrose gradient sedimentation 
Native and recombinant nucleosomes were purified from free or excess DNA 
and poly-nucleosomes or non-native species, respectively, by sucrose gradient 
sedimentation (McCarty et al., 1974). 12.2 mL 5-30 % exponential gradients 
were constructed by filling a 10 mL sealed mixing chamber with 5 % sucrose 
solution (in 10 mM Tris-HCl pH 7.5, 100 mM NaCl, 0.25 mM EDTA, 0.1 mM 
PMSF, 0.1 mM benzamidine) and pumping in a 40 % sucrose solution (in the 
same buffer). Gradients were formed by upwards displacement in Ultra-
Clear™ 13.2 mL, 14 x 89 mm tubes (Beckman Coulter, 344059). Gradients 
were overlaid with 1 mL nucleosomes and centrifuged at 288,000 g for 20-24 
hr. Gradients were fractionated by upward displacement using Fluorinert™ 
FC-40 and 0.33 mL fractions collected. Peak fractions were analysed on 
agarose and native gels and stored frozen at -20 or -80 ˚C.  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2.1.12 Agarose gel electrophoresis 
DNA samples were mixed with agarose loading buffer and analysed on 1.5 or 
2.0 % agarose-TAE gels by electrophoresis at 90 V for a suitable length of time. 
Gels and electrophoresis buffer were supplemented with with 0.5 µg/mL 
ethidium bromide to allow visualisation of DNA by fluorescence under UV 
illumination in a G:BOX gel doc (Syngene). 
2.1.13 Polyacrylamide gel electrophoresis 
Histones, octamers and nucleosomes were analysed by a number of 
polyacrylamide gel electrophoresis (PAGE) systems. Gel dimensions (length x 
width x thickness) were varied according to the samples requiring analysis. 
2.1.13.1 Native PAGE 
Nucleosomes were analysed by native TBE-PAGE (Davis, 1964), as described 
(Dyer et al., 2004). 5 % native mini-gels (8 x 8 x 0.1 cm) were pre-
electrophoresed at 200 V for 1 hr at 4 ˚C and electrophoresis buffer (TBE) was 
mixed and re-distributed between the cathode and anode reservoirs. Samples 
were mixed with native loading buffer and electrophoresed towards the anode 
at 200 V for 1.5 hr at 4 ˚C. DNA was visualised by post-staining gels in 0.5 µg/
mL ethidium bromide. Coomassie stain (0.01 % w/v coomassie R-250; 30 % v/v 
methanol; 10 % v/v acetic acid) was subsequently used to visualise proteins. 
2.1.13.2 SDS PAGE 
Proteins were commonly analysed by 15 % SDS PAGE, according to Laemmli 
(1970). Samples dissolved in 8 M urea/10 mM DTT were mixed with 0.5 
volumes SDS loading buffer, loaded onto mini-gels and electrophoresed at 
150 V for 1 hr 50 min. Following electrophoresis, proteins were detected with 
coomassie stain. 
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Following SILAC nucleosome affinity pull downs (SNAP), proteins were 
resolved on 1 mm NuPAGE® Novex® 4-12 % Bis-Tris gels (Life Technologies, 
NP0322) (Margolis and Kenrick, 1967). To avoid cross-contamination between 
lanes, samples were only loaded in every-other well. Gels were 
electrophoresed in MES electrophoresis buffer (including 1mL/L NuPAGE® 
Antioxidant (Life Technologies, NP0005) in the cathode reservoir) at 185 V for 
35 min and proteins visualised using the Novex® Colloidal Blue Staining Kit 
(Life Technologies, LC6025), incubating the gel in Stainer A for 10 min, 
followed by Stainer B for 5 min. Gels were destained and retained in water for 
a maximum of two days prior to in-gel trypsin digestion. 
2.1.13.3 Acid urea (Triton™ X-100) PAGE 
Analysis of the modification state of histone samples was performed using a 
modified version of Panyim and Chalkley’s (1969) AU PAGE method. This gel 
system utilises a low pH to ensure the basic histone proteins have a net 
positive charge, allowing resolution of histones with single charge differences. 
Gel solutions were degassed for 1-2 min prior to initiating polymerisation and 
casting. Large gels (20 x 16 x 0.1 cm, BioRad PROTEAN® II xi Cell) were pre-
electrophoresed at 250 V for ≥9 hr. Histones were dissolved in 8 M urea/10 
mM DTT, mixed with AU loading buffer and loaded with 5-25 µg (total acid 
extracts) or 0.2-4.0 µg (single alkylated histones) per lane. Samples were 
electrophoresed towards the cathode at 15 mA per gel (~400 V) for 9-10 hr, 
with water cooling. 
Addition of a non-ionic detergent, such as Triton™ X-100, to the AU system 
(Bonner et al., 1980) removes the necessity for pre-electrophoresis of the gel, 
improves well formation, generally produces sharper bands and allows 
resolution of primary sequence variants but does reduce the loading capacity 
(Zweidler, 1978; Bonner et al., 1980; Paulson and Higley, 1999). Loadings were 
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similar to those described above for the AU system. Samples were 
electrophoresed at 300 V for 10.5 hr. Proteins were visualised with coomassie 
stain. 
2.1.14 Western blot 
Proteins were electrophoretically transferred from SDS polyacrylamide gels to 
PVDF membranes towards the anode at 100 V for 1 hr at 4 ˚C. AU 
polyacrylamide gels required incubation in AU equilibration buffer (10 % v/v 
methanol, 5 % v/v acetic acid) for 30 min prior to electrophoretic transfer of 
proteins to PVDF membranes towards the cathode at 250 mA for 14 hr at 4 ˚C. 
Transfer efficiency was confirmed by reversible staining of membranes with 
Ponceau-S stain (0.4 % w/v Ponceau-S, 5 % v/v acetic acid). Non-specific 
antibody binding sites on the membrane were blocked with 1 hr incubation in 
TBST/5 % w/v Marvel . Membranes were incubated with primary antibodies, 1
diluted as appropriate (1:1,000-1:10,000) in TBST/2 % w/v Marvel (figure 2.3, 
panel A), for a further 1 hr, washed three times 5 min with TBST/5 % w/v Marvel 
and then incubated with HRP-conjugated secondary antibodies, diluted 
1:10,000 in TBST/2% w/v Marvel (panel A), for 1 hr. Finally, membranes were 
washed three times 5 min with TBST/5 % w/v Marvel, twice 5 min with TBST 
alone and temporarily retained in PBS until detection. 
Chemiluminescence (CL) solutions A (100 mM Tris-HCl pH 8.5, 2.5 mM 
luminol; 0.396 mM p-Coumaric Acid) and B (100 mM Tris-HCl pH 8.5, 0.036 % 
v/v H2O2) were prepared immediately before use, mixed 1:1 and incubated on 
the surface of the membranes for 30 s prior to detection using a LAS 3000 
(Fujifilm), ImageQuant LAS 4000 (GE Healthcare) or G:BOX 5.1 (Syngene) 
digital darkroom system.  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 Marvel in all blocking solutions was substituted with BSA for the detection of H3K27me3 with anti-H3K27me3 1
antibody (Abcam, ab6002).
!!!!!!!!
   !!!!!!!!!!!
2.3 • Antibodies used for Western blotting, native ChIP and IP experiments 
(A) ChIP-grade antibodies were selected from the Antibody Validation Database (Egelhofer et al., 
2011) and purchased from Abcam. (B) Sheep anti-H3K4me2 was prepared in-house using the 
peptide carrying di-methyl lysine (●, me2) at residue 4. Antibodies prepared in-house or 
purchased from Abcam or Pierce were used at the indicated dilutions (and corresponding 
concentrations) for Western blot. For ChIP, immunocomplexes were allowed to form using 25 µg 
of antibody and 100 µg mono-nucleosomes.  
Antibody Species Catalogue number WB dilution WB concentration
H3 Rabbit ab1791 (Abcam) 1:1000 1.000 µg/mL
H3K4me1 Rabbit ab8895 (Abcam) 1:10000 0.100 µg/mL
H3K4me2 Sheep raised in-house 1:5000 0.200 µg/mL
H3K4me3 Rabbit ab8580 (Abcam) 1:10000 0.057 µg/mL
H3K27ac Rabbit ab4729 (Abcam) 1:5000 0.200 µg/mL
H3K27me3 Mouse ab6002 (Abcam) 5:2000 1.000 µg/mL
SSRP1 Rabbit PA1-12699 (Pierce) 1:500 2.000 µg/mL
Spt16 Rabbit PA1-12697 (Pierce) 1:500 2.000 µg/mL
Rabbit (HRP) Goat A0545 (Sigma) 1:10000 1.030 µg/mL
Sheep (HRP) Donkey A3415 (Sigma) 1:10000 0.500 µg/mL
Mouse (HRP) Rabbit A9044 (Sigma) 1:10000 1.100 µg/mL
A
B
H N - A R T K Q T A R K S T G G - CPG2
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2.2 Preparation of native histones, octamers and nucleosomes 
2.2.1 Chicken embryo development 
Fertilised Bovans Brown chicken eggs (Henry Stewart) were incubated in a 
humidified, still air Polyhatch incubator (Brinsea Products Ltd.) at 37-39 ˚C. 
Eggs were turned regularly by the built-in rolling assembly. Developmental 
stage was confirmed according to Hamburger and Hamilton (1951). 
2.2.2 Chicken blood collection 
Five day chicken embryos were removed from yolk sacs and blood collected 
by severing a major blood vessel. Embryos more than half-way through 
development (e.g. fifteen days) were killed by decapitation before collecting 
blood (Home Office, 1997). Blood was collected from mature chickens that 
were killed by exsanguination in a licensed abattoir. In all cases, blood was 
collected into ice-cold blood collection buffer (PBS, 5 mM EDTA, 10 mM 
sodium butyrate, 0.1 mM PMSF, 0.1 mM benzamidine). 
2.2.3 Isolation of nuclei from chicken erythrocytes 
Cells were pelleted at 1,600 g, 5 min and dispersed in CE wash buffer (PBS, 
250 mM sucrose, 10 mM sodium butyrate, 0.1 mM PMSF, 0.1 mM 
benzamidine). Contaminants such as feathers and membrane tissues were 
removed by passing the blood through several layers of gauze. Yolk was 
removed by centrifuging the cells through a 5 mL 30 % w/w sucrose cushion 
(in CE wash buffer) at 2,000 g, 5 min. Cells were resuspended in 40 volumes 
CE lysis buffer (10 mM Tris-HCl pH 7.5, 80 mM NaCl, 10 mM sodium butyrate, 6 
mM MgCl2, 0.1 % Triton™ X-100, 0.1 mM PMSF, 0.1 mM benzamidine) and lysis 
allowed to proceed for 20 min with stirring at 4 ˚C. Nuclei were pelleted with 
2,000 g, 5 min and washed in CE nuclei wash buffer (10 mM Tris-HCl pH 7.5, 80 
mM NaCl, 10 mM sodium butyrate, 6 mM MgCl2, 0.1 mM PMSF, 0.1 mM 
benzamidine) through a 5 mL 30 % sucrose cushion (CE nuclei wash buffer 
with 0.98 M sucrose) at 3,500 g, 5 min. Nuclei were resuspended in the 
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minimum volume of CE nuclei wash buffer and quantified (as DNA) by 
dispersing 1:199 in SSU. If not used immediately, nuclei were adjusted to 40 % 
w/v glycerol for storage at -80 ˚C. 
2.2.4 Acid extraction of histones 
Histones were acid extracted directly from cells or nuclei. Frozen nuclei were 
thawed and washed in 2-3 volumes CE nuclei wash buffer to remove glycerol. 
Cells or nuclei were pelleted by centrifugation (16,000 g, 1 min or 10 s, up to a 
maximum of 14,000 g, respectively) and resuspended in the minimum volume 
of CE nuclei wash buffer. HCl was added to 400 mM and cells or nuclei rolled 
for 2-3 hr at 4 ˚C. Debris (acid insoluble proteins and nucleic acids) was 
pelleted by centrifugation (4,000 g, 10 min) and re-extracted with 400 mM HCl 
for a further 30 min. Debris was re-pelleted as above and histone-containing 
supernatants from both spins combined. Residual debris was removed with 
25,000 g, 10 min and histones precipitated with acetone, as described (section 
2.1.8). 
2.2.5 Preparation of native histone octamers from chicken erythrocytes 
Frozen nuclei were thawed and washed in 2-3 volumes CE nuclei wash buffer. 
Nuclei corresponding to ~10 mg DNA were pelleted at 16,000 g, 1 min and 
resuspended in the minimum volume of CE nuclei wash buffer. The suspension 
was transferred to 15 mL linker histone depletion buffer (50 mM phosphate pH 
6.8, 600 mM NaCl) with 7.5 µL protease inhibitors (Sigma-Aldrich, P8340) and 
DNA sheared by syringing six times with a 3.8 cm 18 gauge needle, then ten 
times with a 5 cm 19 gauge needle. Chromatin was immobilised on 4 g Bio-
Gel® HTP Hydroxyapatite (BioRad, 130-0420), with depletion of linker histones 
left to proceed overnight with rolling at 4 ˚C. The slurry was transferred to an 
Econo-Pac® column (BioRad, 732-1010) containing 0.4 g pre-equilibrated 
Hydroxyapatite and the resin washed extensively at 1 mL/min with 200 mL 
linker histone depletion buffer. Octamers and high molecular weight 
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aggregates were eluted with 40 mL native CE octamer buffer (50 mM 
phosphate pH 6.8, 2.5 M NaCl). Selected protein-containing fractions were 
pooled, concentrated to ~2 mg/mL in a volume of <1.5 mL using a Vivaspin 20 
device with 10 kDa MWCO PES membrane (Sartorius, VS2001) and octamers 
purified from high molecular weight aggregates by size exclusion on a 16/60 
Superdex 200 column (packed in-house), equilibrated with octamer folding 
buffer (10 mM Tris-HCl pH 7.5, 2 M NaCl, 1 mM EDTA, 10 mM DTT). 
2.2.6 Preparation of native mono-nucleosomes from chicken erythrocytes 
Frozen nuclei were thawed and washed in 1 volume CE Nuclei Wash Buffer. 
Nuclei were pelleted at 800 g, 5 min and dispersed in MNase digest buffer (10 
mM Tris-HCl pH 7.5, 10 mM NaCl, 10 mM sodium butyrate, 6 mM MgCl2, 1 mM 
CaCl2, 0.1 mM PMSF, 0.1 mM benzamidine) to 5 mg/mL. The suspension was 
divided into three equal aliquots and digested with 200 U/mL MNase 
(Worthington Biochemical Corporation, LS004797) at 37 ˚C. Digestion was 
allowed to proceed for 6, 8 or 10 min and terminated by the addition of EDTA 
to 10 mM and chilling on ice for 5 min. Nuclei were pelleted (12 s up to a 
maximum of 14,000 g) to yield nucleosome-containing supernatant (S1). 
Pellets were resuspended in 2-4 volumes CE nuclei lysis buffer (10 mM Tris-HCl 
pH 7.5, 10 mM sodium butyrate, 2.5 mM EDTA, 0.1 mM PMSF, 0.1 mM 
benzamidine) and lysis of the nuclei allowed to proceed for 10 min. Following 
centrifugation and removal of supernatant S2, the pellet was again 
resuspended in lysis buffer and centrifuged to yield S3. Nucleosome-
containing supernatants (S2 and S3) were pooled with S1, adjusted to 50 mM 
NaCl and rolled with 30 mg/mL CM Sephadex C-25 (GE Healthcare, 17-0210) 
for 1 hr at 4˚ C to deplete linker histones. Nucleosomes were purified on 
sucrose gradients and stored at -20 ˚C. 
!
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2.3 Native Chromatin Immunoprecipitation (nChIP) 
2.3.1 Preparation of anti-H3K4me2 antibody 
Most ChIP-grade antibodies were obtained commercially (Abcam), except for 
anti-H3K4me2 IgG, which was purified from sheep serum in-house. 
2.3.1.1 Caprylic acid fractionation 
Serum was thawed and diluted in 2 volumes 60 mM sodium acetate [pH 4.0]. 
With constant stirring, caprylic acid was added drop-wise to a final 
concentration of 2.5 % v/v and the solution left to mix for 40 min at room 
temperature. Precipitated serum proteins were removed by centrifugation 
(5,000 g, 20 min, 22 ˚C). The IgG-containing supernatant was passed through 
two layers of Whatman® Grade 1 filter paper (GE Healthcare, 1001-090) to 
remove insoluble lipids that remain within the supernatant and dialysed 
against two changes of PBS at 4 ˚C, with the last dialysis step overnight. 
2.3.1.2 Affinity purification of IgG 
A CpG affinity column on which the H3K4me2 (aa 1-13) peptide (figure 2.3, 
panel B) had been synthesised, was washed with 5 CV 6 M Guanidine HCl, 15 
CV 10 mM HCl and 5 CV PBS. 11 mL of IgG (~88 mg) was loaded onto the 
column three times to ensure maximum binding and the column washed with 
15 CV PBS, 5 CV PBS/500 mM NaCl and 5 CV PBS. Anti-H3K4me2 was eluted 
with 4-5 mL 3.5 M KSCN and immediately desalted on a 8/75 G-25 column 
(packed in-house), equilibrated with 10 mM NaHCO3. Void volume fractions 
were pooled, quantified and stored in lyophilised aliquots at -20 ˚C. 
2.3.2 ChIP 
ChIPs were performed essentially as described (Thorne et al., 2004). Sucrose 
gradient purified mono-nucleosomes were applied to Illustra NAP-10 columns 
(GE Healthcare, 17-0854) equilibrated in ChIP buffer (10 mM Tris-HCl [pH 7.5], 
50 mM NaCl, 10 mM sodium butyrate, 1 mM EDTA, 0.1 mM PMSF, 0.1 mM 
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benzamidine, 1 µL/mL protease inhibitors (Sigma-Aldrich, P8340)) to remove 
sucrose and void volume fractions pooled and concentrated using a Vivaspin 
20 device to ≥1 mg/mL. Small (~10 µg) samples were retained (input). 
Nucleosomes corresponding to 100 µg DNA were rolled with 25 µg of specific 
antibody for 2 hr at 4 ˚C. Immunocomplexes were immobilised on 20-25 mg 
Protein G agarose (pre-washed using a CoStar® Spin-X® unit with 0.45 µm CA 
filter (Corning, 8162) with 5x 200 µL ChIP buffer) with rolling for 2 hr at 4 ˚C. 
Slurries were placed in CoStar® Spin-X® units and centrifuged (6,000 g, 30 s) 
to recover the resin and filtrate. Filtrates were retained (unbound) and the resin 
washed five times with 450 µL ChIP buffer. Resins were incubated once with 
150 µL ChIP buffer containing 1.5 % w/v SDS, then twice with 150 µL ChIP 
buffer containing 0.5 % w/v SDS (15 min for each incubation) to elute the 
bound material. Following each elution step, resins were centrifuged (6,000 g, 
30 s) and filtrates retained and pooled. Input and unbound material was 
adjusted to 0.2 % w/v SDS. DNA and protein was recovered from all three 
samples for real-time PCR or Western blot analyses, respectively. 
2.3.3 Real-time PCR (RT-PCR) 
2.3.3.1 Primer and probe design 
Sequence data for the chicken ß-globin locus was kindly provided by Prof. G 
Felsenfeld (NIH, Bethesda, MA, USA). Primers and probes to amplify selected 
points across the locus were designed by Dr F Myers (IBBS, University of 
Portsmouth, UK) using Primer Express® software, version 2.0 (Life 
Technologies) and synthesised commercially (Eurogentec). Primers were 
designed to: i) be between 18 and 28 nucleotides in length; ii) have a GC 
content within the range of 20-80 %; iii) have a Tm of 58-60 ˚C; and iv) amplify 
50-150 bp of DNA. Ultimately, primers were 17-30 bases in length with a GC 
content of 33.3-70.6 % and Tm of 46-64 ˚C and amplified DNA corresponding 
to less than a nucleosome in length (64-151 bp). TaqMan® FAM™/TAMRA™ 
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probes were designed to: i) anneal within 3 bases of the forward or reverse 
primer, without overlapping; ii) be between 18 and 28 nucleotides in length; 
iii) have a GC content of 20-80 %; and iv) have a Tm of 10 ˚C greater than the 
primers. Furthermore, probes contained more Cs than Gs, with not more than 
four consecutive Gs and no G on the 5’ end, since Gs naturally quench FAM™ 
fluorescence, thus reducing the signal. A full list of primers and probes is 
provided (supplementary figure S3.1). 
2.3.3.2 Preparation of gDNA standards 
gDNA was kindly provided by Dr F Myers. Approximately 1 mg of 15DCE 
nuclei were lysed in 3 mL CE nuclei lysis buffer. Lysates were adjusted to 0.5 % 
SDS and 0.3 mg/mL Proteinase K and incubated overnight at 37 ˚C. Digested 
proteins were salted out by addition of 1 mL saturated NaCl (~6 M), vigorous 
shaking for 15 s and centrifugation with 1,200 g for 15 min. DNA was 
recovered from the supernatants by ethanol precipitation and standards 
prepared by serial dilution in SSC. 
2.3.3.3 RT-PCR 
For each amplicon, serial dilutions of gDNA standards (200 to 0.2 ng) were 
prepared in 31.5 µL reactions and three 10 µL aliquots amplified to produce a 
standard curve using ViiA™ 7 software (Life Technologies). Reaction mixtures 
for input and bound fractions were prepared in triplicate, using 20 ng input or 
1 ng bound DNA. Unbound reactions were prepared in duplicate using 13 ng 
DNA in a 21 µL reaction mixture (figure 2.4, panels A and B). Thermal cycling 
was performed using a ViiA™ 7 system (Life Technologies) and data generated 
using ViiA™ 7 software (panels C and D). 
2.3.3.4 RT-PCR data analysis 
Data was exported to Microsoft Excel and used to determine the enrichments 
or depletions of histone PTMs at each amplicon, as shown (figure 2.4, panel E).  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2.4 • Real-time PCR 
DNA from ChIP experiments was used for Real-Time PCR. (A-B) Reactions were prepared and 
aliquoted into 96-well plates. 5DCE and 15DCE ChIP input, bound and unbound samples were 
placed into wells A-C, D-F and G-H, respectively. gDNA standards and a non-template control 
were placed into wells 11-12. (C-D) Reactions were subject to thermal cycling, where step 1 
activated the AmpliTaq® fast DNA polymerase (in the TaqMan® Fast Advanced Master Mix - Life 
Technologies, 4444963) and step 2 was repeated for 40 cycles of denaturation (“melting”) and 
annealing/extension. Template DNA was melted at 95 ˚C in 20 s cycles and primers and probes 
annealed. Extension by the polymerase was allowed to proceed for 20 s at 60 ˚C. During 
extension from the forward primers (−), TaqMan® probes (●−●) were digested by the 
polymerase to release the FAM™ fluorophore. Increasing fluorescence (resulting from 
decreased proximity of FAM™ with the TAMRA™ quencher) was measured and used to 
quantify the DNA (using the known quantities of gDNA standards) by ViiA™ 7 software to 
generate amplification plots and CT values. (E) CT values and DNA quantities for each sample 
were exported to Microsoft Excel and analysed to calculate enrichments (i), depletions (ii) and 
errors (iii) and plot the representation of each amplicon in the input material. Depletion 
calculations were made if enrichment values were <1. B/I, enrichment; I/B, depletion; QM, 
quantity mean; SD, standard deviation.
   
Component 3 Reactions 2 Reactions 1 Reaction Stock
1X Fast Adv. Master Mix 15.8 µL 10.5 µL 5.3 µL 2X
900 nM Forward Primer 2.8 µL 1.9 µL 0.9 µL 10 µM
900 nM Reverse Primer 2.8 µL 1.9 µL 0.9 µL 10 µM
200 nM TaqMan® Probe 3.2 µL 2.1 µL 1.1 µL 2 µM
200 ng Standard 5.7 µL - - - - - - 35 ng/µL
0.195 - 50 ng Standards 5.0 µL - - - - - - 0.039 - 10 ng/µL
Non-template Control - - - - - - - - - N/A
20 ng Input 2.0 µL - - - - - - 10 ng/µL
2 ng Bound 2.0 µL - - - - - - 1 ng/µL
13 ng Unbound - - - 1.3 µL - - - 10 ng/µL
Water to 31.5 µL to 21.0 µL to 10.5 µL - - -
Step Cycles Temperature Time
1 1 95˚C 20 sec
2 40
95˚C 1 sec
60˚C 20 sec
Melting
Annealing
Polymerase 
binding
Extension
A
B
C
D
1 2 76543 8 9 10 11 12
A
B
C
D
E
F
G
H
E 
      i 
 
      ii 
 
      iii
B/I = ( Bound QM x 10 ) 
         Input QM 
 
I/B =        Input QM 
  ( Bound QM x 10 ) 
 
Error =            Bound SD         Input SD 
     Bound QM    Input QM
+ 1
- 1
(    )
(    )
((    )  (   ))+ x B/I
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2.4 Preparation of recombinant histones, octamers and nucleosomes 
Recombinant Xenopus laevis histone expression plasmids, kindly donated by 
Prof. T Richmond (ETH Zurich, Switzerland), were prepared essentially as 
described (Luger et al., 1997b). 
2.4.1 Site-directed mutagenesis 
Point mutations in histone H3 at residues 4, 27 and 110, necessary for: i) the 
replacement or incorporation of cysteine (C110S or K4C/ K27C) for generation 
of methyl- or acetyl-lysine analogues (KC4me1 or KC27ac, respectively) by 
alkylation (Simon, 2010); or ii) the genetic installation of acetylated lysine 
(K27ac) using the amber codon (TAG) (Neumann et al., 2009), were introduced 
into pET3d-H3 plasmids using the QuikChange II Site-Directed Mutagenesis 
kit (Agilent Technologies, 200523) following the manufacturers’ protocol 
(figure 2.5). Primers were designed using the QuikChange Primer Design 
software (available online at http://www.genomics.agilent.com). Following 
PCR, (hemi-)methylated DNA was removed by digestion with 10 U/µL DpnI for 
1 hr at 37 ˚C and mutant plasmids transformed into E. coli for sub-cloning. 
2.4.2 Expression of canonical and mutant recombinant histones 
All culture media was supplemented with 100 µg/mL ampicillin and 25 µg/mL 
chloramphenicol. BL21 (DE3) pLysS cells were transformed with recombinant 
histone plasmids. Single colonies were used to inoculate 375 mL 2-YT media in 
2 L flasks and cultures were incubated for up to 16 hr at 25 ˚C and 60 rpm. 
Cultures were adjusted to 750 mL with pre-warmed 2-YT media and incubated 
at 37 ˚C and 400 rpm. At OD600 0.6-0.8 AU, histone expression was induced 
with 500 µM IPTG and cultures grown for a further 2.5-3.5 hr. Cells were 
harvested by centrifugation (6,000 g, 20 min), resuspended in histone wash 
buffer (HWB) (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 1 mM DTT, 1 mM PMSF, 
1.mM benzamidine) and stored at -20 ˚C.  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2.5 • Site-directed mutagenesis to incorporate mutations into pET3d-H3 
(A) Primers containing the required mutations were reconstituted in annealing buffer (10 mM Tris-
HCl [pH 8.2], 150 mM NaCl, 10 mM MgCl2). (B) Several amplification reactions were set up for 
each mutation, using a range of template amounts. (C-D) The DNA template (◎) was denatured, 
primers (?) annealed and daughter strands synthesised using a Pfu-based polymerase. 
(Hemi-)methylated parental DNA strands (◎) were digested by DpnI and small aliquots of each 
reaction (containing mutant daughter strands, ◎) transformed into E. coli. 
(D) adapted from the QuikChange Instruction Manual, Revision D  
A
B
5' GAG GAC ACC AAC CTG TCC GCC ATC CAC GCC 3'!
3' CTC CTG TGG TTG GAC AGG CGG TAG GTG CGG 5'!
!
!
5' GG AGA TAT ACC ATG GCC CGT ACC TGC CAG ACC GCC CGT AAA TCC 3'!
3' CC TCT ATA TGG TAC CGG GCA TGG ACG GTC TGG CGG GCA TTT AGG 5'!
!
!
5' ACC AAG GCA GCC AGG TGC TCC GCT CCT GCT ACC 3'!
3' TGG TTC CGT CGG TCC ACG AGG CGA GGA CGA TGG 5'!
!
!
5' C AAG GCA GCC AGG TAG TCC GCT CCT GC 3'!
3' G TTC CGT CGG TCC ATC AGG CGA GGA CG 5'
C110S       fwd 
       rev
K4C       fwd 
       rev
K27C       fwd 
       rev
K27amb     fwd 
       rev
Component 50 µL Reaction Stock
1X Reaction Mix 5 µL 10X
10-50 ng Plasmid DNA 1 - 5 µL 10 ng/µL
125 ng Forward Primer 1 µL 125 ng/µL
125 ng Reverse Primer 1 µL 125 ng/µL
dNTP Mix 1 µL proprietary
Water to 49 µL - - -
Pfu Polymerase 1 µL proprietary
Step Cycles Temperature Time
1 1 95˚C 5 min
2 24
95˚C 1 min
55˚C 30 sec
72˚C 5 min 1 sec
3 1 72˚C 5 min
C
D
DpnI
Transformation
Mutagenesis
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2.4.3 Purification of canonical and mutant recombinant histones 
All histones were insoluble upon expression and were isolated from inclusion 
bodies. Cells from 2 L of culture were lysed on thawing and DNA sheared by 
sonicating the suspension with 5 s pulses (Vibra-Cell™ VCX 500 ultrasonic 
processor, with 19 mm probe, 630-0219) until the viscosity was reduced. 
Inclusion bodies were harvested and washed once with 35 mL HWB-T (HWB 
supplemented with 1 % w/v Triton™ X-100) and once with 35 mL HWB, with 
centrifugations at 23,000 g for 15 min. The pellet was mixed with 500 µL 
DMSO for 30 min, then 9.5 mL histone unfolding buffer (7 M guanidine HCl, 20 
mM Tris-HCl pH 7.5, 10 mM DTT) added and the suspension mixed for a 
further 30 minutes. Debris was pelleted at 23,000 g, 30 min and re-extracted 
with DMSO and unfolding buffer. Histone-containing supernatants were 
retained, pooled and applied to 2 g Bio-Gel® HTP hydroxyapatite columns 
(pre-equilibrated in unfolding buffer) to remove residual DNA. Filtrates were 
applied to a HiPrep 26/10 Desalting (GE Healthcare, 17-5087) or XK 26/20 
column (GE Healthcare, 28-9889, packed in-house with Sephadex™ G-25 fine 
resin), equilibrated with SP binding buffer (6 M urea, 50 mM sodium acetate, 2 
mM Tris, 200 mM NaCl, 0.1 mM EDTA, 1 mM DTT, pH 4.75). Void volume 
fractions were pooled and applied to two 5 mL HiTrap SP HP columns (in 
series) and histones purified from contaminant proteins with a linear 0.2-1.0 M 
NaCl gradient. Finally, histones were applied to a HiPrep 26/10 or XK 26/20 
G-25 column equilibrated with 0.5 % v/v formic acid and void volume fractions 
pooled, quantified, aliquoted and lyophilised. Dry histones were stored  frozen 
at -20 ˚C. For characterisation of some histones, samples were applied to a 
reversed-phase 21.2 mm ID x 25 cm Zorbax 300SB-CN column (Agilent 
Technologies ), equilibrated with 0.1 % v/v TFA, and eluted with a multi-step 2
acetonitrile gradient. Samples of H3 were analysed by ESI-TOF-MS to 
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 Agilent Technologies have discontinued the 21.2 mm ID Zorbax 300SB-CN columns. Alternatives with a 4.6 mm ID 2
include 5, 15 or 25 long columns (catalogue numbers 880950-905, 883995-905 or 880995-905, respectively)
determine the average molecular weight (15,270 Da) (supplementary figure 
S2.1). 
2.4.4 Synthetic methylation and acetylation of histones by alkylation 
2.4.4.1 Incorporation of KC4me1 into H3 by alkylation 
Mutant H3 histones (H3 K4C C110S) were alkylated according to Simon et al. 
(2007) and Simon (2010) to generate mono-methyl lysine analogues (MLA) at 
residue 4 (H3KC4me1). 1 mg of H3 K4C C110S was dissolved in 90 µL 
alkylation buffer (4 M guanidine HCl, 1 M HEPES pH 8.3, 10 mM D/L-
methionine) and 2 µL of 1 M DTT and incubated at 37 ˚C for 1 hr. 40 µL of 3 M 
(2-chloroethyl)methylammonium chloride (Karl Industries, M200) was added 
and reactions allowed to proceed at room temperature for 5 hr. 1 µL of 1 M 
DTT was added half-way through the reaction. Reactions were quenched by 
addition of at least a two-fold molar excess of neat (14.3 M) ßME to reagent 
and incubating at room temperature for 30 min. Alkylated histones were 
desalted into formic acid using NAP-10 (GE Healthcare, 17-0854) or PD-10 (GE 
Healthcare, 17-0851) columns and void volume fractions lyophilised. Histones 
were dissolved in 100 mM DTT and applied to a 7.5 mm ID x 7.5 cm TSKgel® 
CM-3SW column (Sigma-Aldrich, 807162), equilibrated in CM-3SW binding 
buffer (6 M urea, 100 mM NaCl, 50 mM sodium acetate, 0.2 mM EDTA, pH 4.5), 
and eluted with a multi-step NaCl gradient (in the above buffer) to separate 
the MLA from un-reacted material. Samples were analysed by AU PAGE, 
Western blot and mass spectrometry. 
2.4.4.2 Incorporation of KC27ac into H3 by alkylation 
Reactions to incorporate acetyl-lysine analogues were essentially as described 
for the synthesis of H3 KC4me1 but used 16.1 µL of 8.14 M N-(2-
chloroethyl)acetamide (Sigma-Aldrich, 191310 ) as the alkylation reagent. 3
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 Sigma-Aldrich have since discontinued product 191310, which was sold as a 99 % (8.14 M) solution. An alternative 3
(catalogue number CDS001220) is available, sold in 500 mg aliquots.
Alkylated histones were applied to NAP-10 or PD-10 desalting columns, 
equilibrated with 0.5 % v/v formic acid, and void volume fractions pooled and 
lyophilised. Samples were analysed by SDS PAGE, immunoprecipitation, 
Western blot and mass spectrometry. 
2.4.4.3 Histone immunoprecipitation 
Following alkylation trials to generate KC27ac, reaction efficiency was tested by 
immunoprecipitation. 7 mg of Protein G agarose was washed with 5x 100 µL 
RIPA buffer (10 mM Tris-HCl [pH 7.5], 50 mM NaCl, 10 mM sodium butyrate, 1 
mM EDTA, 0.5 % w/v Triton™ X-100, 0.1 % w/v SDS, 0.1 mM PMSF, 0.1 mM 
benzamidine) and blocked in 100 µL RIPA buffer containing 100 µg/mL Type V 
Calf-Thymus DNA (Sigma-Aldrich, D1751) and 40 ng/mL BSA for 2 hr with 
rolling at 4 ˚C. 4 µg of histone (H3 Kc27ac) was dissolved in 80 µL RIPA buffer 
supplemented with 1 µL protease inhibitors (Sigma-Aldrich, P8340) and 
incubated with 25 µg rabbit anti-H3K27ac (Abcam, ab4729) for 2 hr at 4 ˚C. 
Immunocomplexes were immobilised on the pre-blocked Protein G agarose 
for 2 hr at 4 ˚C. The unbound fraction was retained and the resin washed with 
three times 100 µL RIPA Buffer and three times 100 µL RIPA Buffer containing 
500 mM NaCl. The bound fraction was eluted with two 15 min incubations in 
150 µL RIPA buffer supplemented with 1.5 % w/v and 0.5 % w/v SDS. Proteins 
were precipitated with acetone and analysed by SDS PAGE and Western blot. 
2.4.5 Genetic acetylation of histones 
H3 was expressed using a method similar to Neumann et al. (2008, 2009) to 
genetically incorporate K27ac. pET3d-H3 carrying K4C, K27amb and C110S 
mutations was transformed into BL21 (DE3) pLysS cells, together with pBK-
AcKRS3 (kindly provided by Prof. J Chin (MRC LMB, Cambridge, UK)). Cells 
were cultured to an OD600 of 0.7 AU and supplemented with 20 mM 
nicotinamide and 10 mM N-ε-acetyl-lysine. After 30 min incubation, histone 
expression was induced with 500 µM IPTG and cultures grown a further 3.5 hr. 
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H3 K4C K27ac C110S was purified and alkylated, as described above, to 
produce H3 KC4me1 K27ac C110S. 
2.4.6 Preparation of 601.2 DNA 
601.2 DNA, based on the Widom 601 nucleosome phasing sequence (Lowary 
& Widom, 1998), was kindly provided by Dr T Bartke (Gurdon Institute, 
University of Cambridge, UK) as a 16-tandem repeat in pUC19 vector 
(pUC19-16x601.2). 
2.4.6.1 Isolation of 601.2 DNA 
XL10-Gold cells were transformed with pUC19-16x601.2 and the plasmid 
isolated by large-scale alkaline lysis. Plasmids (200 µg/mL) were digested with 
200 U/mL EcoRI-HF™ (NEB, R3101) and 200 U/mL EcoRV-HF™ (NEB, R3195) in 
NEBuffer 4 (NEB, B7004) for 14 hr at 37 ˚C to yield sixteen 601.2 fragments per 
plasmid. 601.2 DNA was purified from vector and linker DNA on five serially 
linked 1 mL HiTrap Q HP columns (GE Healthcare, 17-1153), equilibrated with 
Q binding buffer (10 mM Tris-HCl pH 7.5). 
2.4.6.2 Biotinylation of 601.2 DNA 
The 5’ overhang generated by EcoRI cleavage was end-filled with biotinylated 
dUTP and unmodified dATP nucleotides. 601.2 DNA (407 µg/mL) was 
incubated with 40 µM Biotin-11-dUTP (Yorkshire Bioscience, P1611), 100 µM 
dATP and 33.3 U/mL Klenow fragment lacking exonuclease activity (NEB, 
M0212) in NEBuffer 2 (NEB, B7002) for 2 hr at 25 ˚C. Reactions were quenched 
with 20 mM EDTA (final), phenol-chloroform extracted 2-3x, ethanol 
precipitated and biotinylated 601.2 DNA was purified from excess nucleotides 
by size exclusion on a 10/30 Sephacryl S-300 column (packed in-house), 
equilibrated with S-300 buffer (20 mM Tris-HCl pH 7.5, 100 mM NaCl, 0.2 mM 
EDTA). Void volume fractions were pooled, precipitated with ethanol and 
redissolved in 10 mM Tris-HCl [pH 8.5]. 
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2.4.7 Octamer folding 
Purified histones (H2A, H2B, H3 (or modified H3) and H4) were mixed at 
equimolar ratios in histone unfolding buffer and dialysed against three 
changes of octamer folding buffer (10 mM Tris-HCl pH 7.5, 2 M NaCl, 1 mM 
EDTA, 10 mM DTT) at 4 ˚C, with the third or fourth dialysis step allowed to 
proceed for ≥16 hr. Total dialysis time was typically >25 hr. Octamers were 
concentrated to ≤1.5 mL using Vivaspin 20 centrifugal concentrators with 10 
kDa MWCO PES membranes (Sartorius, VS2001) and purified from high 
molecular weight aggregates by size exclusion on a 16/60 Superdex 200 
column (packed in-house) equilibrated with octamer folding buffer. Peak 
fractions were analysed by SDS PAGE. 
2.4.8 Nucleosome assembly 
Biotinylated 601.2 DNA and folded octamers were dialysed against 
nucleosome assembly buffer A (10 mM Tris-HCl pH 7.5, 2 M KCl, 1 mM EDTA, 1 
mM DTT) for 24 hours in a microdialyser. DNA and octamers were mixed 1:1 
and nucleosomes assembled according to Dyer et al. (2004) with exponentially 
decreasing KCl over 18 hours (figure 2.6). Nucleosomes were dialysed for a 
further 3-6 hours against nucleosome assembly buffer B (buffer A with 250 mM 
KCl). 
Nucleosomes were purified from excess DNA and non-native species (e.g. 
nucleosomes lacking H2A-H2B dimer(s)) using 5-30 % exponential sucrose 
gradients. Peak fractions were analysed by agarose gel electrophoresis and 
native PAGE.  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2.6 • Nucleosome assembly apparatus 
(A) Octamers and 601.2 DNA were mixed to equimolar ratios and dialysed against exponentially 
decreasing salt in the apparatus pictured. A Büchner flask was filled to the side arm (~500 mL) 
with nucleosome assembly buffer A (2 M KCl) to maintain a constant volume. Nucleosome 
assembly buffer B (250 mM KCl) was added to the flask by pump 1 (set to 1.75 mL/min) to 
generate an exponentially decreasing gradient of KCl. At the same time, buffer was pumped 
(pump 2) in a closed loop between the flask and a microdialyser (which contained the samples of 
octamers mixed 1:1 with DNA). (B) The microdialyser allowed simultaneous small-scale assembly 
of up to 20 different nucleosomes. (C) Scheme for the assembly of nucleosomes by salt gradient 
dialysis (concentrations in mM).  
sample wells
'O' rings
buffer inlet/outlet
Dialysis 
membrane
A
B
microdialyser
B: 250 mM KCl
pump 1
A: 
2 M KCl
pump 2 sample wells
overflow
C
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2.4.9 SEC-MALLS analysis of nucleosomes 
Sucrose gradient purified nucleosomes were applied to NAP-10 columns 
equilibrated in SEC-MALLS buffer (10 mM Tris-HCl pH 7.5, 50 mM NaCl, 0.1 
mM EDTA, 0.1 mM PMSF, 0.1 mM benzamidine) and void volume fractions 
pooled and quantified. Nucleosomes corresponding to up to 10 µg DNA were 
applied to a 7.8 mm ID x 30 cm long 5 µm fused silica analytical size exclusion 
column (300 Å pore size with 5-1,250 kDa range) (Wyatt Technology, WTC-
MP030S5), analysed on a miniDAWN™ TREOS® instrument (Wyatt Technology) 
and characterised using ASTRA® 6 software (Wyatt Technology) to determine 
molecular weights, a differential index of diffraction (dn/dc) of 0.175 mL/g 
(Dechassa et al., 2011) was used. 
!
2.5 K562 cell culture 
2.5.1 Starting cell cultures from frozen stocks 
K562 cells, derived from a patient with chronic myelogenous leukaemia (Lozzio 
& Lozzio, 1975), were purchased from HPA Cultures. 1 mL aliquots were 
thawed at 37 ˚C, washed in K562 media (RPMI 1640, 8 % v/v FCS, 100 U/mL 
penicillin, 100 µg/mL streptomycin) and pelleted at 100 g, 5 min, 22 ˚C. Cell 
pellets were resuspended in 5-10 mL fresh K562 media and transferred to 
25-75 cm2 flasks. 
2.5.2 Maintaining cell cultures 
Cultures (10-60 mL) were maintained at 0.5-1.0 x 106 cells/mL at 37 ˚C in a 5 % 
CO2 humidified atmosphere in 25-75 cm2 flasks and passaged every 24-48 hr. 
Suspension cultures were started with 50-200 mL confluent culture in 250 mL 
spinner flasks. After each passage, suspension cultures were purged with 95 % 
air/5 % CO2 and maintained at 37 ˚C with stirring at 100 rpm. Culture densities 
and viabilities were monitored every 24 hr by mixing small aliquots of each 
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culture with 0.4 % Trypan Blue (1:1) and analysing with a Countess™ 
automated cell counter (Life Technologies, C10227) using the following 
parameters: i) sensitivity , 5; ii) cell size , 5-30 µm; and iii) circularity , 80 %. 4 5 6
2.5.3 Stable isotope labelling by amino acids in cell culture (SILAC) 
Labelled K562 media was prepared with RPMI 1640 powder (lacking arginine, 
lysine and glutamine - Biosera, SM-R0379), 200 mg/L arginine-13C6,15N4-HCl 
(Sigma-Aldrich, 608033), 40 mg/L lysine-13C6,15N2-HCl (Sigma-Aldrich, 
608041), 2 mM L-glutamine, 0.1 % v/v NaHCO3, 5.2 mg/L phenol red, 8 % v/v 
dialysed FCS, 100 U/mL penicillin and 100 µg/mL streptomycin. Media was 
filtered using 0.22 µm Stericup® systems (Millipore, SCGVU05RE). Cells were 
harvested from healthy cultures by centrifugation (100 g, 5 min, 22 ˚C), 
resuspended in labelled K562 media and cultured for at least six doublings, to 
ensure full incorporation of labelled amino acids (Ong et al., 2002; Ong et al., 
2004). Labelling was verified by tryptic MS (section 2.6.2). 
2.5.4 Preparing frozen cell stocks 
Cells were harvested from healthy cultures (as described above) and 
resuspended in K562 freezing medium (RPMI 1640, 10 % v/v FCS, 10 % v/v 
DMSO). 1.0-1.5 mL aliquots were cooled at -1 ˚C/min using a Mr Frosty™ 
freezing container (Thermo Scientific, 5100-0001) until frozen and stored 
under liquid or vapour phase nitrogen. 
!
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 Sensitivity refers to the contrast between cells and the background. Values of 6-10 or 1-4 are used to increase 4
sensitivity of the instrument in case of poor cell staining or high background, respectively.
 Cell size refers to diameter of the objects being counted. K562 have an average diameter of 17 µm.5
 Circularity refers to the roundness of the cells to define which objects are included in the measurements. Values 6
above or below 80 % indicate very round or odd-shaped cells, respectively.
2.6 SILAC nucleosome affinity pull down (SNAP) 
2.6.1 K562 nuclear protein extract preparation 
Protein extracts were prepared from K562 cells according to Dignam et al. 
(1983). All buffers were pre-chilled on ice. Cultures were grown to 0.8-1.0 x 106 
cells/mL and centrifuged at 1,000 g, 10 min, 4 ˚C. Cell pellets were washed 
twice in 50 mL PBS, centrifuging at 2,000 g, 10 min, 4 ˚C prior to resuspending 
the final pellet in 5-10 volumes K562 swelling buffer (10 mM HEPES pH 7.9, 10 
mM KCl, 4 mM MgCl2, 0.1 mM PMSF, 0.1 mM benzamidine, 1 µL/mL protease 
inhibitors (Sigma-Aldrich P8340)) and incubating on ice, 10 min. Cells were 
pelleted, resuspended in 1 volume K562 lysis buffer (K562 swelling buffer 
supplemented with 0.2 % w/v NP-40) and lysis effected in a Dounce 
homogeniser with 10 strokes of the tight pestle. A small aliquot was retained 
to confirm lysis by trypan blue staining. Nuclei were pelleted at 4,000 g, 15 
min, 4 ˚C and the cytoplasmic fraction (supernatant) retained on ice. Nuclei 
were resuspended in 10 volumes K562 nuclei wash buffer (K562 swelling 
buffer containing 150 mM NaCl), and re-pelleted. At this point, nuclei could be 
stored at -80 ˚C, after centrifuging through a 5 mL sucrose cushion (K562 
nuclei wash buffer containing 0.98 M sucrose), resuspending the pellets in the 
minimum volume of K562 nuclei wash buffer and adjusting to 40 % w/v 
glycerol. 
Frozen nuclei were thawed and washed in 1 volume K562 nuclei wash buffer. 
Nuclear pellets were resuspended in 2 volumes K562 extraction buffer (20 mM 
HEPES pH 7.9, 420 mM NaCl, 4 mM MgCl2, 0.2 mM EDTA, 25 % w/v glycerol, 
0.1 % w/v NP-40, 0.1 mM PMSF, 0.1 mM benzamidine, 1 µL/mL protease 
inhibitors (Sigma-Aldrich P8340)) and rolled at 4 ˚C for 1 hr. Extracts 
(cytoplasmic and nuclear) were centrifuged at 25,000 g, 20 min, 4 ˚C and 
chromatin pellets retained at -80 ˚C. Extracts were transferred to Ultra-Clear™ 
4 mL, 11 x 60 mm tubes (Beckman Coulter, 344062) and re-centrifuged with 
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485,000 g, 1 hr, 4 ˚C. Tubes were punctured at the base using a hypodermic 
needle and extracts collected into a syringe without taking lipids (which float 
at the top of the tube). Extracts were quantified by BCA assay and stored 
frozen at -80 ˚C. 
2.6.2 SILAC verification 
Protein extracts were mixed at 1:1, 1:3 and 1:10 ratios (using BCA assay-
determined protein concentrations) to verify the stable isotope labelling (Ong 
et al., 2002). 10 µg aliquots of the extract mixtures were resolved on 4-12 % 
Bis-Tris gels and gel slices subject to trypsin digestion (section 2.6.4) followed 
by mass spectrometry.  
2.6.3 SNAP 
SNAP was performed essentially as described by Bartke et al. (2010) using 
both forward and reverse experiments (see below). Sucrose gradient purified 
recombinant mono-nucleosomes were applied to NAP-10 columns 
equilibrated in nucleosome assembly buffer B (250 mM KCl) and void volume 
fractions pooled and quantified. Nucleosomes corresponding to 13.2 µg of 
DNA were supplemented with 0.1 % w/v NP-40 and immobilised on 700 µg 
Dynabeads® MyOne™ Streptavidin T1 (Life Technologies, 65601) by rolling for 
1 hr at 4 ˚C. Beads were washed three times with 1 mL SNAP binding buffer (20 
mM HEPES pH 7.9, 150 mM NaCl, 0.2 mM EDTA, 20 % w/v glycerol, 0.1 % w/v 
NP-40, 0.1 mM PMSF, 0.1 mM benzamidine, 1 µL/mL protease inhibitors 
(Sigma-Aldrich P8340)). Protein extracts were adjusted to 0.5 mg/mL and 150 
mM NaCl in SNAP binding buffer and 1 mL (0.5 mg) incubated with the beads 
for 4 hr. In the forward pull downs, control (unmodified) or modified 
nucleosomes were incubated with unlabelled or labelled extracts, respectively, 
whilst in reverse experiments, control or modified nucleosomes were 
incubated with labelled or unlabelled extracts, respectively. Following five 1 
mL SNAP binding buffer washes, beads from each pair of pull downs were 
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pooled and bound proteins eluted in 30 µL NuPAGE® LDS sample buffer with 
15 min agitation at 75 ˚C. Proteins were resolved on NuPAGE/Novex 4-12 % 
Bis-Tris gels. 
2.6.4 In-gel trypsin digestion 
All incubation steps were performed at 25 ˚C on a shaking hot block operating 
at 1,400 rpm, unless otherwise stated. Proteins were subject to in-gel trypsin 
digestion (Olsen et al., 2004) and peptides purified on C18 tips, as described 
(Rosenfeld et al., 1992; Rappsilber et al., 2003). Whole lanes were excised from 
the gels on glass plates (previously cleaned with chromic acid for 1 hr, 
thoroughly rinsed with deionised water and air dried) using a clean razor 
blade for each lane. Lanes were cut into eight roughly equal sized pieces prior 
to finally dividing into 1 x 1 mm squares. Gel pieces were destained with 1 mL 
25 mM NH4HCO3 with 50 % v/v methanol (HPLC grade) and 1 mL 25 mM 
NH4HCO3 with 50 % v/v ethanol, incubating for 20 min each time. Gel pieces 
were dehydrated twice with 300 µL acetonitrile for 10 min, dried in a vacuum 
centrifuge, 10 min, and proteins reduced with 200 µL DTT (10 mM in 50 mM 
NH4HCO3) for 1 hr at 56 ˚C (without agitation). Excess buffer was removed and 
cysteine residues alkylated with 150 µL iodoacetamide (10.2 mg/mL in 50 mM 
NH4HCO3) for 45 min at 25 ˚C, in the dark (without agitation). Excess buffer was 
removed and gel pieces washed with 200 µL 50 mM NH4HCO3 for 20 min and 
dehydrated with 300 µL acetonitrile, 10 min. Washing and dehydration were 
repeated once, the gel pieces dehydrated again and dried in a vacuum 
centrifuge for 10 min. Gel pieces were rehydrated in 150 µL 50 mM NH4HCO3 
with 12.5 ng/µL sequencing grade modified trypsin (Promega, V5113) at 4 ˚C 
until swollen (20-30 min, without agitation). Excess solution was removed, 
leaving the gel pieces just covered and digestion allowed for proceed for 
16-18 hr at 37 ˚C (without agitation). Digests were terminated with 100 µL 
peptide extraction buffer (30 % v/v acetonitrile, 3 % v/v TFA) and incubating for 
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10 min and peptide-containing supernatants retained. Gel pieces were re-
extracted twice more with 150 µL peptide extraction buffer and dehydrated 
twice with 150 µL acetonitrile, each time retaining the supernatants. All 
supernatants were pooled and lyophilised. Pierce® C18 tips (Thermo Scientific, 
87784) were pre-wetted twice with 100 µL 50 % v/v acetonitrile and 
equilibrated twice with 100 µL 0.1 % v/v TFA. Peptides were dissolved in 50 µL 
0.8 % v/v TFA and bound to the tips by aspirating and dispensing ten times. 
The resin was washed twice with 100 µL 0.1 % v/v TFA in 5 % v/v acetonitrile 
and excess buffer removed by centrifuging at 2,000 g for 30 s. Tips were 
stored at 4 ˚C until analysis of the peptides by mass spectrometry. 
2.6.5 Mass spectrometry of peptides and computational analysis 
C18 tips were re-equilibrated with 50 µL 0.1 % v/v TFA and peptides eluted 
into 96-well MS plates with 30 µL 0.1 % v/v TFA in 80 % v/v acetonitrile. To 
remove acetonitrile, samples were dried in a vacuum centrifuge until ~6 µL in 
volume. The volume was made to 12 µL with 0.1 % v/v TFA and peptide masses 
and sequences were measured by LC-ESI-MS/MS on a maXis HD™ UHR TOF 
system (Bruker Daltonics). Proteins were identified and quantified from at least 
one peptide using Mascot Distiller in conjunction with the Quantitation 
Toolbox (Matrix Science) and ProHits software (Liu et al., 2010; Liu et al., 2012). 
Log2 ratios of labelled:unlabelled (heavy:light, H/L) between forward and 
reverse pull down values were calculated and plotted for cluster analysis. 
2.6.6 Peptide pull downs 
Short peptides of H3 (aa 1-8, 1-14 or 22-33) were synthesised on CPG beads 
carrying appropriate modifications at K4 (me1) or K27 (ac) (Alta Bioscience) 
(figure 2.7). 20 µL aliquots of 50 % slurries (with ~25 µmole of peptide per 
gram of CPG) were washed three times with 100 µL peptide binding buffer (50 
mM Tris-HCl pH 7.9, 325 mM NaCl, 1 mM EDTA, 10 mM sodium butyrate, 0.1 % 
w/v NP-40, 10 mM DTT, 0.1 mM PMSF, 0.1 mM benzamidine, 10 µL/mL 
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protease inhibitors (Sigma-Aldrich, P8340)). Protein extracts (unlabelled) were 
exchanged into peptide binding buffer by dialysis for 24 hr at 4 ˚C, re-
quantified by BCA assay and adjusted to 1.3 mg/mL. 385 µL (0.5 mg) aliquots 
of extract were incubated with the beads for 4 hr at 4 ˚C, with agitation. 
Unbound fractions were retained for analysis by SDS PAGE and, following 
three 100 µL peptide binding buffer washes, bound proteins were eluted from 
the beads in 30 µL 1.5X SDS sample buffer with 5 min incubation at 75 ˚C. 
Proteins in the unbound and bound fractions were resolved on 15 % SDS gels 
(15 µL of each, per lane) and transferred to PVDF membranes for Western 
blotting with antibodies raised against SSRP1 and Spt16 (figure 2.3, panel A). 
!!!!!!!!!!!!!!!!
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2.7 • H3 peptides used for pull downs to verify candidate proteins identified by SNAP 
Peptides comprising aa 1-8 or 1-14 of histone H3 were synthesised on CPG beads. K4 (long), K4 
(short) and K4me1 peptides had a C, GG or GGC spacer at their C-termini that were coupled to 
the CPG beads. Control K4 (long) and K4 (short) peptides were unmodified, whilst the 
experimental K4me1 peptide was mono-methylated  (●) at K4.  
H N - A R T K Q T A R K S T G G K C - CPG2
H N - A R T K Q T A R G G - CPG2
H N - A R T K Q T A R G G C - CPG2
K4 (long)
K4 (short)
K4me1
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2.7 Buffers and solutions 
All compositions are at working concentrations, unless otherwise specified. 
2-YT media 1.6 % w/v bacto tryptone 
1.0 % w/v yeast extract 
0.5 % w/v NaCl
2D equilibration buffer 500 mM Tris-HCl [pH 6.5] 
0.6 % w/v SDS
40 % sucrose solution 1.375 M sucrose 
10 mM Tris-HCl [pH 7.5] 
100 mM NaCl 
0.25 mM EDTA 
0.1 mM PMSF 
0.1 mM benzamidine
5 % sucrose solution 149 mM sucrose 
10 mM Tris-HCl [pH 7.5] 
100 mM NaCl 
0.25 mM EDTA 
0.1 mM PMSF 
0.1 mM benzamidine
Agarose loading buffer [5X] 80 % w/v glycerol 
0.125 % w/v orange G
Alkylation buffer 4 M guanidine HCl 
1 M HEPES [pH 8.3] 
10 mM D/L methionine
Annealing buffer 
used to dissolve lyophilised primers for 
site-directed mutagenesis
10 mM Tris-HCl [pH 8.2] 
150 mM NaCl 
10 mM MgCl
AU electrophoresis buffer 5 % v/v acetic acid
AU equilibration buffer 10 % v/v methanol 
5 % v/v acetic acid
AU resolving gel 4 M urea 
15 % w/v acrylamide 
0.2 % w/v bis-acrylamide 
0.5 % v/v acetic acid 
0.4 % v/v TEMED 
0.2 % w/v ammonium persulphate
AU sample buffer [2X] 8 M urea 
5 % v/v acetic acid 
0.1 mg/mL pyronin Y
AU stack gel 8 M urea 
7.5 % w/v acrylamide 
0.1 % w/v bis-acrylamide 
0.5 % v/v acetic acid 
0.7 % v/v TEMED 
0.35 % w/v ammonium persulphate
 64
AU transfer buffer 10 % v/v methanol 
0.1 % v/v acetic acid
AUT electrophoresis buffer 6 % v/v acetic acid 
100 mM glycine
AUT loading buffer [2X] 15 % v/v acetic acid 
15 % w/v glycerol 
0.001 % w/v methylene blue
AUT resolving gel 8 M urea 
15 % w/v acrylamide 
0.1 % w/v bis-acrylamide 
6 % v/v acetic acid 
0.3 % v/v NH
0.00026 % w/v riboflavin 
0.5 % w/v Triton™ X-100 
0.5 % v/v TEMED
AUT sample buffer 8 M urea 
10 mM DTT
AUT stack gel 8 M urea 
6 % w/v acrylamide 
0.16 % w/v bis-acrylamide 
6 % v/v acetic acid 
0.3 % v/v NH
0.00026 % w/v riboflavin 
0.5 % w/v Triton™ X-100 
0.5 % v/v TEMED
BCA reagent A 
Thermo Scientific, 23221
29 mM BCA 
161.3 mM Na
8.3 mM sodium tartrate 
113 mM NaHCO
100 mM NaOH
BCA reagent B 160.2 mM CuSO
BCA working reagent 
BCA reagents A & B mixed 50:1
28.4 mM BCA 
158.1 mM Na
8.1 mM sodium tartrate 
110.8 mM NaHCO
98 mM NaOH 
3.1 mM CuSO
Blood collection buffer 137 mM NaCl 
2.7 mM KCl 
8.16 mM Na
1.47 mM KH
5 mM EDTA 
10 mM sodium butyrate 
0.1 mM PMSF 
0.1 mM benzamidine
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CE lysis buffer 10 mM Tris-HCl [pH 7.5] 
80 mM NaCl 
10 mM sodium butyrate 
6 mM MgCl
0.1 % w/v Triton™ X-100 
0.1 mM PMSF 
0.1 mM benzamidine
CE nuclei lysis buffer 10 mM Tris-HCl [pH 7.5] 
10 mM sodium butyrate 
2.5 mM EDTA 
0.1 mM PMSF 
0.1 mM benzamidine
CE nuclei sucrose cushion 10 mM Tris-HCl [pH 7.5] 
80 mM NaCl 
10 mM sodium butyrate 
6 mM MgCl
980 mM Sucrose 
0.1 mM PMSF 
0.1 mM benzamidine
CE nuclei wash buffer 10 mM Tris-HCl [pH 7.5] 
80 mM NaCl 
10 mM sodium butyrate 
6 mM MgCl
0.1 mM PMSF 
0.1 mM benzamidine
CE sucrose cushion 137 mM NaCl 
2.7 mM KCl 
8.16 mM Na
1.47 mM KH
10 mM sodium butyrate 
980 mM sucrose 
0.1 mM PMSF 
0.1 mM benzamidine
CE wash buffer 137 mM NaCl 
2.7 mM KCl 
8.16 mM Na
1.47 mM KH
10 mM sodium butyrate 
250 mM sucrose 
0.1 mM PMSF 
0.1 mM benzamidine
ChIP buffer 10 mM Tris-HCl [pH 7.5] 
50 mM NaCl 
10 mM sodium butyrate 
1 mM EDTA 
0.1 mM PMSF 
0.1 mM benzamidine 
1 µL/mL protease inhibitors (Sigma-Aldrich, P8340)
CL solution A 100 mM Tris-HCl [pH 8.5] 
2.5 mM luminol 
0.396 mM p-Coumaric acid
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CL solution B 100 mM Tris-HCl [pH 8.5] 
0.036 % v/v H
CL working reagent 
ECL solutions A & B mixed 1:1
100 mM Tris-HCl [pH 8.5] 
1.25 mM luminol 
0.198 mM p-Coumaric acid 
0.018 % v/v H
CM-3SW binding buffer 6 M urea 
100 mM NaCl 
50 mM sodium acetate 
0.2 mM EDTA 
[pH 4.5]
CM-3SW elution buffer 6 M urea 
400 mM NaCl 
50 mM sodium acetate 
0.2 mM EDTA 
[pH 4.5]
Coomassie destain 10 % v/v methanol 
10 % v/v acetic acid
Coomassie stain 0.01 % w/v coomassie R-250 
30 % v/v methanol 
10 % v/v acetic acid
CutSmart™ buffer 
NEB, B7204
50 mM potassium acetate 
20 mM Tris-acetate 
10 mM magnesium acetate 
100 µg/mL BSA 
[pH 7.9]
Histone unfolding buffer 7 M guanidine HCl 
20 mM Tris-HCl [pH 7.5] 
10 mM DTT
Histone wash buffer (HWB) 50 mM Tris-HCl [pH 7.5] 
100 mM NaCl 
1 mM DTT 
1 mM PMSF 
1 mM benzamidine
Histone wash buffer with Triton™ 
(HWB-T)
50 mM Tris-HCl [pH 7.5] 
100 mM NaCl 
1 % w/v Triton™ X-100 
1 mM DTT 
1 mM PMSF 
1 mM benzamidine
K562 extraction buffer 20 mM HEPES [pH 7.9] 
420 mM NaCl 
4 mM MgCl
0.2 mM EDTA 
25 % w/v Glycerol 
0.1 % w/v NP-40 
0.1 mM PMSF 
0.1 mM benzamidine 
1 µL/mL protease inhibitors (Sigma-Aldrich, P8340)
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K562 freezing medium RPMI 1640 
10 % v/v FCS 
10 % v/v DMSO
K562 lysis buffer 10 mM HEPES [pH 7.9] 
10 mM KCl 
4 mM MgCl
0.2 % w/v NP-40 
0.1 mM PMSF 
0.1 mM Benzamidine 
1 µL/mL protease inhibitors (Sigma-Aldrich, P8340)
K562 media RPMI 1640 (Sigma-Aldrich, R8758) 
8 % v/v FCS (Biosera, FB-1000 or FB-1000D) 
100 U/mL penicillin 
100 µg/mL streptomycin
K562 nuclei sucrose cushion 10 mM HEPES [pH 7.9] 
150 mM NaCl 
10 mM KCl 
4 mM MgCl
980 mM sucrose 
0.1 mM PMSF 
0.1 mM benzamidine 
1 µL/mL protease inhibitors (Sigma-Aldrich, P8340)
K562 nuclei wash buffer 10 mM HEPES [pH 7.9] 
150 mM NaCl 
10 mM KCl 
4 mM MgCl
0.1 mM PMSF 
0.1 mM benzamidine 
1 µL/mL protease inhibitors (Sigma-Aldrich, P8340)
K562 swelling buffer 10 mM HEPES [pH 7.9] 
10 mM KCl 
4 mM MgCl
0.1 mM PMSF 
0.1 mM benzamidine 
1 µL/mL protease inhibitors (Sigma-Aldrich, P8340)
Labelled K562 media RMPI 1640 (Arg-/Lys-/Gln-) (Biosera, SM-R0379) 
200 mg/L arginine-
40 mg/L lysine-
2 mM L-glutamine 
0.1 % v/v NaHCO
5.2 mg/L phenol red 
8 % v/v dialysed FCS (Biosera, FB-1000D) 
100 U/mL penicillin 
100 µg/mL streptomycin
LB agar 1.0 % w/v bacto tryptone 
0.5 % w/v yeast extract 
1.0 % w/v NaCl 
1.5 % w/v agar
LB media 1.0 % w/v bacto tryptone 
0.5 % w/v yeast extract 
1.0 % w/v NaCl
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Linker histone depletion buffer 50 mM phosphate [pH 6.8] 
600 mM NaCl 
0.5 µL/mL protease inhibitors (Sigma-Aldrich, P8340)
MES electrophoresis buffer 
Life Technologies, NP0002
50 mM MES 
50 mM Tris 
0.1 % w/v SDS 
1 mM EDTA 
[pH 7.3]
MNase digest buffer 10 mM Tris-HCl [pH 7.5] 
10 mM NaCl 
10 mM sodium butyrate 
6 mM MgCl
1 mM CaCl
0.1 mM PMSF 
0.1 mM benzamidine
Native electrophoresis buffer 22.5 mM Tris 
22.5 mM boric acid 
0.5 mM EDTA
Native gel 5 % v/v acrylamide:bis-acrylamide (29:1) 
22.5 mM Tris 
22.5 mM boric acid 
0.5 mM EDTA 
10 % w/v glycerol 
0.048 % v/v TEMED 
0.08 % w/v ammonium persulphate
Native sample buffer [3X] 6.3 % w/v glycerol 
100 mM EDTA 
0.125 % w/v bromophenol blue 
0.125 % w/v xylene cyanol
NEBuffer 2 
New England Biolabs, B7002
50 mM NaCl 
10 mM Tris-HCl 
10 mM MgCl
1 mM DTT 
[pH 7.9]
NEBuffer 4 
New England Biolabs, B7004
50 mM potassium acetate 
20 mM Tris-acetate 
10 mM magnesium acetate 
1 mM DTT 
[pH 7.9]
Novex® colloidal blue fixer 50 % v/v methanol (HPLC grade) 
10 % v/v acetic acid
Novex® colloidal blue stainer A 
Life Technologies, LC6025
20 % v/v methanol (HPLC grade) 
20 % v/v stainer A
Novex® colloidal blue stainer B 
Life Technologies, LC6025
5 % v/v Stainer B 
in Novex® colloidal blue stainer A
Nucleosome assembly buffer A 10 mM Tris-HCl [pH 7.5] 
2 M KCl 
1 mM EDTA 
1 mM DTT
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Nucleosome assembly buffer B 10 mM Tris-HCl [pH 7.5] 
250 mM KCl 
1 mM EDTA 
1 mM DTT
NuPAGE® antioxidant 
Life Technologies, NP0005
proprietary reagent
NuPAGE® LDS sample buffer 
Life Technologies, NP0008
2X NuPAGE® LDS sample buffer 
10 mM DTT
Octamer folding buffer 10 mM Tris-HCl [pH 7.5] 
2 M NaCl 
1 mM EDTA 
10 mM DTT
PBS 137 mM NaCl 
2.7 mM KCl 
8.16 mM Na
1.47 mM KH
Peptide binding buffer 50 mM Tris-HCl [pH 7.9] 
325 mM NaCl 
1 mM EDTA 
10 mM sodium butyrate 
0.1 % w/v NP-40 
10 mM DTT 
0.1 mM PMSF 
0.1 mM benzamidine 
10 µL/mL protease inhibitors (Sigma-Aldrich, P8340)
Peptide extraction buffer 30 % v/v acetonitrile 
3 % v/v TFA
Protease inhibitors 
Sigma-Aldrich, P8340 
used at dilutions of 1:1,000 - 1:10,000
104 mM AEBSF 
80 µM aprotinin 
4 mM bestatin 
1.4 mM E-64 
2 mM leupeptin 
1.5 mM pepstatin 
in DMSO
Q binding buffer 10 mM Tris-HCl [pH 7.5]
Q elution buffer 10 mM Tris-HCl [pH 7.5] 
1 M NaCl
RIPA buffer 10 mM Tris-HCl [pH 7.5] 
50 mM NaCl 
10 mM sodium butyrate 
1 mM EDTA 
0.5 % w/v Triton™ X-100 
0.1 % w/v SDS 
0.1 mM PMSF 
0.1 mM benzamidine 
12.5 µL/mL protease inhibitors (Sigma-Aldrich, P8340)
S-300 buffer 20 mM Tris-HCl [pH 7.5] 
100 mM NaCl 
0.2 mM EDTA
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SDS electrophoresis buffer 25 mM Tris 
192 mM glycine 
0.1 % w/v SDS 
[pH 8.3]
SDS loading buffer [3X] 150 mM Tris-HCl [pH 6.8] 
15 % v/v ßME 
9 % w/v SDS 
15 % v/v glycerol 
0.2 % w/v bromophenol blue
SDS resolving gel 15 % v/v acrylamide:bis-acrylamide (37.5:1) 
375 mM Tris-HCl [pH 8.8] 
0.1 % w/v SDS 
0.06 % v/v TEMED 
0.18 % w/v ammonium persulphate
SDS sample buffer 8 M urea 
10 mM DTT
SDS stack gel 5.66 % v/v acrylamide:bis-acrylamide (37.5:1) 
141.5 mM Tris-HCl [pH 6.8] 
0.1 % w/v SDS 
0.14 % v/v TEMED 
0.045 % w/v ammonium persulphate
SDS transfer buffer 25 mM Tris 
192 mM glycine 
0.1 % w/v SDS 
20 % v/v methanol
SEC MALLS buffer 10 mM Tris-HCl [pH 7.5] 
50 mM NaCl 
0.1 mM EDTA, 
0.1 mM PMSF 
0.1 mM benzamidine
SNAP binding buffer 20 mM HEPES [pH 7.9] 
150 mM NaCl 
0.2 mM EDTA 
20 % w/v glycerol 
0.1 % w/v NP-40 
0.1 mM PMSF 
0.1 mM benzamidine 
1 µL/mL protease inhibitors (Sigma-Aldrich, P8340)
SOB 2.0 % w/v bacto tryptone 
0.5 % w/v yeast extract 
10 mM NaCl 
2.5 mM KCl 
10 mM MgCl
10 mM MgSO
SOC 2.0 % w/v bacto tryptone 
0.5 % w/v yeast extract 
10 mM NaCl 
2.5 mM KCl 
10 mM MgCl
10 mM MgSO
20 mM glucose
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SP binding buffer 6 M urea 
2 mM Tris 
200 mM NaCl 
50 mM sodium acetate 
0.1 mM EDTA 
1 mM DTT 
[pH 4.75]
SP elution buffer 6 M urea 
2 mM Tris 
1 M NaCl 
50 mM sodium acetate 
0.1 mM EDTA 
1 mM DTT 
[pH 4.75]
SSC 15 mM NaCl 
1.5 mM tri-sodium citrate 
[pH 7.0]
SSU 8 M urea 
5 M NaCl
TAE 40 mM Tris 
40 mM acetic acid 
1 mM EDTA
TBE 45 mM Tris 
45 mM boric acid 
1 mM EDTA
TBST 20 mM Tris-HCl [pH 7.5] 
10 mM NaCl 
0.05 % w/v Tween® 20
TE 10 mM Tris-HCl [pH 7.5] 
1 mM EDTA
Transformation buffer 55 mM MnCl
15 mM CaCl
250 mM KCl 
10 mM PIPES [pH 6.7]
Trypan Blue 
Sigma-Aldrich, T8154
0.4 % w/v trypan blue 
0.81 % w/v NaCl 
0.06 % w/v K
Vanadate solution 400 mM sodium orthovanadate 
131 mM NaCl 
4.8 mM KCl 
1.2 mM MgSO
1.3 mM CaCl
1.2 mM NaH
25 mM HEPES [pH 7.4]
Zorbax 300SB-CN binding buffer 0.1 % v/v TFA
Zorbax 300SB-CN elution buffer 0.1 % v/v TFA in acetonitrile
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3 Analysis of H3 methylation and acetylation 
by chromatin immunoprecipitation 
Studies from this and other laboratories have suggested that mono-methyl 
histone H3K4 is enriched at the enhancers of poised and active genes 
(Bernstein et al., 2005; Barski et al., 2007; Heintzman et al., 2007, Amar, 2010) 
and that enhancers at active genes are additionally distinguished by H3K27ac 
(Creyghton et al., 2010; Rada-Iglesias et al., 2011). The chicken ß-globin locus 
is comprised of four globin genes (ρ, ßH, ßA and ε) flanked at the 5’ end by 16 
kb of inactive heterochromatin and the folate receptor (FR) gene and at the 3’ 
end by the odorant receptor (OR) gene. It has been very well characterised in 
terms of its chromatin features including DNaseI hypersensitive sites (DHS, see 
below) and has become a useful model for understanding the role of various 
histone modifications, since expression of the genes it contains is restricted to 
erythrocytes and is developmentally regulated in the embryonic chicken 
(review in Guerrero et al., 2007). 
3.1 Developmental regulation of erythropoiesis at the ß-globin locus 
Haematopoiesis has been extensively studied throughout the development of 
the chicken (Lucas & Jamroz, 1961). There are two origins of the erythrocytic 
series of cells - the yolk sac (reviews in Ingram, 1972 and Dieterlen-Lièvre, 
1978) and the thymus and spleen (Dieterlen-Lièvre, 1975; reviews in Bollerot 
et al., 2005 and Dzierzak & Medvinsky, 2008). The fully differentiated cells 
arising from the yolk sac are termed ‘primitive’ erythrocytes, whilst those 
originating from the thymus and spleen are called ‘definitive’ erythrocytes 
(figure 3.1). It has been shown that these primitive and definitive erythrocytes 
exhibit differential expression of the globin genes - the former exclusively 
expressing rho and epsilon (ρ and ε, respectively) and the latter, hatching and 
adult (ßH and ßA, respectively) (Groudine et al., 1981; Landes &  Martinson, 
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1982; Landes et al., 1982). Therefore, replacement of the embryonic 
haemoglobins by their adult homologues actually occurs between two 
separate lineages of erythroid cells rather than through the differential 
regulation of the locus within a single lineage (although it has been 
demonstrated by immunofluorescence that human embryonic globin genes 
are expressed at significant levels in up to ~8 % of definitive erythroid cells 
and in ~1 % of new-born erythrocytes (Luo et al., 1999)). This switching of 
erythrocytic lineages (and therefore globin gene expression) occurs between 
five and twelve days of incubation (Landes & Martinson, 1982; Landes et al., 
1982), with primitive erythrocytes rapidly decreasing in number from seven 
days of incubation (7D) and definitive cells increasing in abundance from 9D 
(Lassila et al., 1982). 
The four developmentally regulated chicken ß-globin genes occur on 
chromosome 1 within a locus spanning approximately 33 kb (review in Recillas-
Targa & Razin, 2001) (figure 3.2). There are a number of regions required for 
the regulation of the globin genes which are hypersensitive to DNaseI (Stalder 
et al., 1980), three of which (HS1, HS2 and HS3) are erythroid-specific (Reitman 
et al., 1990) and contained within the so called ‘locus control region’ (LCR). 
DNaseI sensitivity correlates with de-condensed chromatin (Hebbes et al., 
1994), which has been suggested for the chicken, mouse and human ß-globin 
loci to arise from interaction with other regulatory elements such as the gene 
promoters by looping, tracking or linking (figure 3.3, panels C to D) (Mason et 
al., 1995; review in Li et al., 2002). HS2 and HS3 have indeed been shown to 
have activity which enhances globin gene expression (Abruzzo & Reitman, 
1994). Further hypersensitive sites lie upstream of the LCR (HS4) and 
downstream of the globin genes (3’HS) (Stalder et al., 1980; Chung et al., 
1993). These are insulators containing CCCTC-binding protein factor (CTCF) 
sequence elements, necessary for blocking the influence of cis-regulatory 
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3.1 • Erythropoeisis and erythrocytic cell populations during development 
(A) Haematopoietic stem cells give rise to multi potent progenitors which have the potential to 
differentiate into several lineages, including the erythrocytic series. In chickens, two waves of 
erythropoeisis proceed from the erythroblast to to the mature erythrocyte. (B) The primitive 
erythroid cells are abundant up to ~150 hours (6.25 days) of incubation before rapidly yielding to 
almost complete replacement with definitive cells by 300 hours (12.5 days). Points corresponding 
to 5D and 15D of incubation are indicated 
Adapted from Lucas & Jamroz, 1961  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3.2 • The chicken ß-globin locus and its differential expression through development 
(A) The chicken ß-globin locus has been extensively studied and shown to contain a number of 
regulatory elements (yellow and red), some of which (HS1, 2 and 3) are specific to the erythrocytic 
series of blood cells. (B) Expression of the folate receptor occurs before activation of the globin 
genes (blue, embryonic; green, hatching and adult), whilst the olfactory receptor gene is 
constitutively repressed throughout development in erythroid cells. (C) Expression of the 
embryonic, hatching and adult globin genes occurs from two distinct waves of erythropoeisis. ρ 
and ε are expressed up until ~10-11 days of development and are completely repressed from 12 
days. ßH and ßA genes begin to express from ~6-7 days and ßH is repressed by 7 weeks after 
hatching (Landes et al., 1982). Red gradients, expression. 
(C) adapted from a figure by T Hebbes  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elements lying outside of the ß-globin locus by CTCF binding (Bell et al., 1999, 
review in Wallace & Felsenfeld, 2007). Chromatin conformation capture (3C) 
has recently been used to study the spatial organisation of the chicken ß-
globin locus in 3-day and 9-day embryos. This demonstrated that the 5’ and 3’ 
insulators interact with each other (presumably by CTCF binding) to hold the 
globin genes in a closed loop for gene regulation (Ulianov et al., 2012) (figure 
3.3, panel A) forming an active chromatin hub (ACH) (de Laat & Grosveld, 
2003; Razin et al., 2013). The globin genes are also regulated by a 
bidirectional enhancer, located between the ßA and ε genes, which has been 
demonstrated to activate gene expression by promoter competition (Foley & 
Engel, 1992). Transcription factors, such as GATA-1, interact with both DHS 
(Abruzzo & Reitman, 1994) and the ßA/ε enhancer (Barton et al., 1993), and in 
transgenic mice carrying the chicken ß-globin gene cluster (with or without 
upstream HS), both upstream and enhancer elements were necessary for the 
optimal expression of the globin genes (Mason et al., 1995). In the 3C study 
described above, the ACH was shown to form a complex with the ßA/ε 
enhancer and the promoters of the globin genes (except ε) were recruited to 
this complex to interact with the LCR (Ulianov et al., 2012) (figure 3.3, panel E). 
Since the ε promoter did not interact with the LCR or the enhancer, it was 
suggested that active transcription of this gene might be initiated by a tracking 
mechanism from the enhancer, which is just upstream of the promoter (Ulianov 
et al., 2012). 
The erythroid-specific FR gene present upstream of the locus is expressed only 
in the CFU-e cell line 6C2, prior to the expression of globin genes (Prioleau et 
al., 1999), in keeping with the role of folate receptors in cell proliferation 
(Antony et al., 1987; Antony et al., 1991). At the opposite end of the locus is 
the OR gene, which is never expressed in erythroid cells (Bulger et al., 1999; 
Saitoh et al., 2000).  Regulatory elements of these genes, such as the FR HSA  
 77
   !
3.3 • Models for the regulation of gene expression by regulatory elements 
(A) Insulator elements in HS4 and 3’HS are bound by CTCF (●) to hold the globin genes (blue, 
embryonic; green, hatching and adult) in a loop, preventing enhancer action from cis-elements 
outside of the locus. (B-D) Regulation of the globin genes by the LCR has not been fully 
determined but a number of studies (reviewed in Li et al., 2002) support linking, looping and 
tracking models for the activation and/or maintenance of globin gene transcription. ●, 
transcription factors/chromatin modifying enzymes. (B) Linking involves the sequential 
recruitment of transcription factors and chromatin modifying enzymes from an HS site to the 
gene promoter (?). (C) Looping is caused by direct interaction between the LCR and the gene, 
effected by transcription factor binding to an HS site and the promoter (?). (D) Tracking occurs by 
means of a transcription factor complex that binds an HS site and moves along the DNA (?) until 
it reaches a promoter-bound transcription factor. (E) Recently, 3C has been used to show that a 
looping mechanism is utilised at the globin locus throughout development to form an active 
chromatin hub (ACH, ●), to which most of the regulatory elements are recruited. 
Adapted from Wallace et al., 2007 (A), Li et al., 2002 (B-D), and Ulianov et al., 2012 (E)  
A
B
C
D
E
3DCE 9DCE
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and the brain-specific 3’HS, can therefore serve as useful controls when 
mapping histone modifications to the active globin genes in fully 
differentiated erythrocytes, since modifications present at these points should 
not differ between the primitive and definitive cells. 
Studies of the chicken ß-globin locus have been useful for elucidating the 
mechanisms of gene regulation at the globin locus. In particular, mapping 
histone post-translational modifications to the regulatory elements of the 
globin genes is important to better understand their roles in modulating gene 
expression. Several studies have examined these modifications in 
haematopoietic cells and erythrocytes from 5, 10 and 15D embryos (Hebbes et 
al., 1992; Hebbes et al., 1994; Litt et al., 2001a; Litt et al., 2001b; Myers et al., 
2001; Myers et al., 2003; Schneider et al., 2004; Bruce et al., 2005; Huang et 
al., 2005; Amar, 2010). Acetylated forms of histones H2B, H3 and H4 were 
identified across the entire locus in definitive 15D erythrocytes, indicative of a 
permissive mark for transcription, rather than a method of modulating 
differential expression (Hebbes et al., 1992; Hebbes et al., 1994; Myers et al., 
2001; Myers et al., 2003). Comparison of 15D erythrocytes with cell lines 
representing erythroid progenitors (the CFU-e and blast-forming unit (BFU-e) 
cell lines 6C2 and HD24, respectively) demonstrated that the acetylation status 
of these histones is increased as the globin genes become actively expressed 
(Litt et al., 2001b). Mapping of histone methylation has been less extensive but 
Litt and colleagues (2001a) showed increasing levels of H3K4me2 at the ß-
globin locus through erythropoiesis by comparing progenitor (HD24 and 6C2) 
cells with 10DCE. Schneider and colleagues (2004) extended these studies, 
showing that H3K4me2 is increased at the active globin genes in primitive and 
definitive erythrocytes (5 and 15DCE). Similarly, enrichment of H3K4me3 in the 
promoters and transcribed regions of the genes in 5 or 15DCE correlated with 
active transcription of the embryonic or adult and hatching genes, respectively 
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(Schneider et al., 2004). H3K4me1, however, has not been studied at the 
globin locus until recently. This modification was mapped in haematopoietic 
progenitor (HD37 and HD24) cell lines and 15DCE and was enriched at the 
enhancer prior to activation of the globin genes (Amar, 2010), in keeping with 
the association of H3K4me1 with the enhancers of active and poised genes 
(Barski et al. 2007; review in Bernstein et al., 2007; Heintzman et al., 2007; 
Heintzman et al., 2009 Cui et al., 2009). H3K4me1 was also enriched at the 
promoters and transcribed regions of the embryonic genes in 15DCE, 
suggesting a novel role in repression (Amar, 2010). Loss of this mark at the ßA 
promoter and transcribed region in 15DCE was suggested to result from 
increased methylation (to me2 and me3 forms) to maintain transcriptional 
activity (Amar, 2010). It was therefore of interest to extend this study to 5DCE, 
a relatively easily obtainable cell type, to monitor H3K4me1 enrichments in the 
two terminally differentiated cell types of the erythrocytic series in more detail. 
Another modification of histone H3 - acetylation at K27 - has recently been 
suggested to distinguish active and poised enhancers by its co-occurrence 
with K4me1 (Creyghton et al., 2010; Rada-Iglesias et al., 2011). H3K27ac also 
marks the transcribed regions of active genes together with H3K4me3 (Jin et 
al., 2011). Therefore, both H3K4me3 and H3K27ac were also modifications of 
interest for mapping to the globin locus by ChIP in the present study. 
H3K4me2 enrichments were also mapped to test and compare previously 
observed changes in enrichment and depletion patterns across the locus 
between 5 and 15DCE. 
!
3.2 Chromatin immunoprecipitation (ChIP) 
The technique of chromatin immunoprecipitation was initially developed to 
study the genomic distribution of regulatory proteins, such as HMG17, that 
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were bound to chromatin (Dorbic & Wittig, 1986). Chromatin is selectively 
precipitated using an antibody against the protein or modification of interest. 
It was clear that, for the study of regulatory proteins, it is necessary to cross-link 
live cells, typically using formaldehyde, so as to remove the possibility of 
relocation of the protein of interest during the chromatin preparation and ChIP 
processes. This is referred to as cross-linked chromatin immunoprecipitation 
(xChIP). The method was subsequently adapted to the analysis of histone 
PTMs (Hebbes et al., 1988), for which the formaldehyde cross linking is 
unnecessary, due to the strong interaction of the basic histones with DNA, 
allowing chromatin enriched in the modified core histones to be precipitated 
by antibodies, the binding of which might otherwise have been precluded by 
the presence of regulatory proteins. Since chromatin is fractionated with 
antibodies raised against modified histones, any observed enrichment in DNA 
sequences is directly linked to the histone modification of interest, which 
provides evidence of a direct relationship between PTMs and gene regulation. 
This protocol is known as native chromatin immunoprecipitation (nChIP). 
To map histone PTMs across the chicken ß-globin locus, mono-nucleosomal 
chromatin was isolated and purified from five and fifteen day chicken embryo 
erythrocyte nuclei by digestion with micrococcal nuclease (MNase) followed 
by rate-zonal sedimentation through sucrose gradients. Mono-nucleosomes 
were bound by antibodies recognising particular modified states and 
immobilised on Protein G agarose and input, unbound and antibody-bound 
fractions analysed by Western blotting and real-time PCR (figure 3.4).  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3.4 • Summary of the nChIP protocol 
Nuclei (●) isolated from chicken erythrocytes were digested with MNase, lysed twice and 
chromatin-containing supernatants (S1, S2 and S3) retained and pooled. Chromatin was 
depleted of linker histones by ion exchange in low salt and fractionated on 5-30 % sucrose 
gradients. Mono-nucleosomes were precipitated with antibodies against histone PTMs of interest 
and DNA and protein recovered from input, unbound and bound fractions for analysis by real-
time PCR and Western blotting, respectively. For further detail, refer to the main text.  
Collect cells from chick embryos
Lyse cells and isolate nuclei
Digest nuclei with MNase at 37˚C for 
6, 8 and 10 minutes
Retain nucleosome-containing 
supernatants (S1)
Lyse nuclei and retain nucleosome-
containing supernatant (S2)
Re-lyse nuclei and retain nucleosome-
containing supernatant (S3)
Pool nucleosomes and deplete linker 
histones with C-25 in 50 mM NaCl
Purify mononucleosomes on sucrose 
gradients
S1
S2
S3
Incubate nucleosomes with antibodies 
(retain some nucleosomes as 'input')
Immobilise immunocomplexes on 
Protein G Agarose
Retain supernatant ('unbound') and 
incubate resin with SDS
Recover protein and DNA by Phenol-
Chloform extraction and analyse by 
Western blot and Real-Time PCR
'unbound'
'bound'
'input'
Retain supernatant ('bound')
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3.2.1 Isolation of blood cells from chicken embryos 
Blood was collected from embryos following 5 or 15D incubation as outlined 
in chapter 2 (section 2.2.2). Developmental stage was routinely confirmed 
using published images and descriptions (Hamburger & Hamilton, 1951) 
(figure 3.5). Erythrocytes were not separated from other blood cell types 
(except for careful removal of some white cells, which sediment on the top of 
the red blood cell pellets). However, since white cells only represent 0.97 to 
1.23 % of the total blood cell population in chickens (Lucas & Jamroz, 1961) 
they should have negligible influence on the final data set. 
3.2.2 Digestion of 5 and 15DCE nuclei with MNase 
The well-documented restricted accessibility of DNA to enzymatic cleavage by 
MNase (Hewish & Burgoyne, 1973; Noll 1974a & 1974b) has long been 
exploited for the preparation of mono-nucleosomes suitable for high 
resolution ChIP analysis (Hebbes et al., 1988). Since different regions of 
chromatin exhibit differential rates of digestion by MNase (Wood & Felsenfeld, 
1982; Sun et al., 1986), it was important to employ a range of digestion times 
so as to isolate mono-nucleosomes with good sequence representation 
(section 3.4.1). 
3.2.2.1 Time course digestion 
Time-course digestion of small amounts of nuclei were used to determine the 
optimal conditions for mono-nucleosome isolation, since under-digestion will 
limit the yield and prolonged digestion can deplete active sequences (Thorne 
et al., 2004). Figure 3.6 shows increasing intensity of the mono-nucleosome 
bands on agarose gels with increasing digestion time (up to ~10 min), whilst 
prolonged digestion (>12 min) showed decreasing levels of mono-
nucleosomes and loss of the nucleosome ladder.  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3.5 • Confirmation of 5 and 15D chicken embryo developmental stages 
Developmental stages of embryos from which blood was collected for ChIP experiments was 
confirmed according to Hamburger & Hamilton (1951). Features of 5D embryos (HH stages 
26-28, top) included lengthened limbs (lb) (compared to previous stages) with groves visible 
between the digits and appearance of the beak (bk). Furthermore, the maxillary process (mx) was 
curved and features of the mandibular process (md) included: i) projection of a and d over the 
surface; ii) lack of subdivision of b; iii) almost complete fusion of b and e; and iv) widening of the 
groove between c and f due to forward and backward growth of these features, respectively. 
Somites (so) extended to the tip of the tail and pigmentation of the eye (ey) was distinct 
(consistent with an embryo ≥3.5D (HH stage 22) of development). The lack of more distinct 
grooves between the digits of the limbs and no egg-tooth indicated that the embryos had not 
exceeded 5.5D (HH stage 28) of development, since those features are only present from 6-6.5D 
(HH stages 29-30). 15D embryos were generally comparable to that pictured (HH stage 41, 
bottom). 
(B) taken from Hamburger & Hamilton, 1951  
5D chicken embryo
15D chicken embryo
lb
bk
md
mx
so
lb
ey
bk
md
a
b
c
d
e
f
mx
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3.2.2.2 Bulk mono-nucleosome preparation 
All MNase digests were performed in the presence of 1 mM Ca2+, a divalent 
cation essential for the activity of MNase (Sanders, 1978) and were terminated 
by addition of EDTA to chelate the Ca2+. The flow diagram (figure 3.4) 
summarises the key features of chromatin digestion used to isolate 
nucleosomes from five and 15 day chicken erythrocytes. In brief, following 
MNase digestion, chromatin was recovered from the supernatants of digested 
(S1) and lysed (S2 & S3) nuclei by low speed centrifugation. Note that the small 
amount of nuclear chromatin released in S1 (~15 %) is largely mono-
nucleosomal (figures 3.7 & 3.8, panel C, lane 2) and essentially devoid of 
linker histones (panel D, lane 3). Linker histone-containing chromatin is 
released on lysis of the digested nuclei (S2 & S3), representing 75 % of the 
nuclear chromatin (panel D, lanes 4-5). Released chromatin (S1, S2 & S3) was 
pooled and linker histones were depleted under low salt conditions (see 
below) prior to isolation of mono-nucleosomes on sucrose gradients. 
!!!
   !
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3.6 • Time-course digestion of 15DCE nuclei by MNase 
15DCE nuclei at 5 mg/mL were digested with 200 U/mL MNase for 0-20 min. Digestion was 
terminated by addition of EDTA to 10 mM and phenol-chloroform extracted for analysis by 2 % 
agarose-TAE gel electrophoresis. For bulk digestion, nuclei were separated into three aliquots, 
which were separately digested for 6, 8 or 10 minutes.  
02-
Lo
g 
M
ar
ke
r
Minutes
EtBr
1k
bp 
500
84 102 6 12 14 16
400
300
200
100
700
mono
di
tri
tetra
penta
18 20
 85
3.2.3 Linker histone depletion 
Immunocomplexes formed during chromatin immunoprecipitation protocols 
were traditionally immobilised on formalin-fixed Staphylococcus aureus cells. 
As such, it was necessary to deplete linker histones from the chromatin, which 
was suggested would otherwise bind non-specifically to protein A on the S. 
aureus cells (Dorbic & Wittig, 1986). As use of protein A bound to Sepharose 
or protein G bound to agarose beads was developed, ChIP experiments in our 
laboratory have, in some cases, omitted the linker histone depletion step with 
no H1/H5 enrichment observed in the immunoprecipitated material (Dr A 
Thorne, personal communication). This suggests that linker histones actually 
bind non-specifically to a component(s) of the S. aureus cells other than 
protein A. However, since the non-specific binding of linker histones to S. 
aureus cells has never been fully characterised and salt-dependent insolubility 
of chromatin is observed when H1 is present (Muyldermans et al., 1980), 
chromatin was routinely depleted of linker histones for these experiments. 
Early methods for the removal of linker histones used high salt concentrations 
(~600 mM) (Ohlenbusch et al., 1967), although this was demonstrated by 
electron microscopy to affect the structure of the chromatin by nucleosome re-
positioning (Spadafora et al., 1979). Depletion of linker histones was therefore 
performed at 50 mM salt with CM Sephadex C-25 resin, according to Libertini 
& Small (1980) (figures 3.7 & 3.8, panel D, compare lanes 3-5 with 6). This 
method of using low ionic strength and an ion exchange resin was shown to 
effectively remove the linker histones from chicken erythrocyte chromatin 
without nucleosome sliding (Muyldermans et al., 1980). 
3.2.4 Sucrose gradient sedimentation 
Chromatin was centrifuged through 5-30 % exponential sucrose gradients, 
(Thorne et al., 2004) to separate mono-nucleosomes from larger species (di-, 
tri-, tetra-nucleosomes, etc.). Following fractionation (figures 3.7 & 3.8, panel 
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B), samples were analysed and mono-nucleosome containing fractions 
pooled. DNA length was checked by agarose gel electrophoresis and SDS 
PAGE was used to monitor linker histone depletion and integrity of the core 
histones (panel C, lanes 6-16 & panel D, lanes 7-12). Spectrophotometry was 
used at various stages of the preparation to quantify the chromatin and mono-
nucleosome yield (~11 % for both 5 and 15DCE) (panel A). 
!!!!!
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3.7 • Mono-nucleosomes produced by MNase digestion of 5DCE nuclei 
Nucleosomes were prepared by MNase digestion. (A) Typical recoveries of nucleosomes in 
supernatants S1, S2 and S3 following digestion and lysis of 5DCE nuclei were determined by 
spectrophotometry. (B) Released chromatin was depleted of linker histones and centrifuged 
through 5-30 % exponential sucrose gradients 24 h at 288,000 g to purify mono-nucleosomes (▼) 
from higher molecular weight products (di-, tri-, tetra-nucleosomes, etc.). (C) DNA was isolated 
from S1, S2, S3 and peak fractions from the sucrose gradients by phenol-chloroform extraction 
and analysed by 2 % agarose-TAE gel electrophoresis. (D) Histones were precipitated from each 
fraction using vanadate and analysed by 15 % SDS PAGE to test their integrity and depletion of 
linker histones.  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3.8 • Mono-nucleosomes produced by MNase digestion of 15DCE nuclei 
Nucleosomes were prepared by MNase digestion of 15DCE nuclei, as described for 5DCE (figure 
3.6). (A) Typical recoveries of nucleosomes were determined by spectrophotometry. (B) 
Nucleosomes were depleted of linker histones and mono-nucleosomes (▼) purified. (C-D) As for 
5DCE nucleosome preparations, DNA was analysed by 2 % agarose-TAE gel electrophoresis and 
histone integrity and linker histone depletion tested by 15 % SDS PAGE. 
!
!
3.2.5 Native chromatin immunoprecipitation (nChIP) 
Mono-nucleosomes (100 µg) were incubated with appropriate antibodies (25 
µg) and immunocomplexes immobilised on Protein G agarose (for all 
antibodies raised in rabbit, sheep or mouse). The unbound fraction was 
retained and, after washing of the resin, bound material was eluted and 
samples prepared for protein and DNA analyses. Typically, 0.84 - 2.64 µg DNA 
was recovered in the bound fractions following immunoprecipitation (figure 
3.9). 
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3.9 • Chromatin recoveries in the bound fractions following nChIP 
Recovery of DNA in the bound fractions following immunoprecipitation was typically in the range 
of 0.84 - 2.64 µg from 100 µg of input chromatin. Although some recoveries were low, these 
samples could still be used for a number of analyses by real-time PCR, since they were enriched in 
the modification of interest and the analysis therefore only called for 0.5 ng per triplicate of 
amplification reactions. !
!
3.2.6 Analysis of histones following nChIP 
Quantification of protein from input, unbound and bound fractions was 
determined by the recovered quantities of DNA, assuming a ratio of DNA to 
histone of 1:1. Core histones were resolved on SDS gels and, following 
electrophoretic transfer onto PVDF membranes, analysed by Western blotting 
to monitor the efficacy of the ChIP by testing for enrichment of the 
modification of interest in the bound fraction relative to the input (figure 3.10). 
Core histones were observed in all fractions by Ponceau-S staining with 
additional high molecular weight bands in the bound samples corresponding 
to the antibodies used for immunoprecipitation. Comparison of roughly equal 
loadings of input, unbound and bound fractions in the Western blot revealed 
enrichment of the modification of interest in the bound fraction and depletion 
in the unbound fraction relative to the input, as expected. 
 89
Cell Type Antibody Bound (µg)
5DCE
H3K4me1 2.23
H3K4me2 1.98
H3K4me3 0.36
H3K27ac 0.14
H3K27me3 1.32
15DCE
H3K4me1 2.18
H3K4me2 2.64
H3K4me3 0.84
H3K27ac 1.10
H3K27me3 1.44
!!!!
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3.10 • Analysis of proteins recovered from immunoprecipitation of 5 and 15DCE chromatin 
100 µg aliquots of mono-nucleosomes from embryonic CE were mixed with 25 µg of antibody 
raised against the histone modifications of interest to form immunocomplexes. Proteins were 
recovered from input (I), unbound (U) and bound (B) fractions by phenol-chloroform extraction 
and precipitation with acetone. Equal quantities of each sample (as determined by 
spectrophotometry of the corresponding DNA samples following phenol-chloroform extraction) 
were resolved by 15 % SDS PAGE, transferred to PVDF membranes and visualised by reversible 
staining with Ponceau-S. Membranes were probed with antibodies raised against the 
modifications of interest to confirm depletion of the modified histones in the unbound fractions 
from 5DCE and 15DCE ChIPs.  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3.2.7 Distributions of histone PTMs determined by RT-PCR 
Following ChIP, real-time PCR was performed with the ViiA™ 7 system (Life 
Technologies) to quantify sequences (and therefore PTMs) enriched and 
depleted in the antibody-bound fractions relative to the input material. 
TaqMan® probes consist of a fluorophore (FAM™) and a quencher (TAMRA™) 
at the 5’ and 3’ ends of the oligonucleotides, respectively. As an intact probe, 
FAM™ fluorescence is quenched by TAMRA™. However, as a sequence is 
amplified, AmpliTaq® polymerase digests the probe, releasing FAM™ from 
close proximity to TAMRA™. The resulting fluorescent signal (Rn) is therefore 
proportional to copy number. The change in Rn (ΔRn) is plotted for each 
amplification cycle and a threshold is automatically set by the ViiA™ 7 software 
above the background fluorescence but as low as possible in the exponential 
phase of amplification (figure 3.11, panel A). The number of cycles at which Rn 
of a sample reaches this threshold is defined as its crossing threshold (CT) 
value. Use of known amounts of gDNA allows a standard curve (panel B), to be 
generated, which allows quantification of the sequence in each unknown 
(input, unbound and bound). 1 ng of bound (B) and unbound (U) and 20 ng of 
input (I) samples were used as template DNA in triplicate reactions. Primers 
were designed by Dr Fiona Myers to produce amplicons smaller than a 
nucleosome (64-151 bp) at specific points in the globin locus. However, the 
primer pair designed to amplify DNA covering the enhancer nucleosome in 
the chicken ß-globin locus (amplicon 41860) was found to miss the 5’ end of 
this nucleosome by 25 bp. New primers were designed to amplify a 123 bp 
sequence (amplicon 42032), 79 bp of which covers the 3’ end of the enhancer 
nucleosome. Full details of all amplicons used and an annotated sequence of 
the chicken ß-globin locus are provided in supplementary figures S3.1 to S3.3. 
Ratios of B/I or I/B and their errors were calculated using the quantity means 
and standard deviations determined by the ViiA™ 7 software (chapter 2, figure 
2.4) to represent absolute enrichments or depletions at each amplicon. 
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3.2.7.1 Input sample sequence representation across the ß-globin locus 
It is important to test the representation of the selected sequences in the input 
chromatin used for ChIPs to map histone modifications to a locus or entire 
genome. Regions of interest might comprise nucleosomes that associate with 
the DNA more or less strongly or be completely devoid of nucleosomes and 
would therefore exhibit differences in their susceptibility to MNase digestion. 
Absolute amounts of each amplicon sequence in the input chromatin were 
determined from the standard curve produced by the ViiA™ 7 software from 
known quantities of gDNA and plotted against their locations in the ß-globin 
locus (figure 3.12). This allows identification of sequences where enrichments 
and depletions might not be reliable. 
Patterns of sequence representation across the globin locus were generally 
similar between 5 and 15DCE chromatin, with the absolute value of most 
amplicons lying between 5 and 20 ng. Genome-wide mapping experiments 
have shown that salt concentration and transcriptional activity affect the 
sequences that are recovered following MNase digestion (Henikoff et al., 
2009). The latter may account for the significant differences in sequence 
representation observed between the 5DCE and 15DCE samples, particularly 
for amplicons 39652 (6 and 11 or 26 ng), 42032 (18 and 2 or 3 ng), 44990 (16 
and 12 or 24 ng) and 50732 (22 and 26 or 13 ng) due to changes in sensitivity 
of these regions of the globin locus to digestion by MNase. The difference 
from good to low sequence representation of amplicon 42032 (from 5 to 
15DCE) might be representative of loss of the nucleosome at the enhancer in 
15DCE. Furthermore, changes in representation at the adult promoter 
(amplicon 39652) might be expected due to nucleosome repositioning for 
active transcription. 
There is a surprisingly large difference in the sequence representation of of a 
single amplicon between the two pools of 15DCE input chromatin, namely 
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amplicon 7811 (10 and 130 ng). Characterisation of these two preparations by 
agarose and SDS gel electrophoresis showed a difference in extent of MNase 
digestion, with the heavier digest showing higher levels of this amplicon. This 
suggests that nucleosomes at this point are highly resistant to MNase 
digestion, though monomer yields were similar between the preparations. 
Furthermore, enrichments and depletions of H3K4me1 determined using the 
input sample that differed most significantly from the 5DCE input sample 
(figure 3.12) were essentially identical to those observed before in our 
laboratory (Amar, 2010). 
Low sequence representation (<2.5 ng) was observed in both 5 and 15DCE at 
amplicons 21485 and 25620, which correspond to sequences close to the 
CTCF site of HS4 and between HS3 and HS2 in the LCR, respectively. This may 
indicate that these sequences are representative of nucleosome free regions 
or the presence of very labile nucleosomes in both cell types. Since 
representation was low for these amplicons, observed enrichments may be 
subject to greater errors. Conversely, amplicon 7811 was highly represented in 
the 5DCE preparation (see above). A BLAST search was used to confirm that 
the sequence of this amplicon is not repeated elsewhere in the chicken 
genome. Therefore, it is not likely to be a repeated sequence. Other amplicons 
(5614 and 21073 in 5DCE and 39652, 44990 and 50732 in 15DCE) showed 
modest increases in representation compared with genomic DNA, probably 
representing nucleosomes that are slightly more resistant to MNase digestion.  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3.11 • Quantification of DNA by ViiA™ 7 software following RT-PCR 
Fluorescence from the reporter (FAM™) is directly proportional to the amount of PCR product 
produced. (A) Signals from serially diluted gDNA (▬/▬/▬/▬, 0.195 - 200 ng) were used to 
generate the standard curve from which the quantities of unknown samples (▬, input; ▬, 
unbound; ▬, bound) were calculated. ViiA™ 7 software establishes a threshold (⋯) as early as 
possible in the exponential phase of amplification and above background signals. The point at 
which the amplification curve intercepts this threshold defines the CT value (= cycle number) for a 
given gDNA amount. (B) The standard curve (▬) uses a logarithmic scale of the quantity of gDNA 
(●). CT values of the unknown samples (●/●/●) are then calculated from the standard curve to 
generate absolute quantities of B, I and U samples, which were used to calculate enrichments and 
depletions (see figure 2.4). All B and I samples were analysed in triplicate, U samples were 
analysed in duplicate.  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3.12 • Sequence representation of input chromatin used for mapping histone modifications 
Input DNA samples from 5DCE and 15DCE were quantified by spectrophotometry and 20 ng 
used for analysis (in triplicate) by real-time PCR. Absolute quantities of each amplicon were 
determined by ViiA™ 7 software (Life Technologies) from standard curves generated using known 
amounts of serially diluted gDNA standard samples. Sequences represented in the input 
chromatin at <2.5 ng or >22.5 ng (grey shading) were considered to be under- or over-
represented, respectively.  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3.2.7.2 Distribution of H3K4me1 
Enrichments and depletions of H3K4me1 across the globin locus in 5 and 
15DCE are shown in figure 3.13 and show consistently lower enrichments at 
the active genes in each cell type. The data for 15DCE are very close to 
previous work in our laboratory, with the majority of the amplicons showing 
absolute enrichment or depletion values within ±2 of the values determined 
earlier (Amar, 2010) (supplementary figure S3.4). Generally, the patterns of 
enrichment are similar in the locus control region (LCR) in both cell types but 
with marked decreases in 15DCE, relative to 5DCE (e.g. the CTCF site and HS 
4, 3, 2 and 1, which show high enrichments in 5DCE (~7 to 18-fold), but lower 
levels (~2 to 9-fold) at 15 days). The situation is similar at the 3’ CTCF site, 
where in 5DCE an enrichment of ~10-fold is found but reduced to ~7-fold in 
15DCE. The 3’HS site exhibits similar enrichments in both cell types (~5-fold). 
Striking differences between the 5 and 15DCE profiles are, however, evident at 
the globin genes themselves. Active genes in each case show significantly 
lower enrichments than do the inactive genes. In 5DCE the inactive (ßH and ßA) 
genes show ~14-fold enrichment of H3K4me1 whilst the active (ρ and ε) genes 
show ~5-fold enrichment. The pattern of enrichment at the inactive genes is 
maintained in 15DCE with the inactive embryonic genes showing higher 
enrichments (~8-fold) than the ßH and ßA genes (~3-fold), though the absolute 
enrichments are again slightly lower in 15DCE. The levels of H3K4me1 are low 
in the transcribed region of the FR gene, brain-specific HS and close to the OR 
gene (small enrichments and depletions) in both 5 and 15DCE. Conversely, 
there are high H3K4me1 enrichments at the promoter and HSA of the FR gene 
in both 5 and 15DCE. 
The apparent inverse correlation between H3K4me1 enrichments and gene 
activity suggests an association of this modification with inactivity. The lower 
levels at active genes may result from conversion to higher methylated states 
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(me2/3). Indeed, a similar association of H3K4me1 with gene inactivity was 
observed for the FR gene, where active transcription in HD37 (erythroblasts) 
was correlated with lower enrichments and inactivity in 15DCE with higher 
enrichments (Amar, 2010). 
Earlier data suggested that the enhancer became depleted in definitive 
erythrocytes (15DCE) (Amar, 2010). In the present study, lower levels of 
H3K4me1 at the enhancer have also been observed in 5DCE and confirmed in 
15DCE (5-fold enrichment and 2.4-fold depletion, respectively) (figure 3.13). 
These enrichments are lower than those observed in progenitor cells; HD24 
(20-fold) and HD37 (10-fold) (Amar, 2010) (supplementary figure S3.4). This 
reduction in H3K4me1 levels had previously been postulated to be the result 
of increased methylation status (to me2/3) and so it was also important to test 
the distributions of those modifications across the locus, in particular at the 
enhancer and the globin genes.  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3.13 • Distribution of H3K4me1 enrichments across the chicken ß-globin locus 
100 µg of mono-nucleosomes prepared from 5 or 15DCE nuclei by MNase digestion was 
incubated with 25 µg H3K4me1 antibody (ab8895, Abcam). DNA was recovered from the input, 
unbound and bound fractions by phenol-chloroform extraction and several sequences within the 
globin locus were amplified and monitored by real-time PCR to determine the distribution of 
H3K4me1 across the globin locus. Green shading, active genes; pink shading, repressed genes; 
yellow shading, enhancer. Amplicon 41860 was thought to correspond to the enhancer 
nucleosome but this DNA actually occurs in amplicon 42032 - see main text (section 3.2.7) for 
details. Colour coding is maintained in all globin locus figures.  
-5
1
5
10
15 15DCE
-10!
-5!
0!
5!
10!
15!
20!
25!
-10!
-5!
0!
5!
10!
15!
20!
25!-5
1
25
5
10
15
20
5DCE
-10!
-5!
0!
5!
10!
15!
20!
25!
-10!
-5!
0!
5!
10!
15!
20!
25!
 98
3.2.7.3 Distribution of H3K4me2 
Enrichments of H3K4me2 are low across the entire locus (figure 3.14) with B/I 
values not exceeding ~5-fold for 5DCE and generally slightly lower in 15DCE. 
At the globin genes in 5DCE, the inactive (hatching and adult) genes show 
depletions whilst the active (embryonic) genes show modest enrichments. In 
15DCE however, the inactive genes and the active ßA gene show depletions 
and there is only minor enrichment at the promoter of the hatching gene. 
From these data, there is no clear link of H3K4me2 to ßH/A gene transcription. 
The largest differences occur at the FR promoter where small enrichments in 
5DCE (~4-fold) appear as small depletions (~2-fold) in 15DCE. Similarly, small 
enrichments in 15DCE appear as depletions in 5DCE, for example at HSA, 
HS4, HS3, HS1 and at the 3’ CTCF site. Amplicons covering sequences in the 
FR transcribed region, brain-specific HS and close to the OR gene are all 
depleted of H3K4me2 in both 5 and 15DCE, with insignificant changes 
between the two cell types. Sequences within the 16 kb condensed 
heterochromatin region are also consistently depleted in 5 and 15DCE. 
The switch from low enrichments of H3K4me2 in 5DCE to depletions in 15DCE 
for the embryonic genes was observed, and is consistent with the data 
obtained by Schneider and colleagues (2004). These changes occur in a 
similar pattern to those observed for the HS sites described above. 
Surprisingly, however, such a switch from depletion to enrichment at the genes 
as ßH and ßA become actively transcribed in 15DCE is not as marked. Whilst 
H3K4me2 is depleted at the promoters and transcribed regions of these 
genes in 5DCE (except the transcribed region of ßA), depletions remain in 
15DCE, except at the ßH promoter, which shows a small level of enrichment 
(1.2-fold). The enhancer is essentially depleted of di-methyl K4 in both cell 
types, with only a low 1.6-fold enrichment observed in 5DCE and ~2-fold 
depletion in 15DCE.  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3.14 • Distribution of H3K4me2 enrichments across the chicken ß-globin locus 
100 µg of mono-nucleosomes prepared from 5 or 15DCE nuclei by MNase digestion was 
incubated with 25 µg H3K4me2 antibody (raised in-house). DNA was recovered from the input, 
unbound and bound fractions by phenol-chloroform extraction and several sequences within the 
globin locus were amplified and monitored by real-time PCR to determine the distribution of 
H3K4me2 across the globin locus.  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3.2.7.4 Distribution of H3K4me3 
In contrast to H3K4me2, substantial enrichments of H3K4me3 are seen at 
various points in the locus in both 5 and 15DCE (figure 3.15). Intense peaks of 
tri-methylated H3K4 are found at the active epsilon and rho genes (~50-fold) 
in 5DCE contrasting with negligible levels at the inactive hatching and adult 
genes (<5-fold). This is less marked in 15DCE, which shows modest 
enrichments at the inactive epsilon and rho genes and the active hatching 
gene with high enrichments only at the transcribed part of the adult gene.  
High levels also mark the enhancer, 5’ CTCF site and HS4 in both cell types. 
Similarly high levels are maintained across all of the LCR in 15DCE, whereas 
the enrichments are low at sequences from HS3 to HS1 in 5DCE. Absolute 
enrichments at HS4 are lower in 15DCE, for example at amplicons 21367, 
21485 and 21723, enrichments decrease from 60, 52 and 45-fold in 5DCE to 
40, 19 and 27-fold in 15DCE, respectively. 
Enrichments at the FR transcribed region, promoter and HSA are also 
increased in 15DCE. H3K4me3 remains essentially depleted across the 16 kb 
heterochromatin region and rises to a striking 61-fold enrichment at amplicon 
21367, close to the 5’ CTCF site. 
H3K4me3 is enriched at the promoters and transcribed regions of the active ε 
and ρ genes in 5DCE. In 15DCE, though the ßH and ßA genes carry higher 
enrichments than in 5DCE, unexpectedly high levels of H3K4me3 are 
observed at the embryonic genes, even though they are not actively 
transcribed. However, these enrichments are still reduced relative to those 
observed when the genes are expressed in 5DCE, as indeed they are for the 
hatching and adult globin genes in 5DCE, relative to 15DCE. Very high levels 
of H3K4me3 are found at the enhancer in both cell types, but the absolute 
enrichments increase by about 3 fold (from ~35-fold in 5DCE to ~94-fold in 
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15DCE), though the enhancer sequence had very low representation (2.9 ng) 
in the 15DCE input chromatin. 
Amplicons showing H3K4me3 enrichments >90-fold were re-tested by 
repeating the real-time PCR analysis and the observed levels were consistent 
between the two data sets. 
!!!!!
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3.15 • Distribution of H3K4me3 enrichments across the chicken ß-globin locus 
100 µg of mono-nucleosomes prepared from 5 or 15DCE nuclei by MNase digestion was 
incubated with 25 µg H3K4me3 antibody (ab8580, Abcam). DNA was recovered from the input, 
unbound and bound fractions by phenol-chloroform extraction and several sequences within the 
globin locus were amplified and monitored by real-time PCR to determine the distribution of 
H3K4me3 across the globin locus.  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3.2.7.5 Distribution of H3K27ac 
Figure 3.16 shows the distribution of H3K27ac in both 5 and 15DCE. Strikingly 
high enrichments (~200-fold) are observed at the inactive hatching and adult 
genes in 5DCE but absent in the active embryonic genes. The contrast 
between the inactive and active genes is lost in 15DCE and absolute 
enrichments are much lower. Indeed the active adult and hatching genes show 
marginally higher enrichments (~7-fold) than the inactive rho and epsilon 
genes (<5-fold). The enhancer is strongly marked in 5DCE (~60-fold). 
In the LCR in 5DCE, significant enrichments (~20 to 40-fold) are seen at the 
CTCF site and at all HS. The pattern is similar in 15DCE but levels are much 
lower (~8-fold). The FR gene and HSA are depleted in both 5 and 15DCE, as 
are the brain-specific HS and sequences close to the OR gene. 
The embryonic genes in 5DCE have low K27ac and low H3K4me1 
enrichments, inversely correlating with H3K4me3. Conversely, the inactive 
hatching and adult genes are marked with very high levels of H3K27ac, 
particularly at the promoter of ßA and the transcribed regions of both ßH and 
ßA genes, which have ~321, 147 and 130-fold enrichments and high H3K4me1 
but low levels of H3K4me3. This suggests a novel repressive role for H3K27ac 
in this context. Intriguingly, lower levels of H3K27ac are observed in 15DCE 
with little distinction between the embryonic and hatching or adult genes, as 
noted above. The inverse correlation with H3K4me3 is lost in 15DCE. In 5DCE, 
the enhancer is very highly enriched in H3K27ac (~64-fold), which correlates 
with high levels of H3K4me3. H3K27ac is then significantly reduced in 15DCE 
(~5-fold), whilst the very high enrichment of H3K4me3 persists. 
As for very high H3K4me3, levels of H3K27ac showing enrichments >90-fold 
were tested by repeating the real-time PCR analysis, which indicated 
comparable enrichments between the two data sets.  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3.16 • Distribution of H3K27ac enrichments across the chicken ß-globin locus 
100 µg of mono-nucleosomes prepared from 5 or 15DCE nuclei by MNase digestion was 
incubated with 25 µg H3K27ac antibody (ab4729, Abcam). DNA was recovered from the input, 
unbound and bound fractions by phenol-chloroform extraction and several sequences within the 
globin locus were amplified and monitored by real-time PCR to determine the distribution of 
H3K27ac across the globin locus.  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3.2.7.6 Distribution of H3K27me3 
Unfortunately, it was not possible to determine the distribution of H3K27me3 
across the globin locus, since the antibody appeared to lack the required 
specificity for ChIP, despite having been selected from the Antibody Validation 
Database (Egelhofer et al., 2011). Western blot analysis of fractions following 
ChIP suggested no enrichment of H3K27me3 in the antibody-bound fraction 
and no depletion in the unbound fraction, relative to the input. Furthermore, 
real-time PCR indicated depletion of this modification across the entire locus 
in 5DCE. The situation for 15DCE was similar with very low enrichments of 
~1.5-fold observed at some amplicons (supplementary figure S3.5). 
!
3.3 Discussion 
3.3.1 ß-globin locus regulation by H3 modifications 
3.3.1.1 Modifications at ß-globin gene promoters and transcribed regions 
H3K4me3 and H3K27ac have previously been shown to be localised in the 
vicinity of active promoters (Wang et al., 2008). Indeed, H3K4me3 is highly 
enriched at the active embryonic globin genes in 5DCE and also enriched at 
the hatching and adult genes in 15DCE. However, H3K27ac enrichments were 
very low at the ρ and ε genes in 5DCE and instead was observed with 
strikingly high enrichments at the inactive ßH and ßA genes in this cell type. 
This might suggest that this modification is related to a poised state for later 
transcriptional activation. However, these genes are never expressed in 
primitive erythrocytes (5DCE). H3K27ac enrichments at inactive genes have 
not been reported in genome wide studies but this may be a result of 
grouping of data from genes showing varying expression levels rather than 
following the pattern at genes known to be repressed. H3K27ac, co-
localisation with H3K4me1 at the inactive genes in 5DCE may represent a 
hitherto undocumented repressive mechanism. It would therefore be 
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interesting to test this at the folate receptor gene by determining enrichments 
of H3K27ac in HD24 and HD37 cell lines, in which this gene is inactive and 
active, respectively. This may involve additional repressive modifications, for 
example H3K9me2/3, (Litt et al., 2001a; Czermin et al., 2002; Kuzmichev et al., 
2002; Tamaru et al., 2003) or H3R2me2a, which is laid down by PRMT6 
irrespective of H3K4 methylation status (Iberg et al., 2008). Wang and 
colleagues have suggested that H3K27ac is replaced by H3K27me1, with 
elevated levels of this modification having been observed across active genes 
(Wang et al., 2008) and it would be interesting to test this in this system. From 
these data, it is not clear what modifications contribute to the repression of the 
embryonic globin genes in 15DCE, given the higher absolute enrichments of 
H3K4me3 versus H3K4me1 at these positions in the locus. 
H3K4me2 enrichments were low across the locus in both cell types, however 
significant enrichments were observed in 10DCE, particularly around HS4, HS2 
and the ßH and ßA genes (Litt et al., 2001a). For these ChIPs, a commercially 
obtainable antibody to H3K4me2 was prohibitively expensive. We therefore 
used an antibody that was raised in-house and had been characterised 
previously. However, the low enrichments observed for these ChIPs prompted 
us to revisit the characterisation data for this antibody (Mantouvalou, 2005) 
and it is probable that the serum contains antibodies to two epitopes within 
the peptide; one recognising H3K4me2 and another binding C-terminal to K4, 
recognising un-modified H3. Though this would be expected to have caused 
much higher enrichments than observed, the H3K4me2 ChIP data presented 
here should be interpreted with caution. 
H3K4me3 enrichments more closely followed the pattern described by 
Schneider and colleagues (2004), with high enrichments observed for active 
genes and low enrichments for inactive genes, observations that have since 
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been extended in genome-wide studies (Barski et al., 2007; Bernstein et al., 
2006; Bogdanović et al., 2012; Heintzman et al., 2007; Wang et al., 2008). 
Although relatively high absolute enrichments persisted at the inactive 
embryonic genes in 15DCE, they were reduced relative to those observed in 
5DCE. However, this may reflect expression of the embryonic genes in the 
definitive erythrocytes of 15D embryos, as has been observed previously in 
human definite erythrocytes (Luo et al., 1999). 
3.3.1.2 Modifications at the ß-globin enhancer 
Comparing H3K4me1 levels at the enhancer in 5 and 15DCE with multipotent 
progenitors (HD24) and erythroblasts (HD37) (supplementary figure S3.4) 
shows modest levels in 5DCE and its depletion in 15DCE. H3K4me1 appears 
to have been completely replaced by H3K4me3 and it would therefore be 
interesting to test H3K4me3 and K27ac levels in progenitor cells (HD24, 6C2 
and HD37), i.e. prior to transcriptional activation of the embryonic globin 
genes. Contrary to the general view that H3K4me1 and H3K27ac are enriched 
at active enhancers (Creyghton et al., 2010; Rada-Iglesias et al., 2011), these 
data show rather that H3K4me1 is removed and replaced by H3K4me3 in both 
5 and 15DCE and furthermore the acetylation of H3K27 is lost in 15DCE. 
H3K4me1 and H3K27ac have been observed at the enhancer of the 
neurogenin-1 gene in zebrafish embryos prior to cell differentiation and 
transcriptional activation, suggesting that these modifications mark for future 
enhancer activity (Bogdanović et al., 2012). Data from that study also indicated 
reductions in H3K4me1 and H3K27ac enrichments at enhancers (and an 
increase in H3K4me3) whilst genes remained transcriptionally active 
(Bogdanović et al., 2012). The results presented here suggest that this 
mechanism also applies to the globin enhancer. 
The highest enrichments at the enhancer in 5 and 15DCE were observed for 
H3K4me3 (34 and 94-fold, respectively) and H3K27ac (63 and 5-fold, 
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respectively). The reduced level of H3K27ac at the enhancer in 15DCE might 
suggest that removal of H3K27ac is needed in these cells to effect 
transcription of the hatching and adult globin genes. Enrichments of H3K4me3 
have previously been shown to mark several active enhancers in thymocytes (T 
lymphocyte progenitors) and B cell precursors (Pekowska et al., 2011), which 
would be consistent with the continuing activity of the ß-globin enhancer. It 
would be interesting to test the enhancer for the presence of H3K27me1 in 
15DCE, given that significant enrichments of this modification have been 
correlated with high levels of H3K4me3 at enhancers of active genes, such as 
the CNS22 and CD28RE enhancers of the IFNG and IL2RA genes (Wang et al., 
2008). 
3.3.1.3 Modifications at the LCR 
H3K4me1 and H3K4me3 levels across the LCR appear reciprocally related, 
with higher levels of H3K4me1 (with low levels of me3) in 5DCE contrasting 
with higher enrichments of H3K4me3 (and low me1) in 15DCE. Enrichments of 
H3K4me1 across the LCR have also been observed in human erythroid 
precursor (CD133+ and CD36+) cell lines (Cui et al., 2009). Cui and colleagues 
(2009) also noted that the human ß-globin LCR was not enriched with tri-
methylated H3K4 in these precursors. ChIP analysis of the chicken ß-globin 
LCR supports this, showing elevated levels of H3K4me3 in 10DCE (Litt et al., 
2001a). 
3.3.1.4 Enrichments in the ACH 
It is not easy to correlate these data with changes at the ACH as revealed by 
3C experiments (section 3.1 and figure 3.3, panel E). Higher enrichments of 
H3K4me3 and H3K27ac generally correspond to the ACH in each cell type, 
though there are high enrichments elsewhere, for example, at the epsilon 
gene (for H3K4me3), which is never localised to the ACH. However, given the 
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complexity of histone modifications alone, it is perhaps unsurprising that such 
an association is not so clear cut. 
3.3.2 Choice of modifications to characterise by SNAP 
Based on their co-occurrence at promoters prior to transcriptional activation, 
as identified here in 5DCE (figure 3.17) and by ChIP-seq in CD4+ T cells (Wang 
et al., 2008), H3K4me1 and H3K27ac appear to be key modifications for the 
regulation of ß-globin gene transcription. In addition, H3K4me1 and the 
combinatorial effects of PTMs remained somewhat under-represented in the 
literature, so both this modification and H3K27ac were chosen as marks of 
repressed promoters for further investigation by stable isotope labelling by 
amino acids in cell culture (SILAC) based nucleosome affinity pull downs 
coupled with high resolution mass spectrometry to identify their binding 
partners. By utilising this approach to isolate proteins with nucleosomes 
carrying either one or both of these modifications, co-operative and/or 
antagonistic mechanisms for the recruitment or exclusion of effector proteins 
by H3K4me1 and K27ac could also be elucidated.  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3.17 • Comparison of H3K4 and K27 PTM distributions across the chicken ß-globin locus 
Enrichments and depletions of H3K4me1, me2, me3 and H3K27ac at a number of positions 
within the chicken ß-globin locus were determined by real-time PCR following ChIP of mono-
nucleosomes isolated from 5DCE and 15DCE. To aid comparisons between tracks, variations in 
antibody efficiency were accounted for by normalising enrichment and depletion values against 
the highest enrichment (= 100 %) for each antibody. Note the different scale for H3K27ac 
distribution in 15DCE.  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4 Assembly of nucleosomes carrying defined 
histone PTMs for SNAP 
To identify binding partners to H3K4me1 and H3K27ac by SILAC nucleosome 
affinity pull down (SNAP), it was first necessary to assemble nucleosomes 
carrying these modified histones. The use of nucleosomal substrates was 
important so as to account for accessibility and binding of effector proteins. 
However, it is impossible to isolate sufficient quantities of specifically modified 
histones for this purpose from endogenous sources. Whilst mono-, di-, tri- and 
tetra-acetylated histones can be separated by ion exchange chromatography, 
isoforms (e.g. H3 mono-acetylated at residue K9 or K27) and methylated forms 
cannot, since they have no charge or significant molecular weight differences. 
Several methods exist for the synthesis of modified recombinant proteins but 
most can be difficult, time-consuming and expensive. The aim was therefore to 
synthesise modified histones and isolate a DNA sequence capable of precisely 
positioning histone octamers. These components would then be used to 
assemble nucleosomes carrying specific histone modifications. 
4.1 Methods for in vitro synthesis of modified histones 
4.1.1 Enzymatic modification 
In vitro modification of histones by recombinant enzymes has proven useful to 
determine their activities, substrate specificities and how they are regulated. 
For example, Tip60 has been shown to specifically acetylate histones H2A, H3 
and H4 but not H2B (Yamamoto & Horikoshi, 1997). Further experiments using 
histone acetyltransferase (HAT) enzymes including p300 and Gcn5 indicated 
that their ability to acetylate H3K14 was increased two to six times by the 
presence of phosphoserine at residue 10 (Lo et al., 2000). However, the use of 
recombinant enzymes to produce ‘designer’ modified histones for the 
identification of PTM effector proteins has seen limited use, due to their 
 111
generally low activity and lack of specificity or their ability to lay down different 
modifications (and therefore lack of homogeneity). For instance, with HATs 
such as the MOF complex, which specifically acetylates H4K16 (Hilfiker et al., 
1997; Akhtar & Becker, 2000; Smith et al., 2000), the maximum level of 
modification achieved in vitro was very low, at only ~30 % (Robinson et al., 
2008). Furthermore, a number of histone-modifying enzymes, including 
commercially available recombinant ones, are known to modify histones to 
different extents and at several residues. When used to methylate K79 of 
recombinant H3 in the context of nucleosomes and nucleosomal arrays, the 
Dot1 methyltransferase produced both mono- and di-methylated species 
(Martino et al., 2009). Other examples include the EZH2 component of 
polycomb repressive complex 2 (PRC2), which can di- or tri-methylate H3K27 
(Cao et al., 2002; Kuzmichev et al., 2002; reviews in Simon & Kingston, 2009; 
Margueron & Reinberg, 2011) and the acetyltransferase p300, which is capable 
of acetylating all four core histones (Ogryzko et al., 1996; review in Kalkhoven, 
2004). More applicable to this study were the observations that: i) should 
enzymatic modification prove inefficient, H3K4me1 (which has no significant 
mass difference and no difference in charge from unmodified H3K4) could not 
be purified; and ii) that there was no commercially available acetyltransferase 
specific to H3K27. Consequently, methods to synthesise modified histones in 
vitro were examined. 
4.1.2 Expressed protein ligation 
Expressed protein ligation (EPL) involves the preparation of an N-terminal 
peptide carrying the desired modification and expression of the remaining N-
terminally truncated protein (Muir et al., 1998; Flavell & Muir, 2009). Modified 
peptides and the truncated histone are combined in the presence of thiols to 
produce the full length protein (Shogren-Knaak et al., 2003) (figure 4.1). The 
approach has been applied to the synthesis of modified histones (Shogren-
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Knaak et al., 2003; Shogren-Knaak et al., 2006; Bartke et al., 2010). In one 
study by Shogren-Knaak and colleagues, ligated H3S10ph was assembled into 
nucleosomal arrays with a DNA component that carried a unique central SalI 
restriction site used to monitor nucleosome remodelling by the yeast SWI/SNF 
complex. The results showed that remodelling by SWI/SNF was independent 
of S10 phosphorylation (Shogren-Knaak et al., 2003). In the same study, the 
acetyltransferase activity of Gcn5p was also tested by 3H-acetate incorporation 
into the nucleosomal arrays, demonstrating the acetylation of nucleosome 
arrays containing H3S10ph at a rate two-fold greater than nucleosomes 
lacking the phosphate modification on H3S10 (Shogren-Knaak et al., 2003). 
Importantly, in both sets of experiments, results for both recombinant and 
ligated H3 were similar, demonstrating the biological similarity of ligated and 
wild-type histones (Shogren-Knaak et al., 2003). A further study from the same 
laboratory determined the sedimentation coefficients of nucleosomal arrays to 
show that H4K16ac inhibits the higher-order folding of chromatin. End-
positioned nucleosomes (i.e. where octamers were phased at the 3’ ends of 5S 
DNAs) were also used in gel-shift assays to show that H4K16 inhibits ACF-
mediated nucleosome remodelling (Shogren-Knaak et al., 2006; review in 
Shogren-Knaak & Peterson, 2006). One final example was the study by Bartke 
and colleagues, who used ligated H3K4me3, H3K9me3 and H3K27me3 in 
stable-isotope labelling by amino acids in cell culture (SILAC)-based 
nucleosome affinity pull down experiments to identify a number of 
methylation-sensitive interacting proteins, including a novel origin recognition 
complex subunit, LRWD1 (Bartke et al., 2010; review in Bartke & Kouzarides, 
2011). 
Whilst this technique can potentially be used to synthesise histones carrying 
multiple modifications on their N-termini, the numerous steps involved make it 
a very time-consuming process. Furthermore, this method is also very 
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inefficient and even attempts to improve it by cleaving the truncated histone 
within E. coli with TEV (Bartke et al., 2010), rather than a separate cleavage step 
!!
   !!
!
4.1 • Production of modified histones by peptide ligation to truncated histones 
An N-terminal peptide is synthesised with the desired, side chain protected (×) modification (●) 
and a C-terminal thioester by solid phase synthesis (left). Truncated histone with an N-terminal 
cysteine is expressed in E. coli (right). The peptide is cleaved from the resin and truncated protein 
cleaved with Factor Xa and the two are reacted in the presence of thiol reagents to produce full-
length histone carrying the modification of interest. 
Adapted from Shogren-Knaak et al., 2003  
fMet Factor Xa aa 33-135
X
aa 1-30
X
aa 1-30
X
aa 1-30
aa 1-30
Expression 
IEX purification
aa 33-135aa 1-30
aa 33-135
Factor Xa cleavage 
HPLC purification
Strong acid cleavage 
HPLC purification
Activating agent 
+ thiol
Weak acid cleavage
Thiols, denaturant 
IEX purification
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following purification from inclusion bodies, resulted in the production of 
limited quantities of ligated histone (~2 mg from an input of 12 mg truncated 
histone) (Dr T Bartke, personal communication, 8 June 2010), significantly 
lower than the suggested efficiency of 50 % (Shogren-Knaak et al., 2003). 
Another potential limitation is the incorporation of a cysteine into the histone 
at a position not normally seen in histones, to facilitate ligation. This might 
affect the binding of interacting proteins. Additionally, the high cost of peptide 
synthesis limits its use to the N-terminus, though this can be overcome by 
using multiple ligations or native chemical ligation, which produces entirely 
synthetic proteins. Both of these approaches have been developed for the 
synthesis of modified histones. Ubiquitylated H2B was generated by two 
ligation reactions to show that this modification stimulated methylation of 
H3K79 by hDot1L (McGinty et al., 2009). Entirely synthetic histones H3 and H4 
have also been used (Shimko et al., 2011; Shimko et al., 2013), with the 
production of synthetic H3K56ac being utilised to to show that this 
modification promotes the recruitment of a DNA binding factor (LexA) to the 
nucleosome (Shimko et al., 2011). However, whilst this alternative approach 
allows for the modification of any residue(s) in a protein, it is still an expensive 
approach - even more so than the already costly expressed protein ligation. 
4.1.3 Reductive alkylation 
As well as its use for derivatisation of cysteine thiol groups in proteins prior to 
digestion with trypsin for MS analysis (Sechi & Chait, 1998), reductive 
alkylation has long been utilised to generate modified proteins, using a variety 
of alkylating reagents (Raftery & Cole, 1966; Means & Feeney, 1968). Raftery 
and Cole optimised alkylation of cysteine residues in insulin B chain to the 
lysine analogue aminoethylcysteine, using ethylenimine. This permitted 
hydrolysis at the C-terminus of this amino acid by trypsin as a means of 
quantifying cysteine residues (Raftery & Cole, 1966). Alkylation has also been 
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used to methylate the ε-amino group of lysine residues (Means & Feeney, 
1968) and has more recently been developed with new chemicals to generate 
methylated and acetylated lysine analogues (MLAs and ALAs, respectively, 
denoted by KCme or KCac, respectively) by derivatisation of cysteine, offering a 
cost-effective and efficient method for the synthesis of specifically modified 
histones (Simon et al., 2007; review in Shogren-Knaak, 2007; Simon, 2010; 
Dancy et al., 2012; Simon & Shokat, 2012) (figure 4.2). In initial experiments, 
the binding of H3 peptides to the heterochromatin protein HP1 was tested by 
modelling of an MLA-containing H3KC9me2 peptide onto the crystal structure 
of HP1 in complex with the natural H3K9me2 peptide and using both natural 
and MLA peptides to isolate HP1 from nuclear protein extracts (Simon et al., 
2007). In addition, H3KC9 and H3KC9me2 peptides were compared with their 
natural counterparts to show that both K9 and KC9 can be methylated by the 
SUV39H1 methyltransferase and gel shifts were used to demonstrate that ACF-
mediated remodelling of nucleosomes was not affected by H3KC79me2 or 
H4KC20me3 (Simon et al., 2007). A further study used different acetylated 
lysine analogues, acetyl-azalysine (denoted Kazaac), as substrates to examine 
the ability of the histone deacetylase HDAC8 to remove an acetyl mark at 
position 382 in p53 (Dancy et al., 2012). The data from MALDI HPLC indicated 
that the efficiency of deacetylation of p53Kaza382ac was >20-fold lower than 
for p53K382ac, demonstrating a limitation for these particular analogues 
(Dancy et al., 2012). 
Whilst the analogue produced by the approach of Simon and colleagues 
(aminoethylcysteine) contains a sulphur atom that is not present in natural 
lysine, they are still detected in both full-length histones and peptides by 
antibodies raised against their natural homologues (Simon et al., 2007) and so 
should be useful for the identification of specific interacting proteins. However, 
in the context of peptides representing H3 aa 1-14, detection with an antibody  
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4.2 • Installation of modified lysine analogues into histones by reductive alkylation 
Reductive alkylation converts cysteine residues to aminoethylcysteine, an analogue of lysine. (A) 
To prevent the derivatisation of natural cysteine residues (e.g. C110 in Xenopus H3), these amino 
acids should be mutated, in this example to serine, which has similar electronegativity. (B-D) 
Alkylation can be achieved with various reagents to produce modified lysine analogues such as 
those exemplified (B), according to the reactions outlined (C-D). Atoms are: black, carbon; red, 
oxygen; blue, nitrogen; gold, sulphur; and green, chlorine. Most hydrogens are implicit. 
Adapted from Simon et al. (2007)  
A
C
B
D
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raised against H3K9me2 was reduced five-fold in the peptide bearing a lysine 
analogue, compared to natural lysine (Simon et al., 2007). The main limitations 
of this approach are the inability to add two different types of modification to a 
single histone (all cysteine residues will be converted to a single modified 
form) and the possibility of introducing undesired derivatisation of lysine 
residues (Simon, 2010). However, the reactivity of such nucleophiles is 
significantly reduced, compared to the highly reactive sulphydryl of cysteine, 
with the optimised pH of 7.8 (Simon, 2010; Simon & Shokat, 2012). 
Furthermore, this approach offers an exceptionally economical method for the 
installation of methyl- and acetyl-lysine analogues, given the low cost of the 
reagents used and the well-established protocols for large-scale histone 
expression (Luger et al., 1999; Dyer et al., 2004). Finally, the installation of KC 
and KCme1 have exhibited over- or under-reaction but this can easily be 
overcome by titrating the conditions of the reactions (Simon, 2010). 
4.1.4 Genetic encoding 
In contrast to the techniques described above, genetic encoding is a relatively 
new technique and is based on expansion of the genetic code, using unique 
aminoacyl-tRNA synthetase/tRNA pairs to exploit codons that would otherwise 
signal the termination of translation (Wang et al., 2001b; reviews in Chin, 2012; 
Chin 2014) (figure 4.3). Since its use for the incorporation of non-natural amino 
acids in response to an amber codon (CUA) (Wang et al., 2001b), this 
approach has been adapted to the synthesis of an acetylated tumour 
suppressor, manganese superoxide dismutase (Neumann et al., 2008) and has 
now been extensively applied to the incorporation of modified amino acids in 
histones (Neumann et al., 2009; Nguyen et al., 2009; Nguyen et al., 2010). The 
function of H3K56 acetylation was studied using genetically encoded 
H3K56ac. Previous experiments had suggested that this modification might 
mediate chromatin compaction and remodelling. Experiments on the 
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telomeric heterochromatin protein Sir2 had shown that H3K56 was required 
for chromatin compaction, effected by Sir2 deacetylation of K56 (Xu et al., 
2007), whilst ChIPs had indicated that H3K56ac and the SWI/SNF complex 
coexist at active promoters (Xu et al., 2005). Therefore, nucleosomal arrays 
carrying H3K56ac were produced and subjected to compaction by the linker 
histone H5. Sedimentation coefficients showed that compaction was 
equivalent in both modified and unmodified H3-containing arrays, indicating 
that H3K56ac does not affect higher-order chromatin structure alone 
(Neumann et al., 2009). Gel shifts were used to show 1.2 and 1.4-fold increases 
in the rate of repositioning of H3K56ac nucleosomes, compared to wild-type 
H3 nucleosomes, by RSC and SWI/SNF, respectively, but no significant 
difference to the rate of dimer exchange by these complexes between 
modified and unmodified nucleosomes (Neumann et al., 2009). Furthermore, 
fluorescence resonance energy transfer (FRET) experiments in mono-
nucleosomes showed that both wild-type and H3K56ac-containing 
nucleosomes exhibit near-identical stability in salt-dependent unfolding but a 
single pair FRET approach used in conjunction with alternating excitation 
(ALEX) selection and native PAGE (Koopmans et al., 2007) indicated that DNA 
breathing at the entry/exit point was promoted by H3K56ac (Neumann et al., 
2009). 
Genetic encoding has also been adapted to incorporate methylated lysine into 
H3 (Nguyen et al., 2009). Since production of a tRNA synthetase/tRNA pair that 
could distinguish between Nε-methyl-lysine and lysine was not successful (due 
to the similar sizes of the two amino acids, thus preventing exclusion of lysine), 
the method was adapted to indirectly incorporate mono-methylated lysine at 
H3K9. First, Nε-tert-butyloxycarbonyl-L-lysine was incorporated into the 
growing polypeptide gene and this was followed by the post-translational 
removal of the tert-butyloxycarbonyl (Boc) group (Nguyen et al., 2009). This 
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approach was subsequently developed further for the synthesis of H3K9me2 
(Nguyen et al., 2010). Since di-methylated lysine was not accepted by the 
previously utilised pyrolysyl-tRNA synthetase and Boc-dimethyl-L-lysine is 
unstable, this was achieved by genetically encoding Boc-L-lysine, protecting 
the N-terminal amine and epsilon amino groups of the remaining H3 lysine 
residues using N-(benzyloxycarbonyloxy)succinimide (Cbz-OSu), removing the 
Boc group from residue 9, methylating it by reductive alkylation with 
formaldehyde and dimethylamine and finally removing the Cbz groups 
(Nguyen et al., 2010). 
!!
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4.3 • Genetic encoding of acetylated lysine 
The capacity of the genetic code in Escherichia coli can be expanded to allow for the genetic 
incorporation of modified lysine. This is achieved by transforming cells with an aminoacyl-tRNA 
synthetase/tRNACUA pair, which will install a modified lysine in response to an amber codon (that 
would usually terminate transcription). Co-transforming these cells with a histone expression 
plasmid carrying an amber codon at the desired site of modification and supplementing with 
acetylated lysine (Kac) and nicotinamide (NAM) allows incorporation of acetyl-lysine into the 
growing peptide chain and hence direct expression of acetylated histones. 
Adapted from Neumann et al., 2009  
UAG
+
Kac NAM
Kac
CU
A
CU
A
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The greatest advantage of this approach is its simplicity, at least for the 
incorporation of acetylated lysine. The generation of mutant histone 
expression constructs is very straightforward and is followed by the direct 
synthesis of modified histones using minimally-adapted expression protocols. 
Furthermore, two codons could be utilised to synthesise proteins with two 
distinct modifications and there has been good progress in the development 
of independent, so-called orthogonal translation pathways, which direct the 
incorporation of modified amino acids into the growing polypeptide chain via 
non-natural quadruplet codons and extended anti-codon tRNAs (Wang et al., 
2007; Wang et al., 2012). The main issues with this approach are: i) the 
necessity to construct or evolve novel tRNAs that function efficiently in 
translation and are not recognised by endogenous aminoacyl-tRNA 
synthetases (Wang et al., 2001b); ii) the low yields of histones, typically at only 
~2 mg/L of culture (Neumann et al., 2009); and iii) inherent cost. However, 
some effort can be reduced by introducing a synthetase/tRNA pair into E. coli 
from another organism if aminoacylation between the species is inefficient 
(Wang et al., 2001b). This was the approach used by Neumann and colleagues 
to develop their Nε-acetyllysyl-tRNA synthetase/tRNACUA pair, which was 
derived from the pyrrolysyl-tRNA synthetase/tRNACUA pair of the archaeon 
Methanosarcina barkeri (Neumann et al., 2008). Furthermore, plasmids suitable 
for the expression of histone H3 containing acetylated lysine were kindly 
donated for use in the present study by Prof. J Chin (MRC LMB, Cambridge, 
UK). Finally, the cost of such an approach would be considerably lower than 
that of EPL. 
4.1.5 Choice of modification technique 
Whilst all four approaches offer their difficulties, enzymatic and EPL are the 
most non-specific and inefficient, respectively. Reductive alkylation offers the 
most cost-effective approach but is limited to the incorporation of a single 
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state of modification, since it depends on reaction with cysteine residues, so it 
would not be possible to introduce acetylation and methylation into the same 
histone by this method. Therefore, alkylation was selected for the generation 
of singly modified histones and used together with genetic encoding to 
synthesise histones modified at both K4 and K27, namely H3 K4me1 K27ac. 
!
4.2 Preparation of recombinant wild-type and modified histones 
4.2.1 Histone expression vectors 
Core histone genes were isolated from the Xenopus laevis gene clusters 
prepared by Old et al. (1982) and cloned into pET expression vectors  (Studier 
et al., 1990), following sequence optimisation, by Luger et al. (1997b). These 
pET-histone expression vectors (supplementary figures S4.1 to S4.4) were 
kindly provided by Prof. T Richmond (ETH Zurich, Switzerland) and 
transformed into DH5α E. coli cells to generate laboratory stocks 
(supplementary figure S4.7) by alkaline lysis. 
4.2.2 Site-directed mutagenesis 
Both genetic installation of acetyl-lysine and synthesis of modified lysine 
analogues required mutants of the histone H3 gene. These were generated 
using a commercial kit, according to the manufacturers’ protocol and 
transformed into XL10-Gold E. coli cells to generate laboratory stocks 
(supplementary figure S4.7) by alkaline lysis. 
The reductive alkylation approach exploits the reactivity of a cysteine that 
replaces the targeted lysine residue so as to produce aminoethylcysteine (KC), 
an analogue of lysine. It was therefore necessary to first replace the natural 
cysteine (C110) of wild-type H3 to avoid its derivatisation. In this instance, 
serine was chosen for its similar side-chain length and chemistry to cysteine 
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(both sulphur and oxygen appear in group 16 of the period table and have 
similar electronegativity). Simon et al. (2007) argue that alanine should be 
used instead since it is the natural residue at position 110 in Caenorhabditis 
elegans, although this is not the case. This error seems to have arisen from 
accidental comparison with amino acid sequence of H3 from human, where it 
is actually an additional cysteine at position 96 that is replaced by alanine in 
the worm (supplementary figure S4.5) (Vanfleteren et al., 1987; NCBI Protein 
Database, 2000). Subsequent mutations substituted the lysine requiring 
modification (K4 or K27) with cysteine, as described. This approach was used 
to produce methyl lysine analogues of H3 according to Simon et al. (2010) and 
also developed further to synthesise an acetylated lysine analogue of H3, as 
described (sections 2.4.4 and 4.2.4.3). 
Genetic encoding is based on the incorporation of acetylated lysine into the 
growing histone peptide at the ribosome by an aminoacyl-tRNA synthetase/
tRNACUA pair that responds to an amber codon. Although this approach is 
significantly more expensive than reductive alkylation it provided the 
opportunity to use the two techniques to synthesise histones carrying both 
methyl and acetyl modifications (section 4.1.5). As such, genetic encoding was 
used to incorporate acetylated lysine at residue 27 (K27ac) in the context of an 
H3K4 K27amb C110S mutant and subsequent alkylation used to generate a 
mono-methyl-lysine analogue at residue 4. 
4.2.3 Histone expression and purification 
The pET series of expression vectors was first developed by Studier et al. 
(1986) and utilises the bacteriophage T7 promoter to direct expression of the 
target gene. pET-histone plasmids were transformed into BL21 (DE3) pLysS 
cells, which contain the T7 bacteriophage gene 1, encoding T7 RNA 
polymerase (Davanloo et al., 1984). This gene is placed under control of the 
lacUV5 promoter, which is initially inhibited by binding of the LacI repressor to 
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the lac operator, thus preventing expression of the RNA polymerase (and, as a 
consequence, the histone). However, intracellular cAMP binds to cAMP 
receptor protein, which, in-turn, binds upstream of and derepresses the lac 
promoter, allowing basal expression of T7 RNA polymerase. Therefore, pLysS, 
which encodes for T7 lysozyme, an inhibitor of T7 RNA polymerase, is also 
present in this expression strain of E. coli, to minimise low-level transcription of 
the histone gene. Later addition of IPTG, an analogue of allolactose, to the 
growth medium allows transcription from the lacUV5 promoter and 
subsequent over-expression of the histone by reducing the LacI repressor’s 
affinity for the lac operator. 
All histones - both wild-type and mutants - were initially expressed using a 
method adapted from Luger et al. (1999) (section 2.4.2) but expression levels 
were not as high as reported (Luger et al., 1997b). Recent work in Dr A Flaus’ 
lab (NUI Galway, Ireland) involved the optimisation of histone expression to 
generate yields as high as 400 mg/L of culture (Stephan et al., 2011). Whilst 
this involved the expression of human histones, aspects of the protocol, in 
particular the growth of starter cultures at low temperature (Dr H Stephan, 
personal communication, 3 August 2011), could be applied to the expression 
of any protein. Incubating larger volume starter cultures overnight at 25 ˚C and 
60 rpm (instead of 37 ˚C and 220 rpm) maintained the cultures in the late lag 
or early log growth phases, allowing for improved growth rates and histone 
yields. Use of a rich medium (2-YT) instead of LB and adjusting the 
concentration of IPTG used to induce expression of the histones also seems to 
have helped increase yields (figure 4.4), particularly of H2A and H4, compared 
with previous work in our laboratory (Amar, 2010; Newman, 2011).  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4.4 • Comparison of protocols for the expression of recombinant X. laevis histones 
The original protocol for expression of recombinant histones by Luger et al. (1999) was slightly 
modified by Dyer et al. (2004) (left - see asterisks). In our laboratory, the protocol was adapted 
(centre) and improved (right - key changes and improvements are indicated in red text). The 
yields of histone obtained per litre of culture for each method are indicated.  
Transform BL21 (DE3) pLysS with 
pET histone plasmid 
Culture on LB agar at 37˚C, O/N
Inoculate 10 mL LB media with a 
single transformed colony 
Culture at 37˚C, 220 rpm, O/N
Harvest cells from starter culture 
Resuspend to 1 L in fresh LB Broth 
Culture at 37˚C, 220 rpm
At OD      of 0.8, induce expression 
with 400 µM IPTG 
Culture for 2.5 h (1.5 h for H4)
Harvest cells with 7000 g, 20 min 
Store resuspended in 25 mL HWB
adapted from Dyer et al. (2004)
600
Amar (2010)Dyer et al. (2004) Cashman (2011)
adapted from Stephan et al. (2011)
Transform BL21 (DE3) pLysS with 
pET histone plasmid 
Culture on LB agar at 37˚C, O/N
Inoculate 375 mL 2-YT media with 
a single transformed colony 
Culture at 25˚C, 60 rpm, O/N
Add 375 mL pre-warmed (37˚C) 
2-YT media to the starter culture 
Culture at 37˚C, 400 rpm
At OD      of 0.6 - 0.8, induce 
expression with 500 µM IPTG 
Culture for 3.5 h (2.5 h for H4)
Harvest cells with 7000 g, 20 min 
Store resuspended in 25 mL HWB
600
Transform BL21 (DE3) pLysS with 
pET histone plasmid 
Culture on TYE agar at 37˚C, O/N
Inoculate 4x 4 mL 2-YT* media with 
a single transformed colony 
Culture at 37˚C, with shaking, 2-3 h
Add pre-cultures to 100 mL 2-YT* 
Culture at 37˚C, with shaking
At OD      0.4**, induce expression 
with 200 - 400 µM IPTG 
Culture for 2 h***, with shaking
Harvest cells with 8000 g, 7 min 
Store resuspended in 35 mL HWB
At OD      of 0.4, split the starter 
culture between 6x 1 L 2-YT* 
Culture at 37˚C, with shaking
adapted from Luger et al. (1999)
600
600
*2-YT used by Dyer et al. (2004) contained 0.1% glucose 
**Changed from Luger et al. (1999), who induced at OD     0.8 
***Changed from Luger et al. (1999), who cultured for 2.5 h (1.5 h for H4)
600
12 mg/L 
14 mg/L 
5 mg/L 
7 mg/L
H2A: 
H2B: 
H3: 
H4:
50 - 80 mg/L 
50 - 80 mg/L 
50 - 80 mg/L 
10 - 20 mg/L
H2A: 
H2B: 
H3: 
H4:
H2A: 
H2B: 
H3: 
H4: 
 
H3 C110S: 
H3 K4C: 
H3 K27C: 
H3 K4C K27amb:
36 mg/L 
12.5 mg/L 
17.5 mg/L 
12 mg/L 
 
26 mg/L 
4.5 mg/L 
53 mg/L 
2.2 mg/L
 125
Histones were purified using an adaptation of Luger’s method (Luger et al., 
1999). As reported by Luger et al. (1997b), all histones were expressed as 
insoluble protein, so extraction of the inclusion bodies with neat DMSO 
followed by unfolding in 7 M guanidine hydrochloride was necessary to 
prepare soluble protein. It was found that repeated extraction of the inclusion 
body pellets yielded additional protein. This was shown by coomassie staining 
of 3 µL spots on 3MM paper (figure 4.5), which indicated a significant amount 
of protein (estimated at >10 mg/mL) was solubilised following a second 
extraction. The presence of solubilised histones in these samples could not be 
checked by SDS PAGE since guanidine HCl causes severe band distortion but 
two extractions were routinely used to ensure as much histone as possible was 
solubilised for subsequent purification. 
!!!!!!!!!!!
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4.5 • Repeated extraction of inclusion bodies yields additional protein 
Extraction of inclusion bodies was repeated three times to test for further protein solubilisation. 
For each extraction, pellets were incubated with 500 µL DMSO for 30 min, then with 9.5 mL 
histone unfolding buffer (7 M guanidine HCl, 20 mM Tris-HCl pH 7.5, 10 mM DTT) for a further 30 
min. Following each extraction, 3 µL samples were retained and spotted onto 3MM paper. Protein 
was detected by staining with coomassie R-250. MCE total histone extract standards at 2.5-10.0 
mg/mL were used to estimate the concentration of protein following extraction.  
MCE Total Histone
coomassie
2.5 mg/mL 5 mg/mL 10 mg/mL
Inclusion Body Extractions
1 2 3
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Previous work in our laboratory indicated that the Sephacryl S200 size 
exclusion step was unnecessary, since purification by sulphopropyl (SP) cation 
exchange alone produced >90 % pure histone (Amar, 2010; Newman, 2011), 
suitable for octamer folding. During this work however, histone H3 was 
observed to elute from the HiTrap SP HP column in an asymmetrical peak 
comprised of at least four components (figure 4.6). It was initially postulated 
that this was the result of incomplete denaturation of the histone in 4 M urea, 
so the composition of the SP binding and elution buffers was increased to 6 M 
urea, a trade-off between the 7 M used by Luger et al. (1999) and maintenance 
of the column for repeated purifications. The result was elution of H3 in two 
symmetrical peaks, suggesting that, since H3 is the only one of the four 
canonical histones to carry a cysteine residue, the second peak was the result 
of un-reduced disulphide bonds. However, upon purification of the mutant 
histone H3C110S, which does not contain any cysteine residues (section 
4.1.2), this protein also eluted in two peaks (figure 4.10). Proteins with 
mobilities of ~35 kDa on SDS gels, twice the molecular weight of H3 and 
therefore possible histone dimers, were observed in some samples. However, 
such dimers must have resulted from incomplete reduction of the proteins 
prior to analysis on SDS gels rather than before purification by ion exchange. 
Characterisation of the proteins from each peak by absorbance spectroscopy, 
SDS PAGE, Western blot, reversed-phase HPLC and ESI-TOF-MS confirmed the 
identity of both as histone H3 (figure 4.6). DNA contamination was an unlikely 
cause of the two peaks, since both had very similar A260/280 ratios (~0.49). Both 
species also had the same mobility on SDS gels, were detected by antibodies 
raised against H3, had identical elution profiles from reversed-phase HPLC and 
identical molecular weights (~15272 Da). Contaminant proteins are observed 
only in the first peak of all wild-type and mutant H3 histones following ion 
exchange. This, together with comparison of the chromatograms from 
purifications using 4 M and 6 M urea, suggests that H3 interacts strongly with a 
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bacterial protein(s). The complexes formed would appear to reduce the 
basicity of the histone and therefore cause elution from the column at lower 
salt concentrations. In 6 M urea, these complexes are apparently less stable, 
resulting in an increased amount of H3 eluting at higher salt concentrations. 
Although the proteins from both peaks were apparently identical, fractions 
corresponding to each peak were separately pooled and the second peak 
species, which had greater purity as judged by SDS PAGE, was routinely used 
for octamer folding. 
Due to the labour intensive nature of histone expression and purification, the 
improved protocols described above (figures 4.4, 4.7 and 4.8) were 
standardised for the production of the remaining histones (figures 4.9 and 
4.10). Different mutants of H3 had highly variable yields, as observed by Luger 
et al. (1997b). This may be due to increased (C110S and K27C mutants) or 
reduced (K4C and K27ac) formation of inclusion bodies, although purification 
of any histones expressed as soluble protein is unlikely to have proven useful, 
due to their likely degradation by endogenous bacterial proteases.  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4.6 • Optimised purification and characterisation of recombinant wild-type histone H3 
(A) H3 was initially purified on 5 mL HiTrap SP HP cation exchange columns using column buffers 
containing 4 M urea (pale green). (i) However, histones eluted in an asymmetric peak consisting 
of at least four components. (ii) Elution was improved by increasing the concentration of urea to 6 
M (green). Two peaks, eluting at ~560 mM and ~840 mM NaCl, contained proteins that migrated 
with the expected mobility for H3 on SDS gels. (B-D) Their identities were confirmed by Western 
blotting with antibodies raised against H3 (B), elution volumes from an analytical reversed-phase 
21.2/25 Zorbax 300SB-CN column (C) and molecular weight determination by ESI-TOF-MS (D). 
The two proteins eluting from SP HP columns in 6 M urea are designated 1 and 2 throughout the 
figure, corresponding to the first and second peaks in the elution profile, respectively.  
M
CE
 M
ar
ke
r
Be
nc
hM
ar
k™
Pu
rifi
ed
 H
3
H3
H32
1
coomassie
coomassie
      0 10 20 30
Ab
so
rb
an
ce
CV
%
 B
100 20 30
0
100
1
2I
II
III
IV
A  i            ii
I
HiTrap SP
coomassie
H3
M
CE
 M
ar
ke
r
II III IV
1 2
H3
6 M urea
4 M urea
1 2
ponceau
anti-H3
H3
M
CE
 M
ar
ke
r
immunoblot
B C
D
In
te
ns
ity
 (%
)
mass (kDa)
15272.33 ±1.82 1
14 15 16 170
100
mass (kDa)
In
te
ns
ity
 (%
)
15271.91 ±0.92 2
14 15 16 17
0
100
 129
!!!!
   !!!!!!!
4.7 • Comparison of protocols for the purification of recombinant X. laevis histones 
The original protocol for purification of recombinant histones from Luger et al. (1999) was 
modified by Dyer et al. (2004) (left - key differences are highlighted with asterisks). Protocols used 
within this project were adapted (centre) and improved (right - key changes and improvements 
are indicated in red text). Histone yields are provided for each method.  
Amar (2010)
adapted from Luger et al. (1999)
Pellet inclusion bodies (23000 g, 
15 min), wash in 25 mL HWB/T Re-
pellet inclusion bodies
Wash the pellet in 25 mL HWB 
Re-pellet inclusion bodies
Apply supernatant to 1 g HAP 
Apply filtrate to HiPrep 26/10 DS 
Pool void volume fractions
Apply histone-containing fractions 
to 5 mL HiTrap SP HP 
Elute with linear NaCl gradient
Soak pellet in 500 µL DMSO, 30 min 
Mix pellet with 4.5 mL HUB, 30 min 
Centrifuge and retain supernatant
Desalt histone-containing fractions 
into 0.5% FA and lyophilise
Thaw pellets from 1 L culture to lyse 
Sonicate until viscosity is reduced
12 mg/L 
14 mg/L 
5 mg/L 
7 mg/L
H2A: 
H2B: 
H3: 
H4:
Dyer et al. (2004)
Lyse cells by thawing 
Adjust to 100 mL* with HWB and 
sonicate until viscosity is reduced
Pellet inclusion bodies (12000 g, 20 
min**), wash in 75 mL HWB/T*** 
Re-pellet inclusion bodies
Repeat the HWB-T wash once 
Wash the pellet in 75 mL HWB*** 
Re-pellet inclusion bodies
Apply supernatant to 50/75 S200 
Pool void volume fractions, dialyse 
against 1 mM ßME and lyophilise
Dissolve 10-15 mg in S200 Buffer 
and apply to 25/15 TSK SP-5PW 
Elute with linear NaCl gradient
Soak pellet in 1 mL DMSO, 30 min 
Mix pellet with 50 mL HUB, 1 h 
Centrifuge and retain supernatant
adapted from Luger et al. (1999)
Dialyse histone-containing 
fractions and lyophilise
50 - 80 mg/L 
50 - 80 mg/L 
50 - 80 mg/L 
10 - 20 mg/L
H2A: 
H2B: 
H3: 
H4:
Cashman (2011)
adapted from Luger et al. (1999)
Thaw pellets from 2 L culture to lyse 
Sonicate until viscosity is reduced
Pellet inclusion bodies (23000 g, 
15 min) and wash in 25 mL HWB/T 
Re-pellet inclusion bodies
Wash the pellet in 25 mL HWB 
Re-pellet inclusion bodies
Apply supernatant to 2 g HAP 
Apply filtrate to XK26 G-25 
Pool void volume fractions
Apply histone-containing fractions 
to 2x 5 mL HiTrap SP HP 
Elute with linear NaCl gradient
Soak pellet in 500 µL DMSO, 30 min 
Mix pellet with 9.5 mL HEB, 30 min 
Centrifuge and retain supernatant 
Repeat extraction with DMSO/HUB
Desalt histone-containing fractions 
into 0.5% FA and lyophilise
H2A: 
H2B: 
H3: 
H4: 
 
H3 C110S: 
H3 K4C: 
H3 K27C: 
H3 K4C K27amb:
36 mg/L 
12.5 mg/L 
17.5 mg/L 
12 mg/L 
 
26 mg/L 
4.5 mg/L 
53 mg/L 
2.2 mg/L
*Changed from Luger et al. (1999), who adjusted to 200 mL 
**Changed from Luger et al. (1999), who centrifuged with 23000 g 
***Changed from Luger et al. (1999), who used 200 mL of HWB(/T)
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4.8 • Summary of recombinant histone expression and purification 
BL21 (DE3) pLysS E. coli were transformed with histone plasmids (◎) for expression. Following 
lysis, inclusion bodies were pelted and washed. Histones were solubilised with histone unfolding 
buffer (HUF) and excess DNA removed by binding to hydroxyapatite. Run through proteins were 
exchanged into SP binding buffer using a 26/10 HiPrep Desalting or XK 26/20 G-25 column and 
purified on 2x 5 mL HiTrap SP HP cation exchange columns (linked in series) using a linear salt 
gradient (concentrations in mM). Histone-containing fractions (histone elution points indicated as: 
●, H2A; ●, H2B; ●, H3; ●, H4; ●, H3 mutants) were desalted into 0.5 % v/v formic acid (on a 26/10 
HiPrep Desalting or XK 26/20 G-25 column) and lyophilised.  
G-25
SP HP
100
G-25
Histone extract
1000
480 840
Lyophilise
Hydroxyapatite
Run through
Lysis & washing
+ IPTG
+ HUF
discard supernatants
discard pellet
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4.9 • Preparation of recombinant wild-type histones H2A, H2B and H4 
All histones were insoluble upon expression and were extracted from inclusion bodies with 7 M 
guanidine HCl. Histones were exchanged into SP binding buffer (containing 6 M urea) on a 26/10 
HiPrep Desalting or XK 26/20 G-25 column and purified by cation exchange chromatography on 
two 5 mL HiTrap SP HP columns, linked in series, using a 20 CV 0.1-1.0 M NaCl gradient. H2A, 
H2B and H4 eluted from the columns in ~670 mM, ~480 mM and ~570 mM NaCl, respectively. 
Peak fractions were analysed by SDS PAGE. Histone-containing fractions were exchanged into 0.5 
% v/v formic acid and void-volume fractions pooled and lyophilised.  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4.10 • Preparation of recombinant histone H3 mutants 
Following expression, the mutant histones were purified in the same way as the wild-type 
histones (figures 4.7 to 4.9). Peak fractions were analysed by SDS PAGE and histone-containing 
Histone-containing fractions were exchanged into 0.5 % v/v formic acid and void-volume 
fractions pooled and lyophilised. To confirm the genetic incorporation of acetylated lysine at 
position 27 in H3 K4C K27ac C110S, fractions were analysed by Western blotting with an 
antibody raised against H3 K27ac. The majority of histones H3 C110S, H3 K4C C110S, H3 K27C 
C110S and H3 K4C K27ac C110S eluted in ~800 mM NaCl, with smaller quantities eluting 
earlier, in ~560 mM NaCl.
   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4.2.4 Synthesis of modified H3 
4.2.4.1 Genetically encoding acetylated lysine 
For the genetic installation of acetyl-lysine into histone H3, pET-H3K4C 
K27amb C110S was co-transformed into BL21 (DE3) pLysS with pBK-AcKRS3, 
kindly donated by Prof. J Chin (MRC LMB, Cambridge, UK), and expressed as 
described (see above and chapter 2) but with slight adjustments - at OD600 0.6 
AU, the media was supplemented with 20 mM nicotinamide (NAM) and 10 mM 
Nε-acetyl-lysine, then, after 30 min incubation, expression was induced with 
500 µM IPTG and allowed to proceed for 3.5 hr. Histone wash buffers were 
also supplemented with 20 mM NAM. The yield of purified histone was 2.2 
mg/L - 10 % greater than that achieved  by Neumann and colleagues (2009), 
which may be the result of different culture conditions and/or use of the 
pET3d rather than pCDF expression vector (supplementary figure S4.6). 
Following purification, the genetic acetylation of these histones was checked 
by Western blotting, using antibodies raised against H3K27ac (figure 4.10, 
bottom panel). 
4.2.4.2 Reductive alkylation to synthesise methyl-lysine analogues 
The protocol described by Simon (2010) was initially tested using wild-type H3 
to install mono-methylated aminoethylcysteine using the natural cysteine 
residue at position 110 (KC110me1). For each lysine analogue that is installed, 
the charge of the protein is increased by +1, which can be observed by 
increased mobility on AU gels. Analysis of H3KC110me1 by AU PAGE showed 
this increased mobility for the reacted sample (figure 4.11, panel A), indicative 
of the production of a homogeneously methylated histone. 
However, when the technique was applied to H3K4C C110S, the efficiency of 
alkylation was dramatically reduced, producing only ~30 % modified histone, 
as judged by staining intensity of the unshifted and increased mobility bands 
on AU gels (figure 4.11, panel B). Initial attempts to increase the extent of 
 134
modification by increasing amounts of alkylating reagent to 1.5 to 4x the 
suggested quantity increased this to ~60-70 % (panels B and C). However, this 
was still significantly lower than the >90 % reported by Simon (2010). Removal 
of DTT from the reaction, which was likely to quench the reagent to some 
extent and therefore inhibit alkylation, increased efficiency to ~80-90 % but 
required very high (4-8x the suggested) quantities of reagent and risked 
oxidation of the histones, which would inhibit progression of the reactions 
(panel D). 
Study of the primary structure of aa 1-7 of H3 (in the immediate vicinity of the 
site requiring incorporation of the methyl-lysine analogue) showed the 
potential for salt bridge formation between R2 and K4C (figure 4.12, panel A). 
This was not the case for the derivatisation of C110 (panel B), hence the 
observed ~100 % alkylation in that context (see above). Increasing the pH of 
the reaction was likely to disrupt such an interaction and ensure more of the 
reactive, de-protonated cysteine side chain (pKa = 8.18) was available for 
reaction. Figure 4.12 (panels C and D) shows that increasing the alkalinity of 
the alkylation buffer to pH 8.3 resulted in improved derivatisation of H3K4C 
C110S to H3KC4me1 C110S. These conditions also improved yields of un- and 
di-methylated aminoethylcysteine at residue 4 (KC4 and KC4me2). Efficiency 
was finally increased to typically ≥90 %, by performing reactions at pH 8.3 with 
4x more reagent (~1829-fold molar excess of reagent to histone) than 
suggested by Simon (2010) (panel E). Alkylation was confirmed by Western 
blotting with antibodies raised against H3 and H3K4me1 (panel F).  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4.11 • Reductive alkylation to incorporate KC4me1 into histone H3 is inefficient 
(A) Alkylation was first tested to incorporate KCme1 into wild-type H3, using the natural cysteine at 
residue 110. The reaction adds a (+) charge for each lysine analogue that is installed, which can 
be observed by increased mobility on AU gels. (B-D) To obtain high levels of derivatisation of 
H3K4C C110S, reactions were trialled with increased amounts of reagent (B, C) and removal of 
DTT to prevent quenching of the reactions (D).  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To obtain a homogeneously methylated histone sample, the product of these 
alkylation reactions required purification. An initial attempt to purify by SP 
cation exchange produced two peaks of protein but both, surprisingly, 
containing alkylated and un-reacted species (figure 4.13, panel A). Applying 
the product instead to a CM-3SW cation exchange column produced two 
peaks with the expected 1:8-1:9 ratio of un-reacted to alkylated histone. The 
purification was confirmed by AU PAGE and Western blot (panel B). 
Optimised reaction conditions (figure 4.14, protocol 1.3) were applied to the 
alkylation of H3K4C K27ac C110S (genetically acetylated at K27), although 
purification of the product from unreacted material by CM-3SW cation 
exchange was unsuccessful (figure 4.15). Due to the very limited quantity of 
this histone, the un-purified product was used for octamer folding. 
4.2.4.3 Reductive alkylation to synthesise acetyl-lysine analogues 
Whilst reductive alkylation has been applied extensively to produce lysine 
analogues and their methylated derivatives (Raftery & Cole, 1966; Means & 
Feeney, 1968; Itano & Robinson, 1972; Kenyon & Bruice, 1977) it has only 
been used recently and to much less extent for the incorporation of acetyl-
lysine analogues (Huang et al., 2010; Dancy et al., 2012). Instead of the 
method described by Huang et al. (2010), where the reagent for introducing 
acetyl-lysine analogues was synthesised in-house, a suitable commercially 
available reagent was identified (N-(2-chloroethyl)acetamide), which had 
similar structure to those used for the incorporation of methylated 
aminoethylcysteines, and used with essentially the same protocol described 
above.  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4.12 • Increased pH improves the efficiency of reductive alkylation 
(A) Analysis of the amino acid sequence around residue 4 of H3 suggested that a salt bridge (⋯) 
might be formed between R2 and K4C, which would inhibit alkylation. (B) The sequence around 
residue 110, on the other hand, would not permit such a structure, which is corroborated by 
earlier evidence that alkylation of C110 was ~100 % efficient (figure 4.11, panel A). (C-D) 
Adjusting the pH of the reaction was expected to disrupt this interaction and de-protonate more 
of the sulphydryl group on cysteine required for greater reaction efficiency. Therefore, reactions to 
incorporate un-, mono-, di- and tri-methyl lysine analogues at pH 7.8 (C) and 8.3 (D) were 
compared. (E-F) Different amounts of reagent were also tested at both pH 7.8 and 8.3 and 
derivatisation tested by Western blotting.  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4.13 • Purification of H3KC4me1 for a homogeneously methylated histone sample 
To produce a homogeneously modified sample of H3KC4me1 C110S following alkylation, 
histones were purified by cation exchange. (A) This was initially attempted using HiTrap SP HP 
columns. (B) However, separation of reacted from unreacted histones was ultimately performed 
on a CM-3SW reversed-phase column and peak fractions analysed for mobility on AU gels and 
alkylation of K4C by Western blotting with antibodies raised against H3K4me1.  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As for the K4C mutant, there exists the possibility of a salt bridge forming in 
H3K27C C110S, between R26 and K27C (figure 4.16, panel A). Furthermore, 
unlike the K4C reactions, there would be no charge difference between the 
starting material and alkylated product, so purification by the means described 
above would be impossible. Therefore, reactions were performed at pH 7.8 
and 8.3, using large (100 to 2000-fold) molar excesses of alkylating reagent to 
histone, with a view to producing homogeneously acetylated protein. Reacted 
histones were analysed by Western blot, using equal loadings on SDS gels for 
approximately quantifiable data (panel B). This indicated greater reaction 
efficiency at pH 8.3 with a 2000-fold excess of reagent. Histones reacted under 
these conditions were subject to immunoprecipitation and, whilst some of the 
acetylated histone was isolated, a significant amount remained in the unbound 
sample (panel C). However, Western blotting with antibodies raised against H3 
K27ac indicated that the histone in the unbound fraction was actually 
acetylated, offering fair evidence of a high percentage of derivatisation. Due to 
limited availability and cost of the antibody, immunoprecipitation was not 
repeated, so further reactions were performed under identical conditions 
(panel D). 
!
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4.15 • Reductive alkylation to incorporate KC4me1 into genetically acetylated H3 
H3 K4C K27ac C110S, produced by genetic incorporation of acetylated lysine at residue 27, was 
alkylated to produce H3KC4me1 K27ac C110S - a histone carrying two distinct modifications. 
Following alkylation, histones were applied to a CM-3SW column and peak fractions analysed by 
AU PAGE.  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4.16 • Reductive alkylation to incorporate KC27ac into recombinant histone H3 
The method to produce methylated lysine analogues was adapted to incorporate an analogue of 
acetylated lysine into H3K27C C110S. (A) Similarly to alkylation of H3K4C C110S, this site has an 
arginine residue in close proximity to the cysteine, which might form a salt bridge, inhibiting 
reaction efficiency. (B) Since the product of these reactions would not not have any charge 
difference compared with the input sample, several conditions were trialled and tested with equal 
loadings on SDS gels for Western blotting. (C) Alkylation efficiency was further tested by 
immunoprecipitation of the product from a reaction performed at pH 8.3 with a 2000-fold molar 
excess of reagent, using an antibody raised to H3K27ac (ab4729, Abcam). (D) Further reactions to 
produce H3KC27ac C110S were performed at pH 8.3 with a 2000-fold molar excess of reagent.  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4.3 Preparation of nucleosomal DNA 
A number of DNA sequences that position themselves translationally and 
rotationally, or statistically, relative to the core histones of the nucleosome 
(Flaus, 2011; Struhl & Segal, 2013) (figure 4.17), have been developed in the 
last few decades to offer progressively improved phasing of and affinity for the 
histone octamer. These include: i) a 170 bp sequence derived from human α-
satellite DNA (Yang et al., 1982); ii) a 260 bp DNA containing the coding 
sequence for 5S rRNA from Lytechinus variegatus (Simpson & Stafford, 1983); 
iii) the mouse mammary tumour virus promoter (MMTV) (Richard-Foy & Hager, 
1987); iv) several sequences, ranging from 208-256 bp, based on the human 
DRPLA gene and containing 10, 55 or 62 bp tracts of CTG repeats (Godde & 
Wolffe, 1996); and v) a 174 bp non-natural sequence, designated 
“601.2” (Lowary & Widom, 1998; Anderson & Widom, 2000). 
The 601.2 sequence was chosen for its strong and predictable phasing to 
produce homogeneous nucleosome samples (which is not the case for the 
other sequences listed above). Such affinity for the histone octamer was 
achieved by the distribution of AA and CG di-nucleotides every ~10 bp, as 
observed in natural nucleosomes (Ioshikhes, 1992; Bina, 1994), non-random 
distribution of di- and tri-nucleotides and non-random occurrence of n-mers 
for values of n = 2 to 10 (Lowary & Widom, 1998). Furthermore, short 
extensions of DNA protrude from either end of the expected nucleosome 
position (Anderson & Widom, 2000), providing useful spacers for 
immobilisation on, for example, streptavidin beads, where close proximity to 
said beads might otherwise limit accessibility for effector proteins to bind the 
nucleosome in pull down experiments. 
601.2 DNA was obtained as a 16-tandem repeat in pUC19 vector, prepared by 
amplifying the 601.2 sequence from the 12_177_601 plasmid used by Dorigo 
et al. (2003), cloning the DNA into the KpnI and BamHI restriction sites of 
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pUC19 and amplifying using KpnI, BglII and BamHI sites, as described by Dyer 
et al. (2004) (figure 4.18). This construct was kindly provided by Dr T Bartke 
(Gurdon Institute, University of Cambridge, UK) and its availability negated the 
requirement to produce the 601.2 sequence by PCR amplification, as has 
previously been used in our laboratory (Amar, 2010). This approach enabled 
the 601.2 sequence to be prepared in milligram quantities (typically 1.0-1.9 
mg/L of bacterial culture) from the pUC19-16x601.2 plasmid, isolated by large 
scale alkaline lysis, using a commercially available kit, according to the 
manufacturer instructions (figure 4.19). To economise on the preparations, the 
anion exchange columns provided to purify the isolated plasmids were used 
up to six times (i.e. for isolation of the plasmids from up to 6 L of bacterial 
culture). 
!!!
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4.17 • Rotational, translational and statistical phasing of octamers on nucleosomal DNA 
(A) Rotational phasing indicates which helical face of the DNA (▬) is exposed (i.e. faces outwards 
from the histone octamer, ◌). Positioning therefore differs by 10-11 bp, due to the ~10.5 bp/turn 
of DNA. (B) On the other hand, translational phasing is more precise, defining the linear position 
of the histone octamer (○) with respect to the DNA sequence (▬). (C) In the case of nucleosome 
arrays, phasing is statistically biased due to exclusion by a barrier (◾), for example, an adjacent 
nucleosome or sequence that excludes nucleosomes. Such statistical positioning of nucleosomes 
typically becomes more varied along these arrays. 
Adapted from Flaus (2011)  
A
B
C
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4.18 • Preparation of a plasmid with multiple-tandem repeat of nucleosomal 601.2 DNA 
The 601.2 sequence was ligated into pUC19 using the KpnI and BamHI restriction sites. A 
multiple copy plasmid was produced by repeatedly digesting the resulting plasmids with KpnI 
and BglII and ligating in BglII/BamHI digested 601.2 sequences. 
Adapted from Dyer et al., 2004  
KpnI 
BglII 
BamHI 
Ligated BglII and BamHI
Re
pe
at
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4.19 • Comparison of methods for preparation of 601.2 DNA 
Methods for the preparation of nucleosomal DNA are outlined together with yields of 601.2.  
Seg. 
1 
 
2 
 
3
Cycles 
1 
 
40 
 
1
˚C 
94 
94 
60 
72 
72
min 
3 
1 
1 
1 
5
Transform and culture E. coli 
containing pBS-601.2 
Isolate pBS-601.2 by small scale 
(mini-prep) alkaline lysis
0.5 µg/50 µL reaction
Simultaneous PCR amplification 
and biotinylation (50 µL reactions)
Purify biotin-601.2 on 4x 1 mL 
HiTrap Q HP (GE)
CV 
0 
15 
65 
70 
71
mL 
0 
60 
260 
280 
284
[NaCl], M 
0.00 
0.00 
1.00 
1.00 
0.00
Isopropanol precipitate
Component 
Plasmid 
Fwd Primer 
Rev Primer 
dNTP 
Vent Pol.
Conc. 
2 ng/µL 
500 nM 
500 nM 
200 µM 
0.01 U/µL
Amar, S (2010)
PCR
Transform and culture E. coli 
containing pUC19-16x601.2
Isolate pUC19-16x601.2 by large 
scale (mega-prep) alkaline lysis
1.0 - 2.0 mg/L
Excise 16 x 601.2 with EcoRI and 
EcoRV (0.5 mL rxns at 37˚C, 14 h)
Component 
Plasmid 
EcoRI 
EcoRV
Conc. 
200 µg/mL 
200 U/mL 
200 U/mL
Ethanol precipitate
Phenol:Chloroform extract and 
ethanol precipitate
Biotinylate 
(1 mL reactions at 25˚C, 2 h)
Component 
601.2 
dATP 
Biotin-dUTP 
Klenow
Conc. 
407 µg/mL 
100 µM 
40 µM 
33.3 U/mL
Purify 601.2 from vector DNA on 
5x 1 mL HiTrap Q HP (GE)
CV 
0 
1 
3 
5 
5 
10 
10 
15
mL 
0 
5 
15 
25 
25 
50 
50 
75
[NaCl], M 
0.00 
0.00 
0.66 
0.66 
0.76 
0.76 
1.00 
1.00
Ethanol precipitate
Purify biotin-601.2 from excess 
dNTPs on a 24 mL 10/30 S300 and 
ethanol precipitate
1.0 - 1.9 mg/L of culture
Cashman J (2010)
Transform and culture E. coli 
containing pUC19-16x601.2
Isolate pUC19-16x601.2 by large 
scale (giga-prep) alkaline lysis
Excise 15 x 601.2 with EcoRV 
(1 mL reactions at 37˚C, 16 h)
1.7 - 2.5 mg/L
Isolate 601.2 from vector DNA by 
PEG precipitation and ethanol ppt.
Phenol:Chloroform extract and 
ethanol precipitate
Biotinylate 
(1 mL reactions at 25˚C, 2 h)
Cleave with EcoRI 
(1 mL reactions at 37˚C, 16 h)
Ethanol precipitate
Component 
Plasmid 
EcoRV
Conc. 
1 mg/mL 
130 U/mL
Component 
EcoRV Frag. 
EcoRI
Conc. 
1 mg/mL 
300 U/mL
Component 
601.2 
dATP 
Biotin-dUTP 
Klenow
Conc. 
407 µg/mL 
100 µM 
40 µM 
33.3 U/mL
1.6 - 2.4 mg/L of culture
Bartke, T, et al. (2010)
Restriction Digest
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Individual copies of the 601.2 sequence were excised from the vector by 
restriction enzyme digestion with EcoRI and EcoRV to yield a 181 bp fragment 
with a 4 base overhang at the right-hand (EcoRI) end (figure 4.20). A time-
course experiment was used to optimise excision of 601.2 fragments and 
indicated almost complete digestion by 10 hr, so overnight (14 hr) double 
digests were used (figure 4.21, panel A). This increased the speed of 
preparation compared to other methods (Dyer et al., 2004) and, rather than 
use PEG precipitation, 601.2 fragments were purified by anion exchange 
chromatography to ensure removal of contaminating vector and linker DNA. 
Purification was initially optimised using diethylaminoethanol (DEAE) anion 
exchange (panel B). However, since this resin required low flow rates and the 
maximum loading was up to only ~150 µg, the use of five serially linked 1 mL 
HiTrap quaternary ammonium (Q) HP columns was adopted, to improve 
efficiency (panel D). These columns allowed the purification of 601.2 
fragments from up to ~1 mg of digested material and a step elution gradient 
minimised the volume of sample for subsequent ethanol precipitation. 
To allow the use of nucleosomes as bait in pull down experiments (and to 
prevent dimerisation of 601.2 DNA fragments), the 5’ overhang of 601.2 DNA 
was end filled with biotin-11-dUTPs to produce a 185 bp fragment which could 
be immobilised on streptavidin beads. This fragment was purified from excess 
nucleotides by Sephacryl S-200 size exclusion and biotinylated nucleotide 
incorporation was confirmed by immobilising a small sample on an excess of 
streptavidin beads (figure 4.22). Biotin-601.2 was eluted from the beads by 
boiling in SDS and input, unbound and bound fractions analysed by agarose 
gel electrophoresis. No DNA was observed in the unbound fraction, indicative 
of complete incorporation of the biotinylated nucleotides. Bound biotin-601.2 
DNA had increased mobility on agarose gels, likely due to denaturation during 
the high-temperature of elution in SDS.  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4.20 • DNA fragments produced by restriction digestion of pUC19-16x601.2 with EcoRI/V 
(A) The pUC19-16x601.2 plasmid was prepared by cloning 12_177_601 DNA (Dorigo et al., 
2003) into pUC19 vector using KpnI and BamHI restriction sites and amplified using KpnI, BglII 
and BamHI sites (Dyer et al., 2004) The scheme for this preparation is provided in figure 4.18. (B) 
This plasmid was digested with EcoRI and EcoRV to release the sixteen 601.2 fragments (ii), which 
were then purified from linker (i and iii) and vector (iv) DNA.  
A
B   i AATTCGAGCTCGGTACCAGATCTGAT!
    GCTCGAGCCATGGTCTAGACTA!
!
!
!
ATCGGATCTTACATGCACAGGATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTTAAAACGCGGGGGACAGCGC!
TAGCCTAGAATGTACGTGTCCTACATATATAGACTGTGCACGGACCTCTGATCCCTCATTAGGGGAACCGCCAATTTTGCGCCCCCTGTCGCG!
!
GTACGTGCGTTTAAGCGGTGCTAGAGCTGTCTACGACCAATTGAGCGGCCTCGGCACCGGGATTCTCCAGGGCGGCCGCGTAGTACTG!
CATGCACGCAAATTCGCCACGATCTCGACAGATGCTGGTTAACTCGCCGGAGCCGTGGCCCTAAGAGGTCCCGCCGGCGCATCATGACTTAA!
!
!
!
AATTCATAGGATCTGAT!
    GTATCCTAGACTA!
!
!
!
AATTCATAGGATCCTCTAGAGTCGACCTGCAGGCATGCAAGCTTGGCGTAATCATGGT...!
    GTATCCTAGGAGATCTCAGCTGGACGTCCGTACGTTCGAACCGCATTAGTACCA...!
1x 22 bp 
(+ 4 base overhang)
16x 181 bp 
(+ 4 base overhang)
15x 13 bp 
(+ 4 base overhang)
1x 2668 bp 
(+ 4 base overhang) 
B   ii
B   iii
B   iv
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4.21 • Isolation and purification of 601.2 DNA from pUC19-16x601.2 
(A) 601.2 fragments were isolated from pUC19-16x601.2 (plasmid) by cleavage with EcoRI and 
EcoRV. (i) Plasmid DNA was subject to time course digestion (1-10 hr) and analysed on 2 % 
agarose-TAE gels. (ii) The digests required extended incubation (14 hr) at 37 ˚C to ensure 
completion. (B) Initial purification of 601.2 (▼) from linker (▼) and vector (▼) DNA was performed 
by DEAE anion exchange using a 15/30 column (i) and the elution gradient was subsequently 
reduced to improve resolution (ii). Though effective at resolving the fragments, the low flow rates 
required for this resin and limited loading quantities (maximum 150 µg) made the process time 
consuming. (C) Purifications were more rapidly achieved using five 1 mL HiTrap Q HP columns, 
linked in series. All purifications were performed in 10 mM Tris-HCl pH 7.5 with complex NaCl 
gradients.  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4.22 • Labelling of 601.2 DNA with biotinylated nucleotides 
(A) To allow immobilisation of nucleosomes on streptavidin beads for SNAP experiments, the 5’ 
overhang on 601.2, generated by cleavage with EcoRI, was end-filled with biotin-11-dUTP. (B) 
Following end-filling, biotin-601.2 (▼) was purified from excess nucleotides (▼) on a 10/30 
Sephacryl S-300 size exclusion column (i) and small aliquots immobilised on streptavidin beads to 
confirm incorporation of the biotinylated nucleotides (ii).  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4.4 Preparation of octamers from recombinant histones 
Octamers were assembled using previously described methods (Dyer et al., 
2004). Histones are known to aggregate in high salt, so octamers were folded 
by mixing each of the core histones in 7 M guanidine hydrochloride to 
equimolar ratios and dialysing slowly against 2 M NaCl. 
A 16/60 Superdex 200 column (packed in-house) was first calibrated with 
native octamer from Gallus gallus (figure 4.23). Chromatin from mature 
chicken erythrocytes (MCEs) was bound to hydroxyapatite and depleted of 
linker histones by elution with 600 mM NaCl and then octamers eluted using 
2.5 M NaCl (panel A i). Interestingly, though phosphates have been suggested 
to stabilise octamers by binding lysine and arginine residues (Chantalat et al., 
2003), analysis of these fractions by SDS PAGE indicated partial depletion of 
H2A and H2B during the 600 mM salt wash (panel A ii). It is, however, well 
known that H2A and H2B dissociate more readily than H3 and H4 at lower salt 
concentrations but 600 mM was required to remove H1 and H5. Next, native 
octamers were purified from high molecular weight contaminants (non-native 
aggregates), histone tetramers and dimers by Superdex 200 size exclusion 
(panel B). Column profiles were in keeping with those previously described by 
Luger et al. (1999), with octamers eluting at ~0.5 CV. 
Once the efficiency of the column had been tested, octamers folded from 
recombinant histones were purified on the same column (figure 4.24, panels 
A-D) and characterised by SDS PAGE and Western blotting (panel E). Apart 
from the expected lower yields when using smaller quantities of histones in 
the octamer folding mixtures (typically <1 mg of each), as seen for the 
H3KC27ac and H3KC4me1 K27ac-containing octamers, where greater amounts 
of high molecular weight aggregates, histone tetramers and dimers are 
produced, no issues arose during preparation of octamers.  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4.23 • Calibration of a Superdex 200 column with native G. gallus octamers 
(A) Native octamers were prepared from mature chicken erythrocyte nuclei to calibrate a 16/60 
Superdex 200 column (packed in-house). Nuclei were lysed in linker histone depletion buffer (50 
mM phosphate pH 6.8, 600 mM NaCl) and DNA sheared by passing the solution through syringe 
needles. (i) Depleted linker histones were bound to Bio-Gel® HTP Hydroxyapatite overnight and, 
following extensive washing of the resin, octamers were eluted in 2.5 M NaCl. (ii) Peak fractions 
were checked on SDS gels, pooled, concentrated to ~1.5 mL. (B) Octamers were applied to the 
Superdex 200 column to remove high molecular weight aggregates, H3-H4 tetramers and H2A-
H2B dimers and peak fractions were analysed by SDS PAGE.  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4.24 • Preparation and characterisation of recombinant X. laevis octamers 
(A-D) Octamers were folded by denaturing the core histones and mixing them to equimolar 
ratios for dialysis against high salt. Folded octamers containing wtH3 (A), H3KC4me1 C110S (B), 
H3KC4me1 K27ac C110S (C) and H3KC27ac C110S (D) were purified from high molecular weight 
aggregates, tetramers and dimers by size exclusion chromatography on the S200 column (as 
described previously). (E) Octamer-containing fractions (eluting at ~0.5 CV) were analysed by SDS 
PAGE and immunoblots using 2 µL of each octamer used to test for the presence of KC4me1 and 
KC/K27ac.  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4.5 Assembly of nucleosomes carrying defined histone modifications 
601.2 DNA was used to assemble nucleosomes according to Dyer et al. (2004). 
The DNA and octamer were mixed together in high (2 M) salt, in which the 
histones are known to have negligible affinity for DNA (Tatchell & van Holde, 
1977). Dialysing the mixture against exponentially decreasing salt (to 250 mM) 
allowed deposition of octamers onto the DNA and, therefore, nucleosome 
assembly. 
In initial experiments with both native Gallus gallus and recombinant Xenopus 
laevis octamers, sedimentation of the assembled nucleosomes through 5-30 % 
exponential sucrose gradients showed two peaks in the gradient profiles in 
addition to the expected peak of excess free DNA (figure 4.25, panels A i and 
B i). These are herein referred to as peaks 1 and 2 for the slower and faster 
sedimenting peaks, respectively. When analysed on native polyacrylamide gels 
(panels A ii and B ii), peak 1 migrated with increased mobility compared to 
peak 2. Analysis by agarose gel electrophoresis following phenol-chloroform 
extraction (panels A iii and B iii) showed the lengths of DNA to be the same in 
each peak (as expected). The faster migration of peak 1 through the gel matrix 
during native PAGE was initially thought to be due to greater protrusion of 
unstructured DNA from the core as a result of incorrect phasing of the octamer 
at one or other end of the DNA, compared with ‘native’ nucleosomes, where 
the octamer is phased in the centre of the 601.2 sequence, as observed 
previously (Meersseman et al., 1992). To test this hypothesis, material from 
both peaks was subjected to heat treatment to re-phase any incorrectly 
positioned octamers (Dyer et al., 2004) and restriction digestion, with the 
expectation that cleavage at any position in the sequence would be reduced 
where the octamer was phased. Three restriction enzymes were chosen to 
cleave at unique sites at the left (5’ end), middle and right (3’ end) of the 601.2 
sequence. It was anticipated that heat shifting would re-phase any incorrectly 
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positioned octamers and so banding patterns on agarose gels following 
treatment at 37 ˚C and/or 50 ˚C would be identical between the two peaks. 
However, banding patterns remained distinct between the analysed peak 
fractions, indicating that the two species were unique, since heat shifting did 
not alter the extent of cleavage at any of the three restriction enzyme 
recognition sites (figure 4.26). Samples treated only with NlaIII or ScaI had 
similar banding patterns but digestion with AluI occurred with greater 
efficiency for the peak 1 fraction, as judged by the presence of bands with 
molecular weights of approximately 119 and 66 bp (not present in the peak 2 
samples), indicative of increased accessibility to the centre of the 601.2 
sequence in this peak compared to peak 2. Dyer et al. (2004) described 
species that are resistant to heat shifting as ‘non-native nucleosomes’ and 
suggested that they occur in nucleosome assembly experiments when 
suboptimal ratios of DNA and octamer are present. To test this, material from 
each peak was analysed by SEC-MALLS to determine their molecular weights 
(figure 4.27). This indicated weight-averaged masses of 6.56 x 105 Da for peak 
1 (panel A) and 2.49 x 105 Da for peak 2 (panel B), the latter being close to the 
expected mass of 2.23 x 105 Da for the nucleosome. The larger molecular 
weight of peak 1 seems to be the result of some aggregation of histones and 
DNA and may be equivalent to an aggregate of four nucleosomes, each 
comprised of only H3-H4 tetramers and 601.2 DNA (i.e. nucleosomes lacking 
both H2A-H2B dimers), since the expected molecular weight of such an 
aggregate (6.70 x 105 Da) is close to that determined in this SEC-MALLS 
analysis. Based on their sedimentation characteristics, such aggregates must 
have formed after gradient purification, otherwise they would have been faster 
sedimenting than the native nucleosomes of peak 2. The slower sedimentation 
corresponds well with the proposed loss of histones H2A and H2B from the 
octamer explained above.  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4.25 • Nucleosome assembly from native G. gallus and recombinant X. laevis octamers 
Assembly of native MCE (A) and recombinant X. laevis (B) octamers. DNA and histone octamers 
were mixed to a molar ratio of 1.5:1.0 and nucleosomes assembled by salt deposition. 
Nucleosomes (▼) were purified from free DNA (▼) on exponential sucrose gradients. Sucrose 
gradient profiles (i) also indicated an unknown species (▼). Excess DNA (601.2), unknown species 
(Peak 1 or U) and nucleosome (Peak 2 or N) fractions were analysed by native polyacrylamide (ii) 
and agarose (iii) gel electrophoresis.  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4.26 • Characterisation of nucleosomes by heat shifting and restriction digestion 
(A) Following purification of assembled nucleosomes (▼ or Peak 2) from free DNA (601.2) by 
sedimentation through sucrose gradients, a third unexpected species (▼ or Peak 1) was 
detected. This had slightly increased mobility on native polyacrylamide gels (figure 4.26, panels 
Aii and Bii). The two peak fractions were divided into aliquots and treated at 0 ˚C, 37 ˚C or  50 ˚C 
for 2 hr to test shifting of octamers to a single position on the DNA. Samples were then 
subjected to restriction digestion for 1 or 3 hours with enzymes that cut at single positions on 
the left (5’ end), centre and right (3’ end) of the 601.2 DNA sequence. (B) Restriction enzyme 
recognition sites (NlaIII, AluI and ScaI) and potential positions of the octamer on the 601.2 
sequence (◌ or ◌). (C) Fragment sizes would indicate the position of the octamer on the 601.2 
DNA due to differences in accessibility of the restriction enzyme recognition sites. (D) Following 
heat shifting and restriction digestion, fragments and their sizes were estimated by agarose gel 
electrophoresis.
   
ScaI fragments
66 bp
177 bp
8 bp
Peak 2
Peak 1and/or
Ab
so
rb
an
ce
Sucrose gradient
4 
˚C
37
 ˚C
50
 ˚C
50
 ˚C
37
 ˚C
4 
˚C
Peak 1
bp
200
100
104-8 / 119 bp
601.2
2-
Lo
g
200
100
200
100
200
100
60
1.
2
601.2
601.2
601.2
Peak 2
58 / 66 bp
170-174 bp
EtBr
170-174 bp
119 bp
66 bp
1 hour Digests
Alu I
NlaIII
ScaI
Triple
104-8 / 119 bp
601.2
58 / 66 bp
170-174 bp
EtBr
4 
˚C
37
 ˚C
50
 ˚C
50
 ˚C
37
 ˚C
4 
˚C
Peak 1
60
1.
2
Peak 2
3 hour Digests
601.2
601.2
119 bp
66 bp
601.2
170-174 bp
NlaIII AluI ScaI
15/11 119 177
A
B
C
NlaIII fragments
AluI fragments
170 - 174 bp
11-15 bp
119 bp
D
Triple digest fragments
104 - 108 bp
11-15 bp 58 bp
8 bp
recombinant X. laevis nuc.
 157
!!!!!!!!!
   !!!!!!!!!!
4.27 • Determination of molecular weights of nucleosomal species by SEC-MALLS 
Aliquots of peaks 1 and 2 following sucrose gradient purification of G. gallus nucleosomes were 
applied to a 7.8/30 5 µm fused silica analytical size exclusion column (equilibrated in 10 mM Tris-
HCl pH 7.5, 50 mM NaCl, 0.1 mM EDTA) and eluted peaks analysed by MALLS to determine their 
molecular weights. (A) Peak 1 had a weight-averaged molecular weight (Mw) of 6.56 x 105 Da, 
peak molecular weight (Mp) of 4.26 x 105 Da and average molecular weight (M) of 5.56 x 105 Da. 
(B) Peak 2 had Mw = 2.49 x 105 Da, Mp = 2.34 x 105 Da and M = 2.38 x 105 Da.  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In keeping with the results above, together with evidence that histone 
octamers are strongly phased to a single point (covering positions 15-160 bp) 
on the 601.2 sequence (Anderson & Widom, 2000; Widom, 2001), 
nucleosome assembly was optimised by titration with different ratios of DNA 
to octamer to minimise the amount of non-native nucleosomes produced 
during nucleosome preparations. Initial trials produced approximately equal 
amounts of native and non-native species and, although calculated as 1.2:1.0 
and 1.1:1.0 ratios of DNA to histone octamer, respectively, the areas of the free 
DNA and nucleosomal peaks on sucrose gradient profiles suggested that the 
excess of DNA was in fact much higher (figure 4.28, panels A and B). The 
accuracy of quantification by UV absorption was improved by diluting the 
sample of DNA used for nucleosome assembly mixtures to below 35 µM (from 
~80 µM) and trials using a ratio of 1.0:1.0 DNA to octamer (with DNA at final 
concentrations of ~2-11 µM in the assembly mixtures) yielded large amounts 
of nucleosome, small amounts of the non-native species and barely detectable 
levels of free DNA (panel C). Heat shifting at 37 ˚C or 50 ˚C prior to purification 
of nucleosomes on sucrose gradients, as described above, did not alter the 
position of octamers on DNA, as judged by the relative intensities of non-
native species between samples treated at 0 ˚C and 37 ˚C or 50 ˚C, stained by 
ethidium bromide and coomassie brilliant blue (figure 4.28). 
Although sucrose gradients are effective for nucleosome purification following 
assembly, free DNA is never completely removed. This is not an issue with 
resolution, since the majority of DNA is fractionated in a single peak that 
sediments to less extent than the nucleosomes (as expected). Instead, this may 
be due to: i) an unexpected equilibrium established during centrifugation; ii) 
association of some free DNA with nucleosomes, which is disrupted during 
electrophoresis; or iii) dissociation of a small number of nucleosomes during 
electrophoresis. However, the optimised assembly protocol described above 
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produced nucleosome fractions (after sedimentation) with negligible free 
DNA, as judged by ethidium bromide staining, which stains free DNA with far 
greater intensity than the DNA associated with histone octamers (Dyer et al., 
2004), so further purification of assembled nucleosomes by ion exchange 
chromatography was unnecessary. Octamers carrying wtH3, H3KC4me1, 
H3KC27ac or H3KC4me1 K27ac were assembled with 601.2 DNA to produce 
sufficient quantities of each nucleosome for SILAC nucleosome pull down 
experiments (13.2 µg, as DNA, per pull-down) (figure 4.29). 
!
4.6 Summary 
Histones carrying defined modifications (K4me1 and/or K27ac) were 
synthesised using reductive alkylation and genetic incorporation techniques. 
In so doing, protocols used in this laboratory for the expression and 
purification of histones were improved and the reductive alkylation method of 
Simon and colleagues (2007) for synthesis of methylated histones was 
optimised and extended to the production of acetylated histones. 
Nucleosome positioning DNA sequences were isolated in large quantities 
from E. coli transformed with a plasmid containing multiple copies of the 601.2 
sequence. Octamers were assembled with or without modified histones using 
established protocols. These were deposited onto 601.2 DNA in nucleosome 
assembly reactions. Following characterisation of initial batches of 
nucleosomes by restriction digestion, heat shifting and SEC-MALLS, two 
nucleosomal species were identified, one of which was non-native and might 
have lacked both H2A-H2B dimers. Therefore, the optimal ratio of 601.2 DNA 
to histone octamer was determined by titration so as to efficiently assemble 
sufficient quantities of nucleosomes for SNAP experiments.  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4.28 • Trials to optimise the assembly of recombinant X. laevis nucleosomes 
601.2 DNA and recombinant H3 octamer were mixed 1.2:1.0 (A), 1.1:1.0 (B) or 1.0:1.0 (C) and 
dialysed against exponentially decreasing KCl to determine the ideal ratio required to obtain 
optimum yields of native nucleosomes (▼, * or Nuc). Following assembly, each sample was 
divided into three aliquots for incubation for 2 hours at 0 ˚C, 37 ˚C or 50 ˚C prior to purification of 
nucleosomes from free DNA (601.2) and non-native aggregates (NNN) on 5-30 % exponential 
sucrose gradients. Fractions were analysed by agarose native polyacrylamide gel electrophoresis.  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4.29 • Assembly and characterisation of recombinant X. laevis nucleosomes 
(A-D) Octamers containing H3 (A), H3 KC4me1 (B), H3KC27ac (C) or H3KC4me1 K27ac (D) were 
mixed at equimolar ratios with 601.2 DNA and nucleosomes assembled by salt gradient dialysis. 
Nucleosomes (▼ or Nuc, third peak) were purified from free DNA (601.2, first peak) and non-
native species (NNN and U, second and fourth peaks) on 5-30 % sucrose gradients and analysed 
by agarose and native polyacrylamide gel electrophoresis.  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5 Identification of binding partners to defined 
histone modifications by SNAP 
Nucleosomes were assembled as described (chapter 4) for pull down 
experiments to isolate and identify binding partners to specific histone 
modifications. Since in vivo binding of transcription factors and other 
regulatory proteins occurs in close proximity to DNA and the histones, the use 
of nucleosomes carrying these defined modifications has significant 
advantages over modified peptides. Such experiments account for limitations 
in accessibility of the modified residues to regulatory proteins (steric 
constraints) and overall charge of chromatin substrate (affinities of binding 
partners may well be reduced by the basicity of peptides representing the N-
terminal tails of histones). Previous work in our laboratory to identify binding 
partners of the histone variant H2A.Z using pull down experiments failed to 
identify many unique interactors due to limited differences in staining 
intensities observed between proteins bound to control and H2A.Z-containing 
nucleosomes as non-specific protein binding to the chromatin templates 
results in significant background staining (Amar, 2010). It was therefore 
necessary to select an improved protocol that overcomes the issues associated 
with identifying differential staining intensities in the traditional pull down 
approach. 
5.1 Techniques for mass spectrometry-based proteomics 
Conventional pull-down experiments involve the immobilisation of proteins 
from an extract by the protein of interest (e.g. a modified histone) and, 
separately, a control (e.g. the same histone lacking the modification). Bound 
proteins are eluted and resolved in adjacent lanes on SDS gels. Ideally, 
proteins that have bound specifically to the modified histone will be identified 
by their increased staining intensities in the experimental sample compared to 
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the control. However, non-specific binding proteins (common to both control 
and experimental samples) are often very abundant, making such comparisons 
difficult, since small differences in staining intensities might not be easily 
detected against high background staining. Enrichments of proteins in the 
control and experimental samples can be tested with specific antibodies, 
though this is not practical if there are no candidate proteins, as is the case 
here. These difficulties have lead to increased use of two dimensional gel 
analyses coupled with MS. 
Traditional proteomic approaches to identify differential protein expression or 
protein-protein interactions attempts to improve protein resolution by use of 
two dimensional gel electrophoresis, typically using IEF in the first dimension 
followed by SDS PAGE in the second. Whilst this offers significant advantages 
over one dimensional SDS PAGE, identification of proteins showing different 
band intensities between gels showing perhaps a few thousand spots each 
can still be difficult and variations in sample preparation methods can affect 
protein recovery. Furthermore, the technique remains restricted to analysis of 
individual proteins - spots are cut from the gel and subjected to trypsin 
digestion to allow MS identification of proteins affected. In this context, MS 
data cannot be used to quantify levels in each due to differences in ionisation 
yields and detector response between sample analyses. Together, these issues 
combine to make the validation of changes in protein expression levels or 
identification of legitimate interactors difficult. Despite increases in protein 
resolution 2D PAGE remains limited in its ability to detect and identify all 
proteins in a sample (Gygi et al., 1999b; Gygi et al., 2000). 
In the case of pull-down experiments aimed at identifying protein binding 
partners, the recently published contaminant repository for affinity purification 
(CRAPome) offers a collection of standardised negative control pull down data 
matched to detailed experimental protocols, in an attempt to overcome the 
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issues associated with non-specific binding of proteins (Mellacheruvu et al., 
2013). However, a number of alternative techniques have been developed that 
overcome this issue by using isotopic labelling. Two pools of proteins are used 
for pull down experiments: one unlabelled (or labelled with abundant (‘light’) 
isotopes) and the other labelled with stable (’heavy’) isotopes. Since proteins 
in both pools are chemically identical, they can be mixed and analysed as a 
single sample by tryptic MS. For each peptide, two peaks are detected and the 
ratio of the peak areas are used to quantify the binding of each. Such 
techniques include 15N or 18O labelling (Oda et al., 1999; Shevchenko et al., 
1997), isotope-coded affinity tagging (ICAT) (Gygi et al., 1999a) and stable 
isotope labelling by amino acids in cell culture (SILAC) (Ong et al., 2002) 
(figure 5.1). 
5.1.1 15N labelling 
Substitution of all 14N for 15N atoms has long been used in structural studies of 
proteins. The process is relatively simple to apply to the culture of 
microorganisms (using M9 minimal salts medium, usually containing 
ammonium chloride as the 15N source) and results in 15N incorporation into 
proteins as they are synthesised (figure 5.1, panel A i). Growing one cell 
population in media containing 15N and one population in media with 14N 
allows quantification of differential protein expression between two cell 
populations (Oda et al., 1999; Lahm & Langen, 2000 (review), Regnier et al., 
2002 and Beynon & Pratt, 2005). However, the incorporation of 15N into 
proteins is not always complete (Regnier et al., 2002) and, since the nitrogen 
composition of each amino acid differs, the degree of labelling varies between 
peptides, making MS data difficult to analyse.  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5.1 • Selected isotopic labelling techniques for use in quantitative proteomics 
In vivo isotopic labelling methods (A) include the incorporation of 15N (i) or by SILAC (ii) (orange 
residues) as proteins are synthesised. 15N will differentially label amino acids, making 
quantification in the MS difficult, whilst SILAC incorporates isotopically labelled amino acids with 
known mass differences. Labelling can also be achieved in vitro (B) using enzymatic 18O (●) 
labelling (i, ii) or incorporation of ICATs (iii) to proteins. This can be useful for protein populations 
that cannot be obtained from living sources. Labelling with oxygen isotopes can produce 
peptides with one (i) or two (ii) 18O atoms at the C-terminus. The reaction represented in (ii) can 
also be disadvantageous by replacing isotopic atoms for 16O. ICATs contain either eight hydrogen 
(●) or deuterium (●) atoms (iii) to produce ‘light’ or ‘heavy’ proteins, respectively.  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As well as studying differential protein expression, 15N labelling technique has 
been used to quantify changes in the level of phosphorylation of the yeast 
protein kinase Ste20 (Oda et al., 1999). Whilst such quantifications were shown 
to detect changes in protein expression of ~10 %, the study was limited to the 
quantification of peptides from microorganisms - enriched 15N media for the 
culture of higher eukaryotic cells is not readily obtainable commercially and is 
difficult and expensive to produce. 
5.1.2 18O labelling 
Developed for improved sequencing of peptides from novel proteins by 
tandem mass spectrometry (MS/MS), labelling with 18O is achieved by 
preparing peptides by tryptic digestion in the presence of H218O (Schnölzer et 
al., 1996; Shevchenko et al., 1997). Proteolytic cleavage of proteins occurs by 
the formation of enzyme-peptide ester intermediates, which are hydrolysed to 
yield peptides for analysis by MS (figure 5.1, panel B i and ii). When performed 
in H218O, this hydrolysis exchanges one of the oxygen atoms from the C-
terminal carboxyl group with the oxygen from the active site serine residue of 
trypsin, thus producing a peptide containing one 18O atom with molecular 
mass of +2 Da compared with the unlabelled peptide. The technique enables 
peptides from the C-terminus of proteins to be easily identified since they are 
unlabelled (unless the last residue is arginine or lysine) but this can make it 
difficult to distinguish between C-terminal peptides and proteins or peptides 
not present in one sample of the pool (reviewed in Regnier et al., 2002). 
Although the efficiency of this labelling has been shown to be close to 95 %, 
the degree of labelling (i.e. the incorporation of one or two 18O atoms) is 
variable and dependent on the peptide (Schnölzer et al., 1996; Stewart et al., 
2001), which can make quantification difficult. Incorporation of a second 18O 
appears to occur by a second exchange event, when trypsin re-binds a cleaved 
peptide to re-form the enzyme-peptide ester and thus produce a peptide with 
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+4 Da mass compared to its unlabelled counterpart. Peptides from the C-
terminus of a protein may also be labelled by this exchange event if they a 
contain C-terminal arginine or lysine residue). A similar process can occur with 
detrimental effect at extremes of pH and temperature (conditions not unusual 
in the preparation of peptides), where carboxyl group oxygen(s) are back-
exchanged for abundant oxygen (16O) (Murphy & Clay, 1979). This has the 
potential to remove the isotopic label required for reliable quantitative data of 
those peptides for which trypsin will have greater affinity than others. Loss of 
labelling has also been observed when drying peptide samples (Yao et al., 
2001), again, a necessary step in the preparation of peptides. 
18O labelling has been used in comparative studies such as that by Yao and 
colleagues, where proteins from two serotypes of adenovirus were quantified, 
confirming that most of the proteins are expressed at the same levels in both 
serotypes (Yao et al., 2001). However, some unpaired isotopic peaks were 
observed (e.g. the unlabelled peptides without their +4 Da 18O-labelled 
counterparts). Although in some cases these unpaired peaks were genuinely 
attributed to C-terminal peptides, mutant proteins or differentially post-
translationally modified proteins, this could in other cases account for 
experimental artefacts such as differential protein representation through 
sample loss, which could occur during sample preparation and manipulation 
prior to labelling and mixing. 
5.1.3 ICAT (isotope-coded affinity tagging) 
For ICAT, proteins are denatured and fully reduced prior to labelling by 
biotinylation of cysteine residues with ‘light’ or ‘heavy’ (deuterated) ICAT 
reagents (Gygi et al., 1999a) (figure 5.1, panel B iii). This technique uses excess 
ICAT reagent to ensure complete labelling (the reagent is chromatographically 
removed prior to mixing of the samples for MS). Following proteolytic 
digestion, peptides containing the biotin label are affinity purified using 
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immobilised streptavidin. Whilst removal of non cysteine containing peptides 
simplifies the samples to make data processing easier, substantial numbers 
(potentially 80-90 % of peptides in a given proteome) are removed from the 
analysis. An additional complication is that the deuterated ICAT reagent is 
large enough for the ‘light’ and ‘heavy’ isoforms of peptides to be separated 
by reversed-phase chromatography prior to MS, which can cause very large 
errors in quantification (Zhang et al., 2001; reviewed in Regnier et al., 2002). 
The ICAT approach has been applied to the comparison of protein expression 
in Saccharomyces cerevisiae. Yeast cells were cultured in the absence of 
glucose to quantify the expression levels of glucose-repressed proteins in the 
presence of different carbon sources. As expected from previous studies 
(Ronne, 1995), for example, increased expression of alcohol dehydrogenase 
enzymes was observed when cells were cultured with ethanol compared to 
galactose (Gygi et al., 1999a). However, a complete proteomic analysis was not 
produced since a substantial number of peptides were excluded - 314,236 out 
of the theoretical 344,855 peptides from yeast do not contain cysteine 
residues (Gygi et al., 1999a). 
5.1.4 SILAC (stable isotope labelling by amino acids in cell culture) 
In contrast to 18O and ICAT techniques, the SILAC approach labels proteins as 
they are synthesised in vivo (figure 5.1, panel A ii) by supplementing cell 
culture media with isotopic analogues of one or two amino acids (Ong et al., 
2002; Schmidt et al., 2007). As such, incorporation of the isotopic label is 100% 
and no further purification of proteins is required prior to mixing of the ‘light’ 
and ‘heavy’ samples for MS analysis. SILAC with deuterated leucine uniformly 
labels >50% of the peptides obtained by tryptic digest (Ong et al., 2002). 
SILAC was first used to observe differential regulation of protein expression 
during development of muscle cells (Ong et al., 2002). Myoblasts were 
cultured in media containing deuterated leucine and allowed to differentiate 
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into myotubes. As expected, enzymes involved in glucose metabolism were 
shown to be up-regulated in the differentiated cells compared with myoblasts 
grown in un-labelled media (Ong et al., 2002). In this study, quantification for 
peptides with greater than 6-fold differences in abundance was inaccurate. 
This issue was attributed to the complexity of the analysed samples but could 
be overcome by comparison of the relative intensities of the peptide 
fragments in MS/MS instead of whole peptides in MALDI (Ong et al., 2002). 
Substituting two essential amino acids for isotopic analogues in cell culture 
media, however, has the potential to greatly increase the number of labelled 
peptides. For example, using isotopically labelled arginine and lysine, 
increases the number of labelled tryptic peptides, since trypsin cleaves 
exclusively C-terminal to both of these amino acids (Olsen et al., 2004). It 
should be noted here that heavy arginine used for SILAC can be converted to 
other amino acids in vivo (mostly proline) (Mann, 2006). However, this issue 
can be overcome by limiting its concentration in the media, quantification of 
proline and arginine-containing peptides separately (Mann, 2006) or, where 
practicable, deletion of arginase genes to prevent conversion altogether 
(Bicho et al., 2010). 
Further studies have applied SILAC to the investigation of protein interactions 
(Schulze & Mann, 2004), including identifying cross-talk between histone PTMs 
(Vermeulen et al., 2007). In the latter study, acetylation of H3 at both K9 and 
K14 was shown to promote binding of TFIID to K4me3 occurring in the same 
histone, in keeping with the findings of genome wide ChIP-seq studies that 
showed their co-localisation (Bernstein et al., 2005; Heintzman et al., 2007). 
Furthermore, this binding was found to be inhibited by asymmetric di-
methylation at R2 (Vermeulen et al., 2007). More recent studies have identified 
binding partners to histone PTMs. SILAC nucleosome affinity pull-down (SNAP) 
experiments showed that affinities of proteins for the nucleosome could be 
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dependent on the DNA sequence (e.g MTA2 was more enriched on 
nucleosomes assembled with 603 rather than 601 DNA) and the presence or 
absence of a histone octamer (e.g. MeCP2 did not bind methylated DNA 
without the octamer) (Bartke et al., 2010). Furthermore, binding of protein 
complexes could occur in a co-operative or antagonistic manner effected by 
various combinations of modifications on the nucleosome. For example, the 
origin recognition complex bound H3K9me3 or H3K27me3 modified 
nucleosomes more strongly if they were also methylated at CpG islands, whilst 
PRC2 binding to H3K27me3 nucleosomes was inhibited by DNA methylation 
(Bartke et al., 2010). Other SILAC experiments have isolated proteins in the 
interactomes of H3K4me3 and H3K9me3 in the context of oligo-nucleosomes 
(Nikolov et al., 2011), identified enrichment of co-activator complex subunits 
by symmetric H3R2me2 (Migliori et al., 2012) and analysed the turnover of 
histone PTMs during the cell cycle (Bonenfant et al., 2007).  
Using recombinant chromatin templates consisting of twelve nucleosomes per 
molecule of DNA, a large number of proteins were isolated by affinity pull 
downs, confirming many that had previously been implicated as binding 
partners for H3K4me3 and H3K9me3 (Nikolov et al., 2011). These included 
TAF3 and PHF8 for H3K4me3 and CBX1 and UHRF1 for H3K9me3. The same 
proteins identified in the interactomes of chromatin carrying H3K4me3 or 
H3K9me3 were also isolated in pull downs with modified peptides (Nikolov et 
al., 2011). 
Migliori and colleagues (2012) identified symmetric di-methylation of H3R2 in 
vivo by Western blotting and immunofluorescent labelling of polytene 
chromosomes from Drosophila melanogaster. This indicated that H3R2me2s is 
localised to euchromatin. Further analysis by ChIP-seq using chromatin from 
human B-cells showed that approximately a third of the regions enriched in 
this modification occurred on the -1 nucleosome at the transcription start sites 
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(TSS) of actively transcribed genes. Since these data demonstrated H3R2me2s 
as a novel mark for active gene expression (as opposed to the repressive 
modification, H3R2me2a), SILAC-based peptide pull downs were chosen to 
isolate its binding partners. This identified both proteins that were enriched by 
H3R2me2s, including WDR5, ASH2L, RBBP5 and DPY30 (which are 
components of the MLL, SET1a and SET1b complexes), and those excluded by 
the modification, including RBBP4/7 (components of the repressive NURD and 
Sin3a complexes) (Migliori et al., 2012). 
In one final example, the modification status of histones was determined 
during the cell cycle of HeLa cells initially by MS analysis of histones extracted 
from cells arrested at the G1/S boundary, S phase or the G2/M boundary 
(Bonenfant et al., 2007). This identified a number of changes to PTMs during 
the cell cycle, which were subsequently confirmed using a SILAC approach. 
Heavy arginine was used to label all proteins in HeLa cultures that were 
subsequently arrested at each of the tested stages of the cell cycle and 
modifications of the extracted histones compared with histones isolated from 
unlabelled cultures of a different stage. For example, labelled histones from 
cells arrested at the G2/M boundary were compared with unlabelled histones 
from cells arrested in S phase. The results of this study revealed, 
unsurprisingly, a general reduction in acetylation and increase in methylation, 
corresponding to chromatin condensation in G2/M phase, compared to G1 and 
S phases (Bonenfant et al., 2007). 
5.1.5 Choice of isotopic labelling technique 
All four of the isotopic labelling techniques described have the potential to be 
or have been applied to pull-down experiments for the identification of 
protein-protein interactions (figure 5.2) but ultimately SILAC was chosen for its 
simple and accurate application to identify and quantify specific binding 
partners.  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5.2 • Comparison of isotopic labelling techniques as applied to affinity pull downs 
15N, 18O, ICAT and SILAC can all be applied to affinity purification experiments to identify binding 
partners to, for example, modified proteins (red circles; ●, modification). Labelling proteins as 
they are synthesised (15N and SILAC) is advantageous since fewer manipulations are involved and 
trypsin digestion is not performed separately for the two samples, thus minimising protein loss, 
which could otherwise produce under-represented samples.  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5.2 SILAC coupled with nucleosome affinity pull downs (SNAP) 
5.2.1 K562 cell line 
K562 is a human leukaemic cell line that was established from a patient in 
chronic myelogenous leukaemia blast crisis (Lozzio & Lozzio, 1975). These cells 
have been shown to differentiate into monocytic, granulocytic and erythrocytic 
states (Lozzio et al., 1981). Differentiation into the erythroid pathway was 
induced when the culture media was depleted of essential nutrients (Lozzio et 
al., 1981) or supplemented with inducers such as hemin or butyric acid 
(Rutherford et al., 1979; Rutherford et al., 1981; Testa et al., 1982). As such, 
K562 cells have been described as multi-potential (Lozzio et al., 1981). 
H3K4me1 and H3K27ac were mapped across the globin locus by ChIP from 
5DCE and 15DCE (chapter 3 and Amar, 2010). Both modifications showed 
highly selective enrichments at particular points of the locus, so it followed that 
the K562 cell line, being a multi-potential precursor to the erythroid pathway, 
would be a likely source of binding partners to these histone PTMs. 
Furthermore, peptide assignment from the bound material following SNAP 
was expected to be very efficient, since this cell line has human origin - the 
human genome is currently annotated to a much greater extent than that of 
chicken. 
5.2.2 K562 cells can be cultured with low levels of FCS 
Cells were cultured, similarly to previous studies (Imami et al., 2010; Xiong et 
al., 2010; Halbach et al., 2013) and as recommended by HPA Cultures (now 
Public Health England) (2012), in RPMI 1640 medium containing 10 % foetal 
calf serum (FCS). However, SILAC requires the use of dialysed FCS to remove 
unlabelled amino acids contained within it, adding a significant cost to the 
experiment. Cells were therefore cultured in the presence of 5, 8 or 10 % FCS 
for a period of seven days to test the effects of lower serum levels. Viable cell 
counts were monitored and used to determine fold-growth rates in the 
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established cultures at 24 hr intervals, together with microscopic analysis to 
check for changes in cell morphology (which could indicate cell differentiation) 
(figure 5.3, panel A). This analysis showed that cells maintained the expected 
doubling time of 24-36 hours (Lozzio & Lozzio, 1975) in all three conditions. No 
morphological changes were apparent, suggesting that the cells did not 
differentiate when cultured in lower serum levels. This demonstrates that K562 
cells can be cultured in as little as 5 % FCS, although viability of the cells was 
slightly lower than observed with 8 or 10 % FCS, so for SILAC experiments, 
cells were cultured in media supplemented with 8 % FCS. 
5.2.3 SILAC 
In vivo labelling of proteins was performed essentially as described (Bartke et 
al., 2010; Vermeulen, 2012). Briefly, two populations of K562 cells were 
cultured in RPMI 1640 medium with or without heavy isotopes of arginine (R10) 
and lysine (K8). Labelling shifts the mass of a protein by 10 or 8 Da for each 
incorporated arginine or lysine residue, respectively. As for culture in low 
serum media (see above), K562 cells were shown to grow equally well in light 
and heavy medium compositions (figure 5.3, panel B). To ensure full 
incorporation of the heavy amino acids, cells were maintained in suspension 
cultures for at least five doublings (Ong et al., 2002), as judged by viable cell 
counts. 
5.2.4 K562 nuclear protein extract preparation 
Nuclear protein extracts for SNAP experiments were prepared from K562 cells 
essentially according to Dignam and colleagues (1983). Briefly, cells were 
lysed and proteins extracted from the nuclei by incubation in a hypertonic 
buffer. Extracts were quantified by the Bicinchoninic Acid (BCA) assay (figure 
5.4).  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5.3 • FCS concentration and isotopically labelled amino acids do not affect K562 cultures 
Cell growth was tested in the presence of reduced serum (FCS) concentrations. (A) Cell culture 
medium was supplemented with 5 %, 8 % or 10 % FCS and growth rates monitored using viable 
cell counts. Growth rates are represented as fold change in cell counts from 24 hr previously. Cell 
morphology was monitored by microscopy. (B) Cells cultured in media containing dialysed FCS 
and labelled arginine and lysine were monitored every 24 hr by viable cell counts and microscopy.  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5.4 • Quantification of nuclear protein extracts by BCA assay 
A standard curve was produced by measuring the absorbance at 562 nm of solutions containing 
known concentrations of BSA with BCA reagents to determine the concentration of ‘unknown’ 
samples. Nuclear protein extracts from K562 cells grown in media supplemented with standard 
FCS, dialysed FCS or ‘heavy’ amino acid isotopes were diluted four-fold to prevent inaccurate 
quantification due to glycerol interference (Smith et al., 1985). After quantification, concentrations 
were adjusted to account for this dilution factor.  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5.2.5 Verification of protein labelling 
Light and heavy protein extracts of known concentrations (as determined by 
BCA assay) were mixed at 1:1, 1:3 and 1:10 ratios and separated by 1D PAGE 
(figure 5.5). A small section of each lane was excised and proteins reduced, 
alkylated and digested with trypsin for analysis by MS. 
MS analysis of the control samples was not optimum (Dr M Dickman, personal 
communication, 19 May 2014) but did produce quantifications for 57 proteins 
identified from ≥2 peptides, with the majority (24 out of 45 and 31 out of 49 
for 1:1 and 1:3 mixtures, respectively) clustered around the origin, 
representing the expected H/L ratios (figure 5.6). A number of outliers (21 and 
18 for 1:1 and 1:3 mixtures, respectively) with ≥1-fold variation from the 
expected ratios were observed and might be representative of differential 
protein expression between the heavy and light labelled cell populations. 
However, they would not affect the final data following SNAP, since their ratios 
would not be reversed in the swap pull downs (i.e. from the forward to reverse 
pull downs, or vice versa) (Ong, et al., 2002), therefore being identified as false 
positives or contaminants following MS analysis of the proteins isolated by 
SNAP (see below). Though they will not affect the identification of other 
binding proteins, some of these differentially expressed proteins might 
represent legitimate interactors that will not be identified as such in this study. 
5.2.6 SNAP and mass spectrometry of peptides 
The nucleosome affinity pull-downs using SILAC protein extracts were 
performed as described previously (Bartke et al., 2010) (figure 5.7). Pull downs 
were repeated in two experiments - ‘forward’ and ‘reverse’. In the forward 
experiments, unmodified nucleosomes were used as bait to isolate proteins 
from the unlabelled ‘light’ (R0K0) extracts, whilst modified nucleosomes 
(carrying H3K4me1, H3K27ac, or H3K4me1 & K27ac) were used to isolate 
proteins from the labelled ‘heavy’ (R10K8) extracts. To confirm the ratios of 
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heavy to light (H/L) observed in the forward pull downs, reverse experiments 
were performed in which the extracts were switched. The ratios obtained from 
reverse experiments should be the inverse of the forward ratios for those 
proteins specifically interacting with the unmodified or modified nucleosomes. 
Proteins bound to the SNAP beads from each forward or reverse experiment 
were pooled, separated by 1D PAGE (figure 5.8), reduced, alkylated and 
digested with trypsin. Peptides were desalted on C18 tips to remove 
acrylamide prior to analysis by MS. 
Peptides were eluted from the C18 tips in 80 % acetonitrile and analysed on an 
LC ESI MS/MS ultra high resolution TOF instrument (supplementary figure 5.1). 
Proteins were identified from single peptides and quantified using Mascot 
Distiller in conjunction with the quantitation toolbox (Matrix Science) and 
ProHits software (Liu et al., 2010; Liu et al., 2012) to generate H/L ratios. 
!
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5.5 • Mixed protein extracts to verify the incorporation of heavy amino acids by MS 
(A) To confirm the labelling of proteins by SILAC, light (unlabelled) protein extracts were mixed 
with heavy (labelled) extracts at 1:1, 1:3 and 1:10 ratios and separated by 1D PAGE. (B) A small 
gel slice (S) was cut from each lane (approximate molecular weight range is noted) and proteins 
reduced, alkylated and digested with trypsin. Subsequent analysis by mass spectrometry was used 
to test the expected peptide peak ratios of 1:1 and 1:3.  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5.6 • Observed incorporation of isotopic amino acids in the heavy protein extracts 
Protein extracts were mixed at heavy to light (H/L) ratios of 1:1 or 1:3 and subjected to 1D 
electrophoresis on 4-12 % Bis-Tris gels (figure 5.5), followed by in-gel trypsin digestion. (A) MS 
analysis of the peptides was used to confirm the expected peak ratios. Portions of the mass 
spectra are shown in (B) and (C) and represent m/z 630-830 (dotted box in (A)). Selected light 
and heavy peptide peaks are highlighted (yellow and orange, respectively; or pink and purple, 
respectively, for SPT16 peptides). Peak (H/L) ratios of identified proteins were plotted against 
intensity on logarithmic axes (right hand side of panels (B) and (C)). ○, outliers.  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5.7 • Summary of SILAC nucleosome affinity pull downs 
(A) Two cell cultures are grown in media supplemented with either light (yellow) or heavy 
(orange) amino acids. Nuclear protein extracts are incubated with unmodified (left) or modified 
(●, right) SNAP beads (nucleosomes immobilised on streptavidin by their biotinylated 601.2 DNA) 
and bound proteins pooled and separated by 1D PAGE. (B-C) Isolated proteins are digested with 
trypsin and peptides are extracted from the gel (B) and analysed by mass spectrometry (C).  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5.8 • Separation of proteins isolated by SNAP on polyacrylamide gels for analysis by MS 
Proteins were isolated by SNAP using ‘light’ extracts with unmodified nucleosomes and ‘heavy’ 
extracts with nucleosomes carrying K4me1, K27ac or K4me1K27ac (Fwd) or vice versa (Rev). (A) 
Bound proteins were pooled and separated by 1D PAGE. (B) Each lane was cut into eight pieces 
(approximate size ranges are noted for each) and proteins reduced, alkylated and digested with 
trypsin. Subsequent analysis by mass spectrometry was used to identify binding partners to the 
defined histone modifications.  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5.3 Proteins identified by MS following SNAP 
A total of 289 proteins were identified using ProHits software (Liu et al., 2010; 
Liu et al., 2012) (supplementary figure S5.2). Of these proteins, 259, 264 and 
222 were identified from pull downs that used nucleosomes carrying 
H3KC4me1, H3KC27ac and H3KC4me1 K27ac, respectively, as bait. 
Logarithmic (Log2) plots of the H/L ratios from forward (x axis) and reverse (y 
axis) experiments (figures 5.9 and 5.10) allowed identification of proteins that 
bind specifically to the unmodified or modified nucleosomes. Those 
preferentially binding the unmodified nucleosomes have low H/L ratios in the 
forward experiment and high H/L ratios in the reverse and are represented as 
data points in the top left quadrant. On the other hand, proteins exhibiting 
preferential binding to the modified nucleosomes have high and low H/L 
ratios in the forward and reverse experiments, respectively, indicated in the 
bottom right quadrant. Outliers in the bottom left and top right quadrants are 
contaminant and false positive proteins, respectively. Preference for binding 
unmodified or modified nucleosomes was considered significant if 
enrichments were ≥2-fold. 
5.3.1 H3K4me1 excludes the FACT complex 
Two proteins, SSRP1 and Spt16, were shown to bind nucleosomes carrying 
wtH3 with ~2-fold enrichments relative to nucleosomes carrying H3K4me1 or 
H3K4me1K27ac (figure 5.9, panel A and figure 5.10). These proteins are the 
two components of the FACT (facilitates chromatin transcription) complex, 
which was originally identified as a cofactor necessary for transcription 
elongation through nucleosomes on chromatin templates by in vitro pulse-
chase transcription assays (Orphanides et al., 1998). Since these proteins are 
excluded from nucleosomes carrying K4me1 or K4me1 and K27ac but not 
K27ac alone, this suggests that K4 is involved in the binding of the FACT 
complex to H3 and mono-methylation of this residue prevents this interaction.  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5.9 • Proteins isolated in SNAP experiments using H3KC4me1- or H3KC27ac-nucleosomes 
Log2 values of the SILAC ratios (heavy to light - H/L) of each identified protein were plotted for 
the forward (x axis) and reverse (y axis) nucleosome pull down experiments. Proteins excluded or 
enriched by K4me1 (A) or K27ac (B) would appear in quadrants 2 or 4, respectively. For simplicity, 
proteins identified in only the forward or reverse experiments have been excluded from the plots, 
except for GBLP in (A), which was identified only in the reverse experiment. ●, FACT complex 
proteins (● in (B)); ●, RRP1B; ●, TopoIIß (TOP2B) and GBLP; ●, MCM6.  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5.10 • Proteins isolated in SNAP experiments using H3KC4me1 K27ac nucleosomes 
Log2 values of the SILAC ratios (heavy to light - H/L) of each identified protein were plotted for 
the forward (x axis) and reverse (y axis) nucleosome pull down experiment. Proteins excluded or 
enriched by K4me1 and K27ac would appear in quadrants 2 or 4, respectively. For simplicity, 
proteins identified in only the forward or reverse experiments have been excluded from this plot, 
except RRP1B, which was identified only in the reverse experiment. ●, FACT complex proteins; ●, 
TopoIIß (TOP2B) and RRPB1.  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5.3.2 RRP1B may also be excluded by H3K4me1 
Ribosomal RNA processing 1 homolog B (RRP1B) was also enriched on the 
wtH3 nucleosome compared with the H3K4me1 nucleosome (>1.7-fold) 
(figure 5.9, panel A and 5.10). In the double-modified nucleosome (H3K4me1 
and K27ac), this enrichment may have been as little as 0.8-fold but the protein 
was only identified in the forward pull down and not the reverse (section 
5.5.2). It may be a possible candidate for interaction with un-methylated H3K4, 
given its interaction with both euchromatin- and heterochromatin-associated 
proteins, including PARP1 and histone H1x (Ji & Tulin, 2010; Happel et al., 
2005) and mitotic chromatin, as determined by immunofluorescence and 
immunoprecipitation (Crawford et al., 2009). 
5.3.3 H3K27ac nucleosomes did not enrich or exclude any proteins 
No proteins were found enriched or excluded by nucleosomes carrying 
H3K27ac (figure 5.9, panel B and figure 5.10). However, this cannot be taken 
to be conclusive evidence of a lack of binding partners for K27 or K27ac, since 
a de-acetylase inhibitor was not included in the binding buffer. With an 
extensive incubation period of four hours, it is highly likely that the acetyl 
modification was removed by HDACs endogenous to the K562 nuclear protein 
extracts during the pull downs. 
!
5.4 Verification of FACT binding to H3K4 by peptide pull downs 
To attempt rapid validation of the exclusion of SSRP1 and Spt16 by H3K4me1, 
peptide pull downs were performed in conjunction with Western blotting. 
Nuclear protein extracts from K562 cells were incubated with un-modified or 
modified histone peptides immobilised on CPG beads and the bound proteins 
eluted and resolved by SDS PAGE for analysis by Western blotting using 
antibodies raised against SSRP1 or Spt16. In all Western blots SSRP1 was 
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detected as a doublet and migrated on SDS gels with the expected molecular 
weight of ~80 kDa. Spt16 was detected as a band with the expected molecular 
weight of ~120 kDa. The Spt16 antibody also showed some cross reactivity, 
with additional faint bands observed at around 80 kDa, possibly SSRP1 (figure 
5.11 and supplementary figure S5.5). 
Initial pull downs in 150 mM NaCl showed binding of SSRP1 and Spt16 to 
peptides regardless of modification status (figure 5.11, panel A). However, 
under more stringent salt washes, binding of both SSRP1 and Spt16 to the K4 
(short) peptide was reduced, indicating a reversed preference of FACT 
(relative to the SNAP data) for the K4me1 peptide (figure 5.11, panel B and 
supplementary figure S5.5). 
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5.11 • Loss of FACT binding to unmodified K4 peptides with high salt washes 
Nuclear extracts from K562 cells were dialysed into peptide binding buffer (50 mM Tris-HCl pH 
7.9, 150 (A) or 325 mM NaCl (B), 1 mM EDTA, 10 mM sodium butyrate), adjusted to 1.3 mg/mL 
and 500 µg aliquots incubated with ~10 µL H3 peptides on CPG beads for 4 hr at 4 ˚C. Unbound 
fractions were retained and the resins washed three times with 100 µL binding buffer (150 (A) or 
420 mM NaCl (B)) before eluting bound proteins in SDS sample buffer. Unbound and bound 
fractions were resolved on 15 % SDS gels and tested for the presence of FACT by Western blot.  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5.5 Discussion 
5.5.1 Validity of the results from SNAP 
The FACT complex is a heterodimer of the 80 and 140 kDa proteins SSRP1 and 
Spt16, respectively (Orphanides et al., 1998; Orphanides et al., 1999). It is 
involved in transcriptional elongation through nucleosomes, as demonstrated 
by in vitro transcription assays from recombinant chromatin templates by FACT 
complexes purified from HeLa cells (Orphanides et al., 1998; Orphanides et 
al., 1999) and in vivo transcription, shown by generation and suppression of a 
phenotype (6AUS) (Orphanides et al., 1999) specifically linked to a failure to 
elongate (Losson & Lacroute, 1981). Furthermore, the FACT complex was 
shown to be enriched at transcriptionally active chromatin on polytene 
chromosomes by immunofluorescence and cross-linked ChIP of FACT (using 
an antibody to SSRP1) and RNA polymerase II during the transcriptional 
activation of the hsp70 gene after a heat shock (Saunders et al., 2003). FACT 
was shown by glycerol density gradient sedimentation to interact with mono-
nucleosomes (Orphanides et al., 1999; Winkler et al., 2007) and, more 
importantly, is known to interact with histone H3 (Winkler et al., 2007; Stuwe et 
al., 2008; Myers et al., 2011). Gel filtration chromatography and pull downs 
indicated that Spt16 interacts with the globular domains of H3. Subsequent 
ITC experiments using the peptidase domain (aa1-442) of Spt16 demonstrated 
that FACT also interacts with the N-terminus of H3 (aa1-38) with Kd = 11 µM 
(Stuwe et al., 2008). More recently, a fluorescence microplate assay was 
developed, which involved FACT titration into fluorescently labelled chromatin 
components (H2A-H2B dimers, H3-H4 tetramers and nucleosomes) (Winkler et 
al., 2011). Fluorescence change measurements indicated direct interaction of 
FACT with those components and allowed quantification of their dissociation 
constants. This indicated that FACT interaction with H3-H4 tetramers had lower 
dissociation constants than those observed for the N-terminal tails of these 
histones alone (FACT:H3/H4 Kd = 685 nM; Spt16:H3/H4 Kd = >1 µM; and 
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SSRP1:H3/H4 Kd = 762 nM) (Winkler et al., 2011). Mutagenesis within the 
catalytic site of the Spt16 peptidase domain did not affect the dissociation 
constant, so a region elsewhere in this domain must be responsible for this 
interaction with H3 (Stuwe et al., 2008). The middle domain of Spt16 (Spt16-M) 
has also been shown to associate with H3 (Myers et al., 2011). Using a yeast 
model in which H3 carries a L61W mutation, preventing FACT dissociation 
from chromatin and therefore causing an accumulation of FACT at the 3’ end 
of transcribed genes (Duina et al., 2007; Lloyd et al., 2009), it was suggested 
that Spt16-M interacts with H3, since a number of mutations within this domain 
suppressed the 3’ accumulation phenotype (Myers et al., 2011). The 
abundance of FACT has been estimated to be in excess of 100,000 molecules 
per nucleus (Orphanides et al., 1999), indicative of its importance at active 
genes. 
Of note, when nuclear protein extracts were mixed to verify incorporation of 
the heavy isotopes of lysine and arginine, MS analysis showed that the Spt16 
component of the FACT complex had peak H/L ratios close to those expected 
(1:1 or 1:3), suggesting that its enrichment on unmodified nucleosomes 
relative to nucleosomes carrying H3K4me1 is genuine. SSRP1 was not 
identified in these control samples, since the excised gel slice used for trypsin 
digestion prior to MS analysis did not cover the region to which this protein 
migrated (~80 kDa). 
To attempt further validation of the results from the SILAC-based pull downs, 
proteins identified by MS that are known to interact with either of the FACT 
proteins were tested to determine whether they were enriched by the 
unmodified nucleosomes. Studies have primarily utilised immunoprecipitation 
and pull down protocols (but also immunofluorescence co-localisation, density 
gradient sedimentation and x-ray crystallography) to show that both SSRP1 
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and/or Spt16 interact with a number of proteins and complexes. These include 
all four core histones in S. pombe, S. cerevisiae and C. thermophilum (Stuwe et 
al., 2008; Myers et al., 2011; Hondele et al., 2013) and in humans (Orphanides 
et al., 1999), TFIIE (Kang et al., 2000), the kinases Caesin Kinase II (Keller et al., 
2001; Keller & Lu, 2002) and Nek9 (Tan & Lee, 2004), the tumour suppressors 
p63 and p73 (Zeng et al., 2002), the BAZ1B/WSTF including nucleosome 
assembly complex (WINAC) (Kitagawa et al., 2003 [retracted]), the replication 
helicase complex MCM proteins MCM2, MCM4, MCM6 and MCM7 (Tan et al., 
2006), UAP56 interacting factor (UIF) (Hautbergue et al., 2009) and 
heterochromatin protein 1 (HP1) (Kwon et al., 2010). 
Only two of the proteins that have previously been shown to interact with the 
human FACT complex were identified in these experiments - TopoIIß (TOP2B), 
a component of WINAC, and MCM6, a component of the MCM complex 
(figure 5.9, panel A and 5.10) (Kitagawa et al., 2003 [retracted]; Tan et al., 
2006). WINAC was identified by pull downs with WSTF and shown by ChIP to 
mediate the recruitment of vitamin D receptors to vitamin D response 
elements (VDRE) at promoters (Kitagawa et al., 2003 [retracted]). TopoIIß was 
not enriched by un-methylated H3K4 but this is not unexpected, since the 
601.2 DNA used for nucleosome assembly did not contain a VDRE. The MCM 
complex facilitates DNA replication (Ishimi, 1997; Labib et al., 2000) and its 
interaction with FACT was identified by immunoprecipitation using antibodies 
raised against SSRP1 or MCM4 and helicase activity assays on forked 
chromatin templates indicated that FACT promoted DNA unwinding (Tan et al., 
2006) in S phase, as judged by phosphorylation-dependent electrophoretic 
mobility shifts of MCM4 and immunofluorescence co-localisation of MCM4 
with SSRP1 (Tan et al., 2010). In the present study, MCM6 was not enriched on 
either modified or unmodified nucleosomes. 
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The yeast FACT complex has been shown to interact with other proteins, 
including those of the Paf1 complex (Squazzo et al., 2002; Krogan et al., 2003). 
CDC73, CTR9 and WDR61, components of the human Paf1 complex, were 
identified here by MS but all represented false positive interactors. Though 
these may be genuine contaminants it is possible that they were differentially 
expressed and therefore appear as false positives here. 
5.5.2 Limitations of the SNAP and peptide pull down approaches 
Of the total proteins identified by MS following SNAP, up to 20 % were found 
in only the forward or reverse pull down samples, representing a limitation of 
SILAC-based approach, since no conclusions can be drawn for these proteins. 
For the H3K4me1, H3K27ac and H3K4me1K27ac experiments, 51, 53 and 31 
proteins, respectively, were identified only in one or other sample. A number 
of these (14, 14 and 6, respectively) exceed the 2-fold enrichment threshold 
but it is unclear whether or not they might interact preferentially with the 
unmodified or modified nucleosomes (because of their absence in the other 
data set). Of the proteins that were identified only in the forward or reverse 
pull downs in a single SNAP experiment, most were identified in at least one 
other SNAP data set and were localised to the non-specific quadrants in the 
logarithmic plots. Therefore, these proteins more likely represent contaminants 
or false positives. However, some proteins remain unidentified in the forward 
or reverse direction in all SNAP experiments and these may be additional 
candidates for preferential binding to the unmodified or modified 
nucleosomes. For example, GBLP (also known as RACK1) (figure 5.9, panel A), 
has been shown previously by co-immunoprecipitation to interact with 
histones H3 and H4 (He et al., 2010). 
The peptide pull down approach failed to validate the expected difference in 
FACT binding between mono-methylated and unmodified H3K4. Whilst there 
appears to be slightly reduced binding to the H3K4me1 peptide, as predicted 
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from the SNAP data, there was greater loss of binding to the unmodified 
peptide. Due to differences in the sequence between unmodified and me1 
peptides (figure 2.7), direct comparison of the differences cannot be made. 
These peptides have overall charges of +5 and +3, respectively (at pH 7.0), so 
the persistent binding to the longer unmodified peptide may be the result of 
ionic binding, despite the stringent washing of the beads. Since the shorter 
unmodified peptide was more similar H3K4me1 peptide (only differing in the 
lack of a cysteine residue in the spacer (figure 2.7)), the pattern of binding 
observed (the opposite of that predicted by SNAP, i.e. SSRP1 and Spt16 
specifically bound to the mono-methylated peptide and not to the unmodified 
form) is completely unexpected. Finally, previous experience in this laboratory 
has indicated severe limitations of the peptide pull down approach, with very 
few candidate proteins being identified, quite possibly due to binding 
proteins requiring the nucleosomal context (Bruce, 2006; Amar, 2010). Indeed, 
partial inhibition of FACT complex-mediated transcription with competitor 
DNA suggested that this complex is capable of binding naked DNA 
(Orphanides et al., 1998). 
5.5.3 H3K4me1 is a novel regulator for the association of FACT with H3 
The data obtained from the SNAP experiments has identified H3K4 as a critical 
residue in regulating the binding of FACT to the nucleosome, with mono-
methylation preventing binding. Taken together with the ChIP experiments 
(chapter 3), this suggests a mechanism for gene repression effected by 
H3K4me1 exclusion of FACT. It would be interesting to test the distribution of 
FACT proteins by ChIP analysis at this locus, though this would require 
antibodies to the chicken FACT homologues. Failure to identify binding 
partners to H3K4me1-containing nucleosomes was not entirely unexpected, 
since previous SNAP experiments (Dr T Bartke, personal communications, 16 
June 2010 and 15 July 2014) did not reveal any interactors.  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6 Discussion 
6.1 Roles of histone post translational modifications in gene regulation 
In this study, the distributions of H3K4me1, me2 and me3 and H3K27ac have 
been mapped across the chicken ß-globin locus in the primitive and definitive 
erythrocytes of five and 15 day chick embryos, respectively. 
6.1.1 H3 methylation and acetylation at the ß-globin genes 
The inactive globin gene promoters and transcribed regions in both primitive 
and definitive erythrocytes are marked by H3K4me1. This contrasts with the 
enrichment observed in the active genes for H3K4me3, though, as noted 
earlier, this is less marked in the hatching gene at 15DCE than has been 
observed previously (Schneider et al., 2004). Intriguingly, H3K4me1 also marks 
the inactive folate receptor (FR) promoter and transcribed region in 5DCE but 
only the promoter in 15DCE. Additionally, striking enrichments of H3K27ac 
accompany H3K4me1 at the inactive genes in 5DCE but not in 15DCE, nor at 
the FR in either cell type. There therefore is no simple relationship between 
H3K27 acetylation and gene repression. Furthermore, in 5DCE there is no 
linkage of H3K27ac to future expression, since the hatching and adult genes 
are not destined for expression in these primitive erythrocytes. It would 
therefore be interesting to monitor the H3K27ac levels in erythrocytes from 
mature hens in which the embryonic (ρ and ε) and hatching genes will be 
inactive. 
6.1.2 Replacement of H3K4me1 with K4me3 at the ß-globin enhancer 
The loss of H3K4me1 at the ß-globin enhancer in 15DCE has been observed 
previously (Amar, 2010) and it was speculated that this might be due to an 
increase in methylation status to H3K4me2 or me3 that may also involve 
replacement of H3 with the variant histone H3.3. Since antibodies to the three 
methylated forms of H3K4 were available, it was straightforward to examine 
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this in 5 and 15DCE. ChIP experiments showed that the enhancer in both 5 
and 15DCE is highly enriched in H3K4me3 whilst the levels of H3K4me1 are 
low or show depletion, which is consistent with suggestions (as discussed in 
chapter 3) that H3K4me3 is involved in the establishment of active enhancers 
(Bernstein et al., 2006; Wang et al., 2008; Pekowska et al., 2011). These 
experiments suggest that, at the globin enhancer, H3K4me1 might only mark 
the poised state. 
6.1.3 H3K27ac marks the ß-globin enhancer in 5DCE but not in 15DCE 
The enhancer of the chicken ß-globin locus is highly enriched with H3K27ac in 
5DCE. Its co-occurrence with H3K4me3 has not been observed previously at 
active enhancers. Given that the H3K27ac modification is reduced to fairly low 
levels (~4-fold enrichment) in 15DCE, it would be interesting to test its 
presence in earlier cell types, including HD24 (multipotent precursors) and 
HD37 (erythroblasts). Indeed, H3K27ac has been shown previously to mark 
enhancers prior to differentiation and active transcription (Bogdanović et al., 
2012). Whilst H3K27ac has been globally associated with active enhancers 
(Creyghton et al., 2010; Rada-Iglesias et al., 2011; Bogdanović et al., 2012), it is 
possible that this modification is removed or replaced in 15DCE by a different 
enhancer-associated PTM, such as K27me1 (Wang et al., 2008), to maintain 
activity. 
6.1.4 Distribution of other histone PTMs across the ß-globin locus 
It is clear that additional ChIP studies are required to extend the 
understanding of ß-globin locus activation during development. On this 
occasion, it was not possible to determine the enrichments and depletions of 
H3K27me3, due to the antibody used not having the specificity necessary for 
ChIP. The distribution of this modification will undoubtedly prove useful 
towards understanding its relationship with H3K4me1, me2 and me3 during 
erythropoeisis. 
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Mono-methylation of H3K27 would be another interesting modification to map 
across the globin locus, particularly at the enhancer, given its association with 
active enhancers in humans (Wang et al., 2008). Other potential modifications 
of interest include acetylations at H3K9, K14 and K18, which have all been 
demonstrated previously to be globally associated with H3K4me3 (Hazzalin & 
Mahadevan, 2005; Crump et al., 2011; Hsu et al., 2012). ChIP-seq studies have 
also identified other H3 modifications enriched at active enhancers, including 
H3K9me1, K18ac, K23ac and K36ac (Barski et al., 2007; Wang et al., 2008). 
H3K79me3 has also recently been suggested as a mark of developmental 
enhancers in a batch-isolate tissue specific (BiTS) based ChIP-seq study (Bonn 
et al., 2012). 33 % of enhancers marked with this modification were also 
associated with RNA polymerase II, indicative of a role for K79me3 at some 
active enhancers (Bonn et al., 2012). In addition to H3K4me1, Cui and 
colleagues associated H3K9me1 and K27me1 with the regulatory elements in 
the human ß-globin LCR in a CD133+ cell line prior to differentiation into the 
erythroid pathway and target gene expression (Cui et al., 2009). 
H3K4me3 has previously been associated with active promoters (Schneider et 
al., 2004; Barski et al., 2007; Heintzman et al., 2007; Wang et al., 2008; 
Heintzman et al., 2009; Bogdanović et al., 2012) and this is also true for the 
active ß-globin genes. Additional modifications that have previously been 
associated with active promoters include H3K4ac, K9ac and K36ac (Wang et 
al., 2008). On the other hand, actively transcribed regions are marked by 
H3K9me1, K27me1 and K36me3 (Jenuwein & Allis, 2001; Li et al., 2007a; 
Wang et al., 2008). 
A working summary of the observations from this study is provided in figure 
6.1. This also includes potential modifications which, based on the data of 
previous studies (see above), might regulate ß-globin gene expression in 
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concert with those modifications shown to be enriched here. To test this, work 
is currently underway in this laboratory to map the enrichments and depletions 
of a number of the modifications described above and shown in the figure. 
!!
   !
6.1 • Histone PTMs at the genes and enhancer of the chicken ß-globin locus 
This and earlier studies have indicated H3K4me1, K4me3 and K27ac as key modifications 
localised to the genes (A) and enhancer (B) of the chicken ß-globin locus. Observed and 
potential modifications (●, acetylation; ●, methylation) are indicated. Since they are differentially 
expressed, modifications at the embryonic and adult globin genes are shown separately and are 
further divided into the promoter, P, and transcribed regions, T. ✦, potential modifications that 
have not yet been mapped. The distributions of a number of these suggested modifications are 
currently being determined in our laboratory by ChIP in 5 and 15DCE, to extend the data 
presented here. Analysis in MCE will be useful, since only the adult gene is expressed in the 
erythrocytes of mature chickens. It would also be interesting to extend the mapping of these 
modifications to other cell types such as HD24 (multipotent erythroid precursors) and HD37 
(erythroblasts), as some modifications have been suggested to mark transcriptional activation 
prior to their activation upon differentiation (e.g. H3K4me1 and H3K27ac at the enhancer). 
Unmodified residues do not imply lack of modification in nature.  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6.2 Pull downs to identify binding partners of methyl- and acetyl-H3 
6.2.1 Nucleosomes carrying H3K4me1 exclude the FACT complex 
The apparent association between H3K4me1 and K27ac at the promoters and 
transcribed regions of the inactive hatching and adult genes in 5DCE is 
interesting. With increasing evidence from genome-wide mapping 
experiments suggesting that combinations of epigenetic modifications, rather 
than single marks, are key to the regulation of gene expression, identification 
of effector proteins that interact with H3K4me1 and H3K27ac is of key 
importance. A SILAC-based pull down approach using nucleosomes carrying 
defined modifications coupled with MS was used to demonstrate exclusion of 
FACT by H3K4me1, which constitutes a novel repressive mechanism in gene 
regulation. Three other histone modifications have previously been shown to 
be interdependent with FACT - H2BK123ub1 for the elongation of RNA 
polymerase through nucleosomes of transcribed regions by FACT in yeast 
(Pavri et al., 2006; Fleming et al., 2008), FACT-regulated deposition of 
H3K4me3 for DNA cleavage in class switch recombination in mouse 
lymphocytes (Stanlie et al., 2010) and H2AQ104/105me, which disrupts FACT 
binding at rRNA genes in yeast and human (Tessarz et al., 2014). Since this 
complex has been implicated in transcription elongation past nucleosomes 
(Orphanides et al., 1998; Orphanides et al., 1999), the enrichment of FACT by 
unmodified nucleosomes corresponds well with the observation of elevated 
H3K4me1 levels at the inactive globin genes in both 5 and 15DCE and 
depleted amounts of K4me1 at the active genes. Enrichment of H3K4me1 in 
the LCR might also suggest that exclusion of FACT is necessary at other 
positions to prevent non-genic transcription or other nuclear processes. Pull 
down experiments using N-terminal peptides of histone H3 with or without 
mono-methylation of H3K4 were used but did not confirm this interaction, 
possibly due to the absence of DNA, which might be required to potentiate 
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FACT binding. This is a recognised limitation of the peptide pull down 
approach. 
Whilst FACT preferentially binds H3 lacking the mono-methyl modification at 
K4, H3K4me3 was found to be enriched in both 5 and 15DCE at the active 
genes of the ß-globin locus. An obvious expansion to the data presented here 
would be to repeat the SNAP experiments with nucleosomes carrying this 
modification (H3K4me3) to test for FACT binding - the expectation being that 
binding should be re-established. Significantly, using the same SNAP 
experiments, FACT has previously been shown to bind un-modified H3 and 
H3K4me3 equally well (Bartke et al., 2010). 
Unfortunately, the absence of an HDAC inhibitor in the nucleosome pull downs 
prevented the identification of any specific binding partners to H3K27ac. Due 
to time and material constraints, these experiments could not be repeated, so 
this modification should be re-tested in future work. 
6.2.2 Further characterisation of FACT binding to H3 
The FACT complex and its exclusion from nucleosomes carrying H3K4me1 
should now be studied further. Initial experiments by xChIP can be used to 
confirm this interaction in vivo and identify the spatial and temporal 
distribution of FACT.  It is, of course, highly likely that FACT will primarily be 
bound at transcription start sites and across the coding regions of active 
genes, since it has been associated with transcription elongation through 
nucleosomes (Orphanides et al., 1998; Orphanides et al., 1999; Mason & 
Struhl, 2003; Saunders et al., 2003). Whilst the interaction of FACT with H3 and 
nucleosomes has been studied previously (Orphanides et al., 1999; Stuwe et 
al., 2008; Myers et al., 2011; Winkler et al., 2011), it has not been characterised 
fully. For instance, as described earlier (chapter 5), domains of the FACT 
proteins responsible for binding to H3 have only been generally suggested, 
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for example, the peptidase (Stuwe et al., 2008) and middle domains of SPT16 
(Myers et al., 2011), both of which span several hundred amino acids (aa 1-442 
and aa 630-959, respectively) and so it is quite clear that the whole of these 
domains will not be involved in the interaction with H3. Furthermore, some of 
these experiments have examined binding to peptides (Stuwe et al., 2008), 
which do not allow for the steric constraints imposed by the natural in vivo 
nucleosomal substrate or interactions with DNA. Therefore, biophysical 
analyses, in particular crystallography, would be useful to determine in greater 
detail the precise regions of H3 and FACT that bind to each other in the 
context of the nucleosome. 
6.2.3 Further experiments to identify and characterise PTM interactors 
The application of SILAC has been extended to quantitative proteomics using 
three protein populations labelled with three isotopes of the substituted 
amino acid(s) (Molina et al., 2005). This triple SILAC labelling has been used to 
study the Wnt signalling pathway with extracts from cell cultures in three 
different states to help differentiate further between specific and non-specific 
binding and identify novel interacting proteins (Hilger & Mann, 2012). The 
triple labelling approach has also been applied to demonstrate the temporal 
activation of both previously identified and novel epidermal growth factor 
(EGF) signalling pathway effector proteins (Blagoev et al., 2004; Olsen et al., 
2006) and changes in the proteome of the nucleolus upon transcriptional 
silencing by RNA polymerase inhibitors (Andersen et al., 2005). Applying this 
approach with the use of protein extracts from three different stages of 
erythropoiesis could be useful to test histone modifications for potential 
differential regulation by different interacting proteins during development. 
The complexity of mass spectra generally limits SILAC to the comparison of 
three states. However, further development of the technique has given rise to 
neutron-encoded SILAC (NeuCode SILAC) (Herbert et al., 2013). This approach 
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utilises tiny (3-6.3 mDa) differences between isotopes that comprise different 
numbers of atomic isotopes, such as 12C/13C, 1H/2H, 14N/15N, 16O/18O and 32S/
34S (Sleno, 2012; Hebert et al., 2013) and higher resolution MS. This results in 
mass spectra containing all isotopically labelled peptides in a single m/z peak 
that contains all the quantitative data required for analysis, reducing the 
complexity seen in ‘traditional’ SILAC analysis (where isotopically labelled 
peptides occur as separate peaks and might therefore overlap with other 
peptides) resulting in at least 41 % more quantified proteins (Hebert et al., 
2013). NeuCode SILAC has been tested for two conditions each in yeast and 
mouse and is anticipated to be capable for use in experiments with 12 (and 
potentially more) conditions (Hebert et al., 2013). This method could be used 
to label protein samples metabolically and/or chemically for the comparison 
of effector protein binding between several differentially modified 
nucleosomes. 
As well as isotopic labelling in cell culture, SILAC has also been applied to 
tissues (Ishihama et al., 2005) and whole organisms (Wu et al., 2004). The use 
of SILAC with protein samples from tissue is particularly interesting and could 
be used to further characterise binding partners to histone methylation and 
acetylation between, for example, 5 and 15DCE. This method involves two sets 
of SILAC experiments per modification of interest using unlabelled proteins 
from 5 or 15DCE and labelled proteins from cultured (precursor) cells. By 
comparing isolated binding partners between the two data sets, this might be 
used to test for differential regulation (by different regulatory proteins) 
between precursors and fully differentiated cells, which might suggest 
correlations between histone modifications and expression of regulatory 
proteins (Ishihama et al., 2005). 
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6.2.4 Synthesis of nucleosomes carrying multiple modifications 
Nucleosomes carrying acetylation at H3K27 need to be repeated, since an 
HDAC inhibitor was not used in the SNAP buffers. Furthermore, based on the 
data obtained by real-time PCR following ChIP, a number of other 
combinations of histone PTMs could be tested. These might include H3K4me3 
and K27ac, as observed at the ß-globin enhancer in 5DCE, H3K4me1 and 
K27ac at inactive genes in 5DCE and the possible co-localisation of H3K4me3 
with K27me1 at the enhancer in 15DCE (figure 6.1). 
The major difficulty in studying nucleosomes carrying multiple modifications 
on a single histone is the ability to synthesise histones carrying different types 
of modifications. For instance, H3 could not be synthesised to carry both 
K4me3 and K27me1 by the methods used in this study (i.e. reductive alkylation 
to introduce analogues of methylated lysine). Instead, an amber codon to 
genetically incorporate the mono-methyl modification at K27, as has been 
previously described (Nguyen et al., 2009) could be used, followed by 
reductive alkylation to synthesise a tri-methyl lysine analogue at residue 4. This 
issue is exacerbated where three or more different modifications need to be 
incorporated, such as in the proposed correlation of K9 and K27 mono-
methylation, K4 tri-methylation and K18 and K23 acetylation at the enhancer in 
15DCE (figure 6.1). However, this could be overcome by using peptide 
ligation strategies, which are capable of incorporating a variety of 
modifications into synthetic N-terminal peptides (section 4.1.2). There is also 
the consideration that nucleosomes might be asymmetrically modified in vivo 
(Voigt et al., 2012). Whilst it would be possible to use two differently modified 
histones (H3 and H3’) in nucleosome assembly mixtures, the desired 
asymmetrical nucleosomes carrying H3/H3’ would occur together with 
symmetrical nucleosomes (H3/H3 and H3’/H3’), which could not be 
fractionated, thus making the data obtained from SNAP and other experiments 
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difficult to interpret. Temporal changes in patterns of histone PTMs, including 
the rapid turnover of histone acetylation, also pose an issue for determining 
which modifications actually co-exist in vivo. Nevertheless, further SILAC 
experiments will be necessary to expand our understanding of the 
mechanisms of epigenetic regulation. 
!!!!!!!!!!
   !!!
6.2 • Model for the regulation of FACT binding and transcriptional elongation by H3K4me1 
(A) H3K4me1 (●) at the promoter (▬) of a gene (▬) inhibits FACT binding. This prevents 
nucleosome disassembly, so transcriptional elongation cannot occur. (B) H3 that lacks mono-
methylation of K4 permits FACT binding. FACT remodels nucleosomes by removing H2A/H2B 
dimers (  ) to allow transcriptional elongation (➞) by RNA polymerase (RNAP).  
A
B
FACTFACT
RNAP
RNAP
FACT
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Supplementary figures (chapter 1) 
!!
!!!
S1.1 • Sites of PTMs in the canonical histones and their functional groups 
Histones may be post-translationally modified at a number of specific sites by the addition of 
chemical groups, small proteins or the conversion or isomerisation of amino acids. The location of 
modifications and functional groups for each type of histone PTM is provided.  
PTM Abbr. Targeted histones & residues Functional group
Acetylation ac
H2A 
H2B 
H3 
H4
K5 
K5, K12, K16, K20 
K4, K9, K14, K18, K23, K27, K36, K56, K64 
K5, K8, K12, K16, K91
-C(=O)CH
Methylation me
H2A 
H3 
H4
R11, R29, Q104 
R2, K4, R8, K9, R17, R26, K27, K36, K64, K79 
R3, K20
-CH3
ADP-ribosylation adp
H2A 
H2B 
H3 
H4
K13 
K30 
K27, K37 
K16
Butyrylation but H4 K5, K8, K12, K16, K31, K44, K77, K79, K91 -C(=O)CH
Citrullination cit H3 H4
R2 
R3 arginine → citrulline
Crotonylation cro
H2A 
H2B 
H3 
H4
K36, K119, K120, K126 
K5, K11, K12, K15, K16, K20, K23, K34 
K4, K9, K18, K23, K27, K56 
K5, K8, K12
-C(=O)CH=CHCH
Isomerisation iso H3 P30, P38 cis-trans proline
Malonylation mal H2B K116 -C(=O)CH
O-palmitoylation o-p H4 S47 -C(=O)(CH
Phosphorylation ph
H2A 
H2B 
H3 
H4
S1, K120 
S14 
T3, T6, S10, T11, S28, Y41, T45 
S1
-PO43-
Propionylation pro H3 H4
K23 
K5, K8, K12, K16, K31, K44, K77, K79, K91 -C(=O)CH
Succinylation suc
H2A 
H2B 
H3 
H4
K9, K36, K95 
K34, K116, K120 
K14, K56, K79, K122 
K12, K31, K77, K91
-C(=O)CH
Sumoylation sumo H3 H4
K18, K23 
K12 SUMO
Ubiquitination ub
H2A 
H2B 
H4
K119 
K120 
K91
ubiquitin
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Supplementary figures (chapter 2) 
   
S2.1 • Mutant and alkylated histone expected molecular weights 
Expected molecular weights for mutant and alkylated histones were calculated using nominal, 
monoisotopic and average masses. Highlighted histones were used to reconstitute nucleosomes. !!
!!!
   !
S2.2 • Reaction scheme for the BCA assay 
The colour-change observed in BCA assays occurs when two molecules of BCA are chelated by 
Cu1+. These cuprous ions form when Cu2+ is reduced by proteins in alkaline solution and the 
resulting BCA/Cu1+ complex produces a purple solution that absorbs light at 562 nm. 
Absorbance is linear with increasing protein concentration making this assay suitable for the 
quantification of complex protein mixtures (Smith et al., 1985).  
Histone Nominal MW, Da Monoisotopic MW, Da Average MW, Da
H3 15253 15261.4805 15270.8597
H3 K4C C110S 15211 15219.4097 15228.7568
H3 KC4 C110S 15255 15263.4597 15272.8325
H3 KC4me1 C110S 15269 15277.4753 15286.8591
H3 KC4me2 C110S 15283 15291.4910 15300.8857
H3 KC4me3 C110S 15297 15305.5066 15314.9123
H3 K27C C110S 15211 15219.4097 15228.7568
H3 KC27 C110S 15255 15263.4597 15272.8325
H3 KC27ac C110S 15285 15293.4702 15302.8585
H3 KC27me3 C110S 15297 15305.5066 15314.9123
+1
+2
+
protein
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Supplementary figures (chapter 3) 
Position (bp) 
Start          End
Amplicon 
size (bp)
Description Sequences Tm
(˚C)
GC 
(%)
3952 4033 82 FR intron 4
 F CAGCAAAGAGTCCTTTCCCTTCT 50.2 47.8
 R TTCAACACCATCTTGCTGCAAT 46.0 40.9
 T CAAAACACCCGAGGGCTGCCTG 55.3 63.6
5614 5718 105 FR promoter
 F AACATTACCTGCCTAGAGACTATCCA 51.3 42.3
 R CTGTGTCAGAAGGCTTTCCTGTTA 50.6 45.8
 T CCACAACAACACTCAGAACAGCAGCCTC 57.8 53.6
5986 6086 101 FR HSA (5’ end); CTCF site
 F CCGTGCACCACCAGTAAAGA 62.0 55.0
 R AAGGGACCACAAAGACCATTCA 47.9 45.5
 T TGCAGAGCCCCTCATGGCG 64.0 68.4
7343 7440 98 FR HSA (3’ end)
 F CACAGCACTGCAGCAGCATT 62.0 55.0
 R ATCCAAAAACAAACCCGATATCA 44.8 34.8
 T CTCTGTTTTCTGTTCCTCGCCGAGGA 56.0 53.8
7811 7932 122 Downstream of FR HSA (in 16 kb heterochromatin)
 F CCCAGCATACAGGACACCATT 49.2 52.4
 R CACAAAGACCAGTCCCTCCAAT 49.7 50.0
 T CGCCTGGGTTCCGATCCCATG [rev] 55.1 66.7
13304 13384 81 16kb heterochromatin
 F GACTGTGTCTGTAAGCACCATAAAGAG 53.1 44.4
 R CCTTCTATGCACGTATATGGAAACG 50.9 44.0
 T CACCCGGATCACCAGCTGCAGTTCT [rev] 57.5 60.0
15844 15946 103 16 kb heterochromatin
 F CAGCAGACGCTGTGGTGAA 60.0 57.9
 R CTTGCAGGATGCAGACTGGA 62.0 55.0
 T ATCCCATCGGTGCCACCCTGAG [rev] 55.3 63.6
20157 20221 65
1.4 kb upstream of HS4 
insulator (in 16 kb 
heterochromatin)
 F AGGATGGGACGGGATGGT 58.0 61.1
 R TGTAGGTTTGGCTGGAGGACAT 49.7 50.0
 T AGTGCCGCCCATCTCTGTGCCTT [rev] 55.5 60.9
20645 20717 73
1.0 kb upstream of HS4 
insulator (in 16 kb 
heterochromatin)
 F GAATTCCTTGTTGCCAGCTGTT 47.9 45.5
 R GCCCAGCCAGGTGCTAAGT 62.0 63.2
 T AGCCCACCCAGCACAGGTACTGCA 57.4 62.5
21073 21168 96
0.5 kb upstream of HS4 
insulator (in 16 kb 
heterochromatin)
 F CCAGGAAGAGCATGAATTCTATCC 50.6 45.8
 R CCAACCCCCCAGATGTTG 58.0 61.1
 T CCTGCAGGGAACAGGGCTGGC 57.1 71.4
21367 21445 79
0.2 kb upstream of HS4 
insulator (in 16 kb 
heterochromatin)
 F TCTGTGCTCAGCATCCTTCAA 47.3 47.6
 R CGGCCGAGTGGTTTCCT 56.0 64.7
 T CGGCTCCGCTGCACCTCCTC 70.0 75.0
21485 21635 151 HS4 1.2 kb insulator (5’ end); CTCF site
 F AAGGAAGAAAGTGCCGAAAGG 47.3 47.6
 R TCGCTGCTGCCCCCTAG 58.0 70.6
 T CGTCCGCGGGAGCTCACG 64.0 77.8
21723 21790 68 3’ end of HS4 insulator 250 bp core element
 F GCACGGGATCGCTTTCC 56.0 64.7
 R CCGTATCCCCCAGGTGTCT 62.0 63.2
 T CTGAACGCTTCTCGCTGCTCTTTGAGC 57.7 55.6
22190 22256 67 HS4 1.2 kb insulator (middle)
 F CAGGACAGCATGGACGTGG 62.0 63.2
 R TTCTGAACGCTGTGACTTGGA 47.3 47.6
 T CATGCAGGTGTTGAGGCTCTGGACA 55.9 56.0
 224
22664 22734 71 HS4 1.2 kb insulator (3’ end)
 F GGAGAAGGTAAATCTTGCTAAATCCA 49.7 38.5
 R GGATGAGAGATAATGGCCTTACGT 50.6 45.8
 T CCCGACCCTCCCCTGGCA 64.0 77.8
24484 24555 72 HS3
 F TTCCCTCTCACTCTTCCTTAAAGC 50.6 45.8
 R GCACCCTGCAAATGAAAGCT 60.0 50.0
 T TGCCTCAGTTTCCCTGCCTGGAGA 55.7 58.3
25620 25683 64 Upstream of HS2
 F CTGCCCGTGCTGTTTGC 56.0 64.7
 R TGAGTCACGGTTGTGTGTGGTT 49.7 50.0
 T CCAGCCGTGTTATCGCCCCATG 55.3 63.6
27607 27676 70 HS2
 F TCCCCTGCACCACCTCTCT 62.0 63.2
 R TGGCATCTATGGGAAAACTGAGT 48.4 43.5
 T CTCCCTGCGCAAAACGACGAGAGA 55.7 58.3
28670 28738 69 Upstream of HS1
 F GGAGGTCCTCCGTGCATTT 60.0 57.9
 R TGTGTCTGCTGTTTTGGTCTCA 47.9 45.5
 T TGTTGTGAACAGCCCCAAAGTGCACA 54.4 50.0
29591 29658 66 HS1 (not according to Reitman)
 F GGGCCCAGAGCAGAAGCT 60.0 66.7
 R AACCAGAGCACAGTCTTACAGAACA 50.9 44.0
 T CCACAGACCCAAAGGGACAGGCA [rev] 55.5 60.9
30510 30589 80 Upstream of ρ gene
 F CTCTGGCTACCTGTGTGATACACTTAT 53.1 44.4
 R AGTTACCGCAGTGCTCCGATA 49.2 52.4
 T TGAGCAGCCCGTGCCCCG 64.0 77.8
31971 32047 77 ρ promoter
 F GCAAGATAAGGGCTGCTGTGT 49.2 52.4
 R GCACAAGGTGTGGTCTTCCA 62.0 55.0
 T AGCCGCCTGTTAAGCTGGTCACTGTC 57.6 57.7
33152 33218 67 ρ transcribed; exon 3
 F CACCTTGCTTACCCCATTGC 62.0 55.0
 R CAGCACGATGATGAGGATGTTC 49.7 50.0
 T CCCCTTCTCCCTGCAGCTCCTGG 59.1 69.6
34595 34667 73 Upstream of ß
 F CGTGTTCTGGAGGAGAGAGAAGA 52.0 52.2
 R CTTATCAGCAAGACTGGCAGATGT 50.6 45.8
 T ACAGCCTCTGGACCACAGCCAGTCA [rev] 57.5 60.0
36920 36999 80 ßH promoter
 F TCTTTCCTTCTGCAGCTCAACTC 50.2 47.8
 R CTAGTAACAGCTTGCCCTAATCTCAGT 53.1 44.4
 T CTCCCCAGTCGCAACCAATGACAATG 56.0 53.8
37535 37601 67 ßH transcribed; exon 2
 F TGTGTGAGAGGAGGGATGCA 62.0 55.0
 R TGGCACGTAAATCACTCCACAT 47.9 45.5
 T TGTGCCCATCCACTCCGCCTG [rev] 55.1 66.7
38792 38868 77 Upstream of ß
 F TGATCATTCCACACACAGAAAGG 48.4 43.5
 R GAACTTTTGCTGCTGAAAACCTAGA 49.3 40.0
 T CAGAGCACTTGGTTTCACTGCCCCTACA 57.8 53.6
39652 39729 78 ßA promoter
 F GGTGTGCTGGGAGGAAGGA 62.0 63.2
 R CCAAACCACAGCACTCTGCAT 49.2 52.4
 T ACCCAAGCTGTGGTCTCCTGCCTCA 57.5 60.0
41223 41309 87 ßA transcribed; exon 3
 F CTTAACAAGAGCTGTAGTTTATAGGGTCAT 52.4 36.7
 R GCCCATCCCTCTGCCAAT 58.0 61.1
 T AGCCTAGGAATGTTTCCCTGGTGCTGGT 57.8 53.6
Position (bp) 
Start          End
Amplicon 
size (bp)
Description Sequences Tm
(˚C)
GC 
(%)
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S3.1 • Chicken ß-globin locus primers and probes used for RT-PCR analysis 
Each amplicon was assigned a number corresponding to its start position in the locus, in base 
pairs from the 5’ end. All primer and probe sequences are noted 5’-3’. [rev] indicates TaqMan™ 
probes that bind template DNA in the reverse (3’-5’) orientation. Melting temperature (Tm) and 
GC content is provided for each primer and probe. The original primers and probe used to 
amplify the enhancer miss the enhancer nucleosome bv 25 base pairs (Old enhancer, amplicon 
41860) and were re-designed for this study (Enhancer, amplicon 42032).  
41860 41933 74 Old enhancer
 F AAGGCTTTAATCCTCCCTGGAT ⋯ ⋯
 R TGCTGGGCTAGCATGAGTCA ⋯ ⋯
 T TCTGGCATTCAGCCTCCCCGAAA ⋯ ⋯
42032 42154 123 Enhancer
 F TGCTCTGCGTGAGGGAAGA 60.0 57.9
 R TGCACATTTAAACACCTCTATAGTTTGC 50.4 35.7
 T TTCTGGAACTAAAAATCAATTGGTGTCATTTGCA 53.3 32.4
42948 43039 92 Upstream of ε gene
 F TCCCCTTCTGCTGTGCTACAG 51.2 57.1
 R TTGCATGAAGTATCAGAAGAACAGATT 48.6 33.3
 T CCCCGTGCCTCTTGGATGTCACTG 57.4 62.5
44235 44320 86 ε promoter
 F TCCTGCCCTCCAGCACAA 58.0 61.1
 R TTTTATCCACCGCTGACAGCT 47.3 47.6
 T ACACATCCCAGCCAATGACCCCAC 55.7 58.3
44990 45062 73 ε transcribed, exon 3
 F TCCATTTTTTGTGTCAGTGTAGCA 47.2 37.5
 R CCAAGTGCCCCCTTTAGCTT 62.0 55.0
 T CAGCCTCACAATCCTTTCTCCTTCCCA [rev] 56.2 51.9
50732 50806 75 3’HS (5’ end); CTCF site
 F TGAGATCTTTCACAAAACACCAGTTAT 48.6 33.3
 R CTGCTGCTTCAGAGGCATAGC 51.2 57.1
 T AGACGCCATCTCACCAGCAGATGGA [rev] 55.9 56.0
51021 51115 95 3’HS (3’ end)
 F GACCCATCCCTCAGAATGCA 62.0 55.0
 R GGCAGGAATATCCCCCATCT 62.0 55.0
 T ACACACAGCTCACCTCTTTACCAGGGACC 59.3 55.2
51626 51700 75 Brain-specific DNase HS
 F GGCAGATGGAGTGTGAGTTCC 51.2 57.1
 R GGCTGCAGTAGCTGATGGG 62.0 63.2
 T TGAGTGCTGAGGGCTGGGAAATTTTG 54.4 50.0
52733 52804 72 Close to OR start (ATG) codon
 F CCCTGACGGAGATGAGGATC 64.0 60.0
 R CCCTTCTCCTGGTCCCCAT 62.0 63.2
 T CTTGTCTGGGCAGGAGAGCAGTGTGA 57.6 57.7
Position (bp) 
Start          End
Amplicon 
size (bp)
Description Sequences Tm
(˚C)
GC 
(%)
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GGATCCTTCT ACAATGGATT TACTAAAGCA AAACATTTGT ATGGTGTTCA!
ATGAGTGACC TCAGCCCAAG TAATGGCACT GAGCTGCTGA CTCTGCCCAC! 100!    
CAGGCACAAC AAATCACTGC AGCCCAGGGG ACTCCACACG AGAACAGAAG!
TCCCCATCCA AGGCACCCAC AACGAAAGGA AAGACTTAAG CAATGTCTGA! 200!    
GACAAGCCGC CTGTGGTGGC CCTCCCATCC CCTCACAGCT GGAGCACTGA!
TGCCTCTGGC TCCCCCAGAG CTGATCCAGG GGGAGGACCT CTCTGTGATC! 300!    
TGTTTCATTT TGATGCAGTA NATGATGGGG TTTGGTGGGG AGTGGGGGTG!
ACCACCAAGT ATGTGTTGGC CATGAGGACA TGAACAAGAG AGGAAATGCA! 400!    
TTTGCCNAAG CAGTGAACCA CCANAGCCAG CCATGGGGAT GTNCAAGATC!
AGGATTACCA GGGTTATGGG ACAGGCCATA AAACCTTGTG ATGCTCCATG ! 500!    
CAGGAGGCAA CGCTCAGAGC AGCCCGAACT CTGATGACAT TAAATCCCAA!
AGCATTCCTA AGAGACACCT GCACAGCACA GCCAGGCTGG CTGCCTCCAC ! 600!    
ATACCTCAGC AGTGGAGGAG CATCTCAGCA AGTAGGAGGT GGCCACACTG!
CAACCCAAGG TCGTGGCCAG GGGCACTGAG GACTCCAAGA ATGAGCTTAA ! 700!    
TTTCTTCTCA ATCAGACCAA GCATCGAGAC TAACCTGCCT GGTTCAAGCT!
GCAGAACACT CACAGTTGGC ACTGCAGACA GAGACAAACC CAAACTGGTG ! 800!    
GTGGCTGTGG TGGGAACTGG GCTCAGGGAG GCACTGATCA GCTCTGGTGA!
CAAACAAGTG CATGCAGCTC AGCACAGCTG GCATAAGGAG AACAAAACAC ! 900!    
AGTGGAGAGC ACATCACAAC CATAGGATCA CAGAATGGCC TGGGTCGAAA!
AGGACCACAA TGCTCATCCA GTTCCAACCC CTGCTATGTG CAGGGTCTCC ! 1000!    
AACCAGCAGT CCAGGCTGCC CAGAGCCACA TCCAGCCTGG CCTTGGAAAA!
TCAAACTAGA AAGAGGCAAA ACCAGAAAAC ACACAACAGG AAGAAAACCC ! 1100!    
AAACTGGAGC TGCAGAGCTG CTCAGCCAGA TCTCACCTGG CAGGAGAAGT!
TATCCTGCAG TGTCAAGCGT GGACACAGTA CCAGCAGAGC TGGTGGAGCG ! 1200!    
CCCAGGGAGC ATCTCCAATG GAAGGCTCCA TGTAAAGCAG AGATGTTGGC!
TGAGCCCAGA GCAACTTCCT GAGGACAGAA CAGCTTCTGG AAATAACTGA ! 1300!    
TTTGGTCTCA AGCCTCCTTA AATCAAATAA AGCCCGGCAG AACAGACAGC!
TGTGGGCTGA GCAGCCCCAC GCACTTCCCC ATTACTGTCC TCCTCACTAT ! 1400!    
GCCTTCCAAA AGGAAAACTA CATCCAGCTC CCCTTACAGA GACTTGTTTC!
TACTTCGGGG AAGGAAAACA ACCCAGCACA GCAGGGAGCT TTGCACAGCT ! 1500!    
CCTTACACAG CCTGCAAATC CAAAGTAAAG GGTGGGAGCT GCTGCCTCCA!
GGGAAGATAA TGTTTAGAAG CAACACAGAC ACGTGGCCAA AGCCTGAGCC ! 1600!    
TAAGCAGGGG CTGCGAGCTG CACCAGCAGC CTGAGCCTCA CCACAGCTGT!
GCAGGAGAGG AAGCTTCCCA GATACAGGGC ATGGACAGCT GCAGGATGAA ! 1700!    
TGCCTCACAA TCAGGCCGCT GAACCGCAGG GTCTGTCTGG TCCAAGCCCT!
GCTCCAGCAG GGACACCCAG AGCAGGGCGT ACAGGACCAC ATCCATGCTG ! 1800!    
CTTTGGGGAT CTCCAAGGGG GAACTCCACT CCTCTCTGTT CTGCTAAGAT!
GTTTCTCAGA TGCACCTGCT GGAAAAGCAT GCACTACCTG CACTAGGCTG ! 1900!    
CAGCAATGCA GCTCTGGCAG TCTGTGCCTA GAAGCTCTCA GAGTCCCTGC!
ACTCAGGTCT GATGGAAGAG GAAGAAGCAC AGCAGAGTGG TTGACGAGGG ! 2000!    
AGAGGACAGT AAAGGCAATC CCACCCTGTC TGGGCGTGGG CTGCTGTGGA!
ATCCCCATGC AGGGACACGA GTAACTCTGC ATCTCCTGCA GTGAGATGGA ! 2100!    
GCAGGGCAGA GTCACTAAGG AGTGATCAGG GCAGGAGATG AGGCTGCAGC!
TCTCCAACCC CCAGCCAGAC TTCCACACCT GCANATCCTT TGCCACCACC ! 2200!    
CANACCAGCA GTTTTGTTCC ACCCCCAGAG TGCTTCTCCC TCCCTGGTGG!
GTCTTAGCCT TCAGACAAGG CTGATTCAGA GCAGTTCTTT TATTACCAGC ! 2300!    
CCCACTCCCC AGGCTCGCAG AAGGACCATA TGCCAGCATT CAGAAATGGA!
TCATGAACAA ACACTACCCA CCCAGAGCAC AGCCATCAGC ACCTGTCCTA ! 2400!    
TGGGCAGGAA ACACAGGGTG GGNAAGACAG AAGGACTCAT ACACAAAGGA!
TTGGAAATCA CTGCCTCCAT CAGCTGGAAN CAGCAGCGGG CATCAAAGTC ! 2500!    
CAACACCACA GTCCATGCTG AGCATCCACT GGGGCACACA AGCAAACTGA!
ACAGACCAAG TGCCACTCAT GCCANGGGAG CAGCCTCCTC CTTTGCAGAA ! 2600!    
AGAGAAGCCC CATCCCTTCA GGAGATGTCA CAGGGACCCC CACCCATAGG !  FR transcriptional end!                                    
ACCCCCAGCC TGCAGTGAGC AGCACGAGGG CCAGCAGCAG GGTGAGCCGT ! 2700!    
GGCACAGCAC ACGCAGCTCT GCCTGTCTCA GGAGTCACGT CCTCCATCCT!
GGCAGGAGAG GATCTCTTCT TCCAGGCGTA GTACTTTGCC ACAACCACAT ! 2800!    
TGGGGTTCCC CTGCACGGGG TCAAACCACA TCTGGATCAG GCGCCCGCTG!
CCCCGGCGTT CTGTGGTGTA TTTGTAGGAG TTGGACCAGA TCTTCTCACA ! 2900!    
CAGATCTTTG GGGCTGGGGA AGACCTGGGT GAAGGGTCTG CACATGGAGC!
CCCAGGGACA GCGATTGGTT CCTGAGGACA GCAGCAGAGA AGGAAACAAC ! 3000!    
AACGTGAGCT ATTCACCCGC TTCCTTCCAT AGGGGAGAGC AGGCCAGCAG!
CCTACCCACA GGTCATCACA TCTCAGCAAT GACATTGGTG GCCTGGCTGC ! 3100!    
CTCCCAGTCT GCAACCCCCA TAGGAAGGCG ACAGCAGCCC CTGGTTGGGC!
TCAGGCACCC GGTGGGAGCA GGATCACTCC CAGGGTCCCA CCTGCAGGGG ! 3200!    
GAGGGAAGGC TCTCTGCAGA GCCCACTGAC CTGTTGCCCA GTTCCAGCCC!
TTGTGCCAGT TCTCTTTGCA TGTGACGTAG TCCTTGCAGT CCTCCCACCA ! 3300!    
TTCCTCGCAG TCCTCTTTGC ACAGTGGCAC ATGCAGAATC CTCTCCCGCC!
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GCCAGCTGCT GTCAGCCTAC AAGGGAATTG GGCCATGCGT GCTGGAGGGA ! 3400!    
GCCCTGGACA GCTGGGGCAC AGCATCTGCT GCACCCTACA GTCCCCTCCC!
AGCCCACCCC ACTGCTCTCC AGAACTGATG CCAAAAGATC AGCCCTAAAG ! 3500!    
AGCCAAGCCT CAACAGTAAG ACAGCCATTC CATCCACCTG TCCAAACCCA!
GTAGAAAAAC AGGAGTATCC CTGGACAGCC CACACACCTA TACATGCCAC ! 3600!    
AGCATATCAT ATGGAGGACC ACCATATTAC ACATGACACC ACCATAAGCC!
CCACTCCACC ACACAGCATT TGACTCTACC TGGTCAATCC AGGGCCCCAG ! 3700!    
GTTGGGTGAG CACTCATACA AGCACATATC CTGGATGAAG TGACGCTTGC!
ACTTGGGTGG CATCACCCCA CAGTGGTTCC AGTTGAAGTT GTACAGGTAG ! 3800!    
GACTGGTCCC TGTGGGCTTC TGAGCTGGTG TTGGCCGTGC AGCAGGCATT!
GTCCTTCCAG GGAGCACACT GGAACAGAGC AGGAGAAGGC TATGCAGAGG ! 3900!    
GCCTTAAGGG AGCTCAAGGA TGCTGCACAT GTCAGCATCC CACAAAGCCT!
CCAGCAAAGA GTCCTTTCCC TTCTCCAGGC AGCCCTCGGG TGTTTTGGAA! 4000! 3952-4033!             
AAAAGAACAA GATTGCAGCA AGATGGTGTT GAAGGAAAAA TAAGAGGAGA! ! FR Intron 4!               
ACCTCGAGGG TCAGATCCTC AGCAGAAATG GGTGCCAGGC AGAGGGATGC! 4100!    
AAGAATTGGC ACCTCCTGCA TCCTGGCTTG CTTAGTCCCA TCCACAGCAA!
GGACCTGGCA TCAGAGCTCT TCAACAAGAG GAGGGGTTGT AGCACTGAGA ! 4200!   
GGTAGAAGAT GTCTTTCCCT TGCTATCCAT TATCTTCTGC TCATCTTCAG!
GACCTCAACT TTGGGAAGGA GGCCTCTTCG TGAAAGAAAG GGTGACCACG ! 4300!   
ATTCCAATTA CCCACACCAC TGTCTTTGCC CTTGCCTGGA AGGGAGCAAC!
AAGCAAGCAG GCCTCCTTCT CAGCACAAGC CTTCTTCAGG CAGGTGGCTG ! 4400!   
CTAAGCCGAT CACCTGTGGG AAAGTACAGA CAGCCCAGAC AGCCCCACTC!
ATCCCATCAG CAGCACCATA CCTGGCCATA CAGCATCCCC TCTGGGCCAG ! 4500!   
GCTTGGTTTT GTGGTGCCTG GCATCCATGC AGACGTTGAG CAGCGGGTCC!
TTGGCAGGCA TCACCACGGA GGCAGCCAAC AGCACCAGCA GCACTTGCCC ! 4600!   
TGCTCTCATC TCCACAGCCA GCCCCATGGG TCAGGGATGT CACGGAGCAG !  FR translational start!                                
CAGCAGCAGC CAACACACTG CACGAGCTCC TGGAAACACA CCAGTGGGTT ! 4700!   
GCCAGCAATG CTCATCAGCA AGGACACAAC AGCAGCTCCC CCAGGCAAGG!
CTGCAAGGTC AGCCACGTGT TATCTTCTGG GCAGCTCCAC ACGGGAGGCA ! 4800!   
CAACGTCCCT TTTGTATTCA GGGCGCTTGG CTGCCAACCT ATAGTGTCCT!
ATGGAGCACC CTGATCAGAA GAGGAATGCT GTATGGGGCC CATTTGGAGC ! 4900!   
TGGGGCCTTT CTGCATTAAG CCACCCCCTG CAGAGCTTTT AGACTCCAGG!
TATTTAGTTA GAAAATGCTT TACTGGTTCA AGAATCTCGA GAGTCTTTGT ! 5000!   
GGTAAGTTGC TTAGAAGTCT TACTTAAATG CACCAGTACA CCAAGAACTG!
CAAGAGAACC ATCTCATTTC CAGGAGCATA TGAAAAAATA AAAGCTGTTC ! 5100!   
TTTGCTTTAT TTGGGTCTTC AGAAATCTAC AACTTGGAGT TCAGACTTGA!
GAAACAGAAG GCAGCTTCAC ACTACCGTGC CTTCTCCTCC TCTGCACACC ! 5200!   
CAGAGCTTCA GGAGTTGCCT CCTGACACAG CAGAGCTGCT CTGTGCCCTT!
TGCTAGTGCA GGGAAAGGGG CCAAGCCAGA GCTACGTGCT CTATAGGGAG ! 5300!   
GAGTTCCTGC CTATAGCAGG GGTTGGAACT GCATGATCTT AAAGGTCCCT!
TCCAACCCAA ACCATTCTGT GATCCCAGCT TTTGCAGAGC ATCTCACAGA ! 5400!   
ACACAGAAGG ATGGACCACT GACAGCATTA AAGCAACACA GAAAGGAGCA!
ACTTCAAAAC TAAGAAAACA CATTCAGTCC CAAGGAACAG AGCTAACTTG ! 5500!   
CCTCAAACCT GCATACATGT TATATTGCAA AGAAAAGAGC AACAAAAACA!
GAGCACCACC ACCATCACAA CCCAAATAAC CCCTCACTCA TCAAACAAAC! 5600!    
CCAACCAGAA AGCAACATTA CCTGCCTAGA GACTATCCAG CCCCCTGCTA! ! 5614-5718!                 
ATACCACAAC AACACTCAGA ACAGCAGCCT CCTGCAGTCA GCTTTAACAG! 5700! FR promoter              
GAAAGCCTTC TGACACAGGT GCTGGCACCT GCAATTACTT TCTTAATGTG!
CTTAAGGAGC TTTGACTCCA GCCAGCATTT GTTGCCTTGG AAGTAGCTGC! 5800!    
GTGGTGGCAA CGGGCTGCCC CAACTCTCTG CAGCAATCTG GTAGTGCATG!
GGAAGGGCTG GGCTCTTATC TGCTATGGCC ACACACACAA AGCCCTTCTC! 5900!    
CCTTTGCTTC CCACCAGGCA GTTTAAATTC CTGCATGCTG TTGTGGGAGA!
TAAAGCAGGG GAAGGAGGGC AGATCCAGGA TTCTGCCGTG CACCACCAGT! 6000! 5986-6086!             
AAAGACAGAA GTGCTCATCG CAGAGCGGGG CGTGCAGAGC CCCTCATGGC  FR HSA (5’ end)                                        
GGGGAGGTTG AAACTGAATG GTCTTTGTGG TCCCTTTCAA TCCAGGCCAT! 6100 potential CTCF sites!                        
TCCATGACTC CATGATAAGG AGGTGCTGTT GTCTCAAGGG GAGGAATGAT!
AACTCCCAGC ACAAAAATAG AGGCCGGCTG GTGGAGGGGA ACGGTGCACT ! 6200!   
TATGGCAAAG CTGTGAGATC AGTAACCGAA AGGAAAAGGG GGGGTCCGAC!
CAGGAAGGAA AGCCTCCACA GACCAGCAGA TCTTCCTATT GGCACAGCAC ! 6300!   
ACAGCTGGGG ACCGCATCCC CCTCCCACAG CAGGTCTCCC ACAGCAAGGG!
GGGGGGGGGC TGTTCTGCTT CAATCCTGGC ACTGAATTTT GGAGGTGAAC ! 6400!   
CCNCTTGCCT AAGGAACTCA TCTGAAATTG AACTCCTGAA AGCTTGTANC!
TCCACCAAAT CCCATTTTGG TGATTTCCAC AGCCTGGCCA CATGCTGCAC ! 6500!   
TGGTGTGCTC CTTCTATTGC AGCTCAGAAA GCAAATGGGA TCCTGGGCTC!
CATCAGCAGA AGGGTGGCAG CAGGGACAGG GAGGGGACTG TGCCTCTCTG ! 6600!   
CTCTGCCCTC ATANAGCCCC ATCTGCAGTA CTGCGTCCAG GTCTGGGGCC!
CCCAATACAA NAAAGACAGG GAGCTGTTGG AGAGGGTCCA GAGGAGGCCA ! 6700!   
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CAAAGATGCT CAGAGGGCTG CANCACCTCC CCTACAAAGA CAGGCTGAGG!
GANCTGGGCT TGTTGANCCT GGAGAAAAAA AGCTGCGGGG TGACCTCAGT ! 6800!   
GCAGCCTTCC AGGACCTAAA GAGAGCCTAC ACACAGGAGG GGAGGCAACT!
CTTTACAAGG GGAGATAAGA GCAGGACAAG GGGCAATGGT GTGAAGTTGA ! 6900!   
AGGAGGGCAG ATTGAGGTTG GATGTGAGGG GGAAGTTGTT GACGGAGAGA!
GTGGGGAGGT GCTGGAACAG CTGCCCAGAG AGGCTGTGGA TGCCCCGTCC ! 7000!   
ATCCATGGAG GTGTTGAAGG CCAGGTTGGA TGGGGCCCTG GGCAGCCTGG!
GCTGGTCTGA AACATGGAGG TTGGTGGCCC TGCGTGTGGT GGGGGGGTTG ! 7100!   
GAGCTTCATG ATCCTTGAGG TCCCTTCCAA CCCGGGCCAT TCTGTGATTC!
TGAGCCAGAC ACACACTGCT CCCACTCCTT GTGCTTTCAG CTGTCACAGT ! 7200!   
GGCAGTGACA TGGAGCAGTC TGCCCCCACT CTTCTCGGCT GTGCCTTTGC!
CACCTGTGCC CCACCTCCCC CCAGCTGTCC CTTTACAAAC CCATCCACGC! 7300!    
CGCCCGCTCA TCTCTCATGC CTTGTCTCCC TGCTCCCCGT GGCACAGCAC! ! 7343-7440!               
TGCAGCAGCA TTTCAGATGC ACGGCACTGC CCTTNCCTCT GTTTTCTGTT! 7400 FR HSA (3’ end)!                        
CCTCGCCGAG GAATTTCTGA TATCGGGTTT GTTTTTGGAT GCTGCTGATC!
ACTGAACTGT GCTGCTGTAA AGCTATCGGA GCTGTGACAG CTTGTTCCTG! 7500!    
GGAGATAATT GTTAGCCACG AGCCTGTCAT TTTCCATCTG AAGTGTTGTG!
CTTTGTTCCC CAGACGCATC CTTTCATGTT GATCAGAACT GATTCTTTTG! 7600!    
GTCTGTTGTT TCATTGTTTG GTGGCTCAGC CTTACGAGGG TCCTTGCAGA!
GTTTTGCAGC TGGTCCTCCT GTCCCTGCAG GCATGTAATC CCAGCCCCAC! 7700!    
ACTCACGGCC TTGTTGTTTT CCTGGATCAA GAGCAGCAGC TCCAGNATGG!
ACTGCTGTAG GGCACTGCTG TACAGGACAG CCACAGCTTT GCTTTCGTGG! 7800!    
TATAGCTGTT CCCAGCATAC AGGACACCAT TCTCACCCCA TGGGATCGGA!  7811-7932!                                 
ACCCAGGCGG GGGGAATCCC TGGGTCTGCC TGGTCCTCTT CTTTGAAGAC! 7900 downstream of FR HSA!                        
CTGCAGTACA TTGGAGGGAC TGGTCTTTGT GCTGGGGGAG CCATTCCCAC!
CTTGCTCCCA CCTTTATCTA TTCAGATGCC TGCAGTCACT ATNTNTGTTA! 8000!    
CGTTTTNTGC AGCCTTTTCC CATGGATGCC GCATNTGCAC AGTTCCNTAC!
ATCTCCTCGG AAGGACTGTT GATGTGTCCC ACACAAAGGT GTCCTTGCCN ! 8100!   
TCACAAGGGT ACCTGTACAN ACAGCAGTGC AGAAAACGGG GCCGTTCCCA!
CCCAGCCTGG TCCCAGCCAT ACCCATTCAC TCCATGGGAN GGGTGGGGAC ! 8200!   
CACCTGTGTT TGCTCCATCC TCGGTGGGTC TTTGCTCGGT GCCATCTATC!
ACCGGCTGCT TCTTATATGA TTCTTCCTGG GGTCAGACCT GGGGGAGTGA ! 8300!   
ATGCTTTGGG CACAGCATGT GCACGGTGTC CCTGCCAGGA CCTCCACACA!
CCTCCGGCAC ATCGGAGCTC GCTGGGACTG CGTGTCCCAT TGGAGGTGCG ! 8400!   
TGGTGGGGTC CCACGTGGCT GCTGCTGCTA CTGCTGCCAG GGCTGTGGGC!
GTTGTTATGA GAGAAATGGA GCCACGCAGT GTATGAAGCA AATGATTCTT ! 8500!   
TCAGCATAAT TGAAATCCAA GCAGTCTGAT AGAAGAACCA TCATTAGCCC!
TGATCTGCTA TTGCGGTTTG AATAAAAAGG AGAGAGAGGA AAAATAGGGA ! 8600!   
AATAAAGACT TTGCATCTCA GGGTTCTGCA CACAGATATT AACTCGCAGA!
ACAGCCAANT AAGTGTGGGT GTAAGGGCTC GAGGAACACG AACCCTTAAT ! 8700!   
TGTGTCCGAA CTGAACTGTG GGTGCAGTTA CTCCATGGCA GCACCGACTG!
TAAGAGGAGG CGAGGAAGGT GCCTCACCAC GGAGATCTGA GCAGTGGTTT ! 8800!   
GGGGTCATCC CATTGAATTT GAAGACAAAT CCCAATCTTG GTGGTATCCA!
GTTAATTCTG CTCGTGGCCC CATCACCAAC AAAGCCATCA CATCGTGATG ! 8900!   
ATACCAAATG CTTTGGTGTA TACCGTGCAC TCAGTCACTG CTCCGGGGCT!
AAATCACAGC GGGACGATGC TCGTAAAGCA CTGAAAGTGG GCCCAATGAA ! 9000!   
CCAGAAACAA ATGGCAAACT GTTGATGGGA ACGCGTGCGT TGCTGGGGAA!
CAACAAGGAC TTATTTGTGG GAGTAATGCC ACCAAAGCCC AGGGTGTTTG ! 9100!   
TCTTGGTGCT AAACANAATG TTTGTCATCT TGAAATGCGT TCTGATGAAA!
CTGCTTGTGT ACATTGGAAA AGGTTGTGTT TATAGGGGAG CCTTTTGTGG ! 9200!   
TTCTATATTG GTAGATAATA TTACTGTAGG TACAAGTAGT CACTCAAATG!
TTTGTGTTTT TTTTTTTTAA TTATTGTAAT TATGGGATGT GATTTTGATT ! 9300!   
AATCACCTCC TGTTACATCA CATCTTATCA GCAGTTATAA TTGGATTATA!
TGCAGAGTGC AGATTTGTTG CCTCCTATTG CATCCTTCAT CCAGCTGTGA ! 9400!   
TTTTACTAAC TCAAGTATTT GTCTGTCTAC TGATTATTTT CACATCATAT!
ATGTAGGTTT GGTACAACTT CAGCCACCCA AAACACGGGG AGTAATACAT ! 9500!   
AATGAGGAGC AGTGCTTCAC AGTCTGCTCA CTGAGGATCC CTAAGTGCAC!
AGATTATCAA TACACCACTT ACAGCAGAGA GGTGAGAGGT GACCACACTG ! 9600!   
CTGCTCTGAG GGTCAGACCA ACTGTCTATG GTCATGGGAT GGAGTGTGAT!
GGTTCTCCCC TGCCTCTCAG CCCGGCCCTC CTCCCATACC CCTCTTGGGT ! 9700!   
GATAGCCATC AGGATGGATG TGTCTGGTTG TGACAGCAGA ACCAGGCTAG!
GGTGGATGGA GGGGTGATGG TCAGCAACGC CAACCCGACA CGGCTGGGAT ! 9800!   
GCAGAGATGA GCAGTAGTCA ATCATCTTAC TCCATAATAG GAGACAAATG!
GGATTTTACA ATTGAGCAGG GATGCCTCTC AAGGTCACTC CTGGAGGTCG ! 9900!   
AGAGGCTCCT TACCTGTGGC AGATGCTCGG TAAGAGATTT ATAGCCTGTG!
TCCTGCTTGT AAGCAGAGAG GGACTCGTGG GTGAGGTGGC AGTTGGTGGC ! 10000!   
TGTCTCAGCC ATACTGACCA TGAAATAGTT GAGTTTAAAA CGGTGGTAGA!
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GGGAAAGCTG TCCCCACAAT TTCAGCTCTC CCGTGGATGA AGGGGAGAGT ! 10100!   
NTTCACTGGA ACAGGTTGCC CAAGGAGGCT GTGGATGCCC CATCCCTGCA!
GGCATTCAAG GCCAGGCTGG ATGTGGCTNT GGGCAGCCTG GGCTGCTGGT ! 10200!   
TGGNGACCCT GCACATAGCA GGGGGTTGGA ANTGCATGAG CATTGTGGTC!
CTTTGCAACC CAGGCTGTTC TATGATTCAG TGATCCTATG ATTCAGTGAT ! 10300!   
CNTATGATTC TGTGAAAGCA GANTTNGGGG TGCTTGGGGA ACAAGTTGGC!
AAGGTCCTAT GGGAAACTGC TTTTGAAGGC ANTGGGGTCC ATTAGTGNTG ! 10400!   
GTCACTTTTT AAGTAGCACC CCCGAAAAGC ACATGAACAG GGAACTGCAA!
AANGTNGGCA GCCATACGGG CAGGGCAGAA GATNGGCTTT GCTGAGNAGC ! 10500!   
ATCTTCTACA GCTTATGTGG AAAAAGAATG TGTGGCCACT GGCAGTGAAG!
CTGGGCGACT TGGGAGGGCT ACTTTAAGCA ACAGTTCATA AAGCAGCTCA ! 10600!   
GCGAGTCAGC CAAAGTGCAC GATGGAAATC TGTTTGTGCA GCTTTGGCAG!
ATTTATGGGA TCGGATCGAT CCTAGTTTGT GTCTTTGGTT CACTAATAGA ! 10700!   
GATTTACACT GACTTCTTGT GCCTTCGCTA TGAGCGTGAA GGGCTGCAGA!
ATCCATCACA GGCCAATGTC AGTGGCAGTA CCACAGTACT GCCGTGTGTT ! 10800!   
TGCTCCGTAA TAGTCTTGCT GGTTTACCGC ACAGAAGGTT TCATCCATTC!
CAGATGATTT TGTTAAGGGG AGCAACTTGA AAATGGGGAG CTAAACGCTC ! 10900!   
TCAGCCCTCT CAATTTTCCA GCTTATTCTG GTCATGAAAT CCTTAACTTG!
CAATATATCC TCCAGAGAAT AGGAAAACCC CACATCTAAC TGTTCAACTG ! 11000!   
CAGATAGATA AATATCAGTG CTGAATTTGT GTCTGATTCA GTGGAATGCT!
TATATCAANT CCCAGGAATG AGCCACACGT AATCCCTATG AAAGAACCAG ! 11100!   
TGAAGCATTC ATTTAATGGC TGTGGTTCAG CGACTTGAAT GAGCTCATTT!
CTTGAGCNTT TTACTTGCTG AGAGGGCTGT AGGGAGGAGA AAGGATGCCC ! 11200!   
CATTCCTGGA GGCATTCAAG GCCAGGGCAG CCTGGTCTGC TGGTTGGCGA!
CCCTGCGCAT AGCAGGGGAT TGGAACGAGA TGCTCATTGA TGTCCTTTTC ! 11300!   
AACCCAGGCC ATTCAGTGAT TCTATGAAAA ATGACGCACC AAGAAGAAAT!
GTTTCTGTTC ACAGTAAGTG CTGTGTCCTG GAACCTTACT TGGGGTGAAT ! 11400!   
AAGAGCATAA GTTGGGCTTG GGCTGAGCAG CAACCTCACT GGAGAGTTCA!
GTGATGGGAA AAACGGGACA AAAAGCTGAA GTGGCTGAGA GAGGGAGTAA ! 11500!   
AGACAACGTT GGGGTTATTG TAGAGAATGT TGAGGATAAT CACTGGGACA!
TCTCGGTGGA GGTTTGTAGT GGTGCAGGAA GGAGAAATAG GAGGGAAACA ! 11600!   
AGGAAGAGAA GGGTGGTTGT TGGAAGGACA GTCGGATGGT AGGTTGGTCT!
GTGGTCTGGT TTGTTTGGCA GCTGGGACTC CCCATTGATG GGGATGTTCA ! 11700!   
TGCCNAAACA CTGCATGCCA AAACAATGGG TGTCACATCG ATACAAATAA!
TAAGGAAGGA TTTGTAAAGG TGTCAAATTG CAGATTAGAA GAGAGAACAC ! 11800!   
TGTAGTCTGA GCACAGCCAA AGCCAAACAC TACCAACATT TCTAATACTC!
AGCTGATGCA ATCAGGGGAC TTTCCCTATC AATAATGCAT CTCCTTCAAG ! 11900!   
CTTCAAAGAG CTGATATCTC CCAGTTTGGG GAAACTGTGC ATGAGTGGAG!
AGGCTGGCAG GGAAGGTGTG GGTGTCCATG GCAGGCGTTT CCCAGCAACG ! 12000!   
ACCTCTATTT CCAGCCCCTT ATGTCAGTGT TTGATGCCCT TCTTTCTTCT!
GGCTGGCAAA ACACTCATTT AAAGACAGGT GGAACCGTGG GGCTAATGTC ! 12100!   
ACCTGTTCCC TTCTCACAAC TGACCTAAAT CTCCCCTCTT TTAGTTGAAA!
GCCATTTCCC CTTGTCCTAT CACTGTCAGA CTGTGTAAGA AGTANGTCTC ! 12200!   
CTTCCTGTAT ATGAGCTCCT GACCCGACAC CTTGCACTTG AACCTCATTG!
GGTTCTCATG TGCCCACTTT TCAAACCTGT CCAGGTCTCT CTGGATGCCA ! 12300!   
TCCCTCCCTT CTGCTGTATC AACCGCACCA CTCAGCTCAG TGCCATCAGC!
AGACTGCTGA GGGTTTGCTT GATCCCATCA TCTATGACAC TGATAAAGAT ! 12400!   
GTTGACGAGC ACCCGTCCCA GGATGGACCA CCTGGGGACA CCACTTGTCA!
CAGCCTCCAC CCGGACATGG AGTCACTGAC CACAGCCCTC TTGAGAAATC ! 12500!   
ATGAGGAGCA AAGCATCACT GCAGGCTGGC AATGCTTCCA CCACCACGTG!
GGCCTTGGTT GCAGAGCCCA GACCCACAGC CATGCTGGCT TTTTCCACAA ! 12600!   
ATACTCTCCT TTTACATGGG AGCTTTANGT TGGATATGAA GAAGAAGTTT!
TCCACCCAGA GGTGGTGACA CACTGAATGG GTTGCCAAGG AAGGCTGTGG ! 12700!   
ATGCCCCATC CTTGCAGGCA TTCAAGGCCA GGCTGGATGT GGTTCTGGGC!
AGCCTGGGCT GCTGGTTGGT GACCCTGCAC ATAGCAGGGG GTTGGAACTG ! 12800!   
GGTGAGCACT GTGGGCCTTT CCAACCCAGG CCGTTCTATG AATGCGGTTT!
GCTATCTTTA ATTAGACATT AGAGGTCAGA GGAACTACAA ACATCCTTCA ! 12900!   
AACGTGCAAC AAAGGTAACA ATCTTCACCA CTAAACACAG CTGGATGGGA!
ACGGCTCTGA GATTCATGGC ATCTCACATT TCTGTTCCCA GCAATGCCCG ! 13000!   
TGGGATCGAN ANTTTGCATT TTTTGGATGC TCTGTTGGTC CCCTCGGAAC!
CCGGCTCTGG CAGGGAGGGA CATCCATCCC TCGGTCTGCA GGGCAAGAGC ! 13100!   
AGGGCTGGGG GCTTCCATGT GGTTTGAAGA TGCATCCCTC CCTGGAGAGC!
TTCTGCCTCG TTTTCCCTCT GCTTCCAACC GTGCACAAAA GGGAATGTGT ! 13200!   
CCATCTGCCC TCATCTGTGC TGAGCATGTG GCTGCCTCCG TGCAGGGATG!
GCTTCCCCAG CAGCAACCAG ACCCTGTGCT GCTGCTTTGG GGTCCAGCAG! 13300!    
CAGGACTGTG TCTGTAAGCA CCATAAAGAG CAGAACTGCA GCTGGTGATC!  13304-13384!                                 
CGGGTGTTGC GTTTCCATAT ACGTGCATAG AAGGTCTGAA GTCTGCACTG! 13400 16 kb heterochromatin!                      
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ATTGGATTTA TTGTGTTATT GATGGTGTTG AAATGGGAAG TTTGTACCAA!
CGAGATGTGT CAGTGTACAG CAACGTCTGT TATTTGGCCT GAGCTGTGAC ! 13500!   
AGTGCCTGGC TCACCACAGC CTCTCCTTCA GCTGAGCACC CCCCTCTTCC!
ACTGCATGAT TAGTATGGGG TGGAATCATC CATTTCTGTC TCTTGCAAAC ! 13600!   
GGTGAGGTTA AAAAGAAATT AAGCACAGAG GCTGACCCAG GCAAAGACCA!
TTCTGAACTG AATTAATGGG CAGGGAGTGC ATCCTTGCAT GTGCAGTGTT ! 13700!   
TGCAGTGTAA AGCAATAAAT AGCAGCTGAG GCTTCTGGCT GAGCATGTCA!
GTGCAGGGGT TGCAGGGCTA TGTGGTAAAT CCTCTCTTGG GACTCCATAC ! 13800!   
AACTCATATA AAACATATCT ACAGATCTCT AGACACAAAG AGCATGGGAA!
ACACAAGCCC TGATTCTGCT GCACTGGTCA CAGCAGACGC TCCNTGGCAT ! 13900!   
AGGAAAACAG GGCATCATTT ACCCNCATGT GCTCGAAAGT CACTCAACTG!
ATGGATGTTA TCTTTCGGAT CCTTCATCTT GCTGTNGGCA GTCAGCAGAA ! 14000!   
GCCTTACTGA TATCTCTTGA ANACACAGAG CTGGGAGCAC AGAGTCTCTG!
GAGTGCCACA AGCTCCTCCT GTGCTGCNTT CANACCCTGA CTTTTTGCAC ! 14100!   
TGAAACCATC CCAAATCCAN AGAACCTCTG ACAANGGCAG TGCTCTTATA!
TCTATTTTGT GGTAATATAC TGAGATTGAT GACTGATCTA NTCTCGGCCT ! 14200!   
TGAGCAATGC TAAAAAAAGC AGCTTTACCT TTTCACTGCC ATTCAGACAC!
AATGGTGAGG GAAGAAATAT TAGAAGCCTG GAAAAGGCAG AGAAAATACA ! 14300!   
CATCCCTGAG CCTGGTCAAA AAGTGGTCTG ATTGCTCCAG AGGGAAGAAA!
CTTCCAGCAA AAAGAGTGGC CTGATCATGG CCAGGAGGAA AGGGTAAGGA ! 14400!   
GCCANCACAG GGTTAGGGTC AGGGTTAGGG CTGTTTAGCT TCATGGGATG!
GATTGCTGTG TGCTCCATCA CACCTCCCAG CTTCCAGCAA TTCGTGGTCA ! 14500!   
GGGTCTCCCT GGGATGTTCA TAGAACCATA GAATTGCTCA GGTTGGAAAA!
GACCTTAAAG ATCATCAAGT CCAACCACAA CCCAACCATC CTACCCTAAC ! 14600!   
TCTAACAGCC CTCCACTAAA TCATGTCCCC AAGCCCCACA TCCAGATGGC!
TTGAACTCCA GGGTAAATTT GAACCCAAAT CCCTAGAAAA TGTGTGCACA ! 14700!   
AATGAATGAT TTTGGTGAGT GAATCATGGA ATCATAGAAT CACCAAGGTT!
GGAAAAGACC CACAGGGTCA TCCAGTCCAA CCATTCACCC ATCACCAATG ! 14800!   
GCTCTCACTA AACCACGTCC CTCAACACAA CATCCAAATG TTCCTTGAAC!
GTCCTTCTTT GAAGAAGAAG AGCAGAAACT TGAAGGAGTC CATTGAGTCT ! 14900!   
AAGTCAGATC AATCAGATCA TTTTATCTGC TGTGGGAGGG TGACAGAGTT!
TATACACAGG GNAAAAACAC CATCTGTCCA TCTGTCTTAA TTCTTGAGAT ! 15000!   
GAAGTATATC ACATATATTG CATGGTGTTT TTATAAATGA GCCAGAGTGT!
ATTGCTGAGC TTGAGCCACC ATCAGGTGAT CAGAGGGTTT TCAAGGGTGG ! 15100!   
ATAGTGATAG GACAAGGGGG AATGGTTTTA AACTGAGACA GGGGAGGTTT!
AGGTTGGATA TGAGGAGGAA GTTTTTCCCC CAGAGGGTGG TGACGCACTG ! 15200!   
AACAGGTTGC CCAAGGAGGC TGTGGATGCC CCATCCCTGC AGGCATTCAA!
GGCCAGGCTG GATGCGGCTC TGGGCAGCCT GGGCTGCTGG TTGGNGACCC ! 15300!   
TGCACATANC AGGGGGTTGG AACTGGATGG GCACTGTGCT CCTTTGCANC!
CCAGGCCATT CTATGGTTCT ATGATTCTAT GAAAAATGAG GCACTCCCAG ! 15400!   
CTGAACCAAG GGAGGAATTT CCNTCAGTGT GCTCCTCACA CTGACCCCAC!
CCCCTNGGAA GGACACTGCC AGAGGGCATC AGAGCTTCTT GGGACAGCTG ! 15500!   
AGATAGGATC ATAAATTGGG ATGGTTGTGG GCTGACAGCC TTATTGCAAT!
CAGAATGATT CATGGATCGT GAAACACAAC GTTGCCCGGA ACGTAGATCC ! 15600!   
CACAGAGCTC AAATATACAG CTGAGCCACA GCAGTCGTTA TTATAATGGC!
AATTAGCACA AATAAAAACT GCTCTGGGAC ACAGTGTGCT GTTGCCATAG ! 15700!   
ATGGCCTTAG GCCTGACCAG ATTCGTCCCA CTGCTTTTGT TTTAAATTAC!
ATTTTAAGTG GTGCTTTTAT TTCAGATGAA NGCTGTGGCT CAGGCAGGCG! 15800!    
GAGCAGCCCC TGGGCTCCCT GTGGGCTGCA GCTGATGTTC CACCAGCAGA!  15844-15946!                                 
CGCTGTGGTG AAGGCTGTGC TGCAGCTGGC GTGGCTCCTC AGGGTGGCAC! 15900 16 kb heterochromatin!                      
CGATGGGATC ACATCTGTGC TCTGGGTCCA GTCTGCATCC TGCAAGGAGC!
CATCCCAGTG CAGCCCCAGG CTGTAGGGCC AGAGCCTGGG ATTCATCCCC! 16000!    
TTGGTGCAGT GCCTCAGATA GATGCGTTCC TTCCACTCCT TCTCCAAATT!
TTGTGTGCTA TCACACGCAC AGCCCATGCG GCGTACATCC ATCGTGACAA ! 16100!   
GCTCCATGGC CACCAGGACT GGCATGAGGC TGGCCACCAT AGAGCTACTT!
GTGGTGCTCC TTCCTCCTGA AGAGGCTGCA GTATCAGTGG GTCAATGTTC ! 16200!   
TATCANACTC TTTCCTGTGT GCACTGGGAT GTCACCAGTG TGACCCGGTC!
ATGTCGATGT GTCCTCTACG AGACAGGAAC ACTTTTGGCA TAGTGTTTGC ! 16300!   
ATCTGAAGAG GAGCACTACA AAGCCTTGAA CATCTGTGTC TCCCCTACTC!
ATGCTATNTT AGATTTTGAC ATCCCAATAA TCATAGAATC ATCATAGAAC ! 16400!   
CACGGAATGG CCTGGGTTGG AAAGGACCAC AATGCTCATC CAGATCCAAC!
CCCCTGCTAT GTGCAGGGTC GCCAACCAGC AGCCCAGGCT GCCCAGAGCC ! 16500!   
ACATCCAGCC TGGCCTTGAG TGCCTGCAGG GATGGGTGTT CAATAATCAG!
ACTGTCTCTG ATCTGGGAAA AGATGTTCCT CCCTCTGCTC ACATCCTTAT ! 16600!   
GGCCAACATN TGCTTGCTGG TCCCAGCACA GCGAGCCCCA CTGAATGAGA!
GTGAGAACCA AATAGATTTG TACTTGGCCC ACCAGAGAGC TGCAGAAGAA ! 16700!   
GTGACTCCAT GGCTGCATTT CGGAGCTGAG GGTCTATCTG TGATCGCAGG!
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GGCAAAGTCA TTGCCTGGTG CCAACCTGAA TAGCTCTGCC AGGACCTGGC ! 16800!   
AATAGAGCGC CAGCTGAAAT GTGAGCCATC CTTATGGTCA GCTGTGGCTT!
CTTGCACTGC ACACAAGATA CTATTAATTA GAATCAATGC TTATGACGCT ! 16900!   
GAGTGATATA ACTGCATAAA CATTTTAACC AAATGCAATT TCTTCTATTG!
ATTTGCCTCC TAAAACGATG TCTAATGGGG AATTATGTTC TGTCTGCTTT ! 17000!   
CTCTGGTTAA ATAAAAAGAA GTAAATGCTT CAATAAATTT TAAAACGCTA!
CCAACGAAGT ACTGGATATA CCCATGAATA TTGCGCTGAG AACAACAGCA ! 17100!   
ATTTGTACCA GCTAATTAGG GAACACAGCG ATCACAGGGA CTTGAAAGCA!
GTCATCAGTA AGAACAGTCA CTCTCAGCGG TACAAAGTTA ACGAAGAGAC ! 17200!   
AGTGGAAGTG AATGCGGGCG CTCGGAGATG CACAGTCCTC AACACCCCAC!
CTGTGGGCCT GCAGAGGGGA CCCAGGAGCT CCTCAAGGTG CATTNNTGGG ! 17300!   
GTGGGTCATG GATTGGNTGC AGGCCTTCCC AGGCTTTCCC TCCAGATTGG!
GTTGCTCGAA GTCCCATCCA GTCAAGGCCA GGCTGGCTGG GGCTGTGAGC ! 17400!   
AACCTGGTGT GAGGCGTCCC TGCCTATAGC AGGGGGTTGG AACGAGATGA!
TTTTAGAGGT CCCTTCCAGC CCAAACCATT TTATGATAAT CCATTAATTA ! 17500!   
ATCACGTGCT GTCAGAGATG GCAATCAGGA CTGTCCTTCC AACACACCTT!
GTCTCAGATG CTTCTCCTGG CCTTGAGGCA AACCCACTGA TAGGGCTCTG ! 17600!   
ATGTTCACGG GATGGCACTG GGCTGCTTCA GCTAAAATTC TGCTATGTGG!
TTCCTCCCTG TTTCTTCCTT TTGTAGGAGT GATGTGATTT ATTCCGGGGA ! 17700!   
AGGATCCGTT GGGAAATCTG CTCAGTAAAG ATGCCGAGGT GAGTCTAAAA!
AAGGAGGATA CCGTGTTATC GCACACACAC ACACTTTGTT CGTCTGATGC ! 17800!   
AGACAATTTC TCTGTGATCT CCTTTCAGAG GAAGAACATC CCTGTCACTG!
CCATTGCCCA GTCCTAAGGA GCATCTGGGA CAGCCTTTCC CTGACTAGCT ! 17900!   
TGTTTCTCAC TGTGCAGATG ATGGAGTTTA ACATGGGCGG TAGGAGCACA!
TAGAGGTTGG CCAATGGGAT GTGGACGTGG TAGGGGATGT CGTGGCCAAA ! 18000!   
GCAAAGAGTG AAAAATGCAA ACAGTGCTGG CGTGTAGAAT GTTAATGTAA!
CACACACATG AGAGCTGCAG GTGCCAACTG CCTGGACCTG GGTGGCCATG ! 18100!   
GAGGAGAGCC TGAAGATGGC CCCGAGAATG GGGCTGTAGG ATGCTGTGAT!
GACACCATGC CCACCCTGGG AGGGAGGTGG CAAAGCCATA CCAGATGTTG ! 18200!   
GTGGAGATGT CGGCGCAGGC CAAGCGGGCA ATGCCTATGT GCTCACAGTG!
GATGTGTGGC ATCACATTGT GCCCACAGCA CGGCAGCCTC AGGAGGAGGA ! 18300!   
ATGTGGTTGG GAACACCATG CAGAAGCTNT GGGTTAGGGC AGCCTGCCCT!
GTNTTGGCTA TCACCACGTA CGTGAACACA GCGGTGTATT GCAGGGTGCT ! 18400!   
GCAGGTGGTG ATGGAGCGGT CCAACACCAT GGCAATCAGA ATGGTTGACT!
TTGCAGTGAA GTTGTCCACT CAAGGATCAT GAAGCTCCAA CCCCCCACCA ! 18500!   
CACGCAGGGC CACCAACCTC NACATTCAAT ACCAGCCCAG GNNGCCCNGG!
GCCCCATCCA ANGTGGCNTT CAACACCTCC ANGGATGGAT GGGGCATCCA ! 18600!   
CAGCCTCTNT GGGCAGCTGT TCCAGCACCT CACCACTCTC TNTGTCAACA!
ACTTCCCCCT CACATCCAAC CTCAATCTGC CNTCNTTCAG NTTCACACCA ! 18700!   
TTTCCCNTTG TCCTGNTGTT ATTTACCCTT GTAAAGAGTT GCCTCCCCTC!
CTGTCTGTAG GCTCCCTGTA GGTCNTGGAA GGCTGCANTG AGGTCACCCC ! 18800!   
GCAGCCTTCT CTTNTCCAGG CTGAACAAGC CCAGCTCCCT CAGCCTGTCT!
TTGTAGGGGA GGTGCTGCAG CCCTCTGAGC ATCTTTGTGG CCCTCCTCTG ! 18900!   
GACCCTCTCC AACAGCTCCC TGTCTTTCTN GTANTGGGGG TCCCAGGCCT!
GGACGCTTCG CTCCATCACA GTGACAAACA GGAGGAGAAG GTTGCCGAGG ! 19000!   
AGTGCTGCAA TGTACAGCAG GAAGAAGGGG ATGGAGAGCC CGGCGTGCAG!
CCCCTGGCCC AGCAGCAGGA AGGATGCAGG CTGCTTGCTN TGCTTGGCAG ! 19100!   
CCTCCATGGG GAGGTGGTGT CTGAGCTGCT CTGGGCTCCC AGCCCTGTGA!
GCAGAAACGG GGAGGGTGCG AAGCACAGCT CTTAAGGAGT GGAACACAGC ! 19200!   
TGGGTTTTGC TGGAGCCGTT TGTTTCTCTG GATCCTGAAG CTGTTTGGCA!
ATGTGATTCC CCTCACGCAC TGGAGGAGCG TGCTTTGGGT ACCGACTCCA ! 19300!   
AACCAAGCAA TCAATTAAAT TAAAAAATGT GCCTCGTGGA CCAGGTGCTG!
AAACCCAGCA GAGGGATTTG CTGGCAGTCA CACGTCAGTC CAGGCTTGGC ! 19400!   
CGAGCATCCA GGAACCCACA CCCCCGGGCT CTCATTGCTA TTATTTATTG!
TGTTTTCGTT CTGTCGCACC CAGAAGACAC GAGGCAGGTG AGAGGTTTGG ! 19500!   
GCTGAGTGAT GCTGGTTTCG TGCAGCACAC TGCTTCCTTC TGTGCCTCCC!
TCAGCTCTCT TCCATTCCAC ACTTCGCATG ATGGCAGGCT GTGGTCCCTG ! 19600!   
CGGGGCGCAG CACCCAGGGC AGCACGGTGT TTGATGGCTG ATCCAAGGGG!
CCGTGCAGAA CAAAGCAGTG TGGAAGAGGA GCTCCGTGTG GAGCTCAGGG ! 19700!   
AGTGGCTGTG CTGGGAGGCA GAGCTGCTGC CGAGCTTTAA AGCAAAATTC!
AGAAGGGAAG GTCTGAGGCA GAGCACCGGG AGATGGGAGA GCAGTGCAGC ! 19800!   
AGCACAGAGC TGCTCAGCAT CCTCAGCATT TGCTCAAGCC AGTGCCCGAG!
GACTGCCCCA CTGTGCAATG GGGCATTTAC ACTGCAGCAG AGTGCAGTGC ! 19900!   
TGCCCCATTG CAGTGTGCCT AGTCTGGTGG TCGGTGACCC TGCACACAGC!
AGGGGGGCTG GAACTGGATG AGCATTGTGG TCCTTTACAG CCCATGGGGC ! 20000!   
TTGCATGCAG AGCTCAGCTC TGTGCTGCTG GACAGATGTG ATGAAAAACA!
TGACCAGAGG GAGGGGATTT GGGCTCCCCA AAAACTCCTT CAGTGTGAGC ! 20100!   
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TGACCGGGGA GATTTCAGCC TGACACAACA CCACTGGGAG CAGCGATGGG!
GGGAGCAGGA TGGGACGGGA TGGTGAAGGC ACAGAGATGG GCGGCACTGA! 20200 20157-20221!                      
TGTCCTCCAG CCAAACCTAC AGAGACGGCA CAGGATCTGC TGTGCTCACT!  1.4 kb upstream of HS4 (het)!                                 
GCCTTCCTTT GCCTGCGTGG GCATCCGAAC GCTGCTTTGA GCACGGGGTG! 20300!    
ATTAGCAGAG CAACAGGCAT GCACTGCAGT TCCTGCTCTG CGCACTCACT!
GCTGCACTGT GCTCTGCGAG GGCTCTCTTT GGGGACATAA AAAGGAAATC! 20400!    
CAATATTAAC AGAGAGCGGG AATGGGAAAC AGGTGGGTGA GGAGAGGGAG!
GCTGTGGGGG AATGGGAGCT AATAAAAGGA TAAAAAGCTG GGTACCTTAA! 20500!    
ATTAAGCCAT AAATCTGGAT TTAGTGGCTG AAGTGAAAGC AGACAGATTG!
CCTTAACTTA TATATTTTCT TTTCCCTTTC TTGGAGTTGG GAATAAACAT! 20600!    
TTTAAACTTA GGTTTTCAAG CTCCAGAAAA TGGGGTGTTT GCAGGAATTC!  20645-20717!                                 
CTTGTTGCCA GCTGTTAGCA TGAGCCCACC CAGCACAGGT ACTGCAGCAC! 20700 1.0 kb upstream of HS4 (het)!                      
TTAGCACCTG GCTGGGCTGA ACCTGGTGTA GGAACACATG ATTTTAATCA!
AACGAGGCTC TCATGCCTCA TTCACCCCAC GGAGATGTTT GTCTAACAGT! 20800!    
TGTTTCTGAT GCCTGAAAAC CAGTGTTGTA CTGGTGAAGC TGGAATTACC!
TGTCCCAAAG CTGGCCTGGA TAGGGGAGCG TGCGCTGAGC CATCGGCACA ! 20900!   
CAGAGCTCCC TGCTGGGGTG AGGGCTCTTT CCTCCCAGCC TGGTGCTGGC!
AGGGCAGTGT GAGAAGCTGA AACATCCTTG GCTTGTGTAA GCACTGCTCT ! 21000!   
GCGATAGACC AAACATATCT GTGTTATCAG CATTATTCCC ATCCTAAATC!
CTAAGGAGCT CCATTGCAGC AGCCAGGAAG AGCATGAATT CTATCCCAGC ! 21100 21073-21168!                     
TGAAATCAGG ACAGCTGCCT GCAGGGAACA GGGCTGGCTA TGGCACTGCT!  0.5 kb upstream of HS4 (het)!                                 
CAACATCTGG GGGGTTGGAC TCGATGATCA TTAGAGGTCC CTTCCAATCC! 21200!    
CTACAATTGT GTGATTTCAG GCATTCCCTC TCCTGTCCCA CAGCTGTCCC!
TGCAGCTCAG GCCTGAGAAT CGGGTGCAGA CTTCACGTTC CTCAGCCCCA! 21300!    
AAGTGAAATC ATGAAGGCGC ACACACAGCC TGAAGCCCAG CGGCTGTGCT!
ATGGGCTGGG GACGGCTCTG TGCTCAGCAT CCTTCAATCC ACGGCGGCTC! 21400 21367-21445!                      
CGCTGCACCT CCTCTGCAAA ACGCCTCCAG GAAACCACTC GGCCGAGTGC!  0.2 kb upstream of HS4 (het)!                                 
CCTCTCCCGG AGACCTTACT TAGAGCCTCA GGAAAAGGAA GAAAGTGCCG! 21500 21485-21635!                      
AAAGGTTGAA GAAAAGAAGC AGGCTTTCCT GGAAGGTCCT GGAAGGGGGC!  HS4 1.2 kb insulator (5’ end)!                                 
GTCCGCGGGA GCTCACGGGG ACAGCCCCCC CCCAAAGCCC CCAGGGATGT! 21600 21558: 1.2 kb insulator start!                      
AATTACGTCC CTCCCCCGCT AGGGGGCAGC AGCGAGCCGC CCGGGGCTCC!  21590-21633: CTCF site!                                 
GCTCCGGTCC GGCGCTCCCC CCGCATCCCC GAGCCGGCAG CGTGCGGGGA! 21700 Reitman & Felsenfeld, 1990!                      
CAGCCCGGGC ACGGGGAAGG TGGCACGGGA TCGCTTTCCT CTGAACGCTT!  21723-21790!                                 
CTCGCTGCTC TTTGAGCCTG CAGACACCTC CCCCATACGG GGAAAAAGCT! 21800 HS4 core element (3’ end)!                      
TTAGGCTGAA AGAGAGATTT AGAATGACAG AATCATAGAA CNGCCTGGGT!  (core element: 21558-21798)!                                 
TGCAAAGGAG CACAGTGCTC ATCCAGATCC AACCCCCTGC TATGTGCAGG! 21900 Chung et al., 1993!                      
NNTCATCAAC CAGCAGCCCA GCGCGTCAGA GCCACATCCA GCCTGGCCTT!
GAATGCCTGC CTGCAGGGAT GGGGCATCCA CAGCCTCCTT GGGCAACCTG! 22000!    
TTCAGTGCGT CACCACCCTC TGGGGAAAAA CTGCCTCCTC ATATCCAACC!
CAAACCTCCC CTGTCTCAGT GTAAAGCCAT TCCCCCTTGT CCTATCAAGG! 22100!    
GGGAGTTTGC TGTGACATTG TTGGTCTGGG GTGACACATG TTTGCCAATT!
CAGTGCTCAC GGAGAGGCAG ATCTTGGGAT AAGGAAGTGC AGGACAGCAT! 22200 22190-22256!                      
GGACGTGGAC ATGCAGGTGT TGAGGCTCTG GACACTCCAA GTCACAGCGT! ! HS4 1.2 kb insulator (middle)!               
TCAGAACAGC CTTAAGGTCA AGAAGATAGG ATAGAAGGAC AAAGAGCAAG! 22300!    
TTAAAACCCA GCATGGAGAG GAGCACAAAA AGGCCACAGA CACTGCTGGT!
CCCTGTGTCT GAGCCTGCAT GTTTGATGGT GTCTGGATGC AAGCAGAAGG! 22400!    
GGTGGAAGAG CTTGCCTGGA GAGATACAGG CTGGGTCGTA GGACTGGGAC!
AGGCAGCTGG AGAATTGCCA TGTAGATGTT CATACAATCG TCAAATCATG! 22500!    
AAGGCTGGAA AAGNNCTCCA AGATCCCCAA GACCAACCCC AACCCACCCA!
CCGTGCCACT GGCCATGTCC CTCAGTGCCA CATCCCCACA GTTCTTCATC! 22600!    
ACCTCCAGGG ACGGTGACNC NCNCCTCCTC CGTGGCAGCT GTGCCACTGC!
AGCACCGCTC TTTGGAGAAG GTAAATCTTG CTAAATCCAG CCCGACCCTC! 22700 22664-22734!                      
CCCTGGCACA ACGTAAGGCC ATTATCTCTC ATCCAACTCC AGGACGGAGT! ! HS4 1.2 kb insulator (3’ end)!               
CAGTGAGAAT ATTGCTGTGG GTGGCACGAT GGCCACATCC TGGTCAAAGG! 22800 22763: 1.2 kb insulator end!                      
CTATAGGCAG AATGAAGACA CATTCAATGT CTGTGAGGCT GTGAGTGAAA!
AGCATTTGGA AGAGGCAGGT GCTAAGCTGA TCTCTCTGGC TCTGGCCACA ! 22900!   
GCATCCTCAG TGTGGTTGGG ATGGCAGAAG CGGACAGGCC CAGGACTGCC!
ACAGCTGGCA TAGCGAGGAG GAGGTACATG GGCACGTGCA GGCTCTGCTC ! 23000!   
TGCCTTAATG ACAACAGGGA ACATCCAGTT CCCCAGCAGC ACCAGGAGGT!
ACATGGAGGG GACAGCTGAG TGGTTTTCCA TGATGCAAAG CCACCCAGGA ! 23100!   
AGAATATCAG CATCCTGGTC TGGCTGCTGT TGGTCCCAGG TGGGGTGAGA!
CAGGGATGCT CCGTCTCATC CTTGAGCAGC TGAGGGTCAC AAACTGCACT ! 23200!   
ACAAAGACAG GCTGAGGGAG CTGGGCTTGT TGAGCCTGGA GAACAGAAGG!
CTGCGGGGTG ACCTCAGTGC AGCCTTCCAG GACCTACAGG GAGCCTACAA ! 23300!   
ACAGGAGGGG AGGCAACTCT TTGAGAGGGG AGATAACAGC AGGACAAGGG!
GAAATGGTTT GAAGCTGAAG GAGAGCAGAT TGAGATTGGA TGTGAGGGGG ! 23400!   
AAGTTGTTGA CAGAGAGAGT GGTGAGGTGC TGGAACAGCT GCCCAGAGAG!
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GCTGTGGATG CCTCATCCAT CCGTGAAGGT GTTGAAGGCC AGGTTGGATG ! 23500!   
GGGCCCTGGG CAGCCTGGGC TGGTATTGAG TGTGGAGGTT GGTGGCCCTT!
GTGTGTGGTG GGGGGTTGGA GCTTTCGTGG TCCTTGAGGT CCCTTCCCAA ! 23600!   
CCCAACCATT CTGTGATTCT TATGATTCAC ACACACAGTG AAGGAACACA!
GGTAGTCCTT GGGGTCCTTT GGCCTGAAGC ACTTCAATCA GAGGCATCAC ! 23700!   
CATGACCAGC AGCACTGTGA CACAGCAGAG CCTGGCAGGA TGAGTGTGCT!
CATCTCCCTG CATGCACACA CTGACACAGA CAGCAGGCAG TGAAAGAAAA ! 23800!   
GGGCTGATTG TGGGTCAGAT GCTGAACTGC TCATAGGAAT ACTGCGGCTT!
AGGAGCAGAG AGCTGGAGAT CTTGATTCTT TTAAACCAGC AAAACAACAC ! 23900!   
ACCATGTGCA ACCCCATGGA GGGAAAGAAG GTCTTCCTAA GCTGAAAGAA!
AGTGTTTACT GACAAAGCAA CATCTGGAAA TGGAGCGTGG ATAGAAGTAA ! 24000!   
ACTGGAAATC AGAAGGAAGC TCATCAAAGC TGGATGTCTC TGAGGATCCC!
CCCATTAGAA ATACAGAAGT GGATCTGCTT TTATGGGCAG TTTTCTAAGG! 24100!    
GAACTTTTCG GGCAGGTGAA GGTAGGGTCT GCCAAGGACT GTCACACCCA!
GAGTCCTTTC CCCACAGTGC CTGCAGACTG TTCTGTGTGT CCAACTCTGG! 24200!    
TCCTCATGTC TGCCTTAGAA GGGACACTGA CCAGAGGGAC CCCCACGCCC!
CCTTGGTGGT TTGGGGGCTG TGAGTGGAAA ATGGTCTGAA CAGACACAGG! 24300!    
GCTCGCCTCT TTCCCCTCAT AACCAATGGA AAATGAGAGT TGGGGTCTTT!
GAGAGTTTCC CATCACTGTG GCTTCCCTTG GAATGCCCTG CCAGCACCCA! 24400!    
TGGGTGCCTG TGGGGATCAA AAGTTGCAGT CAGGGTTGGG GTTGGGGCCA!
GCCTGGCCTC TCTTTACCTG TTGGGTTTTT TTCTTCCCTC TCACTCTTCC! 24500 24484-24555!                      
TTAAAGCTGT GCCTCAGTTT CCCTGCCTGG AGAGGAGCTT TCATTTGCAG! ! HS3!                 
GGTGCTTTGG GGTTGAGAGC TGAGCTGCTC CTGGTTGGAG CATTGGGCTG! 24600 Reitman & Felsenfeld, 1990!                      
CTGAAGACAG ACGGAAAGCA AAGCTGCTGC CCGGACTGCT CCTCACATTG!
CCCTGAGGTC TGATCCTCCT CTGCCCCATG CTGGAGGATT TGCAATATGA! 24700!    
ACGGACAGAA TAAAACACAT CCCAGGGCAG CAGCGGTGCC TTCAGCTGCA!
GTCTGCCTGC CCGGTGGGAG GGGGGCTGTG TACAGCTGCA GCTCTGGGGG! 24800!    
TGACGGGCAG CTGAGATGAA GTGGGTCTGG GACCAATTCC AGCCCAAACA!
CTGCTGGAAG CCCAGGTAGA GAGGATTGCA TTTTGCTGTA TCTCACTGGT! 24900!    
TGGAGACAGG TGTGGATGGC AGCACTCAGG CCACCTGGGA TCCCTTTCCT!
CATGGGGACC TTGCCCTGCC TGGAGCATTC TGGGAGCCCT GGGGTGAGAG! 25000!    
GCTGCCCTGC CTCAGTTTCC CCACAGCTGA ATGCCAACCA CCAGCTGAAC!
TGATGGTGGA TCAGGAGCTG CGCCAGCATG GGGAAGCAGG CAGCTCCCTG! 25100!    
ATCTCCTGGG GGCCTTTCTG TGTGCAGGGG AGCGAGGTTT TGTGCCACGG!
AAATAGGGTC AGACACAGTC ATAGAATCAT CACACCACGA AGGTCAGAAA! 25200!    
AGCCCTCTTA GATCCCCAAG TCCAACCCCA ACCCACCCCA TCACGCCTAC!
TGACCACGTC CCTCAGTGCC ACATCTCCAC AGCTCTTAAA CACCTCCATC! 25300!    
CCCGCCGACT CCCCCACCTC CCTGGAGAAG AGGGGTTGGC CCTCAGGATG!
TGTCCCACTG TCCTTTGGGA TTACGGTCAC TGCCACTGCC CTGGGATGGA! 25400!    
GGGCAGCTGG GAAGTCCCAC AGCTGCAGGA CAGGTGCCCA GCCCTTGCTG!
AGTAACGGGG GGCCGCGTGC TCCCCTGGCT CTGCTGGAAA ATGCACATAA! 25500!    
ATCCATAAAA AGCACTAAAT ATTTTTCGGT TGGCTGCCGC ACTGCCTCAG!
CAGAAGTATT TTCTGCTGCC TCAGAACTCT GACACAGCAC AAAAGTGAGC! 25600!    
CAAGGGCCTT ATCACTGCCC TGCCCGTGCT GTTTGCACCA GCCGTGTTAT  25620-25683                                        
CGCCCCATGG CAACCACACA CAACCGTGAC TCAGCACAGC GCTGCTGGGA! 25700 5’ HS2!                      
GCTCCTTGCG CCGATGGACA AAGCATCCTG CTGCAGAAAT GCTCGAGAGC! ! Reitman & Felsenfeld, 1990!               
CCACCCGAGA GCCCCTGCAG GGCAGCCTCA GCACTGTGGC CCTTGAGATG! 25800!    
GGGGAGCCAA TATCTGTGGG CTGTTCTCTG TGCCCGGTTC AGCTCAGCCC!
CGCAGTGCTA CTGCTGTGTG GGACCCCCGG GAGAAAGGTG TCATGCTGTG! 25900!    
CAATGGCCTC ACCTCATGCA ATGTTCTCAG GCTGTGCAGT GGTCCCATGC!
TGTGCAATGG TGTCGTGTTG TGCAGCAGTC CCAGGTTGCA CAATGGTCCC! 26000!    
ACTTCGTGCA ACGGTGTCAC GTGGTGCAGT GGTCTCAGGC TGTGCAGTGG!
TCTCACTTAG GGCAGTGATC TCAGGATGTG CAACAGTCGC ATGTAGTGCA! 26100!    
GTGATCCCAG GTGGTACAAT AGTCTCACCT GTGCAATGGT CCCACGTGGT!
GCAGTGGTCT CAGGTTGTGG AGTGACCTCA TCCTGTGCAA TGGTCCCATG! 26200!    
TAGTGCAGTG GTCAAATGTT GTGCCATGTC ATCATGTTGT GTGCTGGTCT!
CATGCTGTAC AACAGTCCTC TGGAGGCTGG TGGCCATGCC TGTGGCAGGA! 26300!    
GAGTTGGAAC CTGATGATCC TGAGGCCCCT TCCAACCCAA ACCATTCTAT!
GATTCGACGT TGCAGAATGG CCTCATGTTG TGCAGTGGTC CCAGGTTGTG! 26400!    
CCAGGGAAGG TTTAGATTGG GCATGAAGAA GAATTCCTTC ATGGAGAGGG!
TGGTGAAGAG AGGAATGCCC ATGGCTGTGG TGGAGTCCCC ATCCCTGGGG! 26500!    
GTATTTAAAA GGGCATGAGG GCTGAGTGGT GGGACTTGGT AGGTCAGGTT!
AATGGCTGGG CTTGGTGATC TGGAAGGTCT TTTCTGACCT CAATGATTCT! 26600!    
ATGAGCTGAG TAAAATTTGT GATGGACTTC AGGCCCATCC CTGGTTCACC!
GTCAGCATTC ATTGCTTCAA ATGCACTGAG GGGAACATAA CCTATACAGA! 26700!    
AAGTGCATTC CTCACCCAGC GGTTCCATGC TGCAAACAGG AGGAGGAAGG!
CCCAGCTCTG AGCACAGCAC TGCACCTTCC TGGCCCCACG GGAACCTTCC! 26800!    
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TTGCTCACAG GCACCTTCCA CTAGCAACTG CCCGGGGCTG CACAGTTTGG!
GACGCAGCTC TCGTGGTTCC CACTGAGTGC TGCATTTCTG GGGGGGGGTC! 26900!    
CTTCCAGCTC CCTTCTTGCC TGGAGATGGG GAACACCCAC TGTCCAGCCT!
TGGGCAGTGG CCTTGCAGCC ACTTTCTGCT CTCCTGAGCC TACAGCTGTG! 27000!    
AGTTTGGGCC CTGCTCTGGC AGAGCCTCCT CCATAGAACT CCCCAGAAGG!
AATTCCCTGC TGAACGGGCA CTTGTAGGAC ATGTGTGACA TACAGGACAC! 27100!    
AGTGTGACAT ACAGGGCACA GTACGACCTG CAAGCACAGC AGCACCTGTA!
AGATGCAATG TGACATGCAG GGCACAACTG TCACATACAG CACACAATGC! 27200!    
TGAGTGTAGG ACACAATGGG ACATACAGGA CACAGTGTCA CCTGTAGGAA!
ACAGTGTCAC GTATAGGACA TAATGTAATG TATAGGACTC AACATCTCGT! 27300!    
AAGGCTTGAA GACATTTTTG GCTGCTGCCT TCCTGGTCAG GGCAGTACAA!
TTCAGTCTGT GGCACTGCAA TCATTTATTT CACCTGAATG GCCCCGGAAG! 27400!    
GACCTTCTCT GTGGGTCTGT TTCTCCCCCC TTCCTCCTCC CATGCTTACC!
TCCTGCACAG AACCCCCTGG AACACCTTTA GGAACCCCAC AGGATGGAGG! 27500!    
AGGAGATGGG GGGCTCAGCT CCCTCCTGCC CCACCAGCCG TGCTGTGTTC!
ACTTGGTGCC ACTGTCAGCA TTTTGGGCAG CGGTGATGAA GAAGACTCTG! 27600!    
AAATGCTCCC CTGCACCACC TCTCTCCTCC CTGCGCAAAA CGACGAGAGA!  27607-27676!                                 
AAAACTCAGT TTTCCCATAG ATGCCATGGC TGCACAGCAG CACGACCCCA! 27700 HS2!                      
GCAAACGACA GCAGCTGCTG GGTGGAGGCT GCCCGGACCC CCGCCCCACT! ! Reitman & Felsenfeld, 1990!               
CCTGCTAACC CCGAGGGGAA AAAGCAGGCG GCGGTGCGGT GGGCGCAGCC! 27800!    
TGGCGCTGCA TTTATCTCGG GCTGCAGAGA GGGTGGTGAG GAACTATCTG!
GTGTGGGGCT GGCAGGGCGT GGGGCTGCCG GGGGGCGATA GGAGGGCAGA! 27900!    
GGGCAGCGGG CTCGGCGGCA GCTGATAGGG GGTGTTGTGC TGTGGGGTTG!
CTCTGCTCCC AGCACGGCAG GAAGGGCTGA GGCTGCTCCA GGAGTCCATT! 28000!    
ACAATGAGCC CAAATACATC CCATCCTGGT GTTCCTGGGG CTCGGTTTGC!
CCCCGGCCCA AGGCAGGGGC TCTGGTGGGA GAACAGGAGC TGGGACACTT! 28100!    
GGCCATGGGT CTGTGTCCTT GTGCTGAGCA GGTGGACACG GGGGGGGTTT!
TCCCCCAGAG GGTGGTGACA CACTGAACAG GTTGCCCAAG GAGGCTGTGG! 28200!    
ATGCCCCATC CCTGCAGGCA TTCAAGGCCA GGCTGGATGT GGCTCTGGGC!
AGCCTGGGCT GCTGGTTGGC GACCTGCACA TAGCAGGGGG TTGGAACTGG! 28300!    
ATGAGCACTG TGGGCCTTTC CAACCCATAT TGTATGATTC TGTGACACCC!
TGGCAATGAT CCTGGTCCCC CCAGTGAGGA GCGGGGGGGA GAGTCAATCA! 28400!    
TCAGCTTGGT TATAGGCAGG AAAAGCCTTA CTTCAAATGC ACTGCCTTGG!
GACACCTCAT CCGTACTGAG CTGCTTTGGC TCGCTTCTGG ATTCCTTCTT! 28500!    
GCGCTGAGGG ATAACCCAGC AGCTGTGTAA TTAAATCATG CACTTCTGTC!
TGAATATCCT GGCTCTCACA CCTGACCTCG TGCCTCTGCA CAGAGCCTGG! 28600!    
AGAATTCCTT TACATGGATA TGGGGAGAGG GATATGTGAA TAGGGCCAGG!
GCCCTTTGCT GCAGTGCCCG GAGGTCCTCC GTGCATTTCT GTTGTGAACA! 28700 28670-28738!                      
GCCCCAAAGT GCACACTGAG ACCAAAACAG CAGACACATA AGATTTCCTA!  5’ HS1!                                 
CGATATTAAA TCATCACAGC ACAAGGCTGT AAGGCAGCTC CAGTGCTGAT! 28800!    
GTTTGCACTG TAAGTAACCC GTATGGCATG AAGCTCAGGC CCTGAGTGCC!
TGACATTGAA TCACATGAAT CATGACCCGA GCACAGCCAG GGCTGCTCTG! 28900!    
TGCCTCTTGG ATCAGAGCTA ACGTGCATGG AGGGTTAAGC CTGGATCCCA!
AAATGAGACA TCCAGGTTAG GAGTGAGCCC CCGACCCCCA TGAATTTCAC! 29000!    
TGCACTCCTT AAGGCAACGG TTAGATCTGG TGCTTTGCTG TTGCTTTTTT!
TCGCTGCTGC AGTCAGAAGT TTATTAATGG CCAGCAATGC AGAAATGCTG! 29100!    
CGTTCCTGAC CTGTGCAGAT GGAATGAACA GACTGAGGTC CTGCAGCAGC!
ATTCAGGCTG CAGGGCTGGG GCACTGACCT CTGTCTGCAT AGACCCAGTG! 29200!    
CTGTGTACCA GCAGATGCTG TGGGAGCAGA GCAGTGCTCG TGGAACCCAC!
CGTTACATTC TCCCTTAGTT TATTGCTGTG GCACAGAAGC CATTTGAACT! 29300!    
GTCTTCAAGC TGAGGGCGAT GAGCCAGGGC TCAGTTAGGT GACTCTCCTT!
GCAGCAGTAA CATGGAGCCC TCTGCCTGCT GCAAAGCCAC GATCTGCTCT! 29400!    
GACTGCACTT TGCTCTGCCC CTACATCTTC TGGGGTCTTT TCTGCCTCCT!
CTCCCCTCCT AAGGAAACGG CATCCTCAGA AATCCTTGGT GTTTGTGTTC! 29500!    
AGGCACGGCA AGGTGTATCA GTTATGGTGA TACAGGCCAG CTGGTTGCTG!
CTCTCATTTT CCTAAATTGG TCATTAAGTT TGTCCTGAGA GGGCCCAGAG! 29600 29591-29658                       
CAGAAGCTCT GCCTGTCCCT TTGGGTCTGT GGCTGTTCTG TAAGACTGTG!  HS1!                                 
CTCTGGTTCC CATTCTGGGG TTCATCTGGG CAGTAGCCAG AAGGCTGCTG! 29700 Reitman & Felsenfeld, 1990!                      
TTGCCCCTGG AGCAGCTCTG CATCAGCAGC ACGGCAACGG TAGGTCAGCT!
CTGCACCATA TAAGCTTGTT GTGGTACAGT GAAGAGCACC TCTGCCCCAT! 29800!    
CTCCTCTGCT TCCTCCTCCC ATGGCTCTCA GGACCACCGT TACCCATCTC!
ATGGAGATGT GACCCTGCTC CACAGTGCAC CCATGAGAGC AGATCTGAGT! 29900!    
GGGCCACGGT GCGGGACGGG GACCTGAGGT TTCTCTCCTC TCTGCCTGCT!
TTTCCATGGA GTCCAGAAAG TCAGCACTTG TTGACCACAG ACCCTCACTA! 30000!    
ATAGCAATAC TGCAGTGCTC TCCTCTGAGC GCTGTCTGAT GCTCGCTGCT!
TGTCCCAGCC ACCCCTCCCC GAGCTCTGTC GTGCTGCAGG CTCACACACA! 30100!    
GAAGAAAAAC ATCATTATCT TTTTTATTGA AAGTTCAGCT TCACCGAGCT!
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GAAAATGAGA CTCCCATCAC AGATGAGGCA AATGCATTGC TAATAATAAA! 30200!    
CCCAGATGTA GCTTGGATTT TATCCTTTGT GTGGGTCTGC CAGGCAAAGC!
AGACTGCAGG AAGAGAAGTA ATAACCAAGC AGTACGTGAG AGGGGCACTC! 30300!    
CAGGCTGTTC ACTGCCCCCC AGCTGTGCAT GCAGCTGTCC CGGCCAGCTC!
TGCTCAGTGC TGTGCTGGCT GACACATGAT GGGTTGCACG TATTCCATTT! 30400!    
CGTTCTATGA GTCTTAGTAA AAGCTGAGGA GCTTCTGAAG CCTTCAGATC!
TCCTCAGGAA CCGTGGGTGT GTGGCTCTGT GTCTGCTCCG TAGTGAGAGC! 30500!    
TGCAGCAGGC TCTGGCTACC TGTGTGATAC ACTTATCTGT GCTGAGCAGC!  30510-30589!                                 
CCGTGCCCCG CACGGCATTA TCGGAGCACT GCGGTAACTC CTCGCTGCTG! 30600 upstream of rho!                      
GAAGGGGCCC ACGGCGAACG CATGGGACTG AGAAACTTCA AATAAATAAA!
TACATAATTA AATAAACAGA TAATACAAAG TAAGAATTTC TCCTAGGGGG! 30700!    
ACGCAGCAAG GATCGGTAGT GTGGCTGCAT CCATCAGTGA TCCCAACTGG!
ATCACAGTCG GATGTCCAAT GAATCGTAGA GTGGTTTCAG TTGGAAGGGA! 30800!    
CATTTAAAAA CCTTCTGGTC CATTTCCCTG TGCTGAACGA GGACAGCCAC!
GGCTGGATCA GGTGCTCAGA GTGCTGTGTT TGTGCCGCTG CTCAGTGTCA! 30900!    
CACCATGGAG TCAGTGGACC AGTATTGGTC TGTAAGTGGC ACAGCTTAAA!
GGTTTGGATC AGGAATCATA GAACCATAGA ATCCTAAAGG CTGGAAAAGA! 31000!    
CCTCCCAGGA TCATCATCAG GTCCAAACAT CAGTCCATCT CTATCATGCC!
CATCAATACA ATCAATAGAA TCATTCGAGT TGGAGGGGGT CCTTAGAGGT! 31100!    
CATCTACCTC AACTACCCTG CAATAGAATC ATTAAGGCTG GAACAGACCA!
TGAAGATCAA TCCAGCCATC AGCCCAACAC CACCATGCTC ACTAACCACA! 31200!    
TCTCCAAGGG ATGAAGCCTC TGGAAGAGCC AACCCACAGT CCACTGGGGT!
TCTGCATGCC TCCCATATCC TGGCTTTGTG TGCCCGTGCA CAGGGGCACC! 31300!    
ATTTTGCCTG TGCCCTTCAG CCCAGGAATA GCAAAAACCC AATTCAAAGG!
GAGAGCGAGA CCTGGAGCCA AGCAGGAGCC TTTGGTCAGG CTCTGAACCA! 31400!    
GGACATGACT GATCTGGTTG TAGAGTGGCT GATCCTGCTG TCCTTATGCA!
AGGCCTTTTT ACTTCCCAGA AATGAGAGCA CAAGAGAGAT TTAGTCTGGA! 31500!    
CATAAGGAAA ATGATGAAGG TGATGAAGCA CTGGCACAGG TTGCTCAGAG!
GAGTGGTTGA CGTCCTGTCC TTGGAGACAG CCAAGGTCAG GCTGGACAGG! 31600!    
GCTCTGAGCA CCTGATGGAG CTGTGGCTGT CCCTATTCAC TGTGGGACAG!
TCCTACCAGA TGGCTTGTAA AGGTCCCTTC CAAACCAAAT AACTCTATGG! 31700!    
TGCTATGATT CTATGATCCA GAGTTGCATA GCTGCAGCCA GGGACGAGAG!
CCCTCAGCAT CCCCGGGCAG CTGCTCTGAG CAGAAGGGTG AGGGAAGTGC! 31800!    
CCATTGCCAC CTGTCTGAGA AATACCCCTC AGCTTTAGGG AGACTACGAA!
TGCTGCAGAG GAGCCAACAT TTGGGGCGCT GCAGGCGTGA AGCCATTTGA! 31900!    
ATGCATCACC CAGAGGGGGG GGTTTGGTGC CTTCTGCAGG GGTGCTCTGT!
GCAAGGCTGC AGTGAGGACA GCAAGATAAG GGCTGCTGTG TCCGGAGCCG! 32000 31971-32047                       
CCTGTTAAGC TGGTCACTGT CTTGTCATGG AAGACCACAC CTTGTGCACA!  rho promoter!                                 
CTGACCACCC CATGGCGCGG AANNCCCCCG CACGAACCCC CACCCGTCCC! 32100!    
AGCCAATGAC CCCACAGCGC GGGGTGGGGA GGAGCTGTCA GCGGTGGATA!
AAAGCCCCCG GGGTCCGCAG CTCAGCTCCA AGCTCTGAGT GCTCCCACAG! 32200!    
CCGCACGCCA ACCCCGCTGC CACCATGGTG CACTGGTCCG CCGAGGAGAA! ! rho translational start!               
GCAGCTCATC ACCAGCGTCT GGAGCAAAGT CAACGTGGAG GAATGCGGTG! 32300!    
CCGAAGCCCT GGCCAGGTGG GTCTGCTCCT GGGATCGGCT CAGCTGCACC!
CTGGGTACTG AAACCACTGC AGTTTTAGGA GGCAGCGCTA ACGGTGTGTG! 32400!    
CTTGTGTCCC CCGTCTCTCC GCAGGCTGCT GATCGTCTAC CCCTGGACCC!
AGAGGTTCTT TGATAACTTC GGGAACCTCT CCAGCCCCAC CGCCATCATT! 32500!    
GGTAACCCCA AGGTCCGTGC TCACGGCAAA AAAGTGCTGA GCTCCTTTGG!
GGAAGCCGTG AAGAACCTGG ACAACATCAA GAACACCTAC GCCAAGCTGT! 32600!    
CGGAGCTGCA CTGCGAGAAG CTGCACGTGG ACCCCGAGAA CTTCAGGGTG!
AGATGTTGTG CTGAGGCTGY CCGTCTGTCC CTCCACCCTG TGGAGCAGCT! 32700!    
CATTGCCTGC AGGGTYCTGG GGGAACTTAA GTAGCAGATA TTTTAGGGTG!
TGGAACAAGG TGCAGCAGAT GAAGGAGGGA AGCAGGAGGG GAGTAAAAGG! 32800!    
GAGCGGGGTG CTGGGGTGGG CTGTGGCTGC GGGGCTGGGT GAGGCTGTCG!
GCTTCCGTTC CTGCCCCTGC TTTGGGGATG CAGCAGGCAG ACATGGAACT! 32900!    
GACTTGAGCC CCAGCTNCAG TAGGCATGGG GGTTNACAGC AGGAAAAAAT!
GAGAAAAAAC CCAGAAAAGT TTTGGGAATG CAGTTTAGAG GCTGGAGAAA! 33000!    
GCAGGTGGGA GACAATGCAA GGATGGAGTG GGGATCGGCG TCTGTGGTGA!
GCACAGAACA TTTTCCTGCA GAAAGAGCAT CTCTGNAGCC CCTCAAAACA! 33100!    
CTGGGGTTTG GCTGCAGCCC CTGNGTCCTG TGCAGGGCAG GGGATGCTCC!
ACACCTTGCT TACCCCATTG CTCCCCTTCT CCCTGCAGCT CCTGGGGAAC! 33200 33152-33218!                      
ATCCTCATCA TCGTGCTGGC CGCGCACTTC ACCAAGGACT TCACCCCGAC!  rho exon 3!                                 
CTGCCAGGCT GTCTGGCAGA AGCTGGTCAG CGTGGTGGCC CATGCCCTGG! 33300!    
CCTACAAGTA CCACTGAGCT CCCAGAGCAG GACACAGTGT GAAAGTCAAT! ! rho transcriptional end!               
AAAAAAGCAC ATTGCCTGAA CTGCTTGGTG TTCTCCTGTT GTGGGGAGGG! 33400!    
TGGGAGCAAA GGGCACCAGA GGGGAAAGAG GGCTCAGGGC TGTGGGGAGT!
GTCATGGTTC AAAAAGACGG TCAGGTTTGC CAAAGGAGGG GACATCCGGG! 33500!    
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GACATCAGGG GACATGTGGG GGCAGAGGCC TCTCATCCAG CACTTGGCAC!
GTCCCAGCCC ACCCGGCAGT GCCTTCAGTC TGCGGAAATC ACCAGGGAGT! 33600!    
ATTTCTGACC TCTTCTGCGC GGAAGGCAGA GCTGCAGGGC TGGGCGCCTC!
TTGGCCTGCA GTGTGTGCAA GGGTGTAGAT CTGGAGAGAT TCCCCCGAGG! 33700!    
CAGCTTAGAC TGAAAAACGT ATCCTCAGGA AGGTGATAAA AAGCGTTTTC!
TGTATCAGAT GAAAATGCTC CTTCCAGGAG CCTCGGCGTT CTGAGCAGAA! 33800!    
GATGCTCTCT GCAAGAAGAT GTAGATGTCT GGAGAGGAGG GACCAAGGGC!
AGTTTTTACG TAGGATCAGA CCATTTTAAG CTCAGATTGG CTTAATGAAC! 33900!    
AATGATTTTT TCACCGTAAT GGAAGGGTTC TGTCTCAGCA CATCAGTCTT!
ATTCAGAAGT AAGTTAAAGA ACAACAGGGA AAGATATGTC TGTCTCAGAA! 34000!    
TGATGAAACC CATGTTCTGC ATGATTTAGG AATATGTTTT CTGCCTTCCT!
GCAGATAAAG CAGGGATTTG CACTTGTGAC CGCTGTGAGC TACACATCCA! 34100!    
GCCTGTGTGA TAGGCAGAGG ATGCAGGGAT GGGGGGAAAA AGCAAAAAGC!
CAACAGAAAC CAGAACAGCT TTCCTACAAC ACAACACTCT CCTGTCCACC! 34200!    
AGCAAATGGC ATTTCAGCAT TATTTCATAG AATCATACAA TCACATTGAT!
TGGGTTGAAA AGGACCACAA TGCTCATCCA GTTCCAACCC CTGCTACGTG! 34300!    
CAGGGTCGCC AACCAGCAGC CCAGGCTGCC CAGAGCCACA TCCAGCCTGG!
CCTTGAATGC CTGCAGGGAT GGGGCATCCA CAGCCTCCTT GGGCAACCTG! 34400!    
TTCAGTGCGT CACCACCTCT GGGGGAAAAG CTTCCTCCTC ATATCCAACC!
TAAACCTCCC CTGTCTCAGT TTAAACCATT CTCGTAAACA GCCATTTCCC! 34500!    
CTCCTGTTAA TATGCTCCTC ACTTTGGCCA TCACAGAAAC AAACTGGGAG!
CAAAGACACT GACAGGTCTG ACCAGCTTTC AACTCAAGTC ATTGCGTGTT! 34600 34595-34667                       
CTGGAGGAGA GAGAAGAGTG ACTGGCTGTG GTCCAGAGGC TGTACATCTG!  upstream of hatching!                                 
CCAGTCTTGC TGATAAGTAA AGCTTGGCGC AGTGTGCTGC TTTGCTGCAA! 34700!    
TCAGAGTGAC CAACAAACAT TGCTTCTTTT GTAAAGGCCC GGAGCTGCCT!
TTTGCTGCCA GCAGGATGAT TTATCCATAA TATCTTTAAT ATCTTCATCA! 34800!    
GTGATGTCAA CAGTGGGGTC AGGTGCACCC TCAGCAGTTT GCTGCTGACC!
CCGAGCTGTG GGGTGCAGTG ACACAGCAGA GCGATGGGAT GTCATCCAGA! 34900!    
GGGACCCAGA CAGGCTGAGC AGTGGGGCCA GGTGAACCTC ACAGGTTCAA!
CAAAGGCAAC TGCAAGGTCT GCACCCGGGT TAAAGCAACC CCCATCACCA! 35000!    
ATAGAAGCTG GGGGATGAAA GGATTGAGTG CAGCCCTACT GAAAAAGACC!
TGGGGTTACA GGTGGATGGA AGCTGGGCAT GATCCAACAG TGTGCCCTCA! 35100!    
CAGCCCAGAC AGCCAACCGT ACCCTGGGCT GCATCCAGAG CAGCACGGCC!
AGCAGGTCAG GGAGGTGCTG CTGCCCCTCT GCTCTGCTGT GAGGCCTCAC! 35200!    
CTGGAGCACT GCCTGCAGAT GTGGAGTCCT CAGTGCAGGA GAGACATGGA!
GCTGTTGGAG AGCATCCAGA GGAGGGCCAC AAAGATGATG ATCCCATCCA! 35300!    
GGGATGGAAC AGCTCTTCTG TGAGGACAGG CTGAGAGCTG GGGCTGTGCA!
GATGGAGAAG GGAAGGCTGC GAGGTGAGCT GAGAGCAGCC TGTCAGTATC! 35400!    
CAAAGGGGAG TGACTGGAAA GAAGGGGACA GACTCTTGAG CAGGGCCTGT!
GGTGGCAGAA CAAGGGGAAA TGGCTTCAAG CTCAAAGAGG GGAGATTCAG! 35500!    
GTTGGATAAA AGGAAAAAGC CTTTTACAGT GAGGGTGGTG AGGCACTGAA!
CAGGCTGCCC AGACATGTGG TGGGTGCTCC ATCCCTGGAG ACTTTTATGG! 35600!    
TGAGGCTGGA CCAGGCCCTG GGCAACCTGA TCTACCCGTG GTGTCCCTGT!
GCAGTGCAGG GCAGTTGGAC CAGATGGCCC TCAAAGGTTC CTTCCAATTC! 35700!    
TAATGATTCT ATGATTCTAT AAAATAGGAA GGCTCCGGTC CATGGAGCTG!
GCATTGCACA GTGTGCCAAG AGGCAAAGAA CCACGCATGG GGCTCCTTCA! 35800!    
ATCAAACCAA AGGAGACAGC AGGATGGAAG GATGCTGGGG AAGAGTTGTG!
GGTGAAGTGG ATCTGTCCCA TGTGGGTGCA AATGAGCTCA GACTTAGAGA! 35900!    
GATGTGTGAG ATGGAGTCAT CCCTGAAGAA GACCTCCAAA GCAGAGTGCA!
AGGCTGAGAC TGTGTGAGCT GTTCTTTGCT TTTTGCTGAG CATCCCTCAG! 36000!    
TCATTTCACT GTTTGGCAGA AAGAGCTGAT TGCTTCATGC CAGCCTTGCA!
GACACCTTCC AGTCTGAATT CACCTCACTG TGAGCAAAAT CGGGGGGGGG! 36100!    
GCATGCAGCC TCTGGTTCTG CTCAGGAGCA AAAGAGAAAT CAGGTGAAGG!
TCAGCAGGGC CCAGGAGCTG CTTCTTCATC TCTTGGTTCG GTATCTCATC! 36200!    
TTACACCTGG GTTGGAAGTC TGGATCTGCC CTTGTGGGGT GGAGCACCTG!
AGCTGTTCTG GTGCCGAGGC ACTGCAGGAC AGCAGCCACC AATTCACCAT! 36300!    
CCCACCCCGT TAACTATGGA GTCCAGGGAC AATGGAGAAC CAACGTGGAC!
AACTATGGAG AACCACTGTG GTCAACACAA AGAACAACTA TGGAGAACTA! 36400!    
CTGTGGTCAA CACAAAGGAC AACTGTGGAG AACTACTGTG GGCAACAACT!
ATGGACAATT TCAAGGGACA ACAGCTGTGA AACTCTTTAT GAGTACTGAC! 36500!    
AAGAAAGGAG AACCTTGCAT TCAAAGCATG AGGCCTACAT TTGGGATACG!
CACTGAGCTC TCGTTTCCCG GAAAGCCTCT GATCATTCAG TTTGGGGCTG! 36600!    
ATGATGCCTG GAGCTGTTCA CGATGGATTC CCAGGAGTGC AGGCACCAAT!
GCACCATCAA GAGTCTGAAA ACAAGGCCAA GTAAAGGCTG TGAGCTCTTT! 36700!    
GACATCACTG CCTAATCTCA CTGGATCTCC TCCACAAGTT CAGCCCCCAA!
CCACTGGCAG TGACACTGGA AACCTATGGC CATGGAGGAG CCATGCAGGC! 36800!    
AGCTCCACCT GCACTCGGGG CTGTGGCTAC GAGATCATGG GTGTGAGATG!
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AAGCTGGTCC ACTCAAAGGC AGAGGGGTAA TGGGCCCCTT TTCCCCTTGG! 36900!    
ACAGGATCCA AATTTGCTAT CTTTCCTTCT GCAGCTCAAC TCCCTCCCCA!  36920-36999!                                 
GTCGCAACCA ATGACAATGT CAACTGAGAT TAGGGCAAGC TGTTACTAGT! 37000 hatching promoter!                      
GTATAAAAAT CCATGGGAAG ACTTTGGCCC CACTTCCTAC TCATCGTTCA!
GGGAAGCCCA AAGCAAGCCC TTCAGCTGCC ACCATGGTGC ACTGGACTGC! 37100 hatching translational start!                      
TGAGGAGAAG CAGCTCATCA CCGGCCTCTG GGGCAAGGTC AATGTGGCCG!
AATGTGGGGC CGAAGCCCTG GCCAGGTAGG TCCAGCTTCG GGCATCGGCT! 37200!    
CAGCTGCTCC CTGGGTAGGG AAACGGCTGC AGTTGGAGGT GTGTGCTTCT!
GTTCTCCATC TCTCTACAGG CTGCTGATCG TCTACCCCTG GACCCAGAGG! 37300!    
TTCTTTGCGT CCTTTGGGAA CCTCTCCAGT GCCACCGCCA TCATTGGCAA!
CCCCATGGTC CGCGCCCACG GCAAGAAAGT GCTGAGCTCC TTTGGGGAGG! 37400!    
CTGTAAAGAA CCTGGACAAC ATCAAGAAGA GCTTTGCCCA GCTGAGCAAA!
CTGCACTGTG ACAAGCTGCA CGTGGACCCC GAGAACTTCA GGGTGAGTCT! 37500!    
CTGGGGAGTA TAGGCAGGAG TTATAGGACT GAGGTGTGTG AGAGGAGGGA!  37535-37601!                                 
TGCAAGCAGG CGGAGTGGAT GGGCACAAAA TGTGGAGTGA TTTACGTGCC! 37600 hatching exon 2!                      
AGTCTGCAGA GTGAATGGAG CGACACAATA CCAGCCCAGA GGAGCAAGGG!
AGCAGAAGAG AAGAAACAAA GACAGGACTG GAGGGGAGGA GATGAACTTG! 37700!    
GACATGAGGG AATGGTTAAT CCAGGACAGA AAATAGACAC AGCCATTTCA!
ACAGAACAGA TGGGATCTGA GCCAAAGGAG AGCCAGGGGA GGGGAGAAAT! 37800!    
GAAGGGAAAA GATAAACACA TCCAGAGCTG AGAGGGGTCA CTGGCACAGC!
TGGTGTAGGG AAGGCGTTTG GGGCTACAGC ATGTTCCAAC ATCCCAGTGA! 37900!    
GTGCCAGAGA TGCAGGAACA GTGCATGGGC TGCAGTATAT CAGCTCCTTG!
CGTTGTGATG GATCTCCATC ACTGCCCTGG GATGGCTGCA TGGTATGAAG! 38000!    
GAGGTGGGGA CAGCATCGGC TGATGGATTC TCTTCTTCCT CCTTCACCAG!
CTCCTGGGGG ACATCCTGAT CATCGTCCTG GCCTCCCACT TCAGCAAGGA! 38100!    
CTTCACTCCC GCCAGCCAGG CTGCCTGGCA GAAGATGGTG CGTGTGGTGG!
CCCACGCGCT GGCCCACGAG TACCACTGAG CCCCACAGCC ACTTGGAGAT! 38200 hatching transcriptional end!                      
GCTCCTGGCA TCCTCGGGGT CTGCTGGGCT GTAACTGCCA AATAAACACT!
GCTGCAGTCA GGATGGAGTC TCTGCCTCTC TGTGGGGTCA GGGTGGGGGC! 38300!    
TGCCCTGGGG GCTGGGAATG GAACGAGGTG CTCACATACA CGATGCTGCA!
GGACACGTTT TGTTTCCATG AATTCCTGCA GGTGACATTT GTCTAAGCTG! 38400!    
GAGAACACAG GGAGCATTCA AGACCTGAAC AAATGAACAT ACCCCAAAAT!
ACAAATAGGA ACAACTCTGG TTCTGCATTG AGGCATCAGC AACATCACTG! 38500!    
CATTTAATGC TGTAACCTTC CACAGTTCAA GTGGAACAAG TCATTGCACA!
ACGGTGTGCA GCTGCAGTGA GATGAGGTGT GTTGTTTGTA ATGTCCTTGA! 38600!    
TGGAAGGAAG CATGAAAAGG AGCCAGGAGT TGGACTCTGT GATCCTTTTG!
GTCCCTCCCA ACTCAGGATA TTCTATGATT CTATGGTACT GGTTTTCCGC! 38700!    
CCCTGTCTAA ATTGTTATCA TTCTCCAATT ATTAAAGGCA GAATGTAATA!
GTCACAGGAA TCTATTATGG CAAAAAAAAA TGTTCCAAGA ATGATCATTC! 38800 38792-38868!                      
CACACACAGA AAGGACAGAG CACTTGGTTT CACTGCCCCT ACATCTAGGT!  upstream of adult!                                 
TTTCAGCAGC AAAAGTTCCC TGAGGTCCCC ACGCTGTGCA GAGGGCCATG! 38900!    
GTGCTCTCCA GGCTTCCAAC CCCATTTTAG CCAGATGTGG CTCGCAGCAT!
CCCCACAGGT TGCAGAGCAG CTCAGGGACA CCTCTGGATC CTGGCACGAT! 39000!    
GAATTCCTGC CCACACCCTC CTGCCCCGTT ATCAGGGAGA AGGCAGAAGG!
CACAGCTGCA GCGCAGGCAT GCACCAAGCT CAGCTCTTTG CAGCATGGCC! 39100!    
CTTTTGCCAA GCCCTTTCCA AAGCAAGTGT GCAGAGGAGA ACCGGTGCAG!
CTTTGAGCAC AAGTGTCAGC CACAGCCATG GCCAACGCCA GTGCCTTGAT! 39200!    
CCGTGGCCAC CCATCCCCTG GGCCAGCTGG TGCTCCATGT GCAGCCAGGT!
CCTGGCCCCA CTATGTCCAT CCCAGCTCCA GCCCCTGCTT GCTGGCAGCA! 39300!    
GCCGTGGCAG CCCCAGGCAC CTCTCCCAGC ACGCTGCCAT GTCACCGGTC!
AGGTCGGGTG CTGCCTTCCT GCTGCCAGCC AGGCTGTCCC TGGTGTACCC! 39400!    
ACTGTGTCCC ACCTCTCCTA GGTCATCTGT GCACTGATGC CATGCAGGTG!
ATCTCTGTGT TCTGTGTTCT GAGCCTGCCT TGTTTCCCTC TGCCTGCAGG! 39500!    
ATCTTTGAGG CAGGAGCTCT GCACCCCACA GCCTGCAGCT CACTTATTGC!
TACCCCGAAG TCAGCAAAAT GCTCAATAGC TGATGGTAAA GAACCCAATC! 39600!    
CTGGAAGGCC CTTCAGGAAG AGGAAGAGAG AGAAACCACA TGCACGCAGC!
TGGTGTGCTG GGAGGAAGGA CCCAACAGAC CCAAGCTGTG GTCTCCTGCC! 39700 39652-39729!                      
TCACAGCAAT GCAGAGTGCT GTGGTTTGGA ACTGTGTGAG GGGCACCCAG!  adult promoter!                                 
CCTGGCGCGC GCTGTGCTCA CAGCACTGGG GTGAGCACAG GGTGCCATGC! 39800!    
CCACACCGTG CATGGGGATG TATGGCGCAC TCCGGTATAG AGCTGCAGAG!
CTGGGAATCG GGGGGGGGGG GGGGGCGGGT GGTGGTGTGG CCACGGATCT! 39900!    
GGGCACCTTG CCCTGAGCCC CACCCTGATG CCGCGTTCCC TCCCCCGGGG!
TGCCAAGGCT GGGGGCCCCT CCGGAGATGC AGCCAATTGC GGGGTGCCCG! 40000!    
GGGAAGAGGA GGGGCCCGGC GGAGGCGATA AAAGTGGGGA CACAGACGGC!  GATA-1 site!                                 
CGCTCACCAG CGTGCTATCC CCACGGGAGC AAGAGCCCAG ACCTCCTCCG! 40100!    
TACCGACAAC CACACGCTAC CCTCCAACCG CCGCCATGGT GCACTGGACT!  adult translational start!                                 
GCTGAGGAGA AGCAGCTCAT CACCGGCCTC TGGGGCAAGG TCAATGTGGC! 40200!    
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CGAATGTGGG GCCGAAGCCC TGGCCAGGTN GGTCCNGCTT CGGGCATCGG!
CAGCTGCTCC CTGGGTAGGG AAACGGGTGC AGTTGAAGGT GTACACTTCT! 40300!    
GTTCCCCATC TCTCTACAGG CTGCTGATCG TCTACCCCTG GACCCAGAGG!
TTCTTTGCGT CCTTTGGGAA CCTCTCCAGC CCCACTGCCA TCCTTGGCAA! 40400!    
CCCCATGGTC CGCGCCCACG GCAAGAAAGT GCTCACCTCC TTTGGGGATG!
CTGTGAAGAA CCTGGACAAC ATCAAGAACA CCTTCTCCCA ACTGTCCGAA! 40500!    
CTGCATTGTG ACAAGCTGCA TGTGGACCCC GAGAACTTCA GGGTGAGATG!
TCTACTTGGC TGGGTCCCAT CCCAATGCAT CTCCAAGAGG AGATTCTCCC! 40600!    
TATGTCCCCC AGGGCCCATG TGTGGGTGCT CCCCATAGAT CTCCCCATGC!
TGCTGGGGGA ATTGGTGGCT GGGTTCAGGG TCGGAGGTGG GAGAGACGGG! 40700!    
AGGGAAGGGA CCAACCTGCA GCATAGTGAG AAAGGAATGA AGGGGATGGA!
GCGGCTGAGG GGTGGGTGAC AGTGAGGGTA CAAAGGAGAC GGGAAGGCAG! 40800!    
TGAGGAGGTG GCTGCAGTGC AGAAAACGGA GGGGAGAGCA AAGCAAAAGC!
CACTGTTGGA GCGGGAAGAG GTCTGAGCCA AGGGGAAAGT GAAGGAGCAA! 40900!    
GAGTGCAACA CGGCATAGAG CAAGGGACGG TGGCTTGGAT GCTGAGAGCC!
AAGGTGTGAC ATGGGGGGTG GTGGAGTTCC CACATGCCAG CAGGAGTGTG! 41000!    
GCTGTGCTGC CCACTCCCTG GAGCTCCCAC CTGAAGCCAG GTGGAGGATT!
TCTGGAGCTA CTCTTCCCAC AGTAGCAGCA GAGGGAAGGA AATATGTCCT! 41100!    
GAGTGGGAGA GATGGAAAGC TTTGGGCCCA GCAGCCCAGC CCAGACAGGA!
GCTGGTGTGT TTTGCACATT GCGCATTTTG ATGTTTAGAC TGAACAGAAG! 41200!    
GATTAATGAG TTTAAGGTAT GTCTTAACAA GAGCTGTAGT TTATAGGGTC!  41223-41309!                             
ATTTTTAAGC CTAGGAATGT TTCCCTGGTG CTGGTGCAAG CATTGGCAGA! 41300 adult transcribed, exon 3!                      
GGGATGGGCT GGCTTCAGGG CACGCTNACA GAGGGTCCTC CTATTCCCAC!
AGCTCCTGGG TGACATCCTC ATCATTGTCC TGGCCGCCCA CTTCAGCAAG! 41400!    
GACTTCACTC CTGAATGCCA GGCTGCCTGG CAGAAGCTGG TCCGCGTGGT!
GGCCCATGCC CTGGCTCGCA AGTACCACTA AGCACCAGCA CCAAAGATCA! 41500 adult transcriptional end!                      
CGGAGCACCT ACAACCATTG CATGCACCTG CAGAAATGCT CCGGAGCTGA!
CAGCTTGTGA CAAATAAAGT TCATTCAGTG ACACTCATCT GCTGTCTGTG! 41600!    
TGTCCCTGTG CAGCTCGGGG TTGGGGTGGG GGTCGTGGGC TCTGCGGGAG!
CTCCGTGGGC CGGGTTGGCT CTGCCGGAGC GCTTTGTGCT CAGTGGGGTT! 41700!    
TTATGGGGTT CTGTGGGATC TGCCTCTGGA AAGCAAACCT GCAAGCCCGT!
GTCTGGGCAG GCACAGCACT GGGAGGTTTG CAATGGGGCG ATGTCTGTAG! 41800!    
AAATGAGTTT TCTCACTGAC ACAGAGGAGT CATATATTTA ATAGAGAATA!
AACAAAGTGA AGGCTTTAAT CCTCCCTGGA TCATTTCTGG CATTCAGCCT! 41900 41860-41933!                      
CCCCGAAAGG AGCTGACTCA TGCTAGCCCA GCAGCCAGCT GGGTGGGGGC! ! old enhancer Reitman, 1990!               
AGGTTGCAGA TAAACATTTT GCTATCAAGA CTTGCACAGA CCTTGTTTAT! 42000 GATA-1 sites; G = nuc. start!                      
GCACTTCTTC ACCCTACGCT GCCCATTCTG CTGCTCTGCG TGAGGGAAGA!
GAGGGGGTTA ATCCTGTCAA TAGTAGTAAC TATTAATGAT GTTCTGGAAC! 42100 42032-42154!                      
TAAAAATCAA TTGGTGTCAT TTGCATGCAA ACTATAGAGG TGTTTAAATG!  enhancer; A = nuc. end!                                 
TGCACAGCGC AGGGCTCCAT AGGGTGGGGG TTGTTCTTGG CATGGGAGAA! 42200 Buckle et al., 1991!                      
CCACTCATCC CATTGAGATG ATCACAGGGC AGCAAAAGCA GCTGCTGCTG!
GAAGGACGTG CAGCTTTCTA AGGGGAAGCA GAGGGGATAC ACCAGGAACC! 42300!    
TCTGGCACCG AGTCTGTACC ACATCCTGAC CACAGCTGCA TAAACAGCAC!
CTCCATCAAG TTGGCACCAT GTCCCGTCCC TCCTTCATCC CTGCTCGTGG! 42400!    
GCATCTCCCT CTCCTCCCCT GACTCACTGC TGGGCATCAA ACCCCCCACG!
GCCCCTTGAC CCCTCCTCAG GCACTCTGCT CAGTGGAAGG AGGGGCTTGT! 42500!    
TGCTGGCACT GCTTACACAA GGACATAGGA GGACACTCCG TGTTAAGACA!
AAAGGTGCTG TCCTCCTTGC AGGTGTGTGG GCAGGCACAG TGAGTCGTGC! 42600!    
TCAGGTATCA CCAGCAAAAG GCAGATGTAG GCAACTCTAA TCCATGATTC!
AGATCTACTC CAGGTGAAAA GTAATGCATA CAGCCGGAAG GAAAAGGGTA! 42700!    
TTAAAAGGCT GAAGATCTCC CTCAGTATTT TCATTCTTTT AATTGGTTTT!
CCTCCCGTTC CTTTATTTTT GGTACAAGGC CAGGAGGGCA CTGAACAGGT! 42800!    
GGTGCTCAGT GGAGCTGGAT TTAATCTTAA TGATCTTTTC CAACCGTAAT!
GGTTCAATGA TTCAGTGATT CTATGGAGGA AGCAAGCCCA GGGCTCTGGG! 42900!    
GAGGAGCTCA GCCCCTTTCC AGCTCTGCTG CAGCCATGCG AGCACCCTCC!  42948-43039!                                 
CCTTCTGCTG TGCTACAGCA TGACCCCGTG CCTCTTGGAT GTCACTGGTT! 43000 upstream of epsilon!                      
AAGGATACTA ATAATCTGTT CTTCTGATAC TTCATGCAAT AGTAGCTCCA!
CGCAGGGCCA GTGTTCCTGG GGAAGGTACC CAGAGCTGTG TTCTCAGGGG! 43100!    
TGGCACAGGA GAGCAGTTTG CACGGAGTCT GAACAGCTGA ACTCAGGGGA!
GATGTGGCTC ATGCCAGCTT TGTCATAGAA TCACAGAATC ATTCAGACTG! 43200!    
GAAAAGCCTT CCAAGATCTC TGAGCCCACC CTCACCCCAC CATGCCCACC!
GACCACGTCC CTCAGTGCCA CATCCCCGTG GCTTCGGTAC ACCTCCAGCG! 43300!    
ATGGTGACTC CACCACCACC ACGGGCAGCT GTGCCAACGC ATCACCGCTC!
TCTGGGAGAA GAAATGCTTT CCAGAAGTCA ACCTCAATCT CTCTTCACTG! 43400!    
GGGCAGGATC CAAAAGGAAA CCCCTGGGTC CCTGCTGGAC ACCCCTGAGC!
TGAGCTTTTG CTGCTTTCTA AGCCTACATC GGGTGCTGCA GAGACAGCTC! 43500!    
TGGAGTTCAA AGCATGTTTT CCCTGTTCTT TATGGATGTG AATGTAAGCA!
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GAGCTGCGGT GAAAGGGGTG ATCCTGTTCA ATCCCTGTGC AGCAGCTTGG! 43600!    
CACGTGGCCT GACACCTCAC AGCTGATGGG TGAGATTCCA CCGGCCCCAG!
AATGGAAAGT AAATGGCCCA GGTCATGTTT TGTCATAGTA AGCAACAGTG! 43700!    
GGGTTGAAGT CCATTTCAGT GTTCATGGTG CCCGTGGTGC CTCTGCTGCT!
GGAACAGCCC TGGGCTGCAT GGCCACGGGC TGCATGTTGG CCTATGTCAT! 43800!    
GGGGCAGCTC TGGGAGAGCC ACGGTGCAGG GCGTACTCCA TGGAGTCCCA!
TACATGTGCT GCAAATGGAG GCTGGCTCTT GGTTGGATAT CAGGAAGAAC! 43900!    
TTCTTTACAG GAAGGGCTGT TAAGCACTGG AATGGGCTGC CCAGGGAGTT!
GGTTGAGTCA CCAACCCTGG ATGTGTTTAA CAACCATTTG GATGTGGTGC! 44000!    
TCAGGGATGT GATTTAGCGG AGGGCTGTTA GAATTAGGGC AGTTTGGTCG!
GGTTGTGGTT GGACTCAACG ATCTTTAAGG TCTTTTCCAA CCTGAGCAAT! 44100!    
TCTATGATTC GATGATTCCA TGTGCAGCCC TTTCTCTGAA AAGGGGCCCA!
GGTCTGGTAG GGCAGCGCTG GGGGAAGGGT CAGAGCGGGG ATGGCTGGAG! 44200!    
GCCCCTTGGC TGCTGCCACA CCCCGACCAC CCCCTCCTGC CCTCCAGCAC! ! 44235-44320!               
AAACCCCCAC ACATCCCAGC CAATGACCCC ACAGCGTGGG GTGGGGAGGA! 44300 epsilon promoter!                      
GCTGTCAGCG GTGGATAAAA GCCCCGGGGG TCCGCAGCTC CGCTCCAAGC!
TCTGAGTGCT CCCACAGCCG CACGCCAACC CCGCTGCCAC CATGGTGCAC! 44400 epsilon translational start!                      
TGGTCCGCCG AGGAGAAGCA GCTCATCACC AGCGTCTGGA GCAAAGTCAA!
CGTGGAGGAA TGCGGTGCCG AAGCCCTGGC CAGGTAGGTC TGCTCCTGGG! 44500!    
ATCGGCTCAG CTGCACCCTG GGTACTGAAA CCACTGCAGT TTTAGGAGGC!
AGTGCTAACG GTGTGTGCTT GTGTCCCCCA TCCCTCTGCA GGCTGCTGAT! 44600!    
CGTCTACCCC TGGACCCAGA GGTTTTTTGC CTCCTTTGGG AACCTCTCCA!
GCCCCACCGC CATCATGGGC AACCCCAGGG TCCGTGCTCA TGGTAAGAAA! 44700!    
GTGCTGAGCT CCTTTGGGGA AGCCGTGAAG AACCTGGACA ACATCAAGAA!
CACCTACGCC AAGCTGTCGG AGCTGCACTG CGACAAGTTG CACGTGGACC! 44800!    
CCGAGAACTT CAGGGTGAGA TGTTGGCAGC GTGAGCCCCT TCCACTGCGC!
AGTGCTTTGC TTTGAAACAG GGGGGGCTGC CCCGGCCGTG CTGGCTGAGT! 44900!    
ACTTTCTGTC TGGTGAAGGC AACATCCCTG CATAGTACCC AATGAGTGCA!
GAACTCYGCA GGAGAGCAGG TGGCTTCAGG CTGAAAAGTT CCATTTTTTG! 45000 44990-45062!                      
TGTCAGTGTA GCAATGGGAA GGAGAAAGGA TTGTGAGGCT GTAAGCTAAA!  epsilon transcribed, exon 3!                                 
GGGGGCACTT GGGTTGAGGA CAAATAAAAG CAAACCAGAG AAAGGTTCAG! 45100!    
CCTGGGCTGG AGGAAGCAGA GGTGGAGGGA TGCTCGGCAG AGCACTGAAG!
GAAGTCATAC ATCCTATAGA ATTCTATGGT TCTATGGGAA TAATAGCAGT! 45200!    
TCTGAAATGA CAGAGCAGGT TTCTGGCTTG TCCAGTATGG GCTGCCTGTC!
TGGATCATAG AATCATAGAA ACCGTAGAAT GGCTCAGGTT GGAAGGACCT! 45300!    
TAAAACCCCC AGGGCTCAAC CCCTGCTGTG GGCTGGGTGC CCCCTACAAG!
CTCAGGCTGC CCAGGACCCA GTCCGTGGCC TTGAGCACTT CTAGGGGCTT! 45400!    
CTCTGCACAA CCTGGGATAG AATGGGCAGT CCCTCTTCCC CCAACACCCG!
CAAATAAAAA TGTGTAGATT TCTTCATTTG CAAAAAAAAA AAAAAGCAAA! 45500!    
TAAATTACAA GTGGTGTTTT GCAAGGTGGG TGTCAGGCCA AACCGGCACC!
CTAAGAATGG AGGAAAACAG CTTCRAGGCT TTTTCTCTGC CCACTCTCCC! 45600!    
TTTATTYTGG TAAAGATGGA GCAGACAACT TTTTTCCTCC AAACTCAGAG!
CTTCCTAGGC AAAGAGTGAG CATTCGAGCC CAGCAGCCCC AGCAGCAAGC! 45700!    
ACTGAGGCTG TGCTTGGTGG GAAGAGGGGA TGCTGTCTGG CCATCCAAGC!
AGCACTAACC CTGCCTGTTC TCCACTTTCT CCTGCAGCTC CTTGGGGACA! 45800!    
TCCTGATCAT CGTCCTGGCC TCCCACTTTG CCAGGGATTT CACTCCTGCC!
TGCCAATTTG CCTGGCAGAA GCTGGTCAAC GTTGTGGCTC ATGCTCTGGC! 45900!    
CCGCAAGTAC CACTGAGCTG CAGCACAGCC GTGGCCATAG CTCCCAATAA!  epsilon transcriptional end!                                 
ACACCTGCAA TGCATGTGGT CTGCCTGTCT GTGTTGGGGG ATGTATGGGG! 46000!    
AGAGTGTCAT GGGACTGCTG AGGAGCGTTC TCATCACTCT GGGGTACACC!
CATGTGTGTG CTCTGCCTTG GCATGCACAT GGGGCTGGGG GGAGAAAACC! 46100!    
CACACCAAGT TCTGCAGCAC ACCCACAAGG GGCCTGGCAC TGAGAGGGCA!
TCAGAGAGGG CTGCAGGAGT AACTGGGGAC TGGGAAGAAT GCAAGCCTGT! 46200!    
TCTCCTGACT CTAGATTAAT AAGAAATGAG ATGATTCTGT GATTTATCCA!
AGGAGGCTGT GGATGCCCCA TCCTGGAGGC ATTCAAGGCC AGGCTGGATG! 46300!    
TGGCTCTGGG CAGCCTGGGC TGCTGGTTGG TGACCCTGCA CATAGCAGGG!
GGTTGGAACT CAATGAGCAT TGTGGTCCTT TGCAGCCCAG GCCATTCTAT! 46400!    
GGTTCTATGA ATCCATGATT CTATGAAGCC AGCAGTGCCT GGGCATCACA!
GCTCCCTGTC TGCTGCTCCA TCCCCCACCC AATGGTCCTC GTGCTGCTCA! 46500!    
GAGCTGGGCT GCACATCAGA CTCAGTTGTT TGTTCACTGG GATGAGGGTT!
ACAAGGTTGG CTTTTATCTC CTATTTTATT ACCCCCCAAA AAGGAAGAAG! 46600!    
TATAAGAGCA TCCAGGACTC TATCTCCCTC CTACATCTCA GAATCACAGA!
ATCATAGAAT CCTTAGAGTT GTAAGGGACT TCTGAAGGCC ATTTAGTCCA! 46700!    
GTTCCTCTGC ATTTAATAGG GACACCACAG CTAAATCAAG TTGCCCAGGG!
CCTGATCCAG CCTCACCCTG AAAGTCCCCA GGGATGGAGC ATCCACCACA! 46800!    
TCTCTGGGCG GTGACAATAA CTCAGAACAT GGTGGAGAAA ATGTGGTTCA!
GGACATAGGT GCTGCTGAAT GCTGTGCCTC TGGAGGGCAG TGAGGTTGTG! 46900!    
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GGGGGAATGG AGACACAGGA GATGGGATGG GATGCTCCAG AATGAGCTGA!
CGTGCTTTGT GCCTTCCATC AGGAAAGCTG TACCCAGAGG TTTGGCTGTG! 47000!    
CACACCCCAA GATGTGCTTT GGTGTTCCTT CACTTCTGAG GAACTGCAGC!
CCAGACCTGG TTCAGGTCTT GCTTTAAAAT GATGGGAAAA CCCTGAACCT! 47100!    
CTATGAACCG CTGCACTGAA TGGACGGGAA GCTCTTCTCA TCTTCTCTAG!
CAGGTTGATG GATTGCTCTC CTCGCTCACA GCAGCTCCTC TCAGAGCTGA! 47200!    
GGCAGAGCTG CCAACCTCTG ATGAATGAGC ACACCGTGCT GCCTTGGAGA!
GCAATAAGGG AATTTCCACT GTGACAGCAG AGTAACAACT GAATGGACTG! 47300!    
TGTGAGAGGA TGTTAAAATT AGTTGGAAAT AACATGGGGA TGTAATAGAA!
ATCAGCAAAC AGAGCTGAGC TGTGGCTGCA GCCTCCCTCT TTGGGTGCAC! 47400!    
GTCCATCTCT GGGAGCTGCC CTCTGCAGAC CCACCATGCA CAGCTGTGCA!
AATACTGGAT GGAAGATGAA GATTCCTGCT TCATAGAATC ATAGAATCCT! 47500!    
AAAATGGCCT GGGTTGAAAA GGACCACAGT GCTCATCCAG TTCCAACCCC!
CTGCTATGTG CAGGGTCACC AACCAGCAGC CCAGGCTGCC CAGAGCCACA! 47600!    
TCCAGCCTGG CCTTGAATGC CTGCAGGGAT GGGGGCATCC ACAGCCTCCT!
TGGGCAACCT GTTCAGTGCG TCACCACCCT CTGGGGGAAA AGCTTCCTCC! 47700!    
TCATATCCAG CCTAAACCTC CCCTGTCTCA GTTTAAAACC ATTCCCCCTT!
GTCCTATGCT TGTCTCATAA TAGATAGCAT GCACAGCTTT AGTAGGTGTT! 47800!    
AAGGAAAACC AGCAGTCAAA TATCAGTGCT AGGATAGCTG ATGGAGCTGG!
TGCCATGAAA AATGCTGCGG TGGTATTTTG GTACTTATGG GAGAAACTGC! 47900!    
TGTGTTTGCT CCACGGGGAG CCTCTTGTTT GGAAATAAAC CACTCACAAT!
TTGTGCTTAA AGTCACTCTG AACCCATCAA ATCCCAGAGC CTTTTAAGAA! 48000!    
ATCCTTACTG GAAGTTTAAT GCTGGTCTGA GGAGCAGGTG GAGCAGAGCA!
CTGATAGATC TGCTCAGATC CCCACGCTTG CTGCTGTAAG AGGAGTACAA! 48100!    
AATAAAGCAA CTCAATACTC TTTTGGCATA AGCCAAAAAT ATTCCTTCAG!
GGCTGCCCGG GAGCAGCACC TCCTCTTCTT TTCTGCATTG CTATCAAAGT! 48200!    
CTGATGTCAT TGCAACAGCA GCACTGCTGC AAAGAGCTGG AGAGACGTGA!
TTTGCATATG AAGGGATTTT TGATCCATTC CTTTTTGGTA GCTTTGGAAG! 48300!    
AATGAAGGTC TGAAACCCCA CCATGACTCC TCATGGTAGT TCTGCCTCAT!
TTTTCCTTTT TTTCCCCTCT GCTTCTCCCA CCCCGATTTG GTGCCCTTGT! 48400!    
AGCCCAGATT TGCTTCATCA GGAGCACCAG AGATGTGCTT ATTTCCCATC!
CCAGGGCAGA AGTGGAAGGA TATCAGCGCT GAGGCGGTGA GGTAGGAGTT! 48500!    
CCTTTTCCAC ATCCCAAGGA CTCCTTTGGA CAGAAGGACA TGAAGCAAAC!
TTACAGACCA AATTATTTTC CTTTCCATTT GGCAGTCTGT TATCACATCT! 48600!    
CCACCTTTCT TTGTCACTAC ACATCATGGC TGCTGTGCAG ACACCCCACT!
GAAATGAGCA ACTCCTGCAT AGGGACCCAC ATGTTCACTA CATGGAAAAC! 48700!    
AACAGTTGAG GACGTTAATG TGATTTTGAT ATATCCTACA CCACCAAACC!
TGCATGGCTG ACATGGTCTG GAGCAGCACC ACCTTTGTCC ATAAAGCGTG! 48800!    
GCACCATCTC AGAATCAGAA TCACAGAATC ATAGACTTAT AGAATGGTGT!
GGGTTGGAAG GGACCCCAGG GATGATGAAG CTCCAACCCC CCGCCGCAGG! 48900!    
CAGGGCCACC AACCTCCACA TTTAATACCA GCCCAGGCTG CCCAGGGCCC!
CATCCAACCT GGCCTTGAGC ACCTCCAGGG ATGGGGCATC TCACCATGCC! 49000!    
ATGTATTCCT CCTGCTACTT GAGAGAAGAC AAATGGGACA AGAATCTCCT!
GGGTGCTGCC CAGCTTCACT GCAGGGCTAT GCAGCACCTG CTGGGTGGAG! 49100!    
GATGTGCTCA CCCTGACCCA CCAGGCTCTG GTACCACTTC CTTCAGGCGC!
AGCCACGCAC TGCATGTGTC CCTCAAACAG CCATCCAGAG AGCTCCTGCT! 49200!    
TCGCCCCATC TCTTCCTCCA GGGAAGAACT CCCAGTCACA GAGGGGAGAA!
ATTCATTATG GAGTTGTTTC CTTTGGGATG TTTCCGTTTA TTTTATTAAC! 49300!    
ATCCTTTATT TTACACATAT GAAGTTTTCA GCATTTGGCA GCATTAGAGA!
GAAAGAAACC CTTCCAGTGA GAAAGAAGGG CAAAATTACT GGTCTTGGCT! 49400!    
CTTTCTTCAC GTTTCAGCCT GTGTCCTGGG TAATAACTAG TTGAAATGCA!
TGAATGTGGA ACACAAGCAT TGCCAGGCAT GCTCTGAACT GCACTGCTGG! 49500!    
ATCATTTTCC ATTGGCATCT TAGGACAATG TTTCAGCAAA GTACTCCATA!
AATTCTAGCC CTGACCTTTA CTTTTTCTGT TTTGCCTCTT TGCTTTGGTT! 49600!    
ACCCTGTCCA TAACATGGAG AAAATAAAAT GTATGTATCT TTAAAAGGAT!
GTATTGGGAT TCCCCTGCTG ATGTTCAAAA AATGATCGCA CATCACCACG! 49700!    
TGGAAGTGCT TTTGCACAGC CAAAATGTAG GCTCAGCCAC AAAACAGTTT!
AAACCTTCTC AAACACAGGG AGAAAGAAGA ATGAAGAGAC ACCACTTCTG! 49800!    
CTCTACAAGG CCTGGCAGGG ATGTGGATGT TTTTCTAGGG ACACAGAAAC!
CTAAAGATGC ACTGTATTTT ACCTCAAATT CAGTGACAAG CCTAAGCAAT! 49900!    
GTTTCCAGAG TCCCAGGTGA CTCTCACTGC TGCTGGGATT TCACGTGGGT!
GTTATAAAAA CAGACAGCTT CTCCTGCATG TGAAACGCTT GGGCAGCAGT! 50000!    
GTGATTCCCT CCCCCTCTGC CTCGTGTGCC GAAGGACATC AGCCAAACAG!
AGGTAAGGGG GTCGGAGGCA GCCGTGTGTT TCCATGTCAG TTTCACTTTA! 50100!    
CCACTGATGA TTTAATTTTG CAAATGTTAT TTTCCCTTCA GATTTTGTAA!
TGAGACATTG TTTTGTTTCA CAGTCAGCTT GCATATCTAT CACTGCACTT! 50200!    
TCCTGCAGCT CTTACACCCT TCCCTGTTTA TCAGTTTTCC TGTGAAAACA!
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TCACCTAGCC ATCAGGCAGC TACTGCCATC ACACCCTGTG ACTGCCTGTT! 50300!    
TCCATCCATC CGTCCATCTA CCCCTCCGTT CATCCATCCG TCCATCCATC!
TGCCCCTCCA TTCATTCATT CATTCATCCA TCTATCCATC CGTCCATCCA! 50400!    
TCCATCCATC CATCCATCCA TCCATCCATC CATCCATCCA TCTATCCATC!
CATCCATCCA TCCATCCATC CATCCATCTA TCCATCCATC CATTTATCAT! 50500!    
TTATCCATCC ATCCATATAG ATTTTCATCA CCTCTTCCCC TGCCTCCTCT!
CTGCTCTCCT CTGCCCCTAT GATTCTGATG TGCCGCAGGG GCAGTGCAAG! 50600!    
GATGCAGTGC TGATATCCAC TGGACGAAGG TGAGGGCATT TCTACAGAGA!
GCAATCTCCA GTGCTATAAT TGCATATTCC AGGCAGGATT TAAGACTCCA! 50700!    
AAGTCAGACT CGGAGAACTG TGTTTTCTTC ATGAGATCTT TCACAAAACA!  50732-50806!                                 
CCAGTTATGC TCCATCTGCT GGTGAGATGG CGTCTGCTAT GCCTCTGAAG! 50800 3’HS (5’ end), CTCF site                       
CAGCAGGTGC TGAGCACACT TGGATACGGG ACAACGCAGT AGGTGAAGCA! ! Reitman & Felsenfeld, 1990!               
GCCCTTCCAC CCCTTCTGGT CCTTGCATAC CTTGAGCCTG GCAGATGGTG! 50900!    
CTGTGAGACA CAGCTCTGTC AGCAGTCTCC ATCCTCATCC TTTTGGGCAC!
ATAGCTAAGC TTCCCCTGGA GCCACAGCAC TCACACCTCC CCCTGGCACA! 51000!    
GCACTGAGCT GCGCAGTGCA GACCCATCCC TCAGAATGCA CACACACAGC!  51021-51115!                                 
TCACCTCTTT ACCAGGGACC AAAACTGAAG GAGGGTGGGA GGAGCAGATG! 51100 3’HS (3’ end)                       
GGGGATATTC CTGCCTCAGG ATCACCATGA AGCAATCAAG CCGAACAGCT !  Reitman & Felsenfeld, 1990!                                
TAGGGGAGCA CAGGGCGCAG GGTGGGACAC ACGGGCTCTG GGTGCAGAGC! 51200!    
TCCATCTGTG CTGTGGTGCT ATCGGGAAAG GAAAGCCATT TTTTCCCCGT!
TTTATGAGTA TTCACTCAGG ACACAGCAGC TGATGACGCA CAGAAAGAAC! 51300!    
AGCACAACTT TTCATTTTTG CTGGGTAGCC CAAAGCACAT TTCCAGATAG!
ATGTGAAAGT TAGGAACATG TTCAGTTTGA ACATGCAGAT CAAGTACCCC! 51400!    
AAATTTATAT TTCATGTCAC AGATAATTAT AGCATCCTGG AAAGCTGACT!
GTAATTTAGC TAATTACTTA GCTGGCAAAG TAAAGTGTGT AGGCACAGAT! 51500!    
GTCTGGAGCC TTGTCTGAGG GGGGGGGGGG CAGTTGGAAA TAGACTAATG!
CTATTTTTCA TGGAACACTA ATGAATTTAG CCACACGCCC TCCAATTAAA! 51600!    
CAATATCGTG TTCCTTGTTT GCATAGGCAG ATGGAGTGTG AGTTCCTTGA!  51626-51700!                                 
GTGCTGAGGG CTGGGAAATT TTGGCTCCTT CCCCATCAGC TACTGCAGCC! 51700 brain-specific HS!                      
CCTGACAAGA GCAGCAGCAA AGCCATGCAA AGATATCTGC TTTGTTCTAC!
ACTCTTTTGT TTCACCTGCA ACCCCAAAGC GTGCATATGC TGCATTCAGA! 51800!    
GTTTAACTTT TTAAAGCTTT TATGATTACC CTTCACAAAG CACTGCATTT!
TCCCTGAGGT ATTCTGTGGG CTGTGGCTTG GGAGCTGTAG GCTGAGAGTT! 51900!    
CTGCAGAAGA AATGAGAGCT GAGTTTGAGA ACACATTGCT TGATGTCACC!
TGTAGGTTTG TGCTGTGAAA ACATCACTGC TAAGAATGAG AATTGCTGTA! 52000!    
CGTACTATTA TTGCACCCAC TGATCAAAAT ACCCACTGCT TTGAATAGAT!
TGATGAGCTG TCACTAAGCA CAGCAAGCAA AACTGGAATA GTAAATCATC! 52100!    
TTTGAAGTGA AGGGAAATAA TAACATTCTA AATTTCCCGT TGCATTGATG!
AAATTAGACT CATGGGAGTG ACTGTGTCCC CTTGGGGGTC AGGACAGACA! 52200!    
ACTTCACAGT AATTCCTTCT GTTTCTGTAG ATTCACAGGG ACCTTGCATG!
ATGGAATTTA ATGGAATTCC ACCGATGGTT TGGGTCCTTA AAGCCCATCA! 52300!    
ACCAACCCCT CCATGGGCAG GGTACACCTC CCATAGCCCA GTGCCCATAG!
CCCCATCCAT GGCCTTGGGC AACTGAATAC AGGAGCCCAT TCCTGTTGTG! 52400!    
CCTGTTACTG TGTGGGCACA ACACAGAGAA GAGAGTGGCC TTTTCTTCTT!
TCCCTTCAGC ATATGGGTAG GATAAGAATA GCAAAGGGTG CAGGTGGAGG! 52500!    
ACAGGAGGAC AAGCAAGACC ACATCTGCCA AGAGCCTGGC CGTGGTGAAA!
GCTCAGCAGC TGGGCGGAGG GCAGTGGTTG GTGCAGACAG GGCATCCTGC! 52600!    
ACTGGGAAAT CTGAAAATCC AGCACGGGAA GCTGAGATCT GGCTGGGGCA!
TGTGTGCCCT CCAAGCAAGT CCAGACAGAG GGCTGGGGAC ATGGCCTAGG! 52700!    
AGGGAGAACC CATGTGGAAA GCCTGAGGGG GACCCTGACG GAGATGAGGA!  52733-52804!                                 
TCATGGCTTG TCTGGGCAGG AGAGCAGTGT GATCCATGGG GACCAGGAGA! 52800 close to OR start codon!                      
AGGGGCTGCA GCAGCGCCCT GGGAGGAATG TAGGCTTGCT GCAATAGATA!
ACGTTATTTT CTATTGTACA GGTGAGGAGC CTGTAGAAAT GAAGCAGAAG! 52900!    
AGAAGAGAGC AGAAGCAAGA CCTCCACAAT GAGCCTTAGA CTGTGTCCAG!
ACACCGGTTG GTTTTCATTG CCCTCAGAAT CTAATCCTGC ATTACCTTTG! 53000!    
AACTGTTCAT GAGAGTGAAG TCTTTAGCCC AGGCTGGCCC CAGCCCAAGC!
TGAACATGTA CCCCAGGAAC AGCAGCCAAG CTCAGCCTTT CCTGCTGGCA! 53100 OR translational start!                      
GGCCTTCCCG GGATGGCTCA GTTTCACCAC TGGGTGTTCC TCCCTTTTGG!
TCTCATGTAT CTGGTTGCAG TGCTGGGAAA TGGTACCATC CTGCTGGTTG! 53200!    
TGAGAGTGCA TCGCCAGCTC CACCAGCCCA TGTACTATTT CCTTTTGATG!
CTGGCCACCA CAGACCTGGG CCTGACTCTG TCCACCCTGC CCACCGTTCT! 53300!    
GCGCGTCTTC TGGTTGGGTG CCATGGAAAT CAGCTTCCCC GCCTGCCTCA!
TCCAGATGTT CTGCATCCAT GTCTTTTCCT TCATGGAGTC CTCAGTGCTC! 53400!    
CTGGCCATGG CCTTTGATCG CTATGTGGCC ATCTGCTGCC CGCTGAGGTA!
CTCCTCCATC CTCACTGGTG CCAGGGTTGC ACAGATTGGA CTGGGGATCA! 53500!    
TCTGCCGATG CACACTGTCA CTTCTCCCAT TAATCTGCCT CCTGACGTGG!
CTGCCTTTCT GCAGGTCACA TGTGCTTTCT CACCCCTACT GTCTGCACCA! 53600!    
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GGATATTATA CGACTAGCGT GCACAGATGC CACCCTGAAC AGCCTGTATG!
GATTAATCTT GGTGTTGGTT GCAATCCTGG ACTTTGTTCT CATTGCGTTG! 53700!    
TCCTACATCA TGATCTTTAG GACTGTGCTA GGCATCACCT CCAAAGAGGA!
GCAGACCAAA GCCCTAAACA CTTGTGTCTC TCACTTCTGT GCCGTCCTCA! 53800!    
TCTTCTACAT CCCTTTGGCT GGGCTGTCCA TTATACACCG GTATGGAAGG!
AATGCCCCAC CTATTAGCCA TGCTGTCATG GCCAATGTCT ACCTCTTTGT! 53900!    
CCCACCTATA CTGAACCCAG TCCTCTACAG CATGAAAAGC AAGGCCATTT!
GCAAAGGCCT CCTGAGGCTC CTGTGTCAGA GAGCAGCCTG GCCTGGCCAT! 54000!    
GCCCAGAACT GTTAGAATCA TAGAATCACA GAATGGTTTG AGTTGAAAGG!  OR transcriptional end!                                 
GACCCTTAAA GTCCTTCCAG TCCCACTCCC CGCAATGAAC AGGGATATTC! 54100!    
ATGGCTCCAT CAGTGCTAAG AGCCCCATCC CCTGACCTTG AGTGGCTCTG!
GGAATTGGGC ACCACCATCT CTCTGGGCAA CCTGTGCCAG TGCCTCACCA! 54200!    
TCCTCAATCT CGGTCAGTTT GAAGCTGGTA TGGAGGACAG ATTCCACCAA!
AAAATGTCAC TTAGATATCA TGAACTCCCA GTACCAGGTG TTGCTCATCT! 54300!    
GATTCTGGAA CAAAGTTGGA TGTGAAATTG CAGAGCTGCT GGACAGGTGA!
TTATCAACTT TCCTCCACCT GCAATGATGT CTCCATGGGA TTCTCCCTGA! 54400!    
GACCTACTGA TCAGTGTGCA TTATTTCCTC TCCTGATGGG ACAACAGTGG!
TTTGGAGAAA GAATATTGTG AATAAGCACA TGAATAAGCA CATATGGGTA! 54500!    
AAACTTTTAG AGTCAGACGG GGAAGGGGAA ATCCTCCTAT GGCAGTGGGA!
CTTCTCTGAG GGTGGCTCCA GCTGGAGGAT CC-------- ---------- 54582!            !!!!!!!!!!!!!!!!!!!!!!!!!!
S3.2 • Annotated sequence of the chicken ß-globin locus and its flanking regions 
Complete sequence from the folate receptor, through the 16 kb region of heterochromatin, the 
1.2 kb insulator, complete ß-globin locus and just beyond the start codon of the olfactory 
receptor. The sequence is annotated with primer (red, forward; green, reverse) and TaqMan™ 
probe (blue) binding sites (used in real-time PCR analyses), together with the insulator start and 
end positions (pink), CTCF and GATA-1 sites (orange) and translational start and transcriptional 
stop codons for each gene (purple). The old enhancer amplicon is indicated for comparison 
(brown, primer and probe binding sites). The sequence for positions 24044-54582 was obtained 
using GenBank ID: L17432.1.  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S3.3 • Primers and probes were used to amplify 37 sequences in the chick ß-globin locus 
Thirty-seven primer and probe sets were designed using Primer Express software to amplify 
specific sequences within the chicken ß-globin locus. Amplification of each sequence was tested 
using 10 ng of genomic DNA from 15DCE. The adult transcribed region (▬, amplicon 41223) 
failed to amplify correctly, due to the forward primer and TaqMan™ probe having identical 
sequences. The primers and probe for this amplicon were re-designed and synthesised for 
repeated real-time PCR analysis of ChIP fractions.  
40   0 5 10 15 20 25 30 35
   
   
0
0.5
1
1.5
2
Cycle
ΔR
n
2010 30 400 5 15 25 35
 244
   !
S3.4 • Distribution of H3K4me1 across the chicken ß-globin locus through erythropoeisis 
Mono-nucleosomes prepared from multipotent erythroid precursors (HD24), erythroblasts 
(HD37) and definitive embryonic erythrocytes (15DCE) were subjected to ChIP using antibodies 
raised against H3K4me1 and amplification of several sequences in the input and bound fractions 
by real-time PCR were used to determine the distribution of this modification across the ß-globin 
locus. Primers designed to amplify DNA covering the enhancer nucleosome (brown shading) 
actually miss the 5’ end of this nucleosome by 25 base pairs. 
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2
1
4
10
8
B/
I
I/B
15DCEOFF ON ONOFF OFF
6
-2
16 kb heterochromatinFR ρ εβH βA OR
-5
1
5
10
15
B/
I
I/B
HD37ON OFF OFFOFF OFF
1
-5
5
10
20
B/
I
I/B
HD24OFF OFF OFFOFF OFF
15
 245
!!!!!!!
   !!!!!!!!!!!!!!
S3.5 • H3K27me3 distribution across the chicken ß-globin locus in 5 & 15DCE 
100 µg of mono-nucleosomes prepared from 5DCE or 15DCE nuclei by MNase digestion was 
incubated with 25 µg H3K27me3 antibody (ab6002, Abcam). Histones from a sample of the input, 
unbound and bound fractions were precipitated with vanadate and resolved on SDS gels to test 
for the presence of H3K27me3 by Western blotting (insets). DNA was recovered by phenol-
chloroform extraction and several sequences within the globin locus were amplified and 
monitored by real-time PCR to calculate the enrichments and depletions of H3K27me3.  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S4.1 • pET3a-H2A histone expression vector and insert sequence 
(A) Plasmid map and corresponding positions (in base pairs) of each component are provided. 
The T7 promoter is indicated by an arrow (➧). (B) The insert sequence (GenBank ID: AJ556870.1) 
highlights the ribosome binding site (RBS) (green), NdeI and BamHI restriction sites (purple) and 
start and stop codons (green and red, respectively).  
A
B
. . . T A A C T T T A A G A A G G A G A T A T A C A⋎T A⋏T G T C A G G A A G A G G C A A A C A A G G C G G T 
A A A A C C C G C G C T A A G G C C A A G A C T C G C T C A T C T C G G G C T G G G C T A C A G T T C C C T 
G T T G G C C G T G T T C A C C G G C T G T T A A G G A A A G G C A A T T A T G C A G A G C G G G T G G G A 
G C T G G A G C T C C A G T C T A T C T G G C T G C A G T G T T G G A G T A T C T G A C C G C T G A G A T T 
T T G G A A T T G G C C G G G A A T G C G G C C C G T G A T A A C A A G A A G A C T C G C A T T A T C C C C 
A G A C A C C T G C A G C T C G C T G T G C G C A A C G A T G A G G A A C T G A A C A A A C T G C T C G G A 
A G A G T C A C T A T C G C T C A G G G C G G G G T C C T G C C C A A C A T C C A G T C C G T G C T G C T G 
C C C A A G A A A A C C G A G A G T T C C A A G T C G G C C A A G A G C A A G T G A T C G⋎G A T C⋏C G . . .!
T7 Promoter 
RBS 
NdeI 
Insert 
BamHI 
T7 Terminator 
Amp R 
pBR322 
 
Total size
1-19 
66-72 
78-83 
80-480 
481-486 
555-601 
1204-2061 
2212-2879 
 
5004 bp
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S4.2 • pET3a-H2B histone expression vector and insert sequence  
(A) Plasmid map and corresponding positions (in base pairs) of each component are provided. 
The T7 promoter is indicated by an arrow (➧). (B) The insert sequence (GenBank ID: AJ556871.1) 
highlights the ribosome binding site (RBS) (green), NdeI and BamHI restriction sites (purple) and 
start and stop codons (green and red, respectively).  
A
B
. . . T A A C T T T A A G A A G G A G A T A T A C A⋎T A⋏T G G C C A A G T C C G C T C C A G C C C C G A A G 
A A A G G C T C C A A G A A A G C G G T G A C C A A G A C T C A G A A G A A A G A C G G G A A A A A G C G C!
A G G A A G A C A A G G A A G G A G A G T T A T G C C A T T T A C G T G T A C A A G G T G C T G A A G C A G 
G T G C A C C C C G A T A C C G G C A T C T C G T C C A A G G C C A T G A G C A T C A T G A A C T C C T T T!
G T C A A C G A T G T G T T T G A G C G C A T C G C A G G G G A A G C C T C C C G C C T G G C T C A T T A C 
A A C A A G C G C T C C A C C A T C A C C T C C C G G G A G A T C C A G A C C G C G G T C C G A C T G C T G!
C T G C C T G G G G A G T T G G C C A A A C A C G C C G T G T C C G A G G G C A C C A A G G C T G T C A C C 
A A G T A C A C C A G C G C C A A G T A A C T G C T G C T G C C G⋎G A T C⋏C G G C T G C T A A C A A A . . .
T7 Promoter 
RBS 
NdeI 
Insert 
BamHI 
T7 Terminator 
Amp R 
pBR322 
 
Total size
1-19 
66-72 
78-83 
80-465 
465-470 
539-585 
1188-2045 
2196-2863 
 
4988 bp
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S4.3 • pET3d-H3 histone expression vector and insert sequence  
(A) Plasmid map and corresponding positions (in base pairs) of each component are provided. 
The T7 promoter is indicated by an arrow (➧). (B) The insert sequence (GenBank ID: AJ556872.1) 
highlights the ribosome binding site (RBS) (green), NcoI restriction site (purple) and start and 
stop codons (green and red, respectively).  
A
B
. . . T T A A C T T T A A G A A G G A G A T A T A C⋎C A T G⋏G C C C G T A C C A A G C A G A C C G C C C G T 
A A A T C C A C C G G A G G G A A G G C T C C C C G C A A G C A G C T G G C C A C C A A G G C A G C C A G G!
A A G T C C G C T C C T G C T A C C G G C G G A G T C A A G A A A C C T C A C C G T T A C C G G C C C G G C 
A C A G T C G C T C T C C G C G A G A T C C G C C G C T A C C A G A A A T C C A C C G A G C T G C T C A T C!
C G C A A A C T G C C T T T C C A G C G C C T G G T C C G G G A G A T C G C T C A G G A C T T C A A G A C C 
G A C C T G C G C T T C C A G A G C T C G G C C G T T A T G G C T C T G C A G G A G G C C A G C G A G G C T!
T A T C T G G T C G C T C T C T T T G A G G A C A C C A A C C T G T G C G C C A T C C A C G C C A A G A G G 
G T C A C C A T C A T G C C C A A G G A C A T C C A G C T G G C C C G C A G A A T C C G A G G C G A G A G G!
G C T T A G A T C C G G C T G C T A A C A A A G C C C G A A A G G . . .
T7 Promoter 
RBS 
NcoI 
Insert 
T7 Terminator 
Amp R 
pBR322 
 
Total size
1-19 
66-72 
78-83 
79-490 
564-610 
1213-2070 
2221-2888 
 
5292 bp
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S4.4 • pET3a-H4 histone expression vector and insert sequence 
(A) Plasmid map and corresponding positions (in base pairs) of each component are provided. 
The T7 promoter is indicated by an arrow (➧). (B) The insert sequence (GenBank ID: AJ556873.1) 
highlights the ribosome binding site (RBS) (green), NdeI restriction site (purple) and start and 
stop codons (green and red, respectively).  
A
B
. . . T A A C T T T A A G A A G G A G A T A T A C A⋎T A⋏T G T C T G G T C G T G G T A A A G G T G G T A A A 
G G T C T G G G T A A A G G T G G T G C T A A A C G T C A C C G T A A A G T T C T G C G T G A C A A C A T C!
C A G G G T A T C A C C A A G C C G G C T A T C C G T C G T C T G G C T C G T C G T G G T G G T G T T A A A 
C G T A T C T C C G G T C T G A T C T A C G A A G A A A C C C G C G G T G T T C T G A A A G T T T T C C T G!
G A A A A C G T T A T C C G T G A C G C T G T T A C C T A C A C C G A A C A C G C T A A A C G T A A A A C C 
G T T A C C G C T A T G G A C G T T G T T T A C G C T C T G A A A C G T C A G G G T C G T A C C C T G T A C!
G G T T T C G G T G G T T A A A G A T C C G G C T G C T A A C A A . . .
T7 Promoter 
RBS 
NdeI 
Insert 
T7 Terminator 
Amp R 
pBR322 
 
Total size
1-19 
66-72 
78-83 
80-394 
468-514 
1117-1974 
2125-2792 
 
4917 bp
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S4.5 • Alignment of histone H3 sequences from the frog, worm and human 
The argument made by Simon et al. (2007) to substitute the natural cysteine in Xenopus laevis H3 
with alanine, as the naturally occurring amino acid in Caenorhabditis elegans, is incorrect. It is 
actually an additional cysteine at position 96 (C) in human H3 that is replaced by alanine in the 
worm. C110 is common to all three species in the alignment above. Published sequences 
(GenBank IDs: AAA49765.1 (frog), AAG50235.1 (worm) and CAA58540.1 (human)) were 
obtained from the NCBI Protein Database and alignments (*) made using Clustal Omega 
software (available online at http://www.ebi.ac.uk).  
X. laevis    ARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRRYQKSTEL!
C. elegans   ARTKQTARKSTGGKAPRKQLATKAARKSAPASGGVKKPHRYRPGTVALREIRRYQKSTEL!
H. sapiens   ARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRRYQKSTEL!
             ******************************* ****************************!
!
X. laevis    LIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEASEAYLVGLFEDTNLCAIHAKRVTIM!
C. elegans   LIRRAPFQRLVREIAQDFKTDLRFQSSAVMALQEAAEAYLVGLFEDTNLCAIHAKRVTIM!
H. sapiens   LIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEACEAYLVGLFEDTNLCAIHAKRVTIM!
             ***  ****************************** ************************!
!
X. laevis    PKDIQLARRIRGERA! 135!
C. elegans   PKDIQLARRIRGERA! 135!
H. sapiens   PKDIQLARRIRGERA! 135!
             ***************
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S4.6 • pCDF-PylT H3 and pBK-AcKRS3 vectors used for genetic acetylation of histones 
Neumann et al. (2009) used the pCDF-PylT H3 expression plasmid and pBK-AcKRS3 vector to 
genetically incorporate acetylated lysine into H3 at amber codons. The expressed histone 
contains a hexa-histidine tag, which allows for nickel affinity purification and can be subsequently 
removed by TEV cleavage. Since histone expression and purification had already been 
established in our laboratory without the use of tagged expression constructs, the pET3d-H3 
plasmid (supplementary figure S4.3) was mutated in this project for synthesis of genetically 
acetylated H3 using the tRNA synthetase, AcKRS, encoded by pBK-AcKRS3.  
pCDF-PylT H3 pBK-AcKRS3
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S4.7 • Plasmid library 
Plasmids prepared during this project were assigned three-digit numbers for easier notation. 
These are indicated in the table above and were used for the sequence alignments in 
supplementary figures S4.8 and S4.13. Those plasmids used in this project are highlighted 
(green). Two mutant plasmid sequences did not produce acceptable sequence alignments (pink) 
and therefore were not used - these mutants must be re-synthesised prior to further experiments.  
№ Vector Insert Notes
100 pET3a x.H2A
Gifts of T Richmond
101 pET3a x.H2B
102 pET3d x.H3
103 pET3a x.H4
150 pET23b h.H2A.Z
200 pET3d x.H3 C110S
J Cashman
201 pET3d x.H3 K4C C110S
203 pET3d x.H3 C110A
Gifts of M Simon
204 pET3d x.H3 K4C C110A
205 pET3d x.H3 K9C C110A
206 pET3d x.H3 K27C C110A
207 pET3d x.H3 K36C C110A
208 pET3d x.H3 K79C C110A
209 pET3a x.H4 K20C
210 pET3d x.H3 K27C C110S
J Cashman, E Richardson
211 pET3d x.H3 K27C C110A
212 pET3d x.H3 K27amb
213 pET3d x.H3 K4C K27amb C110S
214 pET3d x.H3 K4C K27amb C110A
215 pCDF PylT H3
Gifts of J Chin
300 pBK AcKRS3
500 pBluescript 601.2 Gift of A Travers
501 pBluescript 601.2.1 J Wiltshire; lacks the 3’ poly-linker
502 pUC19 16x601.2 Gift of T Bartke
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S4.8 • Sequencing analysis of histone expression vectors isolated by alkaline lysis 
All histone expression vectors were analysed by sequencing using T7-F primer (GATC Biotech AG) 
to confirm sequence integrity by comparison with the published sequences (GenBank IDs: 
AJ556870.1 (H2A), AJ556871.1 (H2B), AJ556872.1 (H3) and AJ556873.1 (H4)). Alignments (*) 
were made using Clustal Omega software (available online at http://www.ebi.ac.uk). Start, stop, 
K→C, K→amber and C→S codons are highlighted and mutations indicated (▲).  
H2A
Seq  TAATTTTGTTTAACTTTAAGAAGGAGATATACATATGTCAGGAAGAGGCAAACAAGGCGGT!
100  ATATTTTGTTTAACTTTAAGAAGGAGATATACATATGTCAGGAAGAGGCAAACAAGGCGGT!
       ***********************************************************!
!
Seq  AAAACCCGCGCTAAGGCCAAGACTCGCTCATCTCGGGCTGGGCTACAGTTCCCTGTTGGCC!
100  AAAACCCGCGCTAAGGCCAAGACTCGCTCATCTCGGGCTGGGCTACAGTTCCCTGTTGGCC!
     *************************************************************!
!
Seq  GTGTTCACCGGCTGTTAAGGAAAGGCAATTATGCAGAGCGGGTGGGAGCTGGAGCTCCAGT!
100  GTGTTCACCGGCTGTTAAGGAAAGGCAATTATGCAGAGCGGGTGGGAGCTGGAGCTCCAGT!
     *************************************************************!
!
Seq  CTATCTGGCTGCAGTGTTGGAGTATCTGACCGCTGAGATTTTGGAATTGGCCGGGAATGCG!
100  CTATCTGGCTGCAGTGTTGGAGTATCTGACCGCTGAGATTTTGGAATTGGCCGGGAATGCG!
     *************************************************************!
!
Seq  GCCCGTGATAACAAGAAGACTCGCATTATCCCCAGACACCTGCAGCTCGCTGTGCGCAACG!
100  GCCCGTGATAACAAGAAGACTCGCATTATCCCCAGACACCTGCAGCTCGCTGTGCGCAACG!
     *************************************************************!
!
Seq  ATGAGGAACTGAACAAACTGCTCGGAAGAGTCACTATCGCTCAGGGCGGGGTCCTGCCCAA!
100  ATGAGGAACTGAACAAACTGCTCGGAAGAGTCACTATCGCTCAGGGCGGGGTCCTGCCCAA!
     *************************************************************!
!
Seq  CATCCAGTCCGTGCTGCTGCCCAAGAAAACCGAGAGTTCCAAGTCGGCCAAGAGCAAGTGA!
100  CATCCAGTCCGTGCTGCTGCCCAAGAAAACCGAGAGTTCCAAGTCGGCCAAGAGCAAGTGA!
     *************************************************************!
!
Seq  TCGGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGC!
100  TCGGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGC!
     *************************************************************
Seq   ---------TCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGGCCCGTA!
102   CCAGGGGATTCTCTAGAATATTTTGTTTAACTTTAAGAAGGAGATATACCATGGCCCGTA!
200   -ACAGGGGATTCTCTAGATATTTTGTTTAACTTTAAGAAGGAGATATACCATGGCCCGTA!
201   ----CAAGAATTCTCTAGATATTTTGTTTACTTTAAGAAGGAGATATACCATGGCCCGTA!
210   -----AACGGATTCTCAGATATTTTGTTTACTTTAAGAAGGAGATATACCATGGCCCGTA!
213   -GATCAGGAATTCTCTAGATATTTTGTTTACTTTAAGAAGGAGATATACCATGGCCCGTA!
                           ***  ** *******************************!
!
Seq   CCAAGCAGACCGCCCGTAAATCCACCGGAGGGAAGGCTCCCCGCAAGCAGCTGGCCACCA!
102   CCAAGCAGACCGCCCGTAAATCCACCGGAGGGAAGGCTCCCCGCAAGCAGCTGGCCACCA!
200   CCAAGCAGACCGCCCGTAAATCCACCGGAGGGAAGGCTCCCCGCAAGCAGCTGGCCACCA!
201   CCTGCCAGACCGCCCGTAAATCCACCGGAGGGAAGGCTCCCCGCAAGCAGCTGGCCACCA!
210   CCAAGCAGACCGCCCGTAAATCCACCGGAGGGAAGGCTCCCCGCAAGCAGCTGGCCACCA!
213   CCTGCCAGACCGCCCGTAAATCCACCGGAGGGAAGGCTCCCCGCAAGCAGCTGGCCACCA!
      **???*******************************************************!
!
Seq   AGGCAGCCAGGAAGTCCGCTCCTGCTACCGGCGGAGTCAAGAAACCTCACCGTTACCGGC!
102   AGGCAGCCAGGAAGTCCGCTCCTGCTACCGGCGGAGTCAAGAAACCTCACCGTTACCGGC!
200   AGGCAGCCAGGAAGTCCGCTCCTGCTACCGGCGGAGTCAAGAAACCTCACCGTTACCGGC!
201   AGGCAGCCAGGAAGTCCGCTCCTGCTACCGGCGGAGTCAAGAAACCTCACCGTTACCGGC!
210   AGGCAGCCAGGTGCTCCGCTCCTGCTACCGGCGGAGTCAAGAAACCTCACCGTTACCGGC!
213   AGGCAGCCAGGTAGTCCGCTCCTGCTACCGGCGGAGTCAAGAAACCTCACCGTTACCGGC!
      ***********???**********************************************!
!
Seq   CCGGCACAGTCGCTCTCCGCGAGATCCGCCGCTACCAGAAATCCACCGAGCTGCTCATCC!
102   CCGGCACAGTCGCTCTCCGCGAGATCCGCCGCTACCAGAAATCCACCGAGCTGCTCATCC!
200   CCGGCACAGTCGCTCTCCGCGAGATCCGCCGCTACCAGAAATCCACCGAGCTGCTCATCC!
201   CCGGCACAGTCGCTCTCCGCGAGATCCGCCGCTACCAGAAATCCACCGAGCTGCTCATCC!
210   CCGGCACAGTCGCTCTCCGCGAGATCCGCCGCTACCAGAAATCCACCGAGCTGCTCATCC!
213   CCGGCACAGTCGCTCTCCGCGAGATCCGCCGCTACCAGAAATCCACCGAGCTGCTCATCC!
      ************************************************************!
!
Seq   GCAAACTGCCTTTCCAGCGCCTGGTCCGGGAGATCGCTCAGGACTTCAAGACCGACCTGC!
102   GCAAACTGCCTTTCCAGCGCCTGGTCCGGGAGATCGCTCAGGACTTCAAGACCGACCTGC!
200   GCAAACTGCCTTTCCAGCGCCTGGTCCGGGAGATCGCTCAGGACTTCAAGACCGACCTGC!
201   GCAAACTGCCTTTCCAGCGCCTGGTCCGGGAGATCGCTCAGGACTTCAAGACCGACCTGC!
210   GCAAACTGCCTTTCCAGCGCCTGGTCCGGGAGATCGCTCAGGACTTCAAGACCGACCTGC!
213   GCAAACTGCCTTTCCAGCGCCTGGTCCGGGAGATCGCTCAGGACTTCAAGACCGACCTGC!
      ************************************************************!
!
Seq   GCTTCCAGAGCTCGGCCGTTATGGCTCTGCAGGAGGCCAGCGAGGCTTATCTGGTCGCTC!
102   GCTTCCAGAGCTCGGCCGTTATGGCTCTGCAGGAGGCCAGCGAGGCTTATCTGGTCGCTC!
200   GCTTCCAGAGCTCGGCCGTTATGGCTCTGCAGGAGGCCAGCGAGGCTTATCTGGTCGCTC!
201   GCTTCCAGAGCTCGGCCGTTATGGCTCTGCAGGAGGCCAGCGAGGCTTATCTGGTCGCTC!
210   GCTTCCAGAGCTCGGCCGTTATGGCTCTGCAGGAGGCCAGCGAGGCTTATCTGGTCGCTC!
213   GCTTCCAGAGCTCGGCCGTTATGGCTCTGCAGGAGGCCAGCGAGGCTTATCTGGTCGCTC!
      ************************************************************!
!
Seq   TCTTTGAGGACACCAACCTGTGCGCCATCCACGCCAAGAGGGTCACCATCATGCCCAAGG!
102   TCTTTGAGGACACCAACCTGTGCGCCATCCACGCCAAGAGGGTCACCATCATGCCCAAGG!
200   TCTTTGAGGACACCAACCTGTCCGCCATCCACGCCAAGAGGGTCACCATCATGCCCAAGG!
201   TCTTTGAGGACACCAACCTGTCCGCCATCCACGCCAAGAGGGTCACCATCATGCCCAAGG!
210   TCTTTGAGGACACCAACCTGTCCGCCATCCACGCCAAGAGGGTCACCATCATGCCCAAGG!
213   TCTTTGAGGACACCAACCTGTCCGCCATCCACGCCAAGAGGGTCACCATCATGCCCAAGG!
      *********************?**************************************!
!
Seq   ACATCCAGCTGGCCCGCAGAATCCGAGGCGAGAGGGCTTAGATCCGGCTGCTAACAAAGC!
102   ACATCCAGCTGGCCCGCAGAATCCGAGGCGAGAGGGCTTAGATCCGGCTGCTAACAAAGC!
200   ACATCCAGCTGGCCCGCAGAATCCGAGGCGAGAGGGCTTAGATCCGGCTGCTAACAAAGC!
201   ACATCCAGCTGGCCCGCAGAATCCGAGGCGAGAGGGCTTAGATCCGGCTGCTAACAAAGC!
210   ACATCCAGCTGGCCCGCAGAATCCGAGGCGAGAGGGCTTAGATCCGGCTGCTAACAAAGC!
213   ACATCCAGCTGGCCCGCAGAATCCGAGGCGAGAGGGCTTAGATCCGGCTGCTAACAAAGC!
      ************************************************************!
!
Seq   CCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGC----------------------!
102   CCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGG!
200   CCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGG!
201   CCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGG!
210   CCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGG!
213   CCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGG!
      **************************************
H3 (incl. mutants)
H2B
Seq  TCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATATATGGCCAAGTCCGCTCCAGCC!
101  CTCTAGAATAATTTTGTTTAACTTTAAGAAGGAGATATATATGGCCAAGTCCGCTCCAGCC!
           *******************************************************!
!
Seq  CCGAAGAAAGGCTCCAAGAAAGCGGTGACCAAGACTCAGAAGAAAGACGGGAAAAAGCGCA!
101  CCGAAGAAAGGCTCCAAGAAAGCGGTGACCAAGACTCAGAAGAAAGACGGGAAAAAGCGCA!
     *************************************************************!
!
Seq  GGAAGACAAGGAAGGAGAGTTATGCCATTTACGTGTACAAGGTGCTGAAGCAGGTGCACCC!
101  GGAAGACAAGGAAGGAGAGTTATGCCATTTACGTGTACAAGGTGCTGAAGCAGGTGCACCC!
     *************************************************************!
!
Seq  CGATACCGGCATCTCGTCCAAGGCCATGAGCATCATGAACTCCTTTGTCAACGATGTGTTT!
101  CGATACCGGCATCTCGTCCAAGGCCATGAGCATCATGAACTCCTTTGTCAACGATGTGTTT!
     ************************************************************!
!
Seq  GAGCGCATCGCAGGGGAAGCCTCCCGCCTGGCTCATTACAACAAGCGCTCCACCATCACCT!
101  GAGCGCATCGCAGGGGAAGCCTCCCGCCTGGCTCATTACAACAAGCGCTCCACCATCACCT!
     ************************************************************!
!
Seq  CCCGGGAGATCCAGACCGCGGTCCGACTGCTGCTGCCTGGGGAGTTGGCCAAACACGCCGT!
101  CCCGGGAGATCCAGACCGCGGTCCGACTGCTGCTGCCTGGGGAGTTGGCCAAACACGCCGT!
     ************************************************************!
!
Seq  GTCCGAGGGCACCAAGGCTGTCACCAAGTACACCAGCGCCAAGTAACTGCTGCTGCCGGAT!
101  GTCCGAGGGCACCAAGGCTGTCACCAAGTACACCAGCGCCAAGTAACTGCTGCTGCCGGAT!
     ************************************************************!
!
Seq  CCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGC------!
101  CCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAAC!
     *******************************************************
H4
Seq  TCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACATATGTCTGGTCGTGGTAAAGGTGGTAAAGGTCTGGGTAAAGGTGGTGCTAAACGTCACCGTAAAGTTCTGCGTGACAACATCCAGGGTATCACCAAG!
103  CTCTAGGATAATTTTGTTTAACTTTAAGAAGGAGATATACATATGTCTGGTCGTGGTAAAGGTGGTAAAGGTCTGGGTAAAGGTGGTGCTAAACGTCACCGTAAAGTTCTGCGTGACAACATCCAGGGTATCACCAAG!
            ***********************************************************************************************************************************!
!
Seq  CCGGCTATCCGTCGTCTGGCTCGTCGTGGTGGTGTTAAACGTATCTCCGGTCTGATCTACGAAGAAACCCGCGGTGTTCTGAAAGTTTTCCTGGAAAACGTTATCCGTGACGCTGTTACCTACACCGAACACGCTAAA!
103  CCGGCTATCCGTCGTCTGGCTCGTCGTGGTGGTGTTAAACGTATCTCCGGTCTGATCTACGAAGAAACCCGCGGTGTTCTGAAAGTTTTCCTGGAAAACGTTATCCGTGACGCTGTTACCTACACCGAACACGCTAAA!
     ******************************************************************************************************************************************!
!
Seq  CGTAAAACCGTTACCGCTATGGACGTTGTTTACGCTCTGAAACGTCAGGGTCGTACCCTGTACGGTTTCGGTGGTTAAAGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGC-!
103  CGTAAAACCGTTACCGCTATGGACGTTGTTTACGCTCTGAAACGTCAGGGTCGTACCCTGTACGGTTTCGGTGGTTAAAGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCA!
     ******************************************************************************************************************************************
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S4.9 • Analysis of purified histones by SDS and AU PAGE 
Following purification, 1-5 µg aliquots of each histone were analysed by SDS (A) or AU PAGE (B) 
to check their purity and integrity.  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S4.11 • Installation of other modified lysine analogues into histones by reductive alkylation 
Reductive alkylation converts cysteine residues to aminoethylcysteine, an analogue of lysine. Using 
different reagents for the alkylation reaction allows the incorporation of mono-methylated or 
acetylated lysine analogues (figure 4.2, panels C and D, respectively). Other reagents are available 
for the installation of un- (A), di- (B) and tri-methylated (C) analogues, according to the reaction 
schemes shown.  
+ aziridinium intermediate
+ aziridinium intermediate
A
C
B
+ aziridinium intermediate
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S4.12 • Summary of nucleosomal 601.2 DNA preparation 
601.2 DNA was obtained as a sixteen-tandem repeat in pUC19 from Dr T Bartke (Gurdon 
Institute, University of Cambridge, UK). The plasmid (grey circles) was transformed into E. coli and 
isolated by large-scale alkaline lysis. Treatment with EcoRI and EcoRV yielded all sixteen copies of 
the 601.2 sequence (●), which was purified from linker (●) and vector (●) DNA by Q ion exchange. 
601.2 was biotinylated using Klenow and finally purified from excess nucleotides by S300 size 
exclusion chromatography.  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S4.13 • Sequencing analysis of 601.2 DNA plasmids isolated by alkaline lysis 
601.2 plasmids were analysed by sequencing using PCR1 primer (GATC Biotech AG) to confirm 
sequence integrity by comparison with the available sequence. Alignments (*) were made using 
Clustal Omega software (available online at http://www.ebi.ac.uk).  
Sequence             -------------------------------------------GATATCGGATCTTACAT 17!
pUC19-16x601.2       TTGTAAAACGACGGCCAGTGAATTCGAGCTCGGTACCAGATCTGATATCGGATCTTACAT 120!
                                                                *****************!
!
Sequence             GCACAGGATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTT 77!
pUC19-16x601.2       GCACAGGATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTT 180!
                     ************************************************************!
!
Sequence             AAAACGCGGGGGACAGCGCGTACGTGCGTTTAAGCGGTGCTAGAGCTGTCTACGACCAAT 137!
pUC19-16x601.2       AAAACGCGGGGGACAGCGCGTACGTGCGTTTAAGCGGTGCTAGAGCTGTCTACGACCAAT 240!
                     ************************************************************!
!
Sequence             TGAGCGGCCTCGGCACCGGGATTCTCCAGGGCGGCCGCGTAGTACTGAATTCATAGGATC 197!
pUC19-16x601.2       TGAGCGGCCTCGGCACCGGGATTCTCCAGGGCGGCCGCGTAGTACTGAATTCATAGGATC 300!
                     ************************************************************!
!
Sequence             TGATATCGGATCTTACATGCACAGGATGTATATATCTGACACGTGCCTGGAGACTAGGGA 257!
pUC19-16x601.2       TGATATCGGATCTTACATGCACAGGATGTATATATCTGACACGTGCCTGGAGACTAGGGA 360!
                     ************************************************************!
!
Sequence             GTAATCCCCTTGGCGGTTAAAACGCGGGGGACAGCGCGTACGTGCGTTTAAGCGGTGCTA 317!
pUC19-16x601.2       GTAATCCCCTTGGCGGTTAAAACGCGGGGGACAGCGCGTACGTGCGTTTAAGCGGTGCTA 420!
                     ************************************************************!
!
Sequence             GAGCTGTCTACGACCAATTGAGCGGCCTCGGCACCGGGATTCTCCAGGGCGGCCGCGTAG 377!
pUC19-16x601.2       GAGCTGTCTACGACCAATTGAGCGGCCTCGGCACCGGGATTCTCCAGGGCGGCCGCGTAG 480!
                     ************************************************************!
!
Sequence             TACTGAATTCATAGGATCTGATATCGGATCTTACATGCACAGGATGTATATATCTGACAC 437!
pUC19-16x601.2       TACTGAATTCATAGGATCTGATATCGGATCTTACATGCACAGGATGTATATATCTGACAC 540!
                     ************************************************************!
!
Sequence             GTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTTAAAACGCGGGGGACAGCGCGTACG 497!
pUC19-16x601.2       GTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTTAAAACGCGGGGGACAGCGCGTACG 600!
                     ************************************************************!
!
Sequence             TGCGTTTAAGCGGTGCTAGAGCTGTCTACGACCAATTGAGCGGCCTCGGCACCGGGATTC 557!
pUC19-16x601.2       TGCGTTTAAGCGGTGCTAGAGCTGTCTACGACCAATTGAGCGGCCTCGGCACCGGGATTC 660!
                     ************************************************************!
!
Sequence             TCCAGGGCGGCCGCGTAGTACTGAATTCATAGGATCTGATATCGGATCTTACATGCACAG 617!
pUC19-16x601.2       TCCAGGGCGGCCGCGTAGTACTGAATTCATAGGATCTGATATCGGATCTTACATGCACAG 720!
                     ************************************************************!
!
Sequence             GATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTTAAAACG 677!
pUC19-16x601.2       GATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATCCCCTTGGCGGTTAAAACG 780!
                     ************************************************************!
!
Sequence             CGGGGGACAGCGCGTACGTGCGTTTAAGCGGTGCTAGAGCTGTCTACGACCAATTGAGCG 737!
pUC19-16x601.2       CGGGGGACAGCGCGTACGTGCGTTTAAGCGGTGCTAGAGCTGTCTACGACCAATTGAGCG 840!
                     ************************************************************!
!
Sequence             GCCTCGGCACCGGGATTCTCCAGGGCGGCCGCGTAGTACTGAATTCATAGGATCTGATAT 797!
pUC19-16x601.2       GCCTCGGCACCGGGATTCTCCAGGGCGGCCGCGTAGTACTGAATTCATAGGATCTGATAT 900!
                     ************************************************************!
!
Sequence             CGGATCTTACATGCACAGGATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATC 857!
pUC19-16x601.2       CGGATCTTACATGCACAGGATGTATATATCTGACACGTGCCTGGAGACTAGGGAGTAATC 960!
                     ************************************************************!
!
Sequence             CCCTTGGCGGTTAAAACGCGGGGGACAGCGCGTACGTGCGTTTAAGCGGTGCTAGAGCTG 917!
pUC19-16x601.2       CCCTTGGCGGTTAAAACGCGGGGGACAGCGCGTACGTGCGTTTAAGCGGTGCTAGAGCTG 1020!
                     ************************************************************!
!
Sequence             TCTACGACCAATTGAGCGGCCTCGGCACCGGGATTCTCCAGGGCGGCCGCGTAGTACTGA 977!
pUC19-16x601.2       TCTACGACCAATTGAACGGCCTCGGCACCGGGATTCTCCAGGGCGGCCGCGTAGTACTGA 1080!
                     *************** ********************************************!
!
Sequence             ATTC-------------------------------------------------------- 981!
pUC19-16x601.2       ATTCATAGGATCTGAAATCGGATCTTACATGCACAGGATGTATATTCCTGACACGTGCCT 1140!
                     ****                                                        
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S4.14 • Improved method for synthesis of human H3.1 by expressed protein ligation 
The protocol was essentially as outlined in figure 4.1 but a TEV cleavage site was used instead of 
Factor Xa. Inclusion of the TEV protease gene in the truncated histone expression plasmid 
allowed for expression of the C-terminal domain of the histone with IPTG induction and then later 
induction of TEV expression with L-arabinose to cleave the protein within E. coli rather than after 
purification. This improved the efficiency of the preparation of ligated modified histones. Small 
amounts of histones H3.1 and H3.1K4me1 were kindly provided by Dr T Bartke (Gurdon institute, 
University of Cambridge, UK). 
Adapted from Bartke et al., 2010 !!!!!
   !
S4.15 • Preparation and characterisation of octamers containing hH3.1 or hH3.1 K4me1 
Octamers carrying hH3.1 (A) or hH3.1 K4me1 (B), prepared by expressed protein ligation (Bartke 
et al., 2010), were folded into octamers with recombinant Xenopus H2A, H2B and H4. (C) 
Following purification by size exclusion, octamers were analysed by SDS PAGE and dot Western 
blots.  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S4.16 • Assembly and characterisation of nucleosomes carrying hH3.1 or hH3.1 K4me1 
Nucleosomes were prepared from octamers carrying ligated hH3.1 or hH3.1K4me1 prior to full 
optimisation of the assembly protocol. Having started with a limited quantity of the human ligated 
histones and with the initial nucleosome assembly procedure being so inefficient (a high 
proportion of non-native nucleosomes (NNN) was produced), SILAC pull downs using these 
nucleosomes was not possible.  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Supplementary figures (chapter 5) 
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S5.1 • MS analysis to identify proteins isolated by SNAP 
Schematic representation of the preparation of peptides from proteins isolated by SNAP and 
their analysis on a maXis HD UHR TOF (LC-ESI-MS/MS) instrument. ▬, path of ionised peptides.  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UniProtKB Entry name Protein name K4 K27 K4+K27
Q9NRW3 ABC3C_HUMAN DNA dC->dU-editing enzyme APOBEC-3C [A3C] ✓ ✓
Q9UKV3 ACINU_HUMAN Apoptotic chromatin condensation inducer in the nucleus [ACINUS] ✓ ✓ ✓
P60709 ACTB_HUMAN Actin, cytoplasmic 1 ✓ ✓ ✓
P68032 ACTC_HUMAN Actin, alpha cardiac muscle 1 ✓ ✓
P05141 ADT2_HUMAN ADP/ATP translocase 2 ✓ ✓ ✓
O75531 BAF_HUMAN Barrier-to-autointegration factor ✓ ✓
Q9NYF8 BCLF1_HUMAN Bcl-2-associated transcription factor 1 [Btf] ✓ ✓ ✓
Q8TDN6 BRX1_HUMAN Ribosome biogenesis protein BRX1 homolog ✓ ✓ ✓
O95400 CD2B2_HUMAN CD2 antigen cytoplasmic tail-binding protein 2 ✓ ✓ ✓
Q6P1J9 CDC73_HUMAN Parafibromin ✓ ✓
Q03701 CEBPZ_HUMAN CCAAT/enhancer-binding protein zeta ✓ ✓ ✓
Q7Z7K6 CENPV_HUMAN Centromere protein V [CENP-V] ✓ ✓ ✓
P41208 CETN2_HUMAN Centrin-2 ✓ ✓
Q9BRJ6 CG050_HUMAN Uncharacterized protein C7orf50 ✓
O14646 CHD1_HUMAN Chromodomain-helicase-DNA-binding protein 1 [CHD-1] ✓
O14647 CHD2_HUMAN Chromodomain-helicase-DNA-binding protein 2 [CHD-2] ✓
Q9BUH6 CI142_HUMAN Uncharacterized protein C9orf142 ✓ ✓
P38432 COIL_HUMAN Coilin ✓ ✓ ✓
Q9Y6A4 CP080_HUMAN UPF0468 protein C16orf80 ✓
Q9BV73 CP250_HUMAN Centrosome-associated protein CEP250 ✓
Q6PD62 CTR9_HUMAN RNA polymerase-associated protein CTR9 homolog ✓ ✓
Q92841 DDX17_HUMAN Probable ATP-dependent RNA helicase DDX17 ✓ ✓ ✓
Q9NVP1 DDX18_HUMAN ATP-dependent RNA helicase DDX18 ✓ ✓ ✓
Q9NR30 DDX21_HUMAN Nucleolar RNA helicase 2 ✓ ✓ ✓
Q9BUQ8 DDX23_HUMAN Probable ATP-dependent RNA helicase DDX23 ✓ ✓ ✓
P17844 DDX5_HUMAN Probable ATP-dependent RNA helicase DDX5 ✓ ✓ ✓
Q9BQ39 DDX50_HUMAN ATP-dependent RNA helicase DDX50 ✓ ✓ ✓
Q9Y2R4 DDX52_HUMAN Probable ATP-dependent RNA helicase DDX52 ✓ ✓ ✓
Q16698 DECR_HUMAN 2,4-dienoyl-CoA reductase, mitochondrial ✓ ✓ ✓
Q43143 DHX15_HUMAN Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 ✓ ✓ ✓
Q08211 DHX9_HUMAN ATP-dependent RNA helicase A [RHA] ✓ ✓ ✓
O60832 DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 ✓ ✓ ✓
P49916 DNLI3_HUMAN DNA ligase 3 ✓ ✓ ✓
P06746 DPOLB_HUMAN DNA polymerase betA ✓ ✓
O00148 DX39A_HUMAN ATP-dependent RNA helicase DDX39A ✓ ✓ ✓
P63167 DYL1_HUMAN Dynein light chain 1, cytoplasmic ✓
Q99848 EBP2_HUMAN Probable rRNA-processing protein EBP2 ✓ ✓
O60869 EDF1_HUMAN Endothelial differentiation-related factor 1 [EDF-1] ✓
Q15717 ELAV1_HUMAN ELAV-like protein 1 ✓ ✓ ✓
P84090 ERH_HUMAN Enhancer of rudimentary homolog ✓ ✓ ✓
P22087 FBRL_HUMAN rRNA 2'-O-methyltransferase fibrillarin ✓ ✓ ✓
Q9NZ56 FMN2_HUMAN Formin-2 ✓ ✓
Q5CZC0 FSIP2_HUMAN Fibrous sheath-interacting protein 2 ✓ ✓ ✓
Q9NY12 GAR1_HUMAN H/ACA ribonucleoprotein complex subunit 1 ✓ ✓ ✓
P63244 GBLP_HUMAN Guanine nucleotide-binding protein subunit beta-2-like 1 ✓
Q49A26 GLYR1_HUMAN Putative oxidoreductase GLYR1 ✓ ✓ ✓
P16403 H12_HUMAN Histone H1.2 ✓ ✓ ✓
P10412 H14_HUMAN Histone H1.4 ✓
P16401 H15_HUMAN Histone H1.5 ✓ ✓ ✓
Q92522 H1X_HUMAN Histone H1x ✓ ✓ ✓
Q96QV6 H2A1A_HUMAN Histone H2A type 1-A ✓ ✓ ✓
P04908 H2A1B_HUMAN Histone H2A type 1-B/E ✓
Q99878 H2A1J_HUMAN Histone H2A type 1-J ✓ ✓
Q71UI9 H2AV_HUMAN Histone H2A.V ✓ ✓ ✓
Q96A08 H2B1A_HUMAN Histone H2B type 1-A ✓ ✓ ✓
P33778 H2B1B_HUMAN Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f) ✓ ✓ ✓
P62807 H2B1C_HUMAN Histone H2B type 1-C/E/F/G/I ✓ ✓ ✓
P68431 H31_HUMAN Histone H3.1 ✓ ✓
Q16695 H31T_HUMAN Histone H3.1t [H3t] ✓
P84243 H33_HUMAN Histone H3.3 ✓ ✓
P62805 H4_HUMAN Histone H4 ✓ ✓ ✓
Q99525 H4G_HUMAN Histone H4-like protein type G ✓ ✓
 263
O14979 HNRDL_HUMAN Heterogeneous nuclear ribonucleoprotein D-like [hnRNP D-like] ✓ ✓ ✓
P31943 HNRH1_HUMAN Heterogeneous nuclear ribonucleoprotein H [hnRNP H] ✓ ✓ ✓
P31942 HNRH3_HUMAN Heterogeneous nuclear ribonucleoprotein H3 [hnRNP H3] ✓ ✓ ✓
P07910 HNRPC_HUMAN Heterogeneous nuclear ribonucleoproteins C1/C2 [hnRNP C1/C2] ✓ ✓ ✓
Q14103 HNRPD_HUMAN Heterogeneous nuclear ribonucleoprotein D0 [hnRNP D0] ✓ ✓ ✓
P52597 HNRPF_HUMAN Heterogeneous nuclear ribonucleoprotein F [hnRNP F] ✓ ✓ ✓
P61978 HNRPK_HUMAN Heterogeneous nuclear ribonucleoprotein K [hnRNP K] ✓ ✓ ✓
P14866 HNRPL_HUMAN Heterogeneous nuclear ribonucleoprotein L [hnRNP L] ✓ ✓ ✓
P52272 HNRPM_HUMAN Heterogeneous nuclear ribonucleoprotein M [hnRNP M] ✓ ✓ ✓
O60506 HNRPQ_HUMAN Heterogeneous nuclear ribonucleoprotein Q [hnRNP Q] ✓ ✓ ✓
O43390 HNRPR_HUMAN Heterogeneous nuclear ribonucleoprotein R [hnRNP R] ✓ ✓ ✓
Q00839 HNRPU_HUMAN Heterogeneous nuclear ribonucleoprotein U [hnRNP U] ✓ ✓ ✓
Q5SSJ5 HP1B3_HUMAN Heterochromatin protein 1-binding protein 3 ✓ ✓ ✓
P08107 HSP71_HUMAN Heat shock 70 kDa protein 1A/1B ✓
P11142 HSP7C_HUMAN Heat shock cognate 71 kDa protein ✓ ✓ ✓
P04792 HSPB1_HUMAN Heat shock protein beta-1 [HspB1] ✓ ✓
P38919 IF4A3_HUMAN Eukaryotic initiation factor 4A-III [eIF-4A-III] ✓ ✓
P56537 IF6_HUMAN Eukaryotic translation initiation factor 6 [eIF-6] ✓ ✓ ✓
Q12905 ILF2_HUMAN Interleukin enhancer-binding factor 2 ✓ ✓ ✓
Q12906 ILF3_HUMAN Interleukin enhancer-binding factor 3 ✓ ✓ ✓
Q15397 K0020_HUMAN Pumilio domain-containing protein KIAA0020 ✓
P13645 K1C10_HUMAN Keratin, type I cytoskeletal 10 ✓
P35527 K1C9_HUMAN Keratin, type I cytoskeletal 9 ✓ ✓
P04264 K2C1_HUMAN Keratin, type II cytoskeletal 1 ✓ ✓
Q07666 KHDR1_HUMAN KH domain-containing, RNA-binding, signal transduction-associated protein 1 ✓ ✓ ✓
Q9Y383 LC7L2_HUMAN Putative RNA-binding protein Luc7-like 2 ✓ ✓ ✓
O95232 LC7L3_HUMAN Luc7-like protein 3 ✓ ✓
Q9NX58 LYAR_HUMAN Cell growth-regulating nucleolar protein ✓ ✓ ✓
O15479 MAGB2_HUMAN Melanoma-associated antigen B2 ✓ ✓ ✓
P49137 MAPK2_HUMAN MAP kinase-activated protein kinase 2 [MAPKAP kinase 2] ✓ ✓ ✓
Q9BQG0 MBB1A_HUMAN Myb-binding protein 1A ✓ ✓
Q14566 MCM6_HUMAN DNA replication licensing factor MCM6 ✓
Q9NU22 MDN1_HUMAN Midasin (MIDAS-containing protein) ✓ ✓
P51608 MECP2_HUMAN Methyl-CpG-binding protein 2 [MeCp2] ✓ ✓
P55081 MFAP1_HUMAN Microfibrillar-associated protein 1 ✓
Q9H0A0 NAT10_HUMAN N-acetyltransferase 10 ✓ ✓ ✓
P55769 NH2L1_HUMAN NHP2-like protein 1 ✓ ✓ ✓
Q9NX24 NHP2_HUMAN H/ACA ribonucleoprotein complex subunit 2 ✓ ✓ ✓
Q9Y221 NIP7_HUMAN 60S ribosome subunit biogenesis protein NIP7 homolog ✓ ✓ ✓
Q9HAN9 NMNA1_HUMAN Nicotinamide mononucleotide adenylyltransferase 1 ✓ ✓ ✓
Q9BZE4 NOG1_HUMAN Nucleolar GTP-binding protein 1 ✓ ✓ ✓
Q9H6R4 NOL6_HUMAN Nucleolar protein 6 ✓
Q14978 NOLC1_HUMAN Nucleolar and coiled-body phosphoprotein 1 ✓ ✓ ✓
Q9NPE3 NOP10_HUMAN H/ACA ribonucleoprotein complex subunit 3 ✓ ✓
Q9Y3C1 NOP16_HUMAN Nucleolar protein 16 ✓
P46087 NOP2_HUMAN Putative ribosomal RNA methyltransferase NOP2 ✓ ✓ ✓
O00567 NOP56_HUMAN Nucleolar protein 56 ✓ ✓ ✓
Q9Y2X3 NOP58_HUMAN Nucleolar protein 58 ✓ ✓ ✓
O60287 NPA1P_HUMAN Nucleolar pre-ribosomal-associated protein 1 ✓
P06748 NPM_HUMAN Nucleophosmin [NPM] ✓ ✓ ✓
P19338 NUCL_HUMAN Nucleolin ✓ ✓ ✓
Q14980 NUMA1_HUMAN Nuclear mitotic apparatus protein 1 [NuMA protein] ✓ ✓
Q8NC51 PAIRB_HUMAN Plasminogen activator inhibitor 1 RNA-binding protein ✓
P09874 PARP1_HUMAN Poly (ADP-ribose) polymerase 1 [PARP-1] ✓ ✓ ✓
Q9Y5B6 PAXB1_HUMAN PAX3- and PAX7-binding protein 1 ✓ ✓ ✓
Q9NWT1 PK1IP_HUMAN p21-activated protein kinase-interacting protein 1 ✓ ✓ ✓
O43660 PLRG1_HUMAN Pleiotropic regulator 1 ✓ ✓ ✓
Q9Y3B4 PM14_HUMAN Pre-mRNA branch site protein p14 ✓ ✓ ✓
P62136 PP1A_HUMAN Serine/threonine-protein phosphatase PP1-alpha catalytic subunit ✓ ✓
P36873 PP1G_HUMAN Serine/threonine-protein phosphatase PP1-gamma catalytic subunit ✓
Q8NAV1 PR38A_HUMAN Pre-mRNA-splicing factor 38A ✓ ✓ ✓
P78527 PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit [DNA-PKcs] ✓ ✓
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Q9UMS4 PRP19_HUMAN Pre-mRNA-processing factor 19 ✓ ✓ ✓
Q8WWY3 PRP31_HUMAN U4/U6 small nuclear ribonucleoprotein Prp31 ✓
Q13523 PRP4B_HUMAN Serine/threonine-protein kinase PRP4 homolog ✓ ✓ ✓
O94906 PRP6_HUMAN Pre-mRNA-processing factor 6 ✓ ✓ ✓
Q6P2Q9 PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 ✓ ✓ ✓
Q15269 PWP2_HUMAN Periodic tryptophan protein 2 homolog ✓ ✓
Q9UKM9 RALY_HUMAN RNA-binding protein Raly ✓ ✓
Q96T37 RBM15_HUMAN Putative RNA-binding protein 15 ✓
Q9NW13 RBM28_HUMAN RNA-binding protein 28 ✓ ✓ ✓
P42696 RBM34_HUMAN RNA-binding protein 34 ✓ ✓
P38159 RBMX_HUMAN RNA-binding motif protein, X chromosome ✓ ✓ ✓
Q92804 RBP56_HUMAN TATA-binding protein-associated factor 2N ✓
Q13123 RED_HUMAN Protein Red ✓ ✓ ✓
P35251 RFC1_HUMAN Replication factor C subunit 1 ✓ ✓ ✓
P35250 RFC2_HUMAN Replication factor C subunit 2 ✓ ✓ ✓
P40938 RFC3_HUMAN Replication factor C subunit 3 ✓ ✓
P35249 RFC4_HUMAN Replication factor C subunit 4 ✓ ✓ ✓
P40937 RFC5_HUMAN Replication factor C subunit 5 ✓ ✓ ✓
P27635 RL10_HUMAN 60S ribosomal protein L10 ✓ ✓ ✓
P62906 RL10A_HUMAN 60S ribosomal protein L10a ✓ ✓ ✓
P62913 RL11_HUMAN 60S ribosomal protein L11 ✓ ✓ ✓
P30050 RL12_HUMAN 60S ribosomal protein L12 ✓ ✓ ✓
P26373 RL13_HUMAN 60S ribosomal protein L13 ✓ ✓ ✓
P40429 RL13A_HUMAN 60S ribosomal protein L13a ✓ ✓ ✓
P50914 RL14_HUMAN 60S ribosomal protein L14 ✓ ✓ ✓
P61313 RL15_HUMAN 60S ribosomal protein L15 ✓ ✓ ✓
P18621 RL17_HUMAN 60S ribosomal protein L17 ✓ ✓ ✓
Q07020 RL18_HUMAN 60S ribosomal protein L18 ✓ ✓ ✓
P02543 RL18A_HUMAN 60S ribosomal protein L18a ✓ ✓ ✓
P84098 RL19_HUMAN 60S ribosomal protein L19 ✓ ✓ ✓
O76021 RL1D1_HUMAN Ribosomal L1 domain-containing protein 1 ✓ ✓ ✓
P46778 RL21_HUMAN 60S ribosomal protein L21 ✓ ✓ ✓
P35268 RL22_HUMAN 60S ribosomal protein L22 ✓ ✓ ✓
P62829 RL23_HUMAN 60S ribosomal protein L23 ✓ ✓ ✓
P62750 RL23A_HUMAN 60S ribosomal protein L23a ✓ ✓ ✓
P83731 RL24_HUMAN 60S ribosomal protein L24 ✓ ✓
P61254 RL26_HUMAN 60S ribosomal protein L26 ✓ ✓ ✓
Q9UNX3 RL26L_HUMAN 60S ribosomal protein L26-like 1 ✓ ✓
P61353 RL27_HUMAN 60S ribosomal protein L27 ✓ ✓ ✓
P46776 RL27A_HUMAN 60S ribosomal protein L27a ✓ ✓ ✓
P46779 RL28_HUMAN 60S ribosomal protein L28 ✓ ✓
P47914 RL29_HUMAN 60S ribosomal protein L29 ✓ ✓ ✓
P39023 RL3_HUMAN 60S ribosomal protein L3 ✓ ✓ ✓
P62888 RL30_HUMAN 60S ribosomal protein L30 ✓ ✓ ✓
P62899 RL31_HUMAN 60S ribosomal protein L31 ✓ ✓ ✓
P62910 RL32_HUMAN 60S ribosomal protein L32 ✓ ✓ ✓
P49207 RL34_HUMAN 60S ribosomal protein L34 ✓ ✓ ✓
P42766 RL35_HUMAN 60S ribosomal protein L35 ✓
P18077 RL35A_HUMAN 60S ribosomal protein L35a ✓ ✓
Q9Y3U8 RL36_HUMAN 60S ribosomal protein L36 ✓
P83881 RL36A_HUMAN 60S ribosomal protein L36a ✓
P61513 RL37A_HUMAN 60S ribosomal protein L37a ✓ ✓
P36578 RL4_HUMAN 60S ribosomal protein L4 ✓ ✓ ✓
P46777 RL5_HUMAN 60S ribosomal protein L5 ✓ ✓ ✓
Q02878 RL6_HUMAN 60S ribosomal protein L6 ✓ ✓ ✓
P18124 RL7_HUMAN 60S ribosomal protein L7 ✓ ✓ ✓
P62424 RL7A_HUMAN 60S ribosomal protein L7a ✓ ✓ ✓
P62917 RL8_HUMAN 60S ribosomal protein L8 ✓ ✓ ✓
P32969 RL9_HUMAN 60S ribosomal protein L9 ✓ ✓ ✓
P05388 RLA0_HUMAN 60S acidic ribosomal protein P0 ✓ ✓ ✓
P05386 RLA1_HUMAN 60S acidic ribosomal protein P1 ✓ ✓ ✓
P05387 RLA2_HUMAN 60S acidic ribosomal protein P2 ✓ ✓ ✓
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Q96E39 RMXL1_HUMAN RNA binding motif protein, X-linked-like-1 ✓
Q15287 RNPS1_HUMAN RNA-binding protein with serine-rich domain 1 ✓ ✓ ✓
Q13151 ROA0_HUMAN Heterogeneous nuclear ribonucleoprotein A0 [hnRNP A0] ✓ ✓ ✓
P09651 ROA1_HUMAN Heterogeneous nuclear ribonucleoprotein A1 [hnRNP A1] ✓ ✓ ✓
P22626 ROA2_HUMAN Heterogeneous nuclear ribonucleoproteins A2/B1 [hnRNP A2/B1] ✓ ✓ ✓
P51991 ROA3_HUMAN Heterogeneous nuclear ribonucleoprotein A3 [hnRNP A3] ✓ ✓ ✓
Q99729 ROAA_HUMAN Heterogeneous nuclear ribonucleoprotein A/B [hnRNP A/B] ✓ ✓ ✓
Q14684 RRP1B_HUMAN Ribosomal RNA processing protein 1 homolog B ✓ ✓ ✓
Q14690 RRP5_HUMAN Protein RRP5 homolog ✓ ✓ ✓
Q9Y34A RRP7A_HUMAN Ribosomal RNA-processing protein 7 homolog A ✓ ✓ ✓
O43159 RRP8_HUMAN Ribosomal RNA-processing protein 8 ✓ ✓ ✓
P46783 RS10_HUMAN 40S ribosomal protein S10 ✓ ✓ ✓
P62280 RS11_HUMAN 40S ribosomal protein S11 ✓ ✓ ✓
P25398 RS12_HUMAN 40S ribosomal protein S12 ✓ ✓ ✓
P62277 RS13_HUMAN 40S ribosomal protein S13 ✓ ✓ ✓
P62263 RS14_HUMAN 40S ribosomal protein S14 ✓ ✓ ✓
P62841 RS15_HUMAN 40S ribosomal protein S15 ✓ ✓ ✓
P62244 RS15A_HUMAN 40S ribosomal protein S15a ✓ ✓ ✓
P62249 RS16_HUMAN 40S ribosomal protein S16 ✓ ✓ ✓
P0CW22 RS17L_HUMAN 40S ribosomal protein S17-like ✓ ✓ ✓
P62269 RS18_HUMAN 40S ribosomal protein S18 ✓ ✓ ✓
P39019 RS19_HUMAN 40S ribosomal protein S19 ✓ ✓ ✓
P15880 RS2_HUMAN 40S ribosomal protein S2 ✓ ✓ ✓
P60866 RS20_HUMAN 40S ribosomal protein S20 ✓ ✓ ✓
P63220 RS21_HUMAN 40S ribosomal protein S21 ✓ ✓
P62266 RS23_HUMAN 40S ribosomal protein S23 ✓ ✓ ✓
P62847 RS24_HUMAN 40S ribosomal protein S24 ✓ ✓ ✓
P62851 RS25_HUMAN 40S ribosomal protein S25 ✓ ✓ ✓
P62854 RS26_HUMAN 40S ribosomal protein S26 ✓ ✓ ✓
P62857 RS28_HUMAN 40S ribosomal protein S28 ✓ ✓
P62273 RS29_HUMAN 40S ribosomal protein S29 ✓ ✓
P23396 RS3_HUMAN 40S ribosomal protein S3 ✓ ✓ ✓
P61247 RS3A_HUMAN 40S ribosomal protein S3a ✓ ✓ ✓
P62701 RS4X_HUMAN 40S ribosomal protein S4, X isoform ✓ ✓ ✓
P46782 RS5_HUMAN 40S ribosomal protein S5 ✓ ✓ ✓
P62753 RS6_HUMAN 40S ribosomal protein S6 ✓ ✓ ✓
P62081 RS7_HUMAN 40S ribosomal protein S7 ✓ ✓ ✓
P62241 RS8_HUMAN 40S ribosomal protein S8 ✓ ✓ ✓
P46781 RS9_HUMAN 40S ribosomal protein S9 ✓ ✓ ✓
P14678 RSMB_HUMAN Small nuclear ribonucleoprotein-associated proteins B and B' ✓ ✓ ✓
P08865 RSSA_HUMAN 40S ribosomal protein SA ✓ ✓ ✓
P09661 RU2A_HUMAN U2 small nuclear ribonucleoprotein A' [U2 snRNP A’] ✓ ✓ ✓
P62304 RUXE_HUMAN Small nuclear ribonucleoprotein E [snRNP-E] ✓ ✓
P62306 RUXF_HUMAN Small nuclear ribonucleoprotein F [snRNP-F] ✓ ✓
A8MWD9 RUXGL_HUMAN Small nuclear ribonucleoprotein G-like protein ✓ ✓
Q15424 SAFB1_HUMAN Scaffold attachment factor B1 [SAF-B1] ✓ ✓ ✓
Q14151 SAFB2_HUMAN Scaffold attachment factor B2 [SAF-B2] ✓
O00422 SAP18_HUMAN Histone deacetylase complex subunit SAP18 ✓ ✓ ✓
Q9UQR0 SCML2_HUMAN Sex comb on midleg-like protein 2 ✓ ✓
Q12874 SF3A3_HUMAN Splicing factor 3A subunit 3 ✓ ✓
O75533 SF3B1_HUMAN Splicing factor 3B subunit 1 ✓ ✓ ✓
Q15393 SF3B3_HUMAN Splicing factor 3B subunit 3 ✓ ✓
Q9BWJ5 SF3B5_HUMAN Splicing factor 3B subunit 5 [SF3b5] ✓ ✓
O60264 SMCA5_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5 ✓
P62314 SMD1_HUMAN Small nuclear ribonucleoprotein Sm D1 [Sm-D1] ✓ ✓ ✓
P62316 SMD2_HUMAN Small nuclear ribonucleoprotein Sm D2 [Sm-D2] ✓ ✓ ✓
P62318 SMD3_HUMAN Small nuclear ribonucleoprotein Sm D3 [Sm-D3] ✓ ✓ ✓
Q2TAY7 SMU1_HUMAN WD40 repeat-containing protein SMU1 ✓ ✓ ✓
Q96DI7 SNR40_HUMAN U5 small nuclear ribonucleoprotein 40 kDa protein [U5-40K] ✓ ✓ ✓
O43290 SNUT1_HUMAN U4/U6.U5 tri-snRNP-associated protein 1 ✓ ✓ ✓
Q53GS9 SNUT2_HUMAN U4/U6.U5 tri-snRNP-associated protein 2 ✓ ✓ ✓
Q9Y5B9 SP16H_HUMAN FACT complex subunit SPT16 ✓ ✓ ✓
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S5.2 • Proteins isolated by SNAP and identified by MS 
289 proteins were identified from single peptides using ProHits software (Liu et al., 2010; Liu et al., 
2012) following isolation by SNAP using nucleosomes carrying H3K4me1 (K4), K27ac (K27) or 
both (K4+K27). Protein names are provided together with their short-hand names (in parentheses, 
[]), where available, and the proteins identified from each pull down indicated (✓). The FACT 
complex proteins SSRP1 and Spt16 are indicated (purple). Proteins in bold were identified and 
quantified in control samples to verify incorporation of the heavy isotopes of arginine and lysine.  
O75934 SPF27_HUMAN Pre-mRNA-splicing factor SPF27 ✓ ✓ ✓
Q96I25 SPF45_HUMAN Splicing factor 45 ✓ ✓
Q8IYB3 SRRM1_HUMAN Serine/arginine repetitive matrix protein 1 ✓ ✓ ✓
Q9UQ35 SRRM2_HUMAN Serine/arginine repetitive matrix protein 2 ✓ ✓
O75494 SRS10_HUMAN Serine/arginine-rich splicing factor 10 ✓ ✓ ✓
Q07955 SRSF1_HUMAN Serine/arginine-rich splicing factor 1 ✓ ✓ ✓
Q01130 SRSF2_HUMAN Serine/arginine-rich splicing factor 2 ✓ ✓ ✓
P84103 SRSF3_HUMAN Serine/arginine-rich splicing factor 3 ✓ ✓ ✓
Q08170 SRSF4_HUMAN Serine/arginine-rich splicing factor 4 ✓ ✓ ✓
Q13243 SRSF5_HUMAN Serine/arginine-rich splicing factor 5 ✓ ✓ ✓
Q13247 SRSF6_HUMAN Serine/arginine-rich splicing factor 6 ✓ ✓ ✓
Q16629 SRSF7_HUMAN Serine/arginine-rich splicing factor 7 ✓ ✓ ✓
Q13242 SRSF9_HUMAN Serine/arginine-rich splicing factor 9 ✓ ✓ ✓
Q04837 SSBP_HUMAN Single-stranded DNA-binding protein, mitochondrial [mtSSB] ✓ ✓ ✓
Q9NQ95 SSF1_HUMAN Suppressor of SWI4 1 homolog [Ssf-1] ✓ ✓
Q08945 SSRP1_HUMAN FACT complex subunit SSRP1 ✓ ✓ ✓
Q96SI9 STRBP_HUMAN Spermatid perinuclear RNA-binding protein ✓
Q8N3V7 SYNPO_HUMAN Synaptopodin ✓
Q12788 TBL3_HUMAN Transducin beta-like protein 3 ✓ ✓ ✓
Q13428 TCOF_HUMAN Treacle protein ✓ ✓
Q00059 TFAM_HUMAN Transcription factor A, mitochondrial [mtTFA] ✓
Q9UBB9 TFP11_HUMAN Tuftelin-interacting protein 11 ✓ ✓ ✓
Q86V81 THOC4_HUMAN THO complex subunit 4 [Tho4] ✓ ✓ ✓
P11387 TOP1_HUMAN DNA topoisomerase 1 ✓ ✓ ✓
P11388 TOP2A_HUMAN DNA topoisomerase 2-alpha ✓ ✓ ✓
Q02880 TOP2B_HUMAN DNA topoisomerase 2-beta ✓ ✓ ✓
Q9Y2W1 TR150_HUMAN Thyroid hormone receptor-associated protein 3 ✓ ✓ ✓
P62995 TRA2B_HUMAN Transformer-2 protein homolog beta [TRA2 beta] ✓ ✓ ✓
O75643 U520_HUMAN U5 small nuclear ribonucleoprotein 200 kDa helicase ✓ ✓ ✓
Q15029 U5S1_HUMAN 116 kDa U5 small nuclear ribonucleoprotein component ✓ ✓ ✓
P17480 UBF1_HUMAN Nucleolar transcription factor 1 ✓ ✓ ✓
O00507 USP9Y_HUMAN Probable ubiquitin carboxyl-terminal hydrolase FAF-Y ✓ ✓
Q9Y5J1 UTP18_HUMAN U3 small nucleolar RNA-associated protein 18 homolog ✓ ✓ ✓
Q9UNX4 WDR3_HUMAN WD repeat-containing protein 3 ✓
Q9GZS3 WDR61_HUMAN WD repeat-containing protein 61 ✓ ✓ ✓
Q9H697 WDR76_HUMAN WD repeat-containing protein 76 ✓
Q01831 XPC_HUMAN DNA repair protein complementing XP-C cells ✓ ✓ ✓
P13010 XRCC5_HUMAN X-ray repair cross-complementing protein 5 ✓ ✓ ✓
P12956 XRCC6_HUMAN X-ray repair cross-complementing protein 6 ✓ ✓ ✓
Q96MU7 YTDC1_HUMAN YTH domain-containing protein 1 ✓ ✓ ✓
Q86VM9 ZCH18_HUMAN Zinc finger CCCH domain-containing protein 18 ✓
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H/L Fwd
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K27 fwd 
H/L Fwd
K27 rev 
H/L Rev
K4+K27 fwd 
H/L Fwd
K4+K27 rev 
H/L RevQ9NRW3 ABC3C_HUMAN 0.26411209 0.62321339 0.44935759 0.54888690
Q9UKV3 ACINU_HUMAN 1.25545171 2.38638140 0.00000000 1.68429376 0.00000000 2.03271741
P60709 ACTB_HUMAN 0.05713215 0.10676827 0.06586664 0.08406967 0.07088184 0.08586164
P68032 ACTC_HUMAN 0.07173113 0.16246886 0.12356032 0.12600828
P05141 ADT2_HUMAN 0.85527581 1.06448215 0.85916439 0.00000000 0.86692658 1.22231882
O75531 BAF_HUMAN 0.15148400 0.25134678 0.14922648 0.17326050
Q9NYF8 BCLF1_HUMAN 0.55442036 1.80665999 1.52079163 1.03132301 1.28017034 1.89720659
Q8TDN6 BRX1_HUMAN 0.41565651 0.73210654 0.56168015 0.59069196 0.47742213 0.67993907
O95400 CD2B2_HUMAN 0.00000000 2.03930584 2.12455168 1.51583626 0.00000000 2.76962991
Q6P1J9 CDC73_HUMAN 8.06749473 48.23320097 0.00000000 16.42243873
Q03701 CEBPZ_HUMAN 1.10942620 1.72734889 1.65399782 1.45781836 1.22435360 1.27354339
Q7Z7K6 CENPV_HUMAN 1.83733915 1.88363304 1.95299620 1.62198194 1.74431554 1.88612571
P41208 CETN2_HUMAN 0.00000000 1.17879433 0.91077857 0.00000000
Q9BRJ6 CG050_HUMAN 0.40834579 0.12077767
O14646 CHD1_HUMAN 0.00000000 1.08597140
O14647 CHD2_HUMAN 0.66266186 0.00000000
Q9BUH6 CI142_HUMAN 0.33810051 0.18755935 0.00000000 0.21302578
P38432 COIL_HUMAN 1.06441483 1.67551168 1.42836245 1.42821182 1.19290825 1.84339902
Q9Y6A4 CP080_HUMAN 0.00000000 1.76850145
Q9BV73 CP250_HUMAN 0.00000817 0.00000859
Q6PD62 CTR9_HUMAN 2.57955408 0.00000000 0.00000000 2.53495643
Q92841 DDX17_HUMAN 2.70718871 8.03888848 3.23853981 4.63913511 4.69663890 8.23889758
Q9NVP1 DDX18_HUMAN 0.82695503 1.48083612 1.14378151 1.13357614 0.98585603 1.48601918
Q9NR30 DDX21_HUMAN 0.72930914 1.17923665 0.90635018 0.90845302 0.76471503 1.12464069
Q9BUQ8 DDX23_HUMAN 1.20432437 2.22479937 1.61213151 1.74572958 1.38993745 2.11651760
P17844 DDX5_HUMAN 3.45298764 9.32551801 0.00000000 4.48086698 4.50690100 8.62459035
Q9BQ39 DDX50_HUMAN 1.01056764 2.07232336 1.53862812 2.17694725 1.71200635 1.60063841
Q9Y2R4 DDX52_HUMAN 1.66720866 3.05090791 0.88295984 1.82398935 0.00000000 2.41586895
Q16698 DECR_HUMAN 0.10279504 0.06023968 0.02758986 0.00000000 0.00000000 0.13229168
Q43143 DHX15_HUMAN 1.11357371 2.14052263 1.73418896 1.67098011 1.38093804 2.03904123
Q08211 DHX9_HUMAN 0.32297676 0.59585390 0.45213616 0.47839798 0.37450093 0.59604383
O60832 DKC1_HUMAN 0.33851777 0.60120950 0.49085488 0.43919947 0.39015289 0.56045723
P49916 DNLI3_HUMAN 1.24849451 0.68729364 0.79457571 0.00000000 0.93656130 0.00000000
P06746 DPOLB_HUMAN 0.99470983 0.00000000 0.00000000 1.29615912
O00148 DX39A_HUMAN 0.00000000 2.51542721 1.69049017 2.10497947 0.00000000 2.77274097
P63167 DYL1_HUMAN 1.36817422 0.00000000
Q99848 EBP2_HUMAN 0.17081249 0.42203446 0.32142523 0.24266791
O60869 EDF1_HUMAN 0.00000000 0.31382820
Q15717 ELAV1_HUMAN 1.42715336 2.94952466 2.23946258 2.24402672 1.74854152 2.75961584
P84090 ERH_HUMAN 1.07642349 2.16223013 1.56800241 1.67135729 1.52329170 1.88043090
P22087 FBRL_HUMAN 0.49314091 0.77884357 0.63664774 0.68340265 0.55852527 0.83299538
Q9NZ56 FMN2_HUMAN 0.00000000 161.14700571 139.97854409 125.11363446
Q5CZC0 FSIP2_HUMAN 1.39229855 0.66180680 0.00000000 0.92267679 1.16942872 0.67782461
Q9NY12 GAR1_HUMAN 0.38658348 0.61181203 0.48140558 0.48777656 0.44536107 0.57380420
P63244 GBLP_HUMAN 0.00000000 0.23380070
Q49A26 GLYR1_HUMAN 0.49552644 0.69983969 0.60604969 0.55913271 0.47357950 0.56849005
P16403 H12_HUMAN 0.34132351 0.57364142 0.00000000 0.41759704 0.39791487 0.46616886
P10412 H14_HUMAN 0.40644356 0.00000000
P16401 H15_HUMAN 0.49763403 0.19208464 0.50873595 0.53160275 0.23604334 0.29618409
Q92522 H1X_HUMAN 0.19348623 0.29855679 0.28480749 0.24300160 0.19511808 0.27849537
Q96QV6 H2A1A_HUMAN 0.08230067 0.20641448 0.14742456 0.13682990 0.09641126 0.18110500
P04908 H2A1B_HUMAN 0.06363238 0.09116274
Q99878 H2A1J_HUMAN 0.07605327 0.06369832 0.11263953 0.07611331
Q71UI9 H2AV_HUMAN 0.05498656 0.09458432 0.10688963 0.07722642 0.09563877 0.09100551
Q96A08 H2B1A_HUMAN 0.04168215 0.04282342 0.05006933 0.04875163 0.03821118 0.05311278
P33778 H2B1B_HUMAN 0.04910008 0.09535573 0.09567261 0.07097100 0.06096201 0.08124671
P62807 H2B1C_HUMAN 0.06093875 0.16092467 0.09950831 0.09150093 0.06688914 0.10118601
P68431 H31_HUMAN 0.01802306 0.02549908 0.01851316 0.02676605
Q16695 H31T_HUMAN 0.00000000 0.02141819
P84243 H33_HUMAN 0.02081913 0.02204739 0.02196278 0.02666763
P62805 H4_HUMAN 0.02057414 0.02439758 0.02299636 0.02403043 0.02285421 0.02443601
Q99525 H4G_HUMAN 0.02441053 0.00000000 0.03319798 0.02901387
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O14979 HNRDL_HUMAN 1.89038416 3.25115164 2.37708054 2.56266262 2.20347579 2.50586432
P31943 HNRH1_HUMAN 1.57779517 2.69904666 2.13868016 2.08410046 1.63661370 2.71318567
P31942 HNRH3_HUMAN 1.94096209 5.74704647 3.48375527 2.97204715 2.39624776 4.41966101
P07910 HNRPC_HUMAN 1.58477443 2.68840484 2.13081389 1.91690379 1.71526641 2.62571344
Q14103 HNRPD_HUMAN 1.72495660 3.64203443 2.44735625 2.50279477 2.24780674 3.21420045
P52597 HNRPF_HUMAN 1.60286775 3.28432861 2.34306707 2.06946756 1.70845331 2.89646391
P61978 HNRPK_HUMAN 1.01937901 2.63578479 1.99884237 2.03891436 1.49377627 1.92318988
P14866 HNRPL_HUMAN 1.44660562 2.94282243 2.19342124 2.04191334 1.68402102 2.70906747
P52272 HNRPM_HUMAN 2.50472658 4.06156034 3.52335227 3.29474772 2.82713200 3.97233374
O60506 HNRPQ_HUMAN 0.81586109 1.54674138 1.10707110 1.16895936 0.92637131 1.44670554
O43390 HNRPR_HUMAN 0.79582456 1.48760973 1.15565783 1.06050439 0.85537527 1.44615131
Q00839 HNRPU_HUMAN 1.90997487 3.54626553 2.47792183 2.57748252 2.12875637 3.68657430
Q5SSJ5 HP1B3_HUMAN 0.58553854 0.86151963 0.52890298 0.68233645 0.55385227 0.73023979
P08107 HSP71_HUMAN 0.27355136 0.00000000
P11142 HSP7C_HUMAN 0.88871556 1.29760384 1.15214577 1.09820966 1.00225018 1.40241543
P04792 HSPB1_HUMAN 2.15498557 0.00000000 0.65235182 0.00000000
P38919 IF4A3_HUMAN 0.00000000 2.30541516 0.82445346 0.39251571
P56537 IF6_HUMAN 0.54527447 1.00624198 0.77667987 0.73381172 0.63908740 0.94319250
Q12905 ILF2_HUMAN 0.42476155 0.79906578 0.61751424 0.59630984 0.47343664 0.77537341
Q12906 ILF3_HUMAN 0.43990072 0.76446617 0.61073055 0.57580504 0.45356868 0.75601957
Q15397 K0020_HUMAN 0.00000000 1.61932348
P13645 K1C10_HUMAN 0.02976224 0.00000000
P35527 K1C9_HUMAN 0.06444837 0.00000000 0.01971730 0.00000000
P04264 K2C1_HUMAN 0.10656743 0.00000000 0.00000000 0.07542099
Q07666 KHDR1_HUMAN 0.91001178 1.72427747 1.63233307 1.49978588 1.16676639 1.85508957
Q9Y383 LC7L2_HUMAN 0.27784649 0.54677539 0.40599650 0.39297086 0.33144279 0.64964942
O95232 LC7L3_HUMAN 0.00000000 2.69337822 1.55583123 1.70196936
Q9NX58 LYAR_HUMAN 0.29050828 0.59775238 0.41773307 0.43144111 0.34497506 0.47727108
O15479 MAGB2_HUMAN 0.10856241 0.00000000 0.06849151 0.09107373 0.04446515 0.09545310
P49137 MAPK2_HUMAN 0.01047927 0.01596557 0.01642326 0.03638594 0.01177916 0.00768997
Q9BQG0 MBB1A_HUMAN 1.33199453 12.04577244 4.00278538 0.00000000
Q14566 MCM6_HUMAN 57.79832984 76.37183675
Q9NU22 MDN1_HUMAN 0.00000000 2.43104285 2.44578486 3.02214196
P51608 MECP2_HUMAN 0.00000000 0.07911364 0.14882411 0.06075123
P55081 MFAP1_HUMAN 0.00000049 0.00166804
Q9H0A0 NAT10_HUMAN 0.58379836 0.99492827 0.70508126 0.70910767 0.62142980 1.04179066
P55769 NH2L1_HUMAN 0.50054416 0.82359381 0.67610550 0.66572220 0.61887637 0.77788020
Q9NX24 NHP2_HUMAN 0.25613765 0.40979295 0.32945490 0.32055334 0.28340644 0.44049937
Q9Y221 NIP7_HUMAN 0.17673626 0.40905245 0.29907112 0.29791685 0.24806683 0.39913307
Q9HAN9 NMNA1_HUMAN 0.25953937 0.38980781 0.32494200 0.35913565 0.26245586 0.40337727
Q9BZE4 NOG1_HUMAN 0.84456409 1.29840028 1.15559540 1.17410860 0.89725908 1.40937176
Q9H6R4 NOL6_HUMAN 0.81500785 0.00000000
Q14978 NOLC1_HUMAN 0.50749675 0.81731963 0.51987795 0.67794393 0.41289444 0.64431224
Q9NPE3 NOP10_HUMAN 0.26417410 0.46877146 0.36517343 0.36421008
Q9Y3C1 NOP16_HUMAN 0.38413459 0.00000000
P46087 NOP2_HUMAN 0.23594750 0.47223672 0.33812873 0.40147336 0.29859108 0.43002835
O00567 NOP56_HUMAN 0.59676778 0.92394847 0.76981358 0.66456987 0.67583552 0.93674450
Q9Y2X3 NOP58_HUMAN 0.54059494 0.93407887 0.75731148 0.65021482 0.65042905 0.92540629
O60287 NPA1P_HUMAN 0.00000000 1.91990532
P06748 NPM_HUMAN 0.10917496 0.29688421 0.17005189 0.20441547 0.14852720 0.25365029
P19338 NUCL_HUMAN 0.44248361 0.90989973 0.64713045 0.65311847 0.53977113 0.79606376
Q14980 NUMA1_HUMAN 0.00000000 1.31837913 0.00000000 1.23391871
Q8NC51 PAIRB_HUMAN 0.00000000 0.09450078
P09874 PARP1_HUMAN 0.59694823 0.63955677 0.60544457 0.65436482 0.59272535 0.65395319
Q9Y5B6 PAXB1_HUMAN 0.82714357 1.51417030 1.81611079 0.00000000 0.98621759 1.88014345
Q9NWT1 PK1IP_HUMAN 0.95436928 1.82963874 1.40864815 1.42663428 1.16193936 1.90784676
O43660 PLRG1_HUMAN 0.00000000 3.26688529 2.38445205 2.19943155 0.00000000 2.99142575
Q9Y3B4 PM14_HUMAN 1.18243718 0.00000000 1.65311867 1.59641813 1.44697269 2.22945616
P62136 PP1A_HUMAN 0.60534667 0.99881982 0.00000000 0.98447695
P36873 PP1G_HUMAN 0.81966406 0.00000000
Q8NAV1 PR38A_HUMAN 1.98677654 0.00000000 3.39637226 3.34220384 1.63047329 3.50055534
P78527 PRKDC_HUMAN 0.90113042 0.92554683 0.89225536 0.98174224
UniProtKB Entry name K4 fwd 
H/L Fwd
K4 rev 
H/L Rev
K27 fwd 
H/L Fwd
K27 rev 
H/L Rev
K4+K27 fwd 
H/L Fwd
K4+K27 rev 
H/L Rev
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Q9UMS4 PRP19_HUMAN 1.51585986 2.66651827 2.03351003 1.83948700 1.39860355 2.18680940
Q8WWY3 PRP31_HUMAN 0.95626316 0.00000000
Q13523 PRP4B_HUMAN 1.84696273 3.29641080 2.39108284 2.41335683 2.07526012 2.12803901
O94906 PRP6_HUMAN 1.13565913 2.36879289 1.76594006 1.86084965 1.21376662 2.48120473
Q6P2Q9 PRP8_HUMAN 1.14296193 2.09108807 1.51232384 1.59152558 1.27907771 2.16269769
Q15269 PWP2_HUMAN 0.00000000 1.23877135 0.00000000 1.59326381
Q9UKM9 RALY_HUMAN 0.00000000 3.28540414 4.23761438 0.00000000
Q96T37 RBM15_HUMAN 0.00000000 2.17157170
Q9NW13 RBM28_HUMAN 0.44699168 0.79738469 0.62295780 0.72830084 0.53020112 0.90267814
P42696 RBM34_HUMAN 0.71597392 1.11843957 0.00000000 0.50984445
P38159 RBMX_HUMAN 0.85495568 1.80908956 1.45834892 1.32698946 0.98276828 1.59553287
Q92804 RBP56_HUMAN 4.28094252 0.00000000
Q13123 RED_HUMAN 1.11618668 2.91843828 0.00000000 1.64939838 1.75432595 2.38609855
P35251 RFC1_HUMAN 2.65500831 2.67166328 0.00000000 3.07586199 2.54495524 2.97525455
P35250 RFC2_HUMAN 2.56708106 2.56937666 2.37431795 0.00000000 2.35721335 2.63205437
P40938 RFC3_HUMAN 2.41912316 2.11861043 2.43719326 1.97633651
P35249 RFC4_HUMAN 2.16253994 2.40070405 2.26577743 2.12321228 1.96707933 2.19836832
P40937 RFC5_HUMAN 2.22674433 1.72091828 2.31385167 2.67511449 2.04471596 2.52998181
P27635 RL10_HUMAN 0.14664602 0.26387730 0.20409996 0.22166331 0.17860741 0.25300593
P62906 RL10A_HUMAN 0.19353433 0.30755737 0.27715313 0.29456519 0.23128770 0.32915874
P62913 RL11_HUMAN 0.19433877 0.28213063 0.25159142 0.23652495 0.20373705 0.33017544
P30050 RL12_HUMAN 0.15007259 0.24261184 0.23285034 0.21958469 0.18400338 0.28618499
P26373 RL13_HUMAN 0.15928465 0.29587779 0.20850026 0.22632335 0.15501278 0.25569000
P40429 RL13A_HUMAN 0.16099488 0.31731913 0.24107338 0.26269995 0.22813429 0.28599851
P50914 RL14_HUMAN 0.20929533 0.37877028 0.41041410 0.41609320 0.31629148 0.37993472
P61313 RL15_HUMAN 0.24071982 0.43114993 0.34360081 0.28019834 0.27870473 0.43759177
P18621 RL17_HUMAN 0.10124434 0.30728862 0.13949768 0.14260113 0.13844557 0.15544047
Q07020 RL18_HUMAN 0.31785759 0.50894178 0.42345601 0.35906579 0.35899787 0.48017234
P02543 RL18A_HUMAN 0.17617971 0.35968329 0.29204542 0.27265629 0.24234173 0.34110033
P84098 RL19_HUMAN 0.15288267 0.27340611 0.23319489 0.23692696 0.17935557 0.28504527
O76021 RL1D1_HUMAN 0.31923022 0.56645430 0.42390453 0.38059795 0.34565482 0.53842765
P46778 RL21_HUMAN 0.18904035 0.24419030 0.23157764 0.26464480 0.23279007 0.32402036
P35268 RL22_HUMAN 0.14829237 0.35469063 0.31144603 0.24110646 0.21385231 0.31743790
P62829 RL23_HUMAN 0.23200652 0.43687372 0.35138263 0.34683189 0.27126291 0.40991509
P62750 RL23A_HUMAN 0.12300212 0.18423424 0.14360454 0.15373326 0.13916497 0.21333974
P83731 RL24_HUMAN 0.00000000 0.86778212 0.87664428 0.00000000
P61254 RL26_HUMAN 0.13263322 0.24451254 0.19170802 0.22508467 0.15163580 0.25341657
Q9UNX3 RL26L_HUMAN 0.13723099 0.00000000 0.00000000 0.24222891
P61353 RL27_HUMAN 0.18870995 0.37167648 0.27528980 0.23914865 0.22217170 0.32518503
P46776 RL27A_HUMAN 0.15706972 0.26196849 0.20816229 0.19404306 0.14809933 0.17015148
P46779 RL28_HUMAN 0.00000000 0.70610548 1.30039048 0.00000000
P47914 RL29_HUMAN 0.10459606 0.00000000 0.14765104 0.14334874 0.12143818 0.17075338
P39023 RL3_HUMAN 0.17160072 0.29269501 0.23143984 0.23134639 0.19475261 0.26257645
P62888 RL30_HUMAN 0.15324565 0.29279192 0.24821736 0.26413439 0.18934215 0.27167616
P62899 RL31_HUMAN 0.16314335 0.27888934 0.21331423 0.21110613 0.20006561 0.29836816
P62910 RL32_HUMAN 0.18230901 0.33279179 0.27783785 0.26775095 0.21774786 0.32701459
P49207 RL34_HUMAN 0.19494497 0.00000000 0.29261761 0.28249246 0.21363984 0.35195572
P42766 RL35_HUMAN 0.00000000 0.37474837
P18077 RL35A_HUMAN 0.17257735 0.31017119 0.24411169 0.26926845
Q9Y3U8 RL36_HUMAN 0.17193649 0.06346184
P83881 RL36A_HUMAN 0.26717112 0.00000000
P61513 RL37A_HUMAN 0.20513306 0.34778663 0.28145213 0.27484050
P36578 RL4_HUMAN 0.20041810 0.35215906 0.28455328 0.25826580 0.23582804 0.30552019
P46777 RL5_HUMAN 0.19362873 0.27063745 0.23992326 0.18010298 0.22681399 0.32391575
Q02878 RL6_HUMAN 0.16541571 0.26769583 0.25017715 0.24647157 0.19992082 0.32530219
P18124 RL7_HUMAN 0.17745602 0.26409595 0.22027185 0.22016676 0.15045622 0.27297445
P62424 RL7A_HUMAN 0.21148842 0.35004245 0.26666691 0.29192509 0.28060985 0.34419616
P62917 RL8_HUMAN 0.14662298 0.26972527 0.27610439 0.21114986 0.17293459 0.24416979
P32969 RL9_HUMAN 0.13825277 0.25334538 0.20828781 0.18837310 0.20481817 0.25013284
P05388 RLA0_HUMAN 0.13448351 0.19897417 0.16471101 0.14662375 0.15268165 0.20722334
P05386 RLA1_HUMAN 0.04905819 0.09868794 0.07974200 0.04621424 0.04546848 0.15992417
P05387 RLA2_HUMAN 0.10503232 0.17307787 0.16281684 0.17471876 0.12593756 0.18866255
UniProtKB Entry name K4 fwd 
H/L Fwd
K4 rev 
H/L Rev
K27 fwd 
H/L Fwd
K27 rev 
H/L Rev
K4+K27 fwd 
H/L Fwd
K4+K27 rev 
H/L Rev
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Q96E39 RMXL1_HUMAN 0.00000000 1.27688618
Q15287 RNPS1_HUMAN 1.16949077 2.15244496 1.66474627 1.59568918 1.32118260 0.00000000
Q13151 ROA0_HUMAN 1.31532330 3.09780975 2.13893732 2.14496717 1.63500156 2.62157085
P09651 ROA1_HUMAN 1.31416365 3.30712558 2.06315000 2.05546416 1.75480190 2.85024250
P22626 ROA2_HUMAN 1.26637084 3.20272290 2.08151983 2.03935598 1.59887925 2.72843615
P51991 ROA3_HUMAN 0.97475335 2.39411211 1.61729585 1.53853934 1.19217008 2.03894374
Q99729 ROAA_HUMAN 1.77522342 3.39796321 2.50980385 2.33751645 2.01414362 3.02339951
Q14684 RRP1B_HUMAN 0.30242723 1.32921706 1.12864265 0.00000000 0.55804810 0.00000000
Q14690 RRP5_HUMAN 0.57594589 1.07074426 0.86045024 0.82687720 0.69592244 0.95562901
Q9Y34A RRP7A_HUMAN 0.53570133 1.29595314 0.81351320 0.89649576 0.60256670 0.89618562
O43159 RRP8_HUMAN 0.44458092 0.82266222 0.64131176 0.64046915 0.00000000 0.51722105
P46783 RS10_HUMAN 0.14224852 0.22496334 0.13260488 0.12566158 0.15628755 0.25875881
P62280 RS11_HUMAN 0.20166054 0.32131140 0.24714041 0.22787357 0.20191307 0.31480297
P25398 RS12_HUMAN 0.21419440 0.33556752 0.27018394 0.27363296 0.22826999 0.32842352
P62277 RS13_HUMAN 0.18446445 0.27236482 0.26466084 0.25224802 0.21775243 0.31739282
P62263 RS14_HUMAN 0.14438228 0.25656521 0.21709715 0.19478972 0.15988641 0.21520078
P62841 RS15_HUMAN 0.09658673 0.26934768 0.11550546 0.12654950 0.08494763 0.12762887
P62244 RS15A_HUMAN 0.16852875 0.28990751 0.21642290 0.24048881 0.17364041 0.28749517
P62249 RS16_HUMAN 0.20871974 0.31419904 0.29531145 0.25669126 0.19595283 0.30216189
P0CW22 RS17L_HUMAN 0.14777174 0.21370156 0.20531327 0.20501107 0.17182989 0.25567592
P62269 RS18_HUMAN 0.23161067 0.34503666 0.29876499 0.25489925 0.23883324 0.32511579
P39019 RS19_HUMAN 0.19252928 0.26454296 0.25973201 0.21361541 0.20500769 0.29508733
P15880 RS2_HUMAN 0.14260914 0.22286546 0.20373413 0.21403199 0.16407508 0.24713745
P60866 RS20_HUMAN 0.10597277 0.15013596 0.26332022 0.14945912 0.09399847 0.18418586
P63220 RS21_HUMAN 0.13932093 0.26616903 0.18140552 0.16780688
P62266 RS23_HUMAN 0.17158293 0.19835140 0.19771660 0.19576606 0.15033997 0.21037005
P62847 RS24_HUMAN 0.17530726 0.32795881 0.23834913 0.21704052 0.17640788 0.25686726
P62851 RS25_HUMAN 0.20420267 0.35300854 0.25478127 0.24400000 0.22252138 0.31886388
P62854 RS26_HUMAN 0.15380573 0.26957161 0.21253735 0.11229598 0.16438959 0.23044802
P62857 RS28_HUMAN 0.00000000 0.34458814 0.26206119 0.00000000
P62273 RS29_HUMAN 0.15265363 0.22316176 0.21681128 0.00000000
P23396 RS3_HUMAN 0.14364054 0.23984626 0.18679009 0.17665525 0.13085973 0.23458324
P61247 RS3A_HUMAN 0.19351120 0.32658917 0.25562942 0.25286085 0.21703304 0.32360966
P62701 RS4X_HUMAN 0.17073390 0.27113529 0.22952709 0.22671405 0.18658901 0.27115911
P46782 RS5_HUMAN 0.22143296 0.33727997 0.31019461 0.29142551 0.24195954 0.34508813
P62753 RS6_HUMAN 0.13095637 0.24552522 0.19374220 0.17486312 0.14825780 0.23413952
P62081 RS7_HUMAN 0.08669915 0.17719303 0.12263350 0.13090619 0.09869379 0.16185093
P62241 RS8_HUMAN 0.18972369 0.27648966 0.27759517 0.27366684 0.23385478 0.32710523
P46781 RS9_HUMAN 0.19711178 0.34731294 0.27062015 0.27066451 0.22305550 0.32809203
P14678 RSMB_HUMAN 1.27227623 2.36472230 1.78337244 1.79192260 1.55040202 2.26508495
P08865 RSSA_HUMAN 0.10024554 0.20399807 0.15829299 0.16542647 0.12303236 0.18135239
P09661 RU2A_HUMAN 1.36363225 3.90155708 2.97476131 2.34145218 1.57308729 2.95710511
P62304 RUXE_HUMAN 1.19430997 1.84920562 1.42841819 1.51846409
P62306 RUXF_HUMAN 1.10959253 2.10446189 1.51972496 1.54373807
A8MWD9 RUXGL_HUMAN 1.09351135 2.20538003 1.53117727 1.62080531
Q15424 SAFB1_HUMAN 1.04419905 0.00000000 2.02163164 1.56173676 0.00000000 2.04131721
Q14151 SAFB2_HUMAN 0.00000000 2.75706525
O00422 SAP18_HUMAN 0.70520827 2.04079433 1.26408644 0.00000000 0.90166553 1.51431991
Q9UQR0 SCML2_HUMAN 18.54464793 0.00000000 35.67200420 0.00000000
Q12874 SF3A3_HUMAN 0.00000000 2.94817545 1.88500037 3.43606917
O75533 SF3B1_HUMAN 0.79368593 2.08720742 1.18513313 1.30312291 1.34570211 1.96094649
Q15393 SF3B3_HUMAN 0.00000000 1.64065376 0.00000000 2.54433868
Q9BWJ5 SF3B5_HUMAN 1.17231593 2.14624139 1.66030495 1.64351732
O60264 SMCA5_HUMAN 0.00000000 0.52436355
P62314 SMD1_HUMAN 1.11583706 1.97998983 1.55451463 1.47659791 1.16700621 1.76073853
P62316 SMD2_HUMAN 0.92051504 1.78742628 1.27208815 1.51951417 1.20012364 1.92333620
P62318 SMD3_HUMAN 1.17083817 2.18808416 1.64386999 1.60651456 1.37924220 2.03902651
Q2TAY7 SMU1_HUMAN 1.17764214 2.40082156 1.46998171 1.45572871 1.42727349 1.80698735
Q96DI7 SNR40_HUMAN 1.22242171 2.09732101 1.59294883 1.63742635 1.34368610 2.16605270
O43290 SNUT1_HUMAN 0.58576480 0.92875145 0.84704920 0.00000000 0.90226130 1.79795406
Q53GS9 SNUT2_HUMAN 1.48314383 2.82515442 1.67484336 1.76986120 1.41102057 2.40748590
Q9Y5B9 SP16H_HUMAN 0.23586525 2.12025570 0.84548503 1.25000400 0.21790120 1.94660124
UniProtKB Entry name K4 fwd 
H/L Fwd
K4 rev 
H/L Rev
K27 fwd 
H/L Fwd
K27 rev 
H/L Rev
K4+K27 fwd 
H/L Fwd
K4+K27 rev 
H/L Rev
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S5.3 • SNAP H/L ratio raw data 
Ratios of heavy to light (H/L) were determined for each protein using Mascot Distiller (Matrix 
Science), in conjunction with the Quantitation Toolbox. Heavy (labelled) extracts from K562 cells 
were incubated with modified nucleosomes in the forward experiments and unmodified 
nucleosomes in reverse pull downs. High and low ratios in the forward and reverse pull downs, 
respectively, indicate specific binding to modified nucleosomes, whilst low and high ratios, 
respectively, demonstrate exclusion from modified nucleosomes. Values of zero (red) represent 
proteins that were not identified in either the forward or reverse pull down samples. Empty cells 
correspond to proteins that were not identified in both forward and reverse pull downs. The FACT 
complex proteins SSRP1 and Spt16 are indicated (purple). Ratios are log2 (H/L). For SNAP plots, 
see figures 5.9 and 5.10.  
O75934 SPF27_HUMAN 1.29212518 2.51538017 1.92759890 0.00000000 0.00000000 2.57909433
Q96I25 SPF45_HUMAN 0.00000000 3.12449669 2.37023832 2.39652059
Q8IYB3 SRRM1_HUMAN 0.07519660 0.22311288 0.15715207 0.08892070 0.10976662 0.19398079
Q9UQ35 SRRM2_HUMAN 0.66226462 1.29768942 1.18394086 0.94060846
O75494 SRS10_HUMAN 0.99021268 1.82481960 1.38468176 1.29481884 1.19410260 1.63399492
Q07955 SRSF1_HUMAN 0.56210786 1.47660575 0.97485333 0.89425810 0.67060212 1.21008300
Q01130 SRSF2_HUMAN 0.13201632 0.37974146 0.24569096 0.28451833 0.24627435 0.26451085
P84103 SRSF3_HUMAN 0.29724500 1.01032209 0.61389535 0.60796762 0.32103061 0.88482911
Q08170 SRSF4_HUMAN 0.67389338 1.62272253 1.06259818 1.05596094 0.79890080 1.28964215
Q13243 SRSF5_HUMAN 0.64109558 1.30266561 0.85900441 0.50406030 0.74312352 1.22377799
Q13247 SRSF6_HUMAN 0.67389338 1.62272253 1.06259818 1.05596094 0.79890080 1.28964215
Q16629 SRSF7_HUMAN 0.70993399 1.64560762 1.26345683 1.20587667 0.82365542 1.26897539
Q13242 SRSF9_HUMAN 1.09670543 1.94274256 1.85537591 1.64797547 1.25284080 2.06099213
Q04837 SSBP_HUMAN 0.16803346 0.20631193 0.16949917 0.25250424 0.18951399 0.00000000
Q9NQ95 SSF1_HUMAN 0.00000000 2.95536124 0.00000000 2.42978836
Q08945 SSRP1_HUMAN 0.22114779 2.00123254 0.77328333 1.12083272 0.24841569 1.81646214
Q96SI9 STRBP_HUMAN 0.46976066 0.00000000
Q8N3V7 SYNPO_HUMAN 0.00000000 55.29331167
Q12788 TBL3_HUMAN 1.73607481 2.71915593 2.02212845 2.20510137 1.88302680 2.68691672
Q13428 TCOF_HUMAN 0.00000000 0.08730782 0.00000000 0.24550566
Q00059 TFAM_HUMAN 0.00000000 0.08159950
Q9UBB9 TFP11_HUMAN 0.00000000 2.14544379 1.57039286 1.55045777 1.58664779 1.99377768
Q86V81 THOC4_HUMAN 0.33753988 1.07345791 0.56236547 0.64337240 0.42255953 1.00605822
P11387 TOP1_HUMAN 0.42368358 0.47870615 0.39715996 0.47942839 0.37480312 0.59853823
P11388 TOP2A_HUMAN 0.37257968 0.91553234 0.51889413 0.77736460 0.51288163 0.92596537
Q02880 TOP2B_HUMAN 0.38397158 0.96751801 0.58990609 0.79417807 0.54795719 0.00000000
Q9Y2W1 TR150_HUMAN 0.86453032 1.64423653 1.26606170 1.34255346 0.79600928 1.58202874
P62995 TRA2B_HUMAN 1.24008667 1.71961165 1.67073709 1.40917935 1.39187398 1.73017121
O75643 U520_HUMAN 1.19145279 2.12993551 1.63215625 1.61984522 1.40284588 2.03753591
Q15029 U5S1_HUMAN 0.93798606 2.02282900 1.46124947 1.27351639 1.17448233 1.72537694
P17480 UBF1_HUMAN 0.77349765 0.81849083 0.70389855 0.80136027 0.61760044 1.06135663
O00507 USP9Y_HUMAN 0.00000000 0.05960372 0.04805774 0.04651622
Q9Y5J1 UTP18_HUMAN 2.19887562 1.82842682 0.69248723 0.00000000 0.00000000 6.07352286
Q9UNX4 WDR3_HUMAN 0.00000000 1.52397941
Q9GZS3 WDR61_HUMAN 7.44077886 9.02011895 7.30218167 7.61175588 0.00000000 10.29518096
Q9H697 WDR76_HUMAN 2.09763139 0.00000000
Q01831 XPC_HUMAN 0.65665205 0.00000000 0.76469551 0.73125817 0.59089325 0.00000000
P13010 XRCC5_HUMAN 1.15855842 0.48334758 0.58432048 0.67193674 0.93857980 0.51893668
P12956 XRCC6_HUMAN 1.12178448 0.50187494 0.52248072 0.76632600 0.99266296 0.53657172
Q96MU7 YTDC1_HUMAN 1.50448762 2.37024177 2.66774162 0.00000000 0.00000000 2.88199318
Q86VM9 ZCH18_HUMAN 0.72560704 0.00000000
UniProtKB Entry name K4 fwd 
H/L Fwd
K4 rev 
H/L Rev
K27 fwd 
H/L Fwd
K27 rev 
H/L Rev
K4+K27 fwd 
H/L Fwd
K4+K27 rev 
H/L Rev
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S5.4 • Raw data for labelling verification by H/L ratios 
Control samples were prepared at H/L ratios of 1:1 and 1:3, which were tested by MS analysis. 
Log2 ratios for 1:3 samples (*) were calculated from normalised ratios ((H/L)/3) so as to cluster 
about the origin. For plots, see figure 5.6.  
UniProtKB Entry name 1:1 Log 1:1 Log 1:3 Log 1:3 Log
P12814 ACTN1_HUMAN -3.060531660 3.9610980686 -2.9434712930 3.7309691514
Q8N163 CCAR2_HUMAN -5.9726076520 2.4597404587
Q9UQ88 CD11A_HUMAN 0.3179661287 3.3074765229
P21127 CD11B_HUMAN 0.369780935 4.2406697697
Q99459 CDC5L_HUMAN 1.313656357 4.1428072707 -1.6121165522 3.2920953682
Q9HCG8 CWC22_HUMAN 0.763170665 3.8763521340 -1.4577518687 3.9629624052
Q9NR30 DDX21_HUMAN 0.889235878 4.8106124895 0.8706510328 4.5077662160
Q9BUQ8 DDX23_HUMAN 0.245027007 4.3812851401 1.1196671113 3.9887644466
Q7L014 DDX46_HUMAN -0.217602977 4.2881515697 -0.3433509662 3.9511535823
O60231 DHX16_HUMAN -2.3583681280 3.1289739537
Q08211 DHX9_HUMAN 0.241440973 3.7776642846 -0.1021877932 2.6246399425
P49916 DNLI3_HUMAN -1.429321370 3.2343195123 -1.7391568257 3.0270595919
P55265 DSRAD_HUMAN 1.8714426350 2.9680577753
P13639 EF2_HUMAN -0.350157749 4.5553516841
P14625 ENPL_HUMAN -3.146785541 4.4736511812
Q9BSJ8 ESYT1_HUMAN -1.314174451 3.7224739775 -1.3189241640 3.5722034726
Q01780 EXOSX_HUMAN 1.0880400347 3.6774004158
Q14697 GANAB_HUMAN -1.506144903 4.3567713798
Q1KMD3 HNRL2_HUMAN 0.519528055 4.1342204303 0.7340830856 3.9210947733
Q00839 HNRPU_HUMAN 0.686173704 4.7182089958 0.6556259667 3.4386796137
Q12906 ILF3_HUMAN 2.390623251 4.6510734090 0.6915226234 3.0681572323
Q14974 IMB1_HUMAN -0.459641450 4.1319968667
P36776 LONM_HUMAN -1.475396222 3.4305085689 -2.3740657182 3.9310691038
P43243 MATR3_HUMAN 2.115910091 4.1048907025 5.0303245369 4.0046729631
P49736 MCM2_HUMAN -1.375623344 4.9412664815 -1.1941501056 4.7422875935
P25205 MCM3_HUMAN 1.606473968 3.6511427843 -3.0608774729 4.1456811454
P33991 MCM4_HUMAN 0.515397806 4.2909842128 0.3518106973 4.0725564866
Q14566 MCM6_HUMAN -0.849358809 3.9795304748
Q9H0A0 NAT10_HUMAN 0.114035243 4.2025622893 0.2194379238 4.8023122133
P46087 NOP2_HUMAN 0.172668729 4.0313193229 -1.2923105882 2.9391863923
P19338 NUCL_HUMAN 0.160201616 4.9690011787 -1.5173260922 4.2756414861
Q02218 ODO1_HUMAN 0.018878010 4.2346326819
P09874 PARP1_HUMAN -2.418243930 3.9500131629 0.5536378881 2.6051269985
Q9Y5B6 PAXB1_HUMAN 2.871970611 4.2891262452 0.8201068295 3.9867645778
Q13427 PPIG_HUMAN 4.2515387670 3.3271581681
O75400 PR40A_HUMAN 0.062053041 4.6439372202 0.1885289695 4.4464436139
O94906 PRP6_HUMAN 0.621044539 3.6995341410 0.6665762663 3.4397174559
Q15269 PWP2_HUMAN -0.741315967 3.3685015766 -0.9151766780 4.0601743062
P49756 RBM25_HUMAN -0.344146748 3.7462732266 1.2474226585 3.5906115874
Q15459 SF3A1_HUMAN 0.367545642 4.2946405672 0.0761282265 4.1006767461
O75533 SF3B1_HUMAN -0.735262209 3.6701428275
Q13435 SF3B2_HUMAN 0.144807592 4.1756531010 -3.3884788739 2.6487298418
Q15393 SF3B3_HUMAN 0.109358756 4.2945250583 0.3206662887 3.9307313497
P23246 SFPQ_HUMAN 0.717619505 4.1200065116 0.1033018973 4.6516578605
P42285 SK2L2_HUMAN 0.277533976 4.0002809489 0.1796780519 3.9619143901
O60264 SMCA5_HUMAN 0.837532132 3.5508807277 -3.9064577222 3.1202359094
O43290 SNUT1_HUMAN 1.7283352890 3.8432084139
Q9Y5B9 SP16H_HUMAN -0.387141928 4.1881561830 -0.3292958481 4.0892239385
Q9BXP5 SRRT_HUMAN 0.117161344 4.1827552460 -0.3109217352 3.1632067623
Q9NSE4 SYIM_HUMAN 1.176902853 4.9318501302
P55072 TERA_HUMAN -1.224472524 4.2475476274
P02786 TFR1_HUMAN -2.392811976 4.0546167162
P11387 TOP1_HUMAN 0.213905532 4.1299265082 0.0779544230 4.2709040383
Q15029 U5S1_HUMAN 0.115128608 4.5165628265 0.1772290697 3.6211337845
P17480 UBF1_HUMAN 1.776453884 3.6523155941
Q9UNX4 WDR3_HUMAN 1.052296444 3.9206683931 0.7921071484 3.1926646982
Q01831 XPC_HUMAN 0.1234339412 3.4582590840
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S5.5 • Enrichment of FACT proteins by H3 and H3K4me1 peptide pull downs 
Nuclear extracts from K562 cells were dialysed into peptide binding buffer (50 mM Tris-HCl pH 
7.9, 150 (A-B) or 325 mM NaCl (C), 1 mM EDTA, 10 mM sodium butyrate), adjusted to 1.3 mg/mL 
and 500 µg aliquots incubated with ~10 µL H3 peptides on CPG beads for 4 hr at 4 ˚C. Unbound 
fractions were retained and the resins washed three times with 100 µL binding buffer (325 (A,C) or 
420 mM NaCl (B)) before eluting bound proteins in SDS sample buffer. Unbound and bound 
fractions were resolved on 15 % SDS gels and tested for the presence of FACT by Western blot.  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Addendum: genetic encoding of H3K27ac 
The pBK-AcKRS3 plasmid containing the aminoacyl-tRNA synthetase gene was 
mistaken to also carry the gene encoding tRNACUA. The gene for this tRNA is 
actually encoded on a separate plasmid, pCDF-PylT H3, which was not 
transformed into E. coli for expression of histone H3 K4C K27ac C110S 
(section 4.2.4.1). In summary, only the histone gene (encoded on a pET3d 
plasmid) and tRNA synthetase gene were present in the transformed cells. 
Despite this, the expressed histone had the expected mobility of H3 on SDS 
and AU polyacrylamide gels and was acetylated on lysine 27, as judged by 
Western blotting (figures 4.10, 4.15 and 4.24 (panel B)). The genome of BL21 
(DE3) pLyS cells does not harbour tRNA genes capable of suppressing amber 
(UAG) codons, so it might be surprising that the full length histone was 
synthesised at all. However, it has been shown that common laboratory strains 
of E. coli, including BL21 (DE3) and its derivatives, exhibit background 
suppression of amber codons via incorporation of tyrosine, glutamine or 
tryptophan into the growing polypeptide chain (Johnson et al., 2012; Park et 
al., 2011). This suppression is 3 % in BL21 (DE3) cells (O’Donoghue et al., 
2012) and can be exacerbated by release factor 1 deletion (Johnson et al., 
2012). Whilst this might explain the synthesis of a full length histone at lower 
yields than typically observed for H3 (figure 4.7), this does not account for the 
incorporation of acetylated lysine. 
The following steps should be taken to resolve this issue: i) IP of the histones 
using an antibody raised to H3K27ac; ii) AU PAGE and Western blot of the 
histones following incubation with nuclear protein extracts in the presence or 
absence of HDAC inhibitors; and iii) MS analysis of the histones to determine 
the amino acid sequence and presence or absence of acetylated lysine. 
Johnson, D. B. F., Wang, C., Xu, J., Schultz, M. D., Schmitz, R. J., Ecker, J. R. & Wang, L. (2012). Release Factor One is 
nonessential in Escherichia coli. ACS Chemical Biology, 7(8), 1337–1344. 
O’Donoghue, P., Prat, L., Heinemann, I. U., Ling, J., Odoi, K., Liu, W. R. & Söll, D. (2012). Near-cognate suppression of amber, 
opal and quadruplet codons competes with aminoacyl-tRNAPyl for genetic code expansion. FEBS Letters, 586(21), 3931–3937. 
Park, H. S., Hohn, M. J., Umehara, T., Guo, L. T., Osborne, E. M., Benner, J., et al. (2011). Expanding the genetic code of 
Escherichia coli with phosphoserine. Science, 333(6046), 1151–1154.  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